id	sid	tid	token	lemma	pos
ajlsi-2441	1	1	pa	pa	PROPN
ajlsi-2441	1	2	ge	ge	PROPN
ajlsi-2441	1	3	1	1	NUM
ajlsi-2441	1	4	pa	pa	PROPN
ajlsi-2441	1	5	ge	ge	PROPN
ajlsi-2441	1	6	28	28	NUM
ajlsi-2441	1	7	american	american	PROPN
ajlsi-2441	1	8	journal	journal	PROPN
ajlsi-2441	1	9	of	of	ADP
ajlsi-2441	1	10	life	life	NOUN
ajlsi-2441	1	11	science	science	NOUN
ajlsi-2441	1	12	and	and	CCONJ
ajlsi-2441	1	13	innovation	innovation	NOUN
ajlsi-2441	1	14	(	(	PUNCT
ajlsi-2441	1	15	ajlsi	ajlsi	ADJ
ajlsi-2441	1	16	)	)	PUNCT
ajlsi-2441	1	17	predictive	predictive	ADJ
ajlsi-2441	1	18	value	value	NOUN
ajlsi-2441	1	19	of	of	ADP
ajlsi-2441	1	20	rdw	rdw	ADJ
ajlsi-2441	1	21	/	/	SYM
ajlsi-2441	1	22	plt	plt	NOUN
ajlsi-2441	1	23	for	for	ADP
ajlsi-2441	1	24	progression	progression	NOUN
ajlsi-2441	1	25	of	of	ADP
ajlsi-2441	1	26	covid-19	covid-19	PROPN
ajlsi-2441	1	27	pneumonia	pneumonia	NOUN
ajlsi-2441	1	28	:	:	PUNCT
ajlsi-2441	1	29	a	a	DET
ajlsi-2441	1	30	potential	potential	ADJ
ajlsi-2441	1	31	biomarker	biomarker	NOUN
ajlsi-2441	1	32	for	for	ADP
ajlsi-2441	1	33	disease	disease	NOUN
ajlsi-2441	1	34	severity	severity	NOUN
ajlsi-2441	1	35	kang	kang	PROPN
ajlsi-2441	1	36	huang1	huang1	PROPN
ajlsi-2441	1	37	,	,	PUNCT
ajlsi-2441	1	38	salwa	salwa	PROPN
ajlsi-2441	1	39	m.	m.	PROPN
ajlsi-2441	1	40	imran2	imran2	PROPN
ajlsi-2441	1	41	,	,	PUNCT
ajlsi-2441	1	42	wafa	wafa	PROPN
ajlsi-2441	1	43	mohammad,3	mohammad,3	PROPN
ajlsi-2441	1	44	pengfei	pengfei	PROPN
ajlsi-2441	1	45	liu4	liu4	PROPN
ajlsi-2441	1	46	,	,	PUNCT
ajlsi-2441	1	47	yali	yali	PROPN
ajlsi-2441	1	48	chao5	chao5	NOUN
ajlsi-2441	1	49	,	,	PUNCT
ajlsi-2441	1	50	suming	sum	VERB
ajlsi-2441	1	51	zhang5	zhang5	NOUN
ajlsi-2441	1	52	*	*	PUNCT
ajlsi-2441	1	53	volume	volume	NOUN
ajlsi-2441	1	54	3	3	NUM
ajlsi-2441	1	55	issue	issue	NOUN
ajlsi-2441	1	56	1	1	NUM
ajlsi-2441	1	57	,	,	PUNCT
ajlsi-2441	1	58	year	year	NOUN
ajlsi-2441	1	59	2024	2024	NUM
ajlsi-2441	1	60	issn	issn	X
ajlsi-2441	1	61	:	:	PUNCT
ajlsi-2441	1	62	2833	2833	NUM
ajlsi-2441	1	63	-	-	SYM
ajlsi-2441	1	64	1397	1397	NUM
ajlsi-2441	1	65	(	(	PUNCT
ajlsi-2441	1	66	online	online	ADJ
ajlsi-2441	1	67	)	)	PUNCT
ajlsi-2441	1	68	doi	doi	NOUN
ajlsi-2441	1	69	:	:	PUNCT
ajlsi-2441	1	70	https://doi.org/10.54536/ajlsi.v3i1.2441	https://doi.org/10.54536/ajlsi.v3i1.2441	NOUN
ajlsi-2441	1	71	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	1	72	article	article	NOUN
ajlsi-2441	1	73	information	information	NOUN
ajlsi-2441	1	74	abstract	abstract	ADV
ajlsi-2441	1	75	received	receive	VERB
ajlsi-2441	1	76	:	:	PUNCT
ajlsi-2441	1	77	february	february	NOUN
ajlsi-2441	1	78	02	02	NUM
ajlsi-2441	1	79	,	,	PUNCT
ajlsi-2441	1	80	2024	2024	NUM
ajlsi-2441	1	81	accepted	accept	VERB
ajlsi-2441	1	82	:	:	PUNCT
ajlsi-2441	1	83	march	march	PROPN
ajlsi-2441	1	84	15	15	NUM
ajlsi-2441	1	85	,	,	PUNCT
ajlsi-2441	1	86	2024	2024	NUM
ajlsi-2441	1	87	published	publish	VERB
ajlsi-2441	1	88	:	:	PUNCT
ajlsi-2441	1	89	march	march	PROPN
ajlsi-2441	1	90	19	19	NUM
ajlsi-2441	1	91	,	,	PUNCT
ajlsi-2441	1	92	2024	2024	NUM
ajlsi-2441	1	93	identifying	identify	VERB
ajlsi-2441	1	94	reliable	reliable	ADJ
ajlsi-2441	1	95	predictors	predictor	NOUN
ajlsi-2441	1	96	for	for	ADP
ajlsi-2441	1	97	covid-19	covid-19	PROPN
ajlsi-2441	1	98	pneumonia	pneumonia	NOUN
ajlsi-2441	1	99	progression	progression	NOUN
ajlsi-2441	1	100	is	be	AUX
ajlsi-2441	1	101	crucial	crucial	ADJ
ajlsi-2441	1	102	for	for	ADP
ajlsi-2441	1	103	effective	effective	ADJ
ajlsi-2441	1	104	patient	patient	ADJ
ajlsi-2441	1	105	management	management	NOUN
ajlsi-2441	1	106	.	.	PUNCT
ajlsi-2441	2	1	the	the	DET
ajlsi-2441	2	2	purpose	purpose	NOUN
ajlsi-2441	2	3	of	of	ADP
ajlsi-2441	2	4	this	this	DET
ajlsi-2441	2	5	study	study	NOUN
ajlsi-2441	2	6	is	be	AUX
ajlsi-2441	2	7	to	to	PART
ajlsi-2441	2	8	evaluate	evaluate	VERB
ajlsi-2441	2	9	the	the	DET
ajlsi-2441	2	10	red	red	ADJ
ajlsi-2441	2	11	cell	cell	NOUN
ajlsi-2441	2	12	distribution	distribution	NOUN
ajlsi-2441	2	13	width	width	NOUN
ajlsi-2441	2	14	to	to	PART
ajlsi-2441	2	15	platelet	platelet	NOUN
ajlsi-2441	2	16	ratio	ratio	NOUN
ajlsi-2441	2	17	(	(	PUNCT
ajlsi-2441	2	18	rdw	rdw	X
ajlsi-2441	2	19	/	/	SYM
ajlsi-2441	2	20	plt	plt	NOUN
ajlsi-2441	2	21	)	)	PUNCT
ajlsi-2441	2	22	as	as	ADP
ajlsi-2441	2	23	a	a	DET
ajlsi-2441	2	24	potential	potential	ADJ
ajlsi-2441	2	25	predictive	predictive	ADJ
ajlsi-2441	2	26	biomarker	biomarker	NOUN
ajlsi-2441	2	27	for	for	ADP
ajlsi-2441	2	28	the	the	DET
ajlsi-2441	2	29	development	development	NOUN
ajlsi-2441	2	30	of	of	ADP
ajlsi-2441	2	31	moderate	moderate	ADJ
ajlsi-2441	2	32	to	to	ADP
ajlsi-2441	2	33	severe	severe	ADJ
ajlsi-2441	2	34	covid-19	covid-19	PROPN
ajlsi-2441	2	35	pneumonia	pneumonia	NOUN
ajlsi-2441	2	36	.	.	PUNCT
ajlsi-2441	3	1	conducting	conduct	VERB
ajlsi-2441	3	2	a	a	DET
ajlsi-2441	3	3	retrospective	retrospective	ADJ
ajlsi-2441	3	4	analysis	analysis	NOUN
ajlsi-2441	3	5	from	from	ADP
ajlsi-2441	3	6	august	august	PROPN
ajlsi-2441	3	7	2021	2021	NUM
ajlsi-2441	3	8	to	to	ADP
ajlsi-2441	3	9	march	march	PROPN
ajlsi-2441	3	10	2023	2023	NUM
ajlsi-2441	3	11	,	,	PUNCT
ajlsi-2441	3	12	we	we	PRON
ajlsi-2441	3	13	categorized	categorize	VERB
ajlsi-2441	3	14	patients	patient	NOUN
ajlsi-2441	3	15	with	with	ADP
ajlsi-2441	3	16	moderate	moderate	ADJ
ajlsi-2441	3	17	covid-19	covid-19	PROPN
ajlsi-2441	3	18	pneumonia	pneumonia	NOUN
ajlsi-2441	3	19	at	at	ADP
ajlsi-2441	3	20	admission	admission	NOUN
ajlsi-2441	3	21	into	into	ADP
ajlsi-2441	3	22	different	different	ADJ
ajlsi-2441	3	23	severity	severity	NOUN
ajlsi-2441	3	24	groups	group	NOUN
ajlsi-2441	3	25	.	.	PUNCT
ajlsi-2441	4	1	the	the	DET
ajlsi-2441	4	2	objective	objective	NOUN
ajlsi-2441	4	3	was	be	AUX
ajlsi-2441	4	4	to	to	PART
ajlsi-2441	4	5	explore	explore	VERB
ajlsi-2441	4	6	clinical	clinical	ADJ
ajlsi-2441	4	7	and	and	CCONJ
ajlsi-2441	4	8	laboratory	laboratory	NOUN
ajlsi-2441	4	9	variables	variable	NOUN
ajlsi-2441	4	10	associated	associate	VERB
ajlsi-2441	4	11	with	with	ADP
ajlsi-2441	4	12	disease	disease	NOUN
ajlsi-2441	4	13	progression	progression	NOUN
ajlsi-2441	4	14	.	.	PUNCT
ajlsi-2441	5	1	fifty	fifty	NUM
ajlsi-2441	5	2	-	-	PUNCT
ajlsi-2441	5	3	three	three	NUM
ajlsi-2441	5	4	patients	patient	NOUN
ajlsi-2441	5	5	initially	initially	ADV
ajlsi-2441	5	6	diagnosed	diagnose	VERB
ajlsi-2441	5	7	with	with	ADP
ajlsi-2441	5	8	moderate	moderate	ADJ
ajlsi-2441	5	9	covid-19	covid-19	PROPN
ajlsi-2441	5	10	were	be	AUX
ajlsi-2441	5	11	studied	study	VERB
ajlsi-2441	5	12	,	,	PUNCT
ajlsi-2441	5	13	of	of	ADP
ajlsi-2441	5	14	which	which	PRON
ajlsi-2441	5	15	17	17	NUM
ajlsi-2441	5	16	progressed	progress	VERB
ajlsi-2441	5	17	to	to	ADP
ajlsi-2441	5	18	severe	severe	ADJ
ajlsi-2441	5	19	disease	disease	NOUN
ajlsi-2441	5	20	.	.	PUNCT
ajlsi-2441	6	1	univariate	univariate	ADJ
ajlsi-2441	6	2	logistic	logistic	ADJ
ajlsi-2441	6	3	regression	regression	NOUN
ajlsi-2441	6	4	analyzed	analyze	VERB
ajlsi-2441	6	5	various	various	ADJ
ajlsi-2441	6	6	factors	factor	NOUN
ajlsi-2441	6	7	,	,	PUNCT
ajlsi-2441	6	8	including	include	VERB
ajlsi-2441	6	9	age	age	NOUN
ajlsi-2441	6	10	,	,	PUNCT
ajlsi-2441	6	11	plt	plt	NOUN
ajlsi-2441	6	12	,	,	PUNCT
ajlsi-2441	6	13	rdw	rdw	NOUN
ajlsi-2441	6	14	-	-	PUNCT
ajlsi-2441	6	15	sd	sd	NOUN
ajlsi-2441	6	16	,	,	PUNCT
ajlsi-2441	6	17	rdw	rdw	X
ajlsi-2441	6	18	/	/	SYM
ajlsi-2441	6	19	plt	plt	NOUN
ajlsi-2441	6	20	,	,	PUNCT
ajlsi-2441	6	21	ast	ast	NOUN
ajlsi-2441	6	22	,	,	PUNCT
ajlsi-2441	6	23	alb	alb	PROPN
ajlsi-2441	6	24	,	,	PUNCT
ajlsi-2441	6	25	crp	crp	PROPN
ajlsi-2441	6	26	,	,	PUNCT
ajlsi-2441	6	27	and	and	CCONJ
ajlsi-2441	6	28	il-6	il-6	NOUN
ajlsi-2441	6	29	,	,	PUNCT
ajlsi-2441	6	30	evaluating	evaluate	VERB
ajlsi-2441	6	31	their	their	PRON
ajlsi-2441	6	32	correlation	correlation	NOUN
ajlsi-2441	6	33	(	(	PUNCT
ajlsi-2441	6	34	p	p	X
ajlsi-2441	6	35	<	<	X
ajlsi-2441	6	36	0.05	0.05	NUM
ajlsi-2441	6	37	)	)	PUNCT
ajlsi-2441	6	38	with	with	ADP
ajlsi-2441	6	39	higher	high	ADJ
ajlsi-2441	6	40	odds	odd	NOUN
ajlsi-2441	6	41	ratios	ratio	NOUN
ajlsi-2441	6	42	of	of	ADP
ajlsi-2441	6	43	a	a	DET
ajlsi-2441	6	44	poor	poor	ADJ
ajlsi-2441	6	45	prognosis	prognosis	NOUN
ajlsi-2441	6	46	.	.	PUNCT
ajlsi-2441	7	1	to	to	PART
ajlsi-2441	7	2	ascertain	ascertain	VERB
ajlsi-2441	7	3	these	these	DET
ajlsi-2441	7	4	factors	factor	NOUN
ajlsi-2441	7	5	’	'	PUNCT
ajlsi-2441	7	6	predictive	predictive	ADJ
ajlsi-2441	7	7	power	power	NOUN
ajlsi-2441	7	8	,	,	PUNCT
ajlsi-2441	7	9	receiver	receiver	NOUN
ajlsi-2441	7	10	operating	operate	VERB
ajlsi-2441	7	11	characteristic	characteristic	NOUN
ajlsi-2441	7	12	(	(	PUNCT
ajlsi-2441	7	13	roc	roc	PROPN
ajlsi-2441	7	14	)	)	PUNCT
ajlsi-2441	7	15	curve	curve	NOUN
ajlsi-2441	7	16	analysis	analysis	NOUN
ajlsi-2441	7	17	was	be	AUX
ajlsi-2441	7	18	used	use	VERB
ajlsi-2441	7	19	.	.	PUNCT
ajlsi-2441	8	1	univariate	univariate	ADJ
ajlsi-2441	8	2	logistic	logistic	ADJ
ajlsi-2441	8	3	regression	regression	NOUN
ajlsi-2441	8	4	highlighted	highlight	VERB
ajlsi-2441	8	5	several	several	ADJ
ajlsi-2441	8	6	factors	factor	NOUN
ajlsi-2441	8	7	associated	associate	VERB
ajlsi-2441	8	8	with	with	ADP
ajlsi-2441	8	9	increased	increase	VERB
ajlsi-2441	8	10	odds	odd	NOUN
ajlsi-2441	8	11	ratios	ratio	NOUN
ajlsi-2441	8	12	for	for	ADP
ajlsi-2441	8	13	poor	poor	ADJ
ajlsi-2441	8	14	prognosis	prognosis	NOUN
ajlsi-2441	8	15	.	.	PUNCT
ajlsi-2441	9	1	notably	notably	ADV
ajlsi-2441	9	2	,	,	PUNCT
ajlsi-2441	9	3	rdw	rdw	ADJ
ajlsi-2441	9	4	/	/	SYM
ajlsi-2441	9	5	plt	plt	NOUN
ajlsi-2441	9	6	exhibited	exhibit	VERB
ajlsi-2441	9	7	the	the	DET
ajlsi-2441	9	8	highest	high	ADJ
ajlsi-2441	9	9	predictive	predictive	ADJ
ajlsi-2441	9	10	value	value	NOUN
ajlsi-2441	9	11	(	(	PUNCT
ajlsi-2441	9	12	auc	auc	NOUN
ajlsi-2441	9	13	:	:	PUNCT
ajlsi-2441	9	14	0.925	0.925	NUM
ajlsi-2441	9	15	,	,	PUNCT
ajlsi-2441	9	16	95	95	NUM
ajlsi-2441	9	17	%	%	NOUN
ajlsi-2441	9	18	ci	ci	NOUN
ajlsi-2441	9	19	0.858–0.991	0.858–0.991	NUM
ajlsi-2441	9	20	)	)	PUNCT
ajlsi-2441	9	21	among	among	ADP
ajlsi-2441	9	22	single	single	ADJ
ajlsi-2441	9	23	parameters	parameter	NOUN
ajlsi-2441	9	24	in	in	ADP
ajlsi-2441	9	25	predicting	predict	VERB
ajlsi-2441	9	26	the	the	DET
ajlsi-2441	9	27	risk	risk	NOUN
ajlsi-2441	9	28	of	of	ADP
ajlsi-2441	9	29	covid-19	covid-19	PROPN
ajlsi-2441	9	30	progression	progression	NOUN
ajlsi-2441	9	31	.	.	PUNCT
ajlsi-2441	10	1	this	this	DET
ajlsi-2441	10	2	study	study	NOUN
ajlsi-2441	10	3	underscores	underscore	VERB
ajlsi-2441	10	4	the	the	DET
ajlsi-2441	10	5	potential	potential	NOUN
ajlsi-2441	10	6	of	of	ADP
ajlsi-2441	10	7	rdw	rdw	X
ajlsi-2441	10	8	/	/	SYM
ajlsi-2441	10	9	plt	plt	NOUN
ajlsi-2441	10	10	as	as	ADP
ajlsi-2441	10	11	an	an	DET
ajlsi-2441	10	12	accessible	accessible	ADJ
ajlsi-2441	10	13	and	and	CCONJ
ajlsi-2441	10	14	cost	cost	NOUN
ajlsi-2441	10	15	-	-	PUNCT
ajlsi-2441	10	16	effective	effective	ADJ
ajlsi-2441	10	17	biomarker	biomarker	NOUN
ajlsi-2441	10	18	for	for	ADP
ajlsi-2441	10	19	determining	determine	VERB
ajlsi-2441	10	20	covid-19	covid-19	PROPN
ajlsi-2441	10	21	pneumonia	pneumonia	NOUN
ajlsi-2441	10	22	severity	severity	NOUN
ajlsi-2441	10	23	.	.	PUNCT
ajlsi-2441	11	1	the	the	DET
ajlsi-2441	11	2	findings	finding	NOUN
ajlsi-2441	11	3	support	support	VERB
ajlsi-2441	11	4	its	its	PRON
ajlsi-2441	11	5	utility	utility	NOUN
ajlsi-2441	11	6	in	in	ADP
ajlsi-2441	11	7	risk	risk	NOUN
ajlsi-2441	11	8	stratification	stratification	NOUN
ajlsi-2441	11	9	and	and	CCONJ
ajlsi-2441	11	10	clinical	clinical	ADJ
ajlsi-2441	11	11	decisionmaking	decisionmaking	NOUN
ajlsi-2441	11	12	,	,	PUNCT
ajlsi-2441	11	13	offering	offer	VERB
ajlsi-2441	11	14	valuable	valuable	ADJ
ajlsi-2441	11	15	insights	insight	NOUN
ajlsi-2441	11	16	for	for	ADP
ajlsi-2441	11	17	effective	effective	ADJ
ajlsi-2441	11	18	patient	patient	ADJ
ajlsi-2441	11	19	management	management	NOUN
ajlsi-2441	11	20	strategies	strategy	NOUN
ajlsi-2441	11	21	.	.	PUNCT
ajlsi-2441	12	1	keywords	keyword	VERB
ajlsi-2441	12	2	covid-19	covid-19	PROPN
ajlsi-2441	12	3	,	,	PUNCT
ajlsi-2441	12	4	pneumonia	pneumonia	NOUN
ajlsi-2441	12	5	,	,	PUNCT
ajlsi-2441	12	6	disease	disease	NOUN
ajlsi-2441	12	7	progression	progression	NOUN
ajlsi-2441	12	8	,	,	PUNCT
ajlsi-2441	12	9	biomarker	biomarker	NOUN
ajlsi-2441	12	10	,	,	PUNCT
ajlsi-2441	12	11	clinical	clinical	ADJ
ajlsi-2441	12	12	decision	decision	NOUN
ajlsi-2441	12	13	-	-	PUNCT
ajlsi-2441	12	14	making	make	VERB
ajlsi-2441	12	15	introduction	introduction	NOUN
ajlsi-2441	12	16	global	global	ADJ
ajlsi-2441	12	17	health	health	NOUN
ajlsi-2441	12	18	has	have	AUX
ajlsi-2441	12	19	been	be	AUX
ajlsi-2441	12	20	greatly	greatly	ADV
ajlsi-2441	12	21	impacted	impact	VERB
ajlsi-2441	12	22	by	by	ADP
ajlsi-2441	12	23	the	the	DET
ajlsi-2441	12	24	covid-19	covid-19	PROPN
ajlsi-2441	12	25	pandemic	pandemic	NOUN
ajlsi-2441	12	26	,	,	PUNCT
ajlsi-2441	12	27	which	which	PRON
ajlsi-2441	12	28	has	have	AUX
ajlsi-2441	12	29	resulted	result	VERB
ajlsi-2441	12	30	in	in	ADP
ajlsi-2441	12	31	widespread	widespread	ADJ
ajlsi-2441	12	32	illness	illness	NOUN
ajlsi-2441	12	33	and	and	CCONJ
ajlsi-2441	12	34	mortality	mortality	NOUN
ajlsi-2441	12	35	(	(	PUNCT
ajlsi-2441	12	36	cases	case	NOUN
ajlsi-2441	12	37	,	,	PUNCT
ajlsi-2441	12	38	2020	2020	NUM
ajlsi-2441	12	39	;	;	PUNCT
ajlsi-2441	12	40	fernandes	fernandes	PROPN
ajlsi-2441	12	41	et	et	PROPN
ajlsi-2441	12	42	al	al	PROPN
ajlsi-2441	12	43	.	.	PROPN
ajlsi-2441	12	44	,	,	PUNCT
ajlsi-2441	12	45	2021	2021	NUM
ajlsi-2441	12	46	)	)	PUNCT
ajlsi-2441	12	47	.	.	PUNCT
ajlsi-2441	13	1	the	the	DET
ajlsi-2441	13	2	persistent	persistent	ADJ
ajlsi-2441	13	3	difficulties	difficulty	NOUN
ajlsi-2441	13	4	caused	cause	VERB
ajlsi-2441	13	5	by	by	ADP
ajlsi-2441	13	6	the	the	DET
ajlsi-2441	13	7	covid-19	covid-19	PROPN
ajlsi-2441	13	8	pandemic	pandemic	NOUN
ajlsi-2441	13	9	highlight	highlight	VERB
ajlsi-2441	13	10	the	the	DET
ajlsi-2441	13	11	vital	vital	ADJ
ajlsi-2441	13	12	need	need	NOUN
ajlsi-2441	13	13	for	for	ADP
ajlsi-2441	13	14	strong	strong	ADJ
ajlsi-2441	13	15	prognostic	prognostic	ADJ
ajlsi-2441	13	16	markers	marker	NOUN
ajlsi-2441	13	17	that	that	PRON
ajlsi-2441	13	18	can	can	AUX
ajlsi-2441	13	19	enable	enable	VERB
ajlsi-2441	13	20	early	early	ADJ
ajlsi-2441	13	21	identification	identification	NOUN
ajlsi-2441	13	22	of	of	ADP
ajlsi-2441	13	23	patients	patient	NOUN
ajlsi-2441	13	24	at	at	ADP
ajlsi-2441	13	25	risk	risk	NOUN
ajlsi-2441	13	26	of	of	ADP
ajlsi-2441	13	27	severe	severe	ADJ
ajlsi-2441	13	28	disease	disease	NOUN
ajlsi-2441	13	29	progression	progression	NOUN
ajlsi-2441	13	30	;	;	PUNCT
ajlsi-2441	13	31	the	the	DET
ajlsi-2441	13	32	search	search	NOUN
ajlsi-2441	13	33	for	for	ADP
ajlsi-2441	13	34	trustworthy	trustworthy	ADJ
ajlsi-2441	13	35	indicators	indicator	NOUN
ajlsi-2441	13	36	to	to	PART
ajlsi-2441	13	37	predict	predict	VERB
ajlsi-2441	13	38	disease	disease	NOUN
ajlsi-2441	13	39	severity	severity	NOUN
ajlsi-2441	13	40	and	and	CCONJ
ajlsi-2441	13	41	progression	progression	NOUN
ajlsi-2441	13	42	in	in	ADP
ajlsi-2441	13	43	covid-19	covid-19	PROPN
ajlsi-2441	13	44	patients	patient	NOUN
ajlsi-2441	13	45	remains	remain	VERB
ajlsi-2441	13	46	a	a	DET
ajlsi-2441	13	47	crucial	crucial	ADJ
ajlsi-2441	13	48	focus	focus	NOUN
ajlsi-2441	13	49	as	as	SCONJ
ajlsi-2441	13	50	the	the	DET
ajlsi-2441	13	51	scientific	scientific	ADJ
ajlsi-2441	13	52	community	community	NOUN
ajlsi-2441	13	53	steps	step	VERB
ajlsi-2441	13	54	up	up	ADP
ajlsi-2441	13	55	efforts	effort	NOUN
ajlsi-2441	13	56	to	to	PART
ajlsi-2441	13	57	unravel	unravel	VERB
ajlsi-2441	13	58	the	the	DET
ajlsi-2441	13	59	complex	complex	ADJ
ajlsi-2441	13	60	pathophysiology	pathophysiology	NOUN
ajlsi-2441	13	61	of	of	ADP
ajlsi-2441	13	62	sars	sar	NOUN
ajlsi-2441	13	63	-	-	PUNCT
ajlsi-2441	13	64	cov-2	cov-2	PART
ajlsi-2441	13	65	infection	infection	NOUN
ajlsi-2441	13	66	(	(	PUNCT
ajlsi-2441	13	67	chen	chen	PROPN
ajlsi-2441	13	68	et	et	PROPN
ajlsi-2441	13	69	al	al	PROPN
ajlsi-2441	13	70	.	.	PROPN
ajlsi-2441	13	71	,	,	PUNCT
ajlsi-2441	13	72	2020	2020	NUM
ajlsi-2441	13	73	;	;	PUNCT
ajlsi-2441	13	74	sharma	sharma	PROPN
ajlsi-2441	13	75	et	et	PROPN
ajlsi-2441	13	76	al	al	PROPN
ajlsi-2441	13	77	.	.	PROPN
ajlsi-2441	13	78	,	,	PUNCT
ajlsi-2441	13	79	2020	2020	NUM
ajlsi-2441	13	80	;	;	PUNCT
ajlsi-2441	13	81	sun	sun	PROPN
ajlsi-2441	13	82	et	et	PROPN
ajlsi-2441	13	83	al	al	PROPN
ajlsi-2441	13	84	.	.	PROPN
ajlsi-2441	13	85	,	,	PUNCT
ajlsi-2441	13	86	2020	2020	NUM
ajlsi-2441	13	87	)	)	PUNCT
ajlsi-2441	13	88	.	.	PUNCT
ajlsi-2441	14	1	within	within	ADP
ajlsi-2441	14	2	the	the	DET
ajlsi-2441	14	3	cohort	cohort	NOUN
ajlsi-2441	14	4	of	of	ADP
ajlsi-2441	14	5	covid-19	covid-19	PROPN
ajlsi-2441	14	6	patients	patient	NOUN
ajlsi-2441	14	7	initially	initially	ADV
ajlsi-2441	14	8	presenting	present	VERB
ajlsi-2441	14	9	with	with	ADP
ajlsi-2441	14	10	moderate	moderate	ADJ
ajlsi-2441	14	11	symptoms	symptom	NOUN
ajlsi-2441	14	12	,	,	PUNCT
ajlsi-2441	14	13	a	a	DET
ajlsi-2441	14	14	subset	subset	NOUN
ajlsi-2441	14	15	exhibited	exhibit	VERB
ajlsi-2441	14	16	an	an	DET
ajlsi-2441	14	17	alarming	alarming	ADJ
ajlsi-2441	14	18	deterioration	deterioration	NOUN
ajlsi-2441	14	19	,	,	PUNCT
ajlsi-2441	14	20	progressing	progress	VERB
ajlsi-2441	14	21	towards	towards	ADP
ajlsi-2441	14	22	severe	severe	ADJ
ajlsi-2441	14	23	disease	disease	NOUN
ajlsi-2441	14	24	.	.	PUNCT
ajlsi-2441	15	1	notably	notably	ADV
ajlsi-2441	15	2	,	,	PUNCT
ajlsi-2441	15	3	an	an	DET
ajlsi-2441	15	4	intriguing	intriguing	ADJ
ajlsi-2441	15	5	pattern	pattern	NOUN
ajlsi-2441	15	6	emerged	emerge	VERB
ajlsi-2441	15	7	upon	upon	SCONJ
ajlsi-2441	15	8	meticulous	meticulous	ADJ
ajlsi-2441	15	9	analysis	analysis	NOUN
ajlsi-2441	15	10	:	:	PUNCT
ajlsi-2441	15	11	those	those	PRON
ajlsi-2441	15	12	experiencing	experience	VERB
ajlsi-2441	15	13	the	the	DET
ajlsi-2441	15	14	severe	severe	ADJ
ajlsi-2441	15	15	progression	progression	NOUN
ajlsi-2441	15	16	manifested	manifest	VERB
ajlsi-2441	15	17	elevated	elevated	ADJ
ajlsi-2441	15	18	levels	level	NOUN
ajlsi-2441	15	19	of	of	ADP
ajlsi-2441	15	20	rdw	rdw	X
ajlsi-2441	15	21	/	/	SYM
ajlsi-2441	15	22	plt	plt	NOUN
ajlsi-2441	15	23	.	.	PUNCT
ajlsi-2441	16	1	this	this	DET
ajlsi-2441	16	2	observation	observation	NOUN
ajlsi-2441	16	3	serves	serve	VERB
ajlsi-2441	16	4	as	as	ADP
ajlsi-2441	16	5	the	the	DET
ajlsi-2441	16	6	fulcrum	fulcrum	NOUN
ajlsi-2441	16	7	for	for	ADP
ajlsi-2441	16	8	exploring	explore	VERB
ajlsi-2441	16	9	the	the	DET
ajlsi-2441	16	10	predictive	predictive	ADJ
ajlsi-2441	16	11	value	value	NOUN
ajlsi-2441	16	12	of	of	ADP
ajlsi-2441	16	13	rdw	rdw	X
ajlsi-2441	16	14	/	/	SYM
ajlsi-2441	16	15	plt	plt	NOUN
ajlsi-2441	16	16	in	in	ADP
ajlsi-2441	16	17	predicting	predict	VERB
ajlsi-2441	16	18	covid-19	covid-19	PROPN
ajlsi-2441	16	19	severity	severity	NOUN
ajlsi-2441	16	20	.	.	PUNCT
ajlsi-2441	17	1	rdw	rdw	PROPN
ajlsi-2441	17	2	/	/	SYM
ajlsi-2441	17	3	plt	plt	NOUN
ajlsi-2441	17	4	,	,	PUNCT
ajlsi-2441	17	5	amalgamating	amalgamate	VERB
ajlsi-2441	17	6	red	red	ADJ
ajlsi-2441	17	7	cell	cell	NOUN
ajlsi-2441	17	8	distribution	distribution	NOUN
ajlsi-2441	17	9	width	width	NOUN
ajlsi-2441	17	10	(	(	PUNCT
ajlsi-2441	17	11	rdw	rdw	NOUN
ajlsi-2441	17	12	)	)	PUNCT
ajlsi-2441	17	13	and	and	CCONJ
ajlsi-2441	17	14	platelet	platelet	NOUN
ajlsi-2441	17	15	count	count	NOUN
ajlsi-2441	17	16	(	(	PUNCT
ajlsi-2441	17	17	plt	plt	NOUN
ajlsi-2441	17	18	)	)	PUNCT
ajlsi-2441	17	19	measurements	measurement	NOUN
ajlsi-2441	17	20	,	,	PUNCT
ajlsi-2441	17	21	represents	represent	VERB
ajlsi-2441	17	22	a	a	DET
ajlsi-2441	17	23	composite	composite	ADJ
ajlsi-2441	17	24	metric	metric	NOUN
ajlsi-2441	17	25	derived	derive	VERB
ajlsi-2441	17	26	from	from	ADP
ajlsi-2441	17	27	routine	routine	ADJ
ajlsi-2441	17	28	complete	complete	ADJ
ajlsi-2441	17	29	blood	blood	NOUN
ajlsi-2441	17	30	counts	count	NOUN
ajlsi-2441	17	31	(	(	PUNCT
ajlsi-2441	17	32	pulgar	pulgar	NOUN
ajlsi-2441	17	33	-	-	PUNCT
ajlsi-2441	17	34	sánchez	sánchez	NOUN
ajlsi-2441	17	35	et	et	PROPN
ajlsi-2441	17	36	al	al	PROPN
ajlsi-2441	17	37	.	.	PROPN
ajlsi-2441	17	38	,	,	PUNCT
ajlsi-2441	17	39	2021	2021	NUM
ajlsi-2441	17	40	)	)	PUNCT
ajlsi-2441	17	41	.	.	PUNCT
ajlsi-2441	18	1	the	the	DET
ajlsi-2441	18	2	rdw	rdw	PROPN
ajlsi-2441	18	3	captures	capture	VERB
ajlsi-2441	18	4	the	the	DET
ajlsi-2441	18	5	heterogeneity	heterogeneity	NOUN
ajlsi-2441	18	6	in	in	ADP
ajlsi-2441	18	7	red	red	ADJ
ajlsi-2441	18	8	blood	blood	NOUN
ajlsi-2441	18	9	cell	cell	NOUN
ajlsi-2441	18	10	sizes	size	NOUN
ajlsi-2441	18	11	,	,	PUNCT
ajlsi-2441	18	12	often	often	ADV
ajlsi-2441	18	13	indicative	indicative	ADJ
ajlsi-2441	18	14	of	of	ADP
ajlsi-2441	18	15	underlying	underlie	VERB
ajlsi-2441	18	16	physiological	physiological	ADJ
ajlsi-2441	18	17	perturbations	perturbation	NOUN
ajlsi-2441	18	18	,	,	PUNCT
ajlsi-2441	18	19	while	while	SCONJ
ajlsi-2441	18	20	plt	plt	NOUN
ajlsi-2441	18	21	reflects	reflect	VERB
ajlsi-2441	18	22	the	the	DET
ajlsi-2441	18	23	platelet	platelet	NOUN
ajlsi-2441	18	24	count	count	NOUN
ajlsi-2441	18	25	critical	critical	ADJ
ajlsi-2441	18	26	for	for	ADP
ajlsi-2441	18	27	hemostasis	hemostasis	NOUN
ajlsi-2441	18	28	and	and	CCONJ
ajlsi-2441	18	29	immune	immune	ADJ
ajlsi-2441	18	30	response	response	NOUN
ajlsi-2441	18	31	regulation	regulation	NOUN
ajlsi-2441	18	32	(	(	PUNCT
ajlsi-2441	18	33	ullah	ullah	PROPN
ajlsi-2441	18	34	et	et	PROPN
ajlsi-2441	18	35	al	al	PROPN
ajlsi-2441	18	36	.	.	PROPN
ajlsi-2441	18	37	,	,	PUNCT
ajlsi-2441	18	38	2020	2020	NUM
ajlsi-2441	18	39	;	;	PUNCT
ajlsi-2441	18	40	wynants	wynant	NOUN
ajlsi-2441	18	41	et	et	PROPN
ajlsi-2441	18	42	al	al	PROPN
ajlsi-2441	18	43	.	.	PROPN
ajlsi-2441	18	44	,	,	PUNCT
ajlsi-2441	18	45	2020	2020	NUM
ajlsi-2441	18	46	)	)	PUNCT
ajlsi-2441	18	47	.	.	PUNCT
ajlsi-2441	19	1	these	these	DET
ajlsi-2441	19	2	parameters	parameter	NOUN
ajlsi-2441	19	3	,	,	PUNCT
ajlsi-2441	19	4	individually	individually	ADV
ajlsi-2441	19	5	recognized	recognize	VERB
ajlsi-2441	19	6	for	for	ADP
ajlsi-2441	19	7	their	their	PRON
ajlsi-2441	19	8	diagnostic	diagnostic	ADJ
ajlsi-2441	19	9	utility	utility	NOUN
ajlsi-2441	19	10	across	across	ADP
ajlsi-2441	19	11	various	various	ADJ
ajlsi-2441	19	12	medical	medical	ADJ
ajlsi-2441	19	13	conditions	condition	NOUN
ajlsi-2441	19	14	,	,	PUNCT
ajlsi-2441	19	15	converge	converge	VERB
ajlsi-2441	19	16	in	in	ADP
ajlsi-2441	19	17	rdw/	rdw/	PROPN
ajlsi-2441	19	18	plt	plt	NOUN
ajlsi-2441	19	19	,	,	PUNCT
ajlsi-2441	19	20	offering	offer	VERB
ajlsi-2441	19	21	a	a	DET
ajlsi-2441	19	22	potentially	potentially	ADV
ajlsi-2441	19	23	novel	novel	ADJ
ajlsi-2441	19	24	prognostic	prognostic	ADJ
ajlsi-2441	19	25	avenue	avenue	NOUN
ajlsi-2441	19	26	for	for	ADP
ajlsi-2441	19	27	covid-19	covid-19	PROPN
ajlsi-2441	19	28	.	.	PUNCT
ajlsi-2441	20	1	the	the	DET
ajlsi-2441	20	2	exploration	exploration	NOUN
ajlsi-2441	20	3	of	of	ADP
ajlsi-2441	20	4	rdw	rdw	X
ajlsi-2441	20	5	/	/	SYM
ajlsi-2441	20	6	plt	plt	NOUN
ajlsi-2441	20	7	as	as	ADP
ajlsi-2441	20	8	a	a	DET
ajlsi-2441	20	9	predictive	predictive	ADJ
ajlsi-2441	20	10	biomarker	biomarker	NOUN
ajlsi-2441	20	11	holds	hold	VERB
ajlsi-2441	20	12	significant	significant	ADJ
ajlsi-2441	20	13	implications	implication	NOUN
ajlsi-2441	20	14	for	for	ADP
ajlsi-2441	20	15	clinical	clinical	ADJ
ajlsi-2441	20	16	practice	practice	NOUN
ajlsi-2441	20	17	.	.	PUNCT
ajlsi-2441	21	1	should	should	AUX
ajlsi-2441	21	2	its	its	PRON
ajlsi-2441	21	3	predictive	predictive	ADJ
ajlsi-2441	21	4	potential	potential	NOUN
ajlsi-2441	21	5	be	be	AUX
ajlsi-2441	21	6	validated	validate	VERB
ajlsi-2441	21	7	,	,	PUNCT
ajlsi-2441	21	8	rdw	rdw	X
ajlsi-2441	21	9	/	/	SYM
ajlsi-2441	21	10	plt	plt	NOUN
ajlsi-2441	21	11	could	could	AUX
ajlsi-2441	21	12	emerge	emerge	VERB
ajlsi-2441	21	13	as	as	ADP
ajlsi-2441	21	14	a	a	DET
ajlsi-2441	21	15	non	non	ADJ
ajlsi-2441	21	16	-	-	ADJ
ajlsi-2441	21	17	invasive	invasive	ADJ
ajlsi-2441	21	18	,	,	PUNCT
ajlsi-2441	21	19	cost	cost	NOUN
ajlsi-2441	21	20	-	-	PUNCT
ajlsi-2441	21	21	effective	effective	ADJ
ajlsi-2441	21	22	,	,	PUNCT
ajlsi-2441	21	23	and	and	CCONJ
ajlsi-2441	21	24	readily	readily	ADV
ajlsi-2441	21	25	available	available	ADJ
ajlsi-2441	21	26	tool	tool	NOUN
ajlsi-2441	21	27	for	for	ADP
ajlsi-2441	21	28	risk	risk	NOUN
ajlsi-2441	21	29	stratification	stratification	NOUN
ajlsi-2441	21	30	among	among	ADP
ajlsi-2441	21	31	covid-19	covid-19	PROPN
ajlsi-2441	21	32	patients	patient	NOUN
ajlsi-2441	21	33	.	.	PUNCT
ajlsi-2441	22	1	its	its	PRON
ajlsi-2441	22	2	role	role	NOUN
ajlsi-2441	22	3	in	in	ADP
ajlsi-2441	22	4	the	the	DET
ajlsi-2441	22	5	early	early	ADJ
ajlsi-2441	22	6	identification	identification	NOUN
ajlsi-2441	22	7	of	of	ADP
ajlsi-2441	22	8	individuals	individual	NOUN
ajlsi-2441	22	9	prone	prone	ADJ
ajlsi-2441	22	10	to	to	ADP
ajlsi-2441	22	11	rapid	rapid	ADJ
ajlsi-2441	22	12	disease	disease	NOUN
ajlsi-2441	22	13	progression	progression	NOUN
ajlsi-2441	22	14	may	may	AUX
ajlsi-2441	22	15	revolutionize	revolutionize	VERB
ajlsi-2441	22	16	clinical	clinical	ADJ
ajlsi-2441	22	17	decision	decision	NOUN
ajlsi-2441	22	18	-	-	PUNCT
ajlsi-2441	22	19	making	making	NOUN
ajlsi-2441	22	20	,	,	PUNCT
ajlsi-2441	22	21	enabling	enable	VERB
ajlsi-2441	22	22	timely	timely	ADJ
ajlsi-2441	22	23	interventions	intervention	NOUN
ajlsi-2441	22	24	and	and	CCONJ
ajlsi-2441	22	25	tailored	tailor	VERB
ajlsi-2441	22	26	therapeutic	therapeutic	ADJ
ajlsi-2441	22	27	strategies	strategy	NOUN
ajlsi-2441	22	28	aimed	aim	VERB
ajlsi-2441	22	29	at	at	ADP
ajlsi-2441	22	30	averting	avert	VERB
ajlsi-2441	22	31	severe	severe	ADJ
ajlsi-2441	22	32	complications	complication	NOUN
ajlsi-2441	22	33	(	(	PUNCT
ajlsi-2441	22	34	albahri	albahri	PROPN
ajlsi-2441	22	35	et	et	PROPN
ajlsi-2441	22	36	al	al	PROPN
ajlsi-2441	22	37	.	.	PROPN
ajlsi-2441	22	38	,	,	PUNCT
ajlsi-2441	22	39	2020	2020	NUM
ajlsi-2441	22	40	;	;	PUNCT
ajlsi-2441	22	41	borghesi	borghesi	NOUN
ajlsi-2441	22	42	et	et	PROPN
ajlsi-2441	22	43	al	al	PROPN
ajlsi-2441	22	44	.	.	PROPN
ajlsi-2441	22	45	,	,	PUNCT
ajlsi-2441	22	46	2020	2020	NUM
ajlsi-2441	22	47	;	;	PUNCT
ajlsi-2441	22	48	tian	tian	PROPN
ajlsi-2441	22	49	et	et	PROPN
ajlsi-2441	22	50	al	al	PROPN
ajlsi-2441	22	51	.	.	PROPN
ajlsi-2441	22	52	,	,	PUNCT
ajlsi-2441	22	53	2020	2020	NUM
ajlsi-2441	22	54	;	;	PUNCT
ajlsi-2441	22	55	ullah	ullah	PROPN
ajlsi-2441	22	56	et	et	PROPN
ajlsi-2441	22	57	al	al	PROPN
ajlsi-2441	22	58	.	.	PROPN
ajlsi-2441	22	59	,	,	PUNCT
ajlsi-2441	22	60	2020	2020	NUM
ajlsi-2441	22	61	)	)	PUNCT
ajlsi-2441	22	62	.	.	PUNCT
ajlsi-2441	23	1	moreover	moreover	ADV
ajlsi-2441	23	2	,	,	PUNCT
ajlsi-2441	23	3	the	the	DET
ajlsi-2441	23	4	integration	integration	NOUN
ajlsi-2441	23	5	of	of	ADP
ajlsi-2441	23	6	rdw	rdw	X
ajlsi-2441	23	7	/	/	SYM
ajlsi-2441	23	8	plt	plt	NOUN
ajlsi-2441	23	9	into	into	ADP
ajlsi-2441	23	10	prognostic	prognostic	ADJ
ajlsi-2441	23	11	models	model	NOUN
ajlsi-2441	23	12	may	may	AUX
ajlsi-2441	23	13	streamline	streamline	VERB
ajlsi-2441	23	14	resource	resource	NOUN
ajlsi-2441	23	15	allocation	allocation	NOUN
ajlsi-2441	23	16	within	within	ADP
ajlsi-2441	23	17	healthcare	healthcare	NOUN
ajlsi-2441	23	18	systems	system	NOUN
ajlsi-2441	23	19	,	,	PUNCT
ajlsi-2441	23	20	optimizing	optimize	VERB
ajlsi-2441	23	21	the	the	DET
ajlsi-2441	23	22	allocation	allocation	NOUN
ajlsi-2441	23	23	of	of	ADP
ajlsi-2441	23	24	limited	limited	ADJ
ajlsi-2441	23	25	resources	resource	NOUN
ajlsi-2441	23	26	toward	toward	ADP
ajlsi-2441	23	27	high	high	ADJ
ajlsi-2441	23	28	-	-	PUNCT
ajlsi-2441	23	29	risk	risk	NOUN
ajlsi-2441	23	30	patient	patient	NOUN
ajlsi-2441	23	31	cohorts	cohort	NOUN
ajlsi-2441	23	32	.	.	PUNCT
ajlsi-2441	24	1	this	this	DET
ajlsi-2441	24	2	research	research	NOUN
ajlsi-2441	24	3	endeavor	endeavor	VERB
ajlsi-2441	24	4	transcends	transcend	VERB
ajlsi-2441	24	5	mere	mere	ADJ
ajlsi-2441	24	6	association	association	NOUN
ajlsi-2441	24	7	establishment	establishment	NOUN
ajlsi-2441	24	8	by	by	ADP
ajlsi-2441	24	9	delving	delve	VERB
ajlsi-2441	24	10	into	into	ADP
ajlsi-2441	24	11	the	the	DET
ajlsi-2441	24	12	temporal	temporal	ADJ
ajlsi-2441	24	13	dynamics	dynamic	NOUN
ajlsi-2441	24	14	and	and	CCONJ
ajlsi-2441	24	15	clinical	clinical	ADJ
ajlsi-2441	24	16	correlations	correlation	NOUN
ajlsi-2441	24	17	of	of	ADP
ajlsi-2441	24	18	rdw	rdw	ADJ
ajlsi-2441	24	19	/	/	SYM
ajlsi-2441	24	20	plt	plt	NOUN
ajlsi-2441	24	21	alterations	alteration	NOUN
ajlsi-2441	24	22	concerning	concern	VERB
ajlsi-2441	24	23	covid-19	covid-19	PROPN
ajlsi-2441	24	24	progression	progression	NOUN
ajlsi-2441	24	25	.	.	PUNCT
ajlsi-2441	25	1	understanding	understand	VERB
ajlsi-2441	25	2	whether	whether	SCONJ
ajlsi-2441	25	3	changes	change	NOUN
ajlsi-2441	25	4	in	in	ADP
ajlsi-2441	25	5	rdw	rdw	ADJ
ajlsi-2441	25	6	/	/	SYM
ajlsi-2441	25	7	plt	plt	NOUN
ajlsi-2441	25	8	precede	precede	NOUN
ajlsi-2441	25	9	the	the	DET
ajlsi-2441	25	10	onset	onset	NOUN
ajlsi-2441	25	11	of	of	ADP
ajlsi-2441	25	12	severe	severe	ADJ
ajlsi-2441	25	13	symptoms	symptom	NOUN
ajlsi-2441	25	14	or	or	CCONJ
ajlsi-2441	25	15	coincide	coincide	VERB
ajlsi-2441	25	16	with	with	ADP
ajlsi-2441	25	17	disease	disease	NOUN
ajlsi-2441	25	18	exacerbation	exacerbation	NOUN
ajlsi-2441	25	19	remains	remain	VERB
ajlsi-2441	25	20	a	a	DET
ajlsi-2441	25	21	pivotal	pivotal	ADJ
ajlsi-2441	25	22	1	1	NUM
ajlsi-2441	25	23	department	department	NOUN
ajlsi-2441	25	24	of	of	ADP
ajlsi-2441	25	25	emergency	emergency	NOUN
ajlsi-2441	25	26	intensive	intensive	ADJ
ajlsi-2441	25	27	care	care	NOUN
ajlsi-2441	25	28	unit	unit	NOUN
ajlsi-2441	25	29	,	,	PUNCT
ajlsi-2441	25	30	affiliated	affiliated	ADJ
ajlsi-2441	25	31	hospital	hospital	NOUN
ajlsi-2441	25	32	of	of	ADP
ajlsi-2441	25	33	xuzhou	xuzhou	PROPN
ajlsi-2441	25	34	medical	medical	PROPN
ajlsi-2441	25	35	university	university	PROPN
ajlsi-2441	25	36	,	,	PUNCT
ajlsi-2441	25	37	jiangsu	jiangsu	PROPN
ajlsi-2441	25	38	,	,	PUNCT
ajlsi-2441	25	39	china	china	PROPN
ajlsi-2441	25	40	2	2	NUM
ajlsi-2441	25	41	xuzhou	xuzhou	PROPN
ajlsi-2441	25	42	medical	medical	PROPN
ajlsi-2441	25	43	university	university	PROPN
ajlsi-2441	25	44	,	,	PUNCT
ajlsi-2441	25	45	jiangsu	jiangsu	PROPN
ajlsi-2441	25	46	,	,	PUNCT
ajlsi-2441	25	47	china	china	PROPN
ajlsi-2441	25	48	3	3	NUM
ajlsi-2441	25	49	king	king	PROPN
ajlsi-2441	25	50	abdulaziz	abdulaziz	PROPN
ajlsi-2441	25	51	university	university	PROPN
ajlsi-2441	25	52	hospital	hospital	NOUN
ajlsi-2441	25	53	,	,	PUNCT
ajlsi-2441	25	54	jeddah	jeddah	PROPN
ajlsi-2441	25	55	,	,	PUNCT
ajlsi-2441	25	56	saudi	saudi	PROPN
ajlsi-2441	25	57	arabia	arabia	PROPN
ajlsi-2441	25	58	4	4	NUM
ajlsi-2441	25	59	shandong	shandong	PROPN
ajlsi-2441	25	60	first	first	PROPN
ajlsi-2441	25	61	medical	medical	PROPN
ajlsi-2441	25	62	university	university	PROPN
ajlsi-2441	25	63	,	,	PUNCT
ajlsi-2441	25	64	shandong	shandong	PROPN
ajlsi-2441	25	65	,	,	PUNCT
ajlsi-2441	25	66	china	china	PROPN
ajlsi-2441	25	67	&	&	CCONJ
ajlsi-2441	25	68	department	department	PROPN
ajlsi-2441	25	69	of	of	ADP
ajlsi-2441	25	70	anesthesiology	anesthesiology	NOUN
ajlsi-2441	25	71	,	,	PUNCT
ajlsi-2441	25	72	the	the	DET
ajlsi-2441	25	73	affiliated	affiliated	ADJ
ajlsi-2441	25	74	hospital	hospital	NOUN
ajlsi-2441	25	75	of	of	ADP
ajlsi-2441	25	76	xuzhou	xuzhou	PROPN
ajlsi-2441	25	77	medical	medical	PROPN
ajlsi-2441	25	78	university	university	PROPN
ajlsi-2441	25	79	,	,	PUNCT
ajlsi-2441	25	80	jiangsu	jiangsu	PROPN
ajlsi-2441	25	81	,	,	PUNCT
ajlsi-2441	25	82	china	china	PROPN
ajlsi-2441	25	83	5	5	NUM
ajlsi-2441	25	84	department	department	NOUN
ajlsi-2441	25	85	of	of	ADP
ajlsi-2441	25	86	intensive	intensive	ADJ
ajlsi-2441	25	87	care	care	NOUN
ajlsi-2441	25	88	unit	unit	NOUN
ajlsi-2441	25	89	,	,	PUNCT
ajlsi-2441	25	90	affiliated	affiliated	ADJ
ajlsi-2441	25	91	hospital	hospital	NOUN
ajlsi-2441	25	92	of	of	ADP
ajlsi-2441	25	93	xuzhou	xuzhou	PROPN
ajlsi-2441	25	94	medical	medical	PROPN
ajlsi-2441	25	95	university	university	PROPN
ajlsi-2441	25	96	,	,	PUNCT
ajlsi-2441	25	97	jiangsu	jiangsu	PROPN
ajlsi-2441	25	98	,	,	PUNCT
ajlsi-2441	25	99	china	china	PROPN
ajlsi-2441	25	100	*	*	PUNCT
ajlsi-2441	25	101	corresponding	correspond	VERB
ajlsi-2441	25	102	author	author	NOUN
ajlsi-2441	25	103	’s	’s	PART
ajlsi-2441	25	104	e	e	NOUN
ajlsi-2441	25	105	-	-	NOUN
ajlsi-2441	25	106	mail	mail	NOUN
ajlsi-2441	25	107	:	:	PUNCT
ajlsi-2441	26	1	sumingzhang18@outlook.com	sumingzhang18@outlook.com	X
ajlsi-2441	26	2	pa	pa	PROPN
ajlsi-2441	26	3	ge	ge	PROPN
ajlsi-2441	26	4	29	29	NUM
ajlsi-2441	26	5	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	26	6	am	am	NOUN
ajlsi-2441	26	7	.	.	PUNCT
ajlsi-2441	27	1	j.	j.	PROPN
ajlsi-2441	27	2	life	life	PROPN
ajlsi-2441	27	3	sci	sci	PROPN
ajlsi-2441	27	4	.	.	PUNCT
ajlsi-2441	27	5	innov	innov	PROPN
ajlsi-2441	27	6	.	.	PUNCT
ajlsi-2441	28	1	3(1	3(1	NUM
ajlsi-2441	28	2	)	)	PUNCT
ajlsi-2441	28	3	28	28	NUM
ajlsi-2441	28	4	-	-	SYM
ajlsi-2441	28	5	36	36	NUM
ajlsi-2441	28	6	,	,	PUNCT
ajlsi-2441	28	7	2024	2024	NUM
ajlsi-2441	28	8	aspect	aspect	NOUN
ajlsi-2441	28	9	to	to	PART
ajlsi-2441	28	10	unravel	unravel	VERB
ajlsi-2441	28	11	for	for	ADP
ajlsi-2441	28	12	effective	effective	ADJ
ajlsi-2441	28	13	predictive	predictive	ADJ
ajlsi-2441	28	14	utility	utility	NOUN
ajlsi-2441	28	15	.	.	PUNCT
ajlsi-2441	29	1	the	the	DET
ajlsi-2441	29	2	nuances	nuance	NOUN
ajlsi-2441	29	3	of	of	ADP
ajlsi-2441	29	4	rdw	rdw	X
ajlsi-2441	29	5	/	/	SYM
ajlsi-2441	29	6	plt	plt	NOUN
ajlsi-2441	29	7	kinetics	kinetic	NOUN
ajlsi-2441	29	8	throughout	throughout	ADP
ajlsi-2441	29	9	the	the	DET
ajlsi-2441	29	10	disease	disease	NOUN
ajlsi-2441	29	11	course	course	NOUN
ajlsi-2441	29	12	may	may	AUX
ajlsi-2441	29	13	provide	provide	VERB
ajlsi-2441	29	14	critical	critical	ADJ
ajlsi-2441	29	15	insights	insight	NOUN
ajlsi-2441	29	16	into	into	ADP
ajlsi-2441	29	17	the	the	DET
ajlsi-2441	29	18	trajectory	trajectory	NOUN
ajlsi-2441	29	19	of	of	ADP
ajlsi-2441	29	20	covid-19	covid-19	PROPN
ajlsi-2441	29	21	and	and	CCONJ
ajlsi-2441	29	22	guide	guide	VERB
ajlsi-2441	29	23	intervention	intervention	NOUN
ajlsi-2441	29	24	strategies	strategy	NOUN
ajlsi-2441	29	25	.	.	PUNCT
ajlsi-2441	30	1	additionally	additionally	ADV
ajlsi-2441	30	2	,	,	PUNCT
ajlsi-2441	30	3	investigating	investigate	VERB
ajlsi-2441	30	4	demographic	demographic	ADJ
ajlsi-2441	30	5	variations	variation	NOUN
ajlsi-2441	30	6	and	and	CCONJ
ajlsi-2441	30	7	potential	potential	ADJ
ajlsi-2441	30	8	associations	association	NOUN
ajlsi-2441	30	9	with	with	ADP
ajlsi-2441	30	10	comorbidities	comorbiditie	NOUN
ajlsi-2441	30	11	concerning	concern	VERB
ajlsi-2441	30	12	rdw	rdw	ADJ
ajlsi-2441	30	13	/	/	SYM
ajlsi-2441	30	14	plt	plt	NOUN
ajlsi-2441	30	15	elevations	elevation	NOUN
ajlsi-2441	30	16	in	in	ADP
ajlsi-2441	30	17	covid-19	covid-19	PROPN
ajlsi-2441	30	18	patients	patient	NOUN
ajlsi-2441	30	19	presents	present	VERB
ajlsi-2441	30	20	an	an	DET
ajlsi-2441	30	21	intriguing	intriguing	ADJ
ajlsi-2441	30	22	avenue	avenue	NOUN
ajlsi-2441	30	23	.	.	PUNCT
ajlsi-2441	31	1	determining	determine	VERB
ajlsi-2441	31	2	whether	whether	SCONJ
ajlsi-2441	31	3	specific	specific	ADJ
ajlsi-2441	31	4	patient	patient	NOUN
ajlsi-2441	31	5	subgroups	subgroup	NOUN
ajlsi-2441	31	6	exhibit	exhibit	VERB
ajlsi-2441	31	7	distinct	distinct	ADJ
ajlsi-2441	31	8	rdw	rdw	ADJ
ajlsi-2441	31	9	/	/	SYM
ajlsi-2441	31	10	plt	plt	NOUN
ajlsi-2441	31	11	profiles	profile	NOUN
ajlsi-2441	31	12	could	could	AUX
ajlsi-2441	31	13	facilitate	facilitate	VERB
ajlsi-2441	31	14	personalized	personalized	ADJ
ajlsi-2441	31	15	risk	risk	NOUN
ajlsi-2441	31	16	assessment	assessment	NOUN
ajlsi-2441	31	17	,	,	PUNCT
ajlsi-2441	31	18	tailored	tailor	VERB
ajlsi-2441	31	19	monitoring	monitoring	NOUN
ajlsi-2441	31	20	protocols	protocol	NOUN
ajlsi-2441	31	21	,	,	PUNCT
ajlsi-2441	31	22	and	and	CCONJ
ajlsi-2441	31	23	targeted	target	VERB
ajlsi-2441	31	24	interventions	intervention	NOUN
ajlsi-2441	31	25	.	.	PUNCT
ajlsi-2441	32	1	this	this	DET
ajlsi-2441	32	2	pursuit	pursuit	NOUN
ajlsi-2441	32	3	aligns	align	VERB
ajlsi-2441	32	4	with	with	ADP
ajlsi-2441	32	5	the	the	DET
ajlsi-2441	32	6	broader	broad	ADJ
ajlsi-2441	32	7	goal	goal	NOUN
ajlsi-2441	32	8	of	of	ADP
ajlsi-2441	32	9	precision	precision	NOUN
ajlsi-2441	32	10	medicine	medicine	NOUN
ajlsi-2441	32	11	,	,	PUNCT
ajlsi-2441	32	12	aiming	aim	VERB
ajlsi-2441	32	13	to	to	PART
ajlsi-2441	32	14	tailor	tailor	NOUN
ajlsi-2441	32	15	treatments	treatment	NOUN
ajlsi-2441	32	16	based	base	VERB
ajlsi-2441	32	17	on	on	ADP
ajlsi-2441	32	18	individual	individual	ADJ
ajlsi-2441	32	19	patient	patient	ADJ
ajlsi-2441	32	20	characteristics	characteristic	NOUN
ajlsi-2441	32	21	and	and	CCONJ
ajlsi-2441	32	22	disease	disease	NOUN
ajlsi-2441	32	23	progression	progression	NOUN
ajlsi-2441	32	24	patterns	pattern	NOUN
ajlsi-2441	32	25	.	.	PUNCT
ajlsi-2441	33	1	this	this	DET
ajlsi-2441	33	2	study	study	NOUN
ajlsi-2441	33	3	aims	aim	VERB
ajlsi-2441	33	4	to	to	PART
ajlsi-2441	33	5	scrutinize	scrutinize	VERB
ajlsi-2441	33	6	the	the	DET
ajlsi-2441	33	7	red	red	ADJ
ajlsi-2441	33	8	cell	cell	NOUN
ajlsi-2441	33	9	distribution	distribution	NOUN
ajlsi-2441	33	10	width	width	NOUN
ajlsi-2441	33	11	to	to	PART
ajlsi-2441	33	12	platelet	platelet	NOUN
ajlsi-2441	33	13	ratio	ratio	NOUN
ajlsi-2441	33	14	(	(	PUNCT
ajlsi-2441	33	15	rdw	rdw	X
ajlsi-2441	33	16	/	/	SYM
ajlsi-2441	33	17	plt	plt	NOUN
ajlsi-2441	33	18	)	)	PUNCT
ajlsi-2441	33	19	as	as	ADP
ajlsi-2441	33	20	a	a	DET
ajlsi-2441	33	21	potential	potential	ADJ
ajlsi-2441	33	22	harbinger	harbinger	NOUN
ajlsi-2441	33	23	of	of	ADP
ajlsi-2441	33	24	the	the	DET
ajlsi-2441	33	25	progression	progression	NOUN
ajlsi-2441	33	26	of	of	ADP
ajlsi-2441	33	27	covid-19	covid-19	PROPN
ajlsi-2441	33	28	pneumonia	pneumonia	NOUN
ajlsi-2441	33	29	from	from	ADP
ajlsi-2441	33	30	moderate	moderate	ADJ
ajlsi-2441	33	31	to	to	ADP
ajlsi-2441	33	32	severe	severe	ADJ
ajlsi-2441	33	33	stages	stage	NOUN
ajlsi-2441	33	34	.	.	PUNCT
ajlsi-2441	34	1	amid	amid	ADP
ajlsi-2441	34	2	the	the	DET
ajlsi-2441	34	3	diverse	diverse	ADJ
ajlsi-2441	34	4	clinical	clinical	ADJ
ajlsi-2441	34	5	manifestations	manifestation	NOUN
ajlsi-2441	34	6	and	and	CCONJ
ajlsi-2441	34	7	trajectories	trajectory	NOUN
ajlsi-2441	34	8	observed	observe	VERB
ajlsi-2441	34	9	in	in	ADP
ajlsi-2441	34	10	covid-19	covid-19	PROPN
ajlsi-2441	34	11	cases	case	NOUN
ajlsi-2441	34	12	,	,	PUNCT
ajlsi-2441	34	13	identifying	identify	VERB
ajlsi-2441	34	14	specific	specific	ADJ
ajlsi-2441	34	15	markers	marker	NOUN
ajlsi-2441	34	16	that	that	PRON
ajlsi-2441	34	17	herald	herald	PROPN
ajlsi-2441	34	18	a	a	DET
ajlsi-2441	34	19	transition	transition	NOUN
ajlsi-2441	34	20	to	to	ADP
ajlsi-2441	34	21	severe	severe	ADJ
ajlsi-2441	34	22	illness	illness	NOUN
ajlsi-2441	34	23	holds	hold	VERB
ajlsi-2441	34	24	paramount	paramount	ADJ
ajlsi-2441	34	25	importance	importance	NOUN
ajlsi-2441	34	26	in	in	ADP
ajlsi-2441	34	27	clinical	clinical	ADJ
ajlsi-2441	34	28	management	management	NOUN
ajlsi-2441	34	29	and	and	CCONJ
ajlsi-2441	34	30	resource	resource	NOUN
ajlsi-2441	34	31	allocation	allocation	NOUN
ajlsi-2441	34	32	.	.	PUNCT
ajlsi-2441	35	1	this	this	DET
ajlsi-2441	35	2	study	study	NOUN
ajlsi-2441	35	3	endeavors	endeavor	NOUN
ajlsi-2441	35	4	to	to	PART
ajlsi-2441	35	5	bridge	bridge	VERB
ajlsi-2441	35	6	an	an	DET
ajlsi-2441	35	7	essential	essential	ADJ
ajlsi-2441	35	8	knowledge	knowledge	NOUN
ajlsi-2441	35	9	gap	gap	NOUN
ajlsi-2441	35	10	in	in	ADP
ajlsi-2441	35	11	understanding	understand	VERB
ajlsi-2441	35	12	covid-19	covid-19	PROPN
ajlsi-2441	35	13	prognosis	prognosis	NOUN
ajlsi-2441	35	14	by	by	ADP
ajlsi-2441	35	15	exploring	explore	VERB
ajlsi-2441	35	16	rdw	rdw	ADJ
ajlsi-2441	35	17	/	/	SYM
ajlsi-2441	35	18	plt	plt	NOUN
ajlsi-2441	35	19	as	as	ADP
ajlsi-2441	35	20	a	a	DET
ajlsi-2441	35	21	potential	potential	ADJ
ajlsi-2441	35	22	predictive	predictive	ADJ
ajlsi-2441	35	23	biomarker	biomarker	NOUN
ajlsi-2441	35	24	.	.	PUNCT
ajlsi-2441	36	1	beyond	beyond	ADP
ajlsi-2441	36	2	establishing	establish	VERB
ajlsi-2441	36	3	its	its	PRON
ajlsi-2441	36	4	association	association	NOUN
ajlsi-2441	36	5	with	with	ADP
ajlsi-2441	36	6	disease	disease	NOUN
ajlsi-2441	36	7	progression	progression	NOUN
ajlsi-2441	36	8	,	,	PUNCT
ajlsi-2441	36	9	the	the	DET
ajlsi-2441	36	10	comprehensive	comprehensive	ADJ
ajlsi-2441	36	11	investigation	investigation	NOUN
ajlsi-2441	36	12	aims	aim	VERB
ajlsi-2441	36	13	to	to	PART
ajlsi-2441	36	14	lay	lay	VERB
ajlsi-2441	36	15	the	the	DET
ajlsi-2441	36	16	groundwork	groundwork	NOUN
ajlsi-2441	36	17	for	for	ADP
ajlsi-2441	36	18	its	its	PRON
ajlsi-2441	36	19	potential	potential	ADJ
ajlsi-2441	36	20	clinical	clinical	ADJ
ajlsi-2441	36	21	utility	utility	NOUN
ajlsi-2441	36	22	,	,	PUNCT
ajlsi-2441	36	23	stressing	stress	VERB
ajlsi-2441	36	24	the	the	DET
ajlsi-2441	36	25	necessity	necessity	NOUN
ajlsi-2441	36	26	for	for	ADP
ajlsi-2441	36	27	robust	robust	ADJ
ajlsi-2441	36	28	validation	validation	NOUN
ajlsi-2441	36	29	and	and	CCONJ
ajlsi-2441	36	30	integration	integration	NOUN
ajlsi-2441	36	31	of	of	ADP
ajlsi-2441	36	32	rdw	rdw	X
ajlsi-2441	36	33	/	/	SYM
ajlsi-2441	36	34	plt	plt	NOUN
ajlsi-2441	36	35	into	into	ADP
ajlsi-2441	36	36	existing	exist	VERB
ajlsi-2441	36	37	prognostic	prognostic	ADJ
ajlsi-2441	36	38	frameworks	framework	NOUN
ajlsi-2441	36	39	.	.	PUNCT
ajlsi-2441	37	1	literature	literature	NOUN
ajlsi-2441	37	2	review	review	PROPN
ajlsi-2441	37	3	covid-19	covid-19	PROPN
ajlsi-2441	37	4	pathophysiology	pathophysiology	NOUN
ajlsi-2441	37	5	and	and	CCONJ
ajlsi-2441	37	6	prognostic	prognostic	ADJ
ajlsi-2441	37	7	markers	marker	NOUN
ajlsi-2441	37	8	the	the	DET
ajlsi-2441	37	9	clinical	clinical	ADJ
ajlsi-2441	37	10	spectrum	spectrum	NOUN
ajlsi-2441	37	11	of	of	ADP
ajlsi-2441	37	12	covid-19	covid-19	PROPN
ajlsi-2441	37	13	,	,	PUNCT
ajlsi-2441	37	14	which	which	PRON
ajlsi-2441	37	15	is	be	AUX
ajlsi-2441	37	16	caused	cause	VERB
ajlsi-2441	37	17	by	by	ADP
ajlsi-2441	37	18	sars	sar	NOUN
ajlsi-2441	37	19	-	-	PUNCT
ajlsi-2441	37	20	cov-2	cov-2	NOUN
ajlsi-2441	37	21	,	,	PUNCT
ajlsi-2441	37	22	is	be	AUX
ajlsi-2441	37	23	varied	varied	ADJ
ajlsi-2441	37	24	and	and	CCONJ
ajlsi-2441	37	25	ranges	range	VERB
ajlsi-2441	37	26	from	from	ADP
ajlsi-2441	37	27	mild	mild	ADJ
ajlsi-2441	37	28	respiratory	respiratory	ADJ
ajlsi-2441	37	29	symptoms	symptom	NOUN
ajlsi-2441	37	30	to	to	ADP
ajlsi-2441	37	31	severe	severe	ADJ
ajlsi-2441	37	32	pneumonia	pneumonia	NOUN
ajlsi-2441	37	33	and	and	CCONJ
ajlsi-2441	37	34	multiorgan	multiorgan	NOUN
ajlsi-2441	37	35	dysfunction	dysfunction	NOUN
ajlsi-2441	37	36	.	.	PUNCT
ajlsi-2441	38	1	finding	find	VERB
ajlsi-2441	38	2	trustworthy	trustworthy	ADJ
ajlsi-2441	38	3	prognostic	prognostic	ADJ
ajlsi-2441	38	4	markers	marker	NOUN
ajlsi-2441	38	5	requires	require	VERB
ajlsi-2441	38	6	an	an	DET
ajlsi-2441	38	7	understanding	understanding	NOUN
ajlsi-2441	38	8	of	of	ADP
ajlsi-2441	38	9	the	the	DET
ajlsi-2441	38	10	complex	complex	ADJ
ajlsi-2441	38	11	pathophysiological	pathophysiological	ADJ
ajlsi-2441	38	12	mechanisms	mechanism	NOUN
ajlsi-2441	38	13	guiding	guide	VERB
ajlsi-2441	38	14	the	the	DET
ajlsi-2441	38	15	course	course	NOUN
ajlsi-2441	38	16	of	of	ADP
ajlsi-2441	38	17	the	the	DET
ajlsi-2441	38	18	disease	disease	NOUN
ajlsi-2441	38	19	(	(	PUNCT
ajlsi-2441	38	20	huang	huang	PROPN
ajlsi-2441	38	21	et	et	PROPN
ajlsi-2441	38	22	al	al	PROPN
ajlsi-2441	38	23	.	.	PROPN
ajlsi-2441	38	24	,	,	PUNCT
ajlsi-2441	38	25	2020	2020	NUM
ajlsi-2441	38	26	;	;	PUNCT
ajlsi-2441	38	27	zhang	zhang	PROPN
ajlsi-2441	38	28	et	et	PROPN
ajlsi-2441	38	29	al	al	PROPN
ajlsi-2441	38	30	.	.	PROPN
ajlsi-2441	38	31	,	,	PUNCT
ajlsi-2441	38	32	2020	2020	NUM
ajlsi-2441	38	33	)	)	PUNCT
ajlsi-2441	38	34	.	.	PUNCT
ajlsi-2441	39	1	research	research	NOUN
ajlsi-2441	39	2	into	into	ADP
ajlsi-2441	39	3	markers	marker	NOUN
ajlsi-2441	39	4	that	that	PRON
ajlsi-2441	39	5	reflect	reflect	VERB
ajlsi-2441	39	6	this	this	DET
ajlsi-2441	39	7	dysregulation	dysregulation	NOUN
ajlsi-2441	39	8	has	have	AUX
ajlsi-2441	39	9	been	be	AUX
ajlsi-2441	39	10	prompted	prompt	VERB
ajlsi-2441	39	11	by	by	ADP
ajlsi-2441	39	12	emerging	emerge	VERB
ajlsi-2441	39	13	evidence	evidence	NOUN
ajlsi-2441	39	14	that	that	PRON
ajlsi-2441	39	15	points	point	VERB
ajlsi-2441	39	16	to	to	ADP
ajlsi-2441	39	17	a	a	DET
ajlsi-2441	39	18	dysregulated	dysregulated	ADJ
ajlsi-2441	39	19	immune	immune	ADJ
ajlsi-2441	39	20	response	response	NOUN
ajlsi-2441	39	21	and	and	CCONJ
ajlsi-2441	39	22	an	an	DET
ajlsi-2441	39	23	elevated	elevated	ADJ
ajlsi-2441	39	24	inflammatory	inflammatory	ADJ
ajlsi-2441	39	25	cascade	cascade	NOUN
ajlsi-2441	39	26	as	as	ADP
ajlsi-2441	39	27	indicators	indicator	NOUN
ajlsi-2441	39	28	of	of	ADP
ajlsi-2441	39	29	severe	severe	ADJ
ajlsi-2441	39	30	disease	disease	NOUN
ajlsi-2441	39	31	(	(	PUNCT
ajlsi-2441	39	32	levi	levi	PROPN
ajlsi-2441	39	33	et	et	PROPN
ajlsi-2441	39	34	al	al	PROPN
ajlsi-2441	39	35	.	.	PROPN
ajlsi-2441	39	36	,	,	PUNCT
ajlsi-2441	39	37	2020	2020	NUM
ajlsi-2441	39	38	;	;	PUNCT
ajlsi-2441	39	39	tay	tay	PROPN
ajlsi-2441	39	40	et	et	PROPN
ajlsi-2441	39	41	al	al	PROPN
ajlsi-2441	39	42	.	.	PROPN
ajlsi-2441	39	43	,	,	PUNCT
ajlsi-2441	39	44	2020	2020	NUM
ajlsi-2441	39	45	)	)	PUNCT
ajlsi-2441	39	46	.	.	PUNCT
ajlsi-2441	40	1	red	red	ADJ
ajlsi-2441	40	2	cell	cell	NOUN
ajlsi-2441	40	3	distribution	distribution	NOUN
ajlsi-2441	40	4	width	width	NOUN
ajlsi-2441	40	5	(	(	PUNCT
ajlsi-2441	40	6	rdw	rdw	NOUN
ajlsi-2441	40	7	)	)	PUNCT
ajlsi-2441	40	8	and	and	CCONJ
ajlsi-2441	40	9	platelet	platelet	NOUN
ajlsi-2441	40	10	count	count	NOUN
ajlsi-2441	40	11	(	(	PUNCT
ajlsi-2441	40	12	plt	plt	NOUN
ajlsi-2441	40	13	)	)	PUNCT
ajlsi-2441	40	14	in	in	ADP
ajlsi-2441	40	15	disease	disease	NOUN
ajlsi-2441	40	16	evaluation	evaluation	NOUN
ajlsi-2441	40	17	rdw	rdw	NOUN
ajlsi-2441	40	18	,	,	PUNCT
ajlsi-2441	40	19	traditionally	traditionally	ADV
ajlsi-2441	40	20	a	a	DET
ajlsi-2441	40	21	marker	marker	NOUN
ajlsi-2441	40	22	of	of	ADP
ajlsi-2441	40	23	red	red	ADJ
ajlsi-2441	40	24	blood	blood	NOUN
ajlsi-2441	40	25	cell	cell	NOUN
ajlsi-2441	40	26	size	size	NOUN
ajlsi-2441	40	27	heterogeneity	heterogeneity	NOUN
ajlsi-2441	40	28	,	,	PUNCT
ajlsi-2441	40	29	has	have	AUX
ajlsi-2441	40	30	garnered	garner	VERB
ajlsi-2441	40	31	attention	attention	NOUN
ajlsi-2441	40	32	beyond	beyond	ADP
ajlsi-2441	40	33	its	its	PRON
ajlsi-2441	40	34	conventional	conventional	ADJ
ajlsi-2441	40	35	utility	utility	NOUN
ajlsi-2441	40	36	.	.	PUNCT
ajlsi-2441	41	1	it	it	PRON
ajlsi-2441	41	2	has	have	AUX
ajlsi-2441	41	3	been	be	AUX
ajlsi-2441	41	4	linked	link	VERB
ajlsi-2441	41	5	to	to	ADP
ajlsi-2441	41	6	systemic	systemic	ADJ
ajlsi-2441	41	7	inflammation	inflammation	NOUN
ajlsi-2441	41	8	and	and	CCONJ
ajlsi-2441	41	9	adverse	adverse	ADJ
ajlsi-2441	41	10	outcomes	outcome	NOUN
ajlsi-2441	41	11	in	in	ADP
ajlsi-2441	41	12	various	various	ADJ
ajlsi-2441	41	13	pathological	pathological	ADJ
ajlsi-2441	41	14	conditions	condition	NOUN
ajlsi-2441	41	15	(	(	PUNCT
ajlsi-2441	41	16	lippi	lippi	PROPN
ajlsi-2441	41	17	&	&	CCONJ
ajlsi-2441	41	18	mattiuzzi	mattiuzzi	PROPN
ajlsi-2441	41	19	,	,	PUNCT
ajlsi-2441	41	20	2020	2020	NUM
ajlsi-2441	41	21	;	;	PUNCT
ajlsi-2441	41	22	patel	patel	PROPN
ajlsi-2441	41	23	et	et	PROPN
ajlsi-2441	41	24	al	al	PROPN
ajlsi-2441	41	25	.	.	PROPN
ajlsi-2441	41	26	,	,	PUNCT
ajlsi-2441	41	27	2015	2015	NUM
ajlsi-2441	41	28	)	)	PUNCT
ajlsi-2441	41	29	.	.	PUNCT
ajlsi-2441	42	1	in	in	ADP
ajlsi-2441	42	2	the	the	DET
ajlsi-2441	42	3	context	context	NOUN
ajlsi-2441	42	4	of	of	ADP
ajlsi-2441	42	5	covid-19	covid-19	PROPN
ajlsi-2441	42	6	,	,	PUNCT
ajlsi-2441	42	7	elevated	elevated	ADJ
ajlsi-2441	42	8	rdw	rdw	ADJ
ajlsi-2441	42	9	levels	level	NOUN
ajlsi-2441	42	10	have	have	AUX
ajlsi-2441	42	11	been	be	AUX
ajlsi-2441	42	12	observed	observe	VERB
ajlsi-2441	42	13	and	and	CCONJ
ajlsi-2441	42	14	correlated	correlate	VERB
ajlsi-2441	42	15	with	with	ADP
ajlsi-2441	42	16	disease	disease	NOUN
ajlsi-2441	42	17	severity	severity	NOUN
ajlsi-2441	42	18	,	,	PUNCT
ajlsi-2441	42	19	possibly	possibly	ADV
ajlsi-2441	42	20	reflecting	reflect	VERB
ajlsi-2441	42	21	underlying	underlie	VERB
ajlsi-2441	42	22	inflammatory	inflammatory	ADJ
ajlsi-2441	42	23	processes	process	NOUN
ajlsi-2441	42	24	and	and	CCONJ
ajlsi-2441	42	25	physiological	physiological	ADJ
ajlsi-2441	42	26	stress	stress	NOUN
ajlsi-2441	42	27	(	(	PUNCT
ajlsi-2441	42	28	foy	foy	PROPN
ajlsi-2441	42	29	et	et	PROPN
ajlsi-2441	42	30	al	al	PROPN
ajlsi-2441	42	31	.	.	PROPN
ajlsi-2441	42	32	,	,	PUNCT
ajlsi-2441	42	33	2020a	2020a	NUM
ajlsi-2441	42	34	;	;	PUNCT
ajlsi-2441	42	35	lippi	lippi	PROPN
ajlsi-2441	42	36	&	&	CCONJ
ajlsi-2441	42	37	plebani	plebani	PROPN
ajlsi-2441	42	38	,	,	PUNCT
ajlsi-2441	42	39	2020	2020	NUM
ajlsi-2441	42	40	)	)	PUNCT
ajlsi-2441	42	41	.	.	PUNCT
ajlsi-2441	43	1	similarly	similarly	ADV
ajlsi-2441	43	2	,	,	PUNCT
ajlsi-2441	43	3	alterations	alteration	NOUN
ajlsi-2441	43	4	in	in	ADP
ajlsi-2441	43	5	platelet	platelet	NOUN
ajlsi-2441	43	6	count	count	NOUN
ajlsi-2441	43	7	(	(	PUNCT
ajlsi-2441	43	8	plt	plt	NOUN
ajlsi-2441	43	9	)	)	PUNCT
ajlsi-2441	43	10	have	have	AUX
ajlsi-2441	43	11	been	be	AUX
ajlsi-2441	43	12	implicated	implicate	VERB
ajlsi-2441	43	13	in	in	ADP
ajlsi-2441	43	14	covid-19	covid-19	PROPN
ajlsi-2441	43	15	pathogenesis	pathogenesis	NOUN
ajlsi-2441	43	16	,	,	PUNCT
ajlsi-2441	43	17	with	with	ADP
ajlsi-2441	43	18	thrombocytopenia	thrombocytopenia	PROPN
ajlsi-2441	43	19	often	often	ADV
ajlsi-2441	43	20	associated	associate	VERB
ajlsi-2441	43	21	with	with	ADP
ajlsi-2441	43	22	severe	severe	ADJ
ajlsi-2441	43	23	disease	disease	NOUN
ajlsi-2441	43	24	and	and	CCONJ
ajlsi-2441	43	25	adverse	adverse	ADJ
ajlsi-2441	43	26	clinical	clinical	ADJ
ajlsi-2441	43	27	outcomes	outcome	NOUN
ajlsi-2441	43	28	(	(	PUNCT
ajlsi-2441	43	29	althaus	althaus	PROPN
ajlsi-2441	43	30	et	et	PROPN
ajlsi-2441	43	31	al	al	PROPN
ajlsi-2441	43	32	.	.	PROPN
ajlsi-2441	43	33	,	,	PUNCT
ajlsi-2441	43	34	2021	2021	NUM
ajlsi-2441	43	35	;	;	PUNCT
ajlsi-2441	44	1	xu	xu	PROPN
ajlsi-2441	44	2	et	et	PROPN
ajlsi-2441	44	3	al	al	PROPN
ajlsi-2441	44	4	.	.	PROPN
ajlsi-2441	44	5	,	,	PUNCT
ajlsi-2441	44	6	2020	2020	NUM
ajlsi-2441	44	7	)	)	PUNCT
ajlsi-2441	44	8	.	.	PUNCT
ajlsi-2441	45	1	rdw	rdw	PROPN
ajlsi-2441	45	2	/	/	SYM
ajlsi-2441	45	3	plt	plt	NOUN
ajlsi-2441	45	4	ratio	ratio	NOUN
ajlsi-2441	45	5	as	as	ADP
ajlsi-2441	45	6	a	a	DET
ajlsi-2441	45	7	potential	potential	NOUN
ajlsi-2441	45	8	biomarker	biomarker	NOUN
ajlsi-2441	45	9	the	the	DET
ajlsi-2441	45	10	integration	integration	NOUN
ajlsi-2441	45	11	of	of	ADP
ajlsi-2441	45	12	rdw	rdw	NOUN
ajlsi-2441	45	13	and	and	CCONJ
ajlsi-2441	45	14	plt	plt	NOUN
ajlsi-2441	45	15	into	into	ADP
ajlsi-2441	45	16	the	the	DET
ajlsi-2441	45	17	rdw	rdw	NOUN
ajlsi-2441	45	18	/	/	SYM
ajlsi-2441	45	19	plt	plt	NOUN
ajlsi-2441	45	20	ratio	ratio	NOUN
ajlsi-2441	45	21	represents	represent	VERB
ajlsi-2441	45	22	a	a	DET
ajlsi-2441	45	23	composite	composite	ADJ
ajlsi-2441	45	24	marker	marker	NOUN
ajlsi-2441	45	25	that	that	PRON
ajlsi-2441	45	26	may	may	AUX
ajlsi-2441	45	27	hold	hold	VERB
ajlsi-2441	45	28	significant	significant	ADJ
ajlsi-2441	45	29	prognostic	prognostic	ADJ
ajlsi-2441	45	30	value	value	NOUN
ajlsi-2441	45	31	in	in	ADP
ajlsi-2441	45	32	covid-19	covid-19	PROPN
ajlsi-2441	45	33	.	.	PUNCT
ajlsi-2441	46	1	previous	previous	ADJ
ajlsi-2441	46	2	studies	study	NOUN
ajlsi-2441	46	3	across	across	ADP
ajlsi-2441	46	4	various	various	ADJ
ajlsi-2441	46	5	medical	medical	ADJ
ajlsi-2441	46	6	conditions	condition	NOUN
ajlsi-2441	46	7	have	have	AUX
ajlsi-2441	46	8	demonstrated	demonstrate	VERB
ajlsi-2441	46	9	the	the	DET
ajlsi-2441	46	10	potential	potential	NOUN
ajlsi-2441	46	11	of	of	ADP
ajlsi-2441	46	12	rdw	rdw	X
ajlsi-2441	46	13	/	/	SYM
ajlsi-2441	46	14	plt	plt	NOUN
ajlsi-2441	46	15	as	as	ADP
ajlsi-2441	46	16	a	a	DET
ajlsi-2441	46	17	prognostic	prognostic	ADJ
ajlsi-2441	46	18	indicator	indicator	NOUN
ajlsi-2441	46	19	,	,	PUNCT
ajlsi-2441	46	20	reflecting	reflect	VERB
ajlsi-2441	46	21	systemic	systemic	ADJ
ajlsi-2441	46	22	inflammation	inflammation	NOUN
ajlsi-2441	46	23	and	and	CCONJ
ajlsi-2441	46	24	disease	disease	NOUN
ajlsi-2441	46	25	severity	severity	NOUN
ajlsi-2441	46	26	(	(	PUNCT
ajlsi-2441	46	27	zhou	zhou	X
ajlsi-2441	46	28	et	et	PROPN
ajlsi-2441	46	29	al	al	PROPN
ajlsi-2441	46	30	.	.	PROPN
ajlsi-2441	46	31	,	,	PUNCT
ajlsi-2441	46	32	2020	2020	NUM
ajlsi-2441	46	33	;	;	PUNCT
ajlsi-2441	46	34	zorlu	zorlu	NOUN
ajlsi-2441	46	35	et	et	PROPN
ajlsi-2441	46	36	al	al	PROPN
ajlsi-2441	46	37	.	.	PROPN
ajlsi-2441	46	38	,	,	PUNCT
ajlsi-2441	46	39	2012	2012	NUM
ajlsi-2441	46	40	)	)	PUNCT
ajlsi-2441	46	41	.	.	PUNCT
ajlsi-2441	47	1	applying	apply	VERB
ajlsi-2441	47	2	this	this	DET
ajlsi-2441	47	3	ratio	ratio	NOUN
ajlsi-2441	47	4	specifically	specifically	ADV
ajlsi-2441	47	5	in	in	ADP
ajlsi-2441	47	6	covid-19	covid-19	PROPN
ajlsi-2441	47	7	patients	patient	NOUN
ajlsi-2441	47	8	presents	present	VERB
ajlsi-2441	47	9	a	a	DET
ajlsi-2441	47	10	novel	novel	ADJ
ajlsi-2441	47	11	approach	approach	NOUN
ajlsi-2441	47	12	to	to	PART
ajlsi-2441	47	13	anticipate	anticipate	VERB
ajlsi-2441	47	14	disease	disease	NOUN
ajlsi-2441	47	15	progression	progression	NOUN
ajlsi-2441	47	16	and	and	CCONJ
ajlsi-2441	47	17	severity	severity	NOUN
ajlsi-2441	47	18	.	.	PUNCT
ajlsi-2441	48	1	clinical	clinical	ADJ
ajlsi-2441	48	2	studies	study	NOUN
ajlsi-2441	48	3	investigating	investigate	VERB
ajlsi-2441	48	4	rdw	rdw	ADJ
ajlsi-2441	48	5	/	/	SYM
ajlsi-2441	48	6	plt	plt	NOUN
ajlsi-2441	48	7	in	in	ADP
ajlsi-2441	48	8	covid-19	covid-19	PROPN
ajlsi-2441	48	9	rdw	rdw	X
ajlsi-2441	48	10	/	/	SYM
ajlsi-2441	48	11	plt	plt	NOUN
ajlsi-2441	48	12	’s	’s	PART
ajlsi-2441	48	13	function	function	NOUN
ajlsi-2441	48	14	in	in	ADP
ajlsi-2441	48	15	covid-19	covid-19	PROPN
ajlsi-2441	48	16	prognosis	prognosis	NOUN
ajlsi-2441	48	17	has	have	AUX
ajlsi-2441	48	18	been	be	AUX
ajlsi-2441	48	19	specifically	specifically	ADV
ajlsi-2441	48	20	examined	examine	VERB
ajlsi-2441	48	21	in	in	ADP
ajlsi-2441	48	22	recent	recent	ADJ
ajlsi-2441	48	23	clinical	clinical	ADJ
ajlsi-2441	48	24	studies	study	NOUN
ajlsi-2441	48	25	.	.	PUNCT
ajlsi-2441	49	1	as	as	ADP
ajlsi-2441	49	2	an	an	DET
ajlsi-2441	49	3	illustration	illustration	NOUN
ajlsi-2441	49	4	of	of	ADP
ajlsi-2441	49	5	its	its	PRON
ajlsi-2441	49	6	potential	potential	NOUN
ajlsi-2441	49	7	as	as	ADP
ajlsi-2441	49	8	a	a	DET
ajlsi-2441	49	9	predictive	predictive	ADJ
ajlsi-2441	49	10	marker	marker	NOUN
ajlsi-2441	49	11	for	for	ADP
ajlsi-2441	49	12	disease	disease	NOUN
ajlsi-2441	49	13	severity	severity	NOUN
ajlsi-2441	49	14	,	,	PUNCT
ajlsi-2441	49	15	a	a	DET
ajlsi-2441	49	16	study	study	NOUN
ajlsi-2441	49	17	by	by	ADP
ajlsi-2441	49	18	wang	wang	PROPN
ajlsi-2441	49	19	et	et	PROPN
ajlsi-2441	49	20	al	al	PROPN
ajlsi-2441	49	21	.	.	PROPN
ajlsi-2441	49	22	,	,	PUNCT
ajlsi-2441	49	23	2020	2020	NUM
ajlsi-2441	49	24	found	find	VERB
ajlsi-2441	49	25	that	that	SCONJ
ajlsi-2441	49	26	severe	severe	ADJ
ajlsi-2441	49	27	covid-19	covid-19	PROPN
ajlsi-2441	49	28	cases	case	NOUN
ajlsi-2441	49	29	had	have	VERB
ajlsi-2441	49	30	noticeably	noticeably	ADV
ajlsi-2441	49	31	higher	high	ADJ
ajlsi-2441	49	32	rdw	rdw	X
ajlsi-2441	49	33	/	/	SYM
ajlsi-2441	49	34	plt	plt	NOUN
ajlsi-2441	49	35	ratios	ratio	NOUN
ajlsi-2441	49	36	than	than	ADP
ajlsi-2441	49	37	moderate	moderate	ADJ
ajlsi-2441	49	38	cases	case	NOUN
ajlsi-2441	49	39	(	(	PUNCT
ajlsi-2441	49	40	wang	wang	PROPN
ajlsi-2441	49	41	et	et	PROPN
ajlsi-2441	49	42	al	al	PROPN
ajlsi-2441	49	43	.	.	PROPN
ajlsi-2441	49	44	,	,	PUNCT
ajlsi-2441	49	45	2022	2022	NUM
ajlsi-2441	49	46	)	)	PUNCT
ajlsi-2441	49	47	.	.	PUNCT
ajlsi-2441	50	1	similarly	similarly	ADV
ajlsi-2441	50	2	,	,	PUNCT
ajlsi-2441	50	3	in	in	ADP
ajlsi-2441	50	4	a	a	DET
ajlsi-2441	50	5	retrospective	retrospective	ADJ
ajlsi-2441	50	6	analysis	analysis	NOUN
ajlsi-2441	50	7	,	,	PUNCT
ajlsi-2441	50	8	kilercik	kilercik	PROPN
ajlsi-2441	50	9	et	et	PROPN
ajlsi-2441	50	10	al	al	PROPN
ajlsi-2441	50	11	.	.	PROPN
ajlsi-2441	50	12	,	,	PUNCT
ajlsi-2441	50	13	2021	2021	NUM
ajlsi-2441	50	14	found	find	VERB
ajlsi-2441	50	15	that	that	SCONJ
ajlsi-2441	50	16	in	in	ADP
ajlsi-2441	50	17	covid-19	covid-19	PROPN
ajlsi-2441	50	18	patients	patient	NOUN
ajlsi-2441	50	19	admitted	admit	VERB
ajlsi-2441	50	20	to	to	ADP
ajlsi-2441	50	21	intensive	intensive	ADJ
ajlsi-2441	50	22	care	care	NOUN
ajlsi-2441	50	23	units	unit	NOUN
ajlsi-2441	50	24	,	,	PUNCT
ajlsi-2441	50	25	high	high	ADJ
ajlsi-2441	50	26	rdw	rdw	ADJ
ajlsi-2441	50	27	/	/	SYM
ajlsi-2441	50	28	plt	plt	NOUN
ajlsi-2441	50	29	ratios	ratio	NOUN
ajlsi-2441	50	30	were	be	AUX
ajlsi-2441	50	31	associated	associate	VERB
ajlsi-2441	50	32	with	with	ADP
ajlsi-2441	50	33	unfavorable	unfavorable	ADJ
ajlsi-2441	50	34	outcomes	outcome	NOUN
ajlsi-2441	50	35	and	and	CCONJ
ajlsi-2441	50	36	severe	severe	ADJ
ajlsi-2441	50	37	disease	disease	NOUN
ajlsi-2441	50	38	(	(	PUNCT
ajlsi-2441	50	39	kilercik	kilercik	PROPN
ajlsi-2441	50	40	et	et	PROPN
ajlsi-2441	50	41	al	al	PROPN
ajlsi-2441	50	42	.	.	PROPN
ajlsi-2441	50	43	,	,	PUNCT
ajlsi-2441	50	44	2021	2021	NUM
ajlsi-2441	50	45	)	)	PUNCT
ajlsi-2441	50	46	.	.	PUNCT
ajlsi-2441	51	1	mechanistic	mechanistic	ADJ
ajlsi-2441	51	2	insights	insight	NOUN
ajlsi-2441	51	3	and	and	CCONJ
ajlsi-2441	51	4	future	future	ADJ
ajlsi-2441	51	5	directions	direction	NOUN
ajlsi-2441	51	6	elucidating	elucidate	VERB
ajlsi-2441	51	7	the	the	DET
ajlsi-2441	51	8	mechanistic	mechanistic	ADJ
ajlsi-2441	51	9	underpinnings	underpinning	NOUN
ajlsi-2441	51	10	of	of	ADP
ajlsi-2441	51	11	the	the	DET
ajlsi-2441	51	12	association	association	NOUN
ajlsi-2441	51	13	between	between	ADP
ajlsi-2441	51	14	elevated	elevate	VERB
ajlsi-2441	51	15	rdw	rdw	ADJ
ajlsi-2441	51	16	/	/	SYM
ajlsi-2441	51	17	plt	plt	NOUN
ajlsi-2441	51	18	ratios	ratio	NOUN
ajlsi-2441	51	19	and	and	CCONJ
ajlsi-2441	51	20	covid-19	covid-19	PROPN
ajlsi-2441	51	21	severity	severity	NOUN
ajlsi-2441	51	22	remains	remain	VERB
ajlsi-2441	51	23	a	a	DET
ajlsi-2441	51	24	critical	critical	ADJ
ajlsi-2441	51	25	area	area	NOUN
ajlsi-2441	51	26	for	for	ADP
ajlsi-2441	51	27	exploration	exploration	NOUN
ajlsi-2441	51	28	.	.	PUNCT
ajlsi-2441	52	1	factors	factor	NOUN
ajlsi-2441	52	2	such	such	ADJ
ajlsi-2441	52	3	as	as	ADP
ajlsi-2441	52	4	the	the	DET
ajlsi-2441	52	5	inflammatory	inflammatory	ADJ
ajlsi-2441	52	6	milieu	milieu	NOUN
ajlsi-2441	52	7	,	,	PUNCT
ajlsi-2441	52	8	endothelial	endothelial	ADJ
ajlsi-2441	52	9	dysfunction	dysfunction	NOUN
ajlsi-2441	52	10	,	,	PUNCT
ajlsi-2441	52	11	and	and	CCONJ
ajlsi-2441	52	12	potential	potential	ADJ
ajlsi-2441	52	13	interactions	interaction	NOUN
ajlsi-2441	52	14	between	between	ADP
ajlsi-2441	52	15	platelets	platelet	NOUN
ajlsi-2441	52	16	and	and	CCONJ
ajlsi-2441	52	17	red	red	ADJ
ajlsi-2441	52	18	blood	blood	NOUN
ajlsi-2441	52	19	cells	cell	NOUN
ajlsi-2441	52	20	might	might	AUX
ajlsi-2441	52	21	contribute	contribute	VERB
ajlsi-2441	52	22	to	to	ADP
ajlsi-2441	52	23	alterations	alteration	NOUN
ajlsi-2441	52	24	in	in	ADP
ajlsi-2441	52	25	rdw	rdw	ADJ
ajlsi-2441	52	26	/	/	SYM
ajlsi-2441	52	27	plt	plt	NOUN
ajlsi-2441	52	28	ratios	ratio	NOUN
ajlsi-2441	52	29	(	(	PUNCT
ajlsi-2441	52	30	henry	henry	PROPN
ajlsi-2441	52	31	,	,	PUNCT
ajlsi-2441	52	32	aggarwal	aggarwal	PROPN
ajlsi-2441	52	33	,	,	PUNCT
ajlsi-2441	52	34	et	et	PROPN
ajlsi-2441	52	35	al	al	PROPN
ajlsi-2441	52	36	.	.	PROPN
ajlsi-2441	52	37	,	,	PUNCT
ajlsi-2441	52	38	2020	2020	NUM
ajlsi-2441	52	39	;	;	PUNCT
ajlsi-2441	52	40	lippi	lippi	PROPN
ajlsi-2441	52	41	&	&	CCONJ
ajlsi-2441	52	42	favaloro	favaloro	PROPN
ajlsi-2441	52	43	,	,	PUNCT
ajlsi-2441	52	44	2020	2020	NUM
ajlsi-2441	52	45	)	)	PUNCT
ajlsi-2441	52	46	.	.	PUNCT
ajlsi-2441	53	1	future	future	ADJ
ajlsi-2441	53	2	research	research	NOUN
ajlsi-2441	53	3	endeavors	endeavor	NOUN
ajlsi-2441	53	4	should	should	AUX
ajlsi-2441	53	5	focus	focus	VERB
ajlsi-2441	53	6	on	on	ADP
ajlsi-2441	53	7	unravelling	unravel	VERB
ajlsi-2441	53	8	these	these	DET
ajlsi-2441	53	9	mechanisms	mechanism	NOUN
ajlsi-2441	53	10	and	and	CCONJ
ajlsi-2441	53	11	conducting	conduct	VERB
ajlsi-2441	53	12	prospective	prospective	ADJ
ajlsi-2441	53	13	trials	trial	NOUN
ajlsi-2441	53	14	to	to	PART
ajlsi-2441	53	15	validate	validate	VERB
ajlsi-2441	53	16	rdw	rdw	ADJ
ajlsi-2441	53	17	/	/	SYM
ajlsi-2441	53	18	plt	plt	NOUN
ajlsi-2441	53	19	as	as	ADP
ajlsi-2441	53	20	a	a	DET
ajlsi-2441	53	21	robust	robust	ADJ
ajlsi-2441	53	22	prognostic	prognostic	ADJ
ajlsi-2441	53	23	marker	marker	NOUN
ajlsi-2441	53	24	in	in	ADP
ajlsi-2441	53	25	covid-19	covid-19	PROPN
ajlsi-2441	53	26	.	.	PUNCT
ajlsi-2441	54	1	materials	material	NOUN
ajlsi-2441	54	2	and	and	CCONJ
ajlsi-2441	54	3	methods	method	NOUN
ajlsi-2441	54	4	study	study	VERB
ajlsi-2441	54	5	participants	participant	NOUN
ajlsi-2441	54	6	retrospective	retrospective	ADJ
ajlsi-2441	54	7	review	review	NOUN
ajlsi-2441	54	8	of	of	ADP
ajlsi-2441	54	9	patient	patient	ADJ
ajlsi-2441	54	10	medical	medical	ADJ
ajlsi-2441	54	11	records	record	NOUN
ajlsi-2441	54	12	from	from	ADP
ajlsi-2441	54	13	august	august	PROPN
ajlsi-2441	54	14	1	1	NUM
ajlsi-2441	54	15	,	,	PUNCT
ajlsi-2441	54	16	2021	2021	NUM
ajlsi-2441	54	17	,	,	PUNCT
ajlsi-2441	54	18	to	to	ADP
ajlsi-2441	54	19	march	march	PROPN
ajlsi-2441	54	20	1	1	NUM
ajlsi-2441	54	21	,	,	PUNCT
ajlsi-2441	54	22	2023	2023	NUM
ajlsi-2441	54	23	,	,	PUNCT
ajlsi-2441	54	24	at	at	ADP
ajlsi-2441	54	25	the	the	DET
ajlsi-2441	54	26	third	third	ADJ
ajlsi-2441	54	27	people	people	NOUN
ajlsi-2441	54	28	’s	’s	PART
ajlsi-2441	54	29	hospital	hospital	NOUN
ajlsi-2441	54	30	of	of	ADP
ajlsi-2441	54	31	yangzhou	yangzhou	PROPN
ajlsi-2441	54	32	and	and	CCONJ
ajlsi-2441	54	33	the	the	DET
ajlsi-2441	54	34	affiliated	affiliated	ADJ
ajlsi-2441	54	35	hospital	hospital	NOUN
ajlsi-2441	54	36	of	of	ADP
ajlsi-2441	54	37	xuzhou	xuzhou	PROPN
ajlsi-2441	54	38	medical	medical	PROPN
ajlsi-2441	54	39	university	university	PROPN
ajlsi-2441	54	40	was	be	AUX
ajlsi-2441	54	41	part	part	NOUN
ajlsi-2441	54	42	of	of	ADP
ajlsi-2441	54	43	the	the	DET
ajlsi-2441	54	44	study	study	NOUN
ajlsi-2441	54	45	.	.	PUNCT
ajlsi-2441	55	1	included	include	VERB
ajlsi-2441	55	2	were	be	AUX
ajlsi-2441	55	3	patients	patient	NOUN
ajlsi-2441	55	4	who	who	PRON
ajlsi-2441	55	5	had	have	AUX
ajlsi-2441	55	6	been	be	AUX
ajlsi-2441	55	7	diagnosed	diagnose	VERB
ajlsi-2441	55	8	with	with	ADP
ajlsi-2441	55	9	covid-19	covid-19	PROPN
ajlsi-2441	55	10	and	and	CCONJ
ajlsi-2441	55	11	initially	initially	ADV
ajlsi-2441	55	12	classified	classify	VERB
ajlsi-2441	55	13	as	as	ADP
ajlsi-2441	55	14	having	have	VERB
ajlsi-2441	55	15	a	a	DET
ajlsi-2441	55	16	moderate	moderate	ADJ
ajlsi-2441	55	17	illness	illness	NOUN
ajlsi-2441	55	18	.	.	PUNCT
ajlsi-2441	56	1	according	accord	VERB
ajlsi-2441	56	2	to	to	ADP
ajlsi-2441	56	3	the	the	DET
ajlsi-2441	56	4	world	world	PROPN
ajlsi-2441	56	5	health	health	PROPN
ajlsi-2441	56	6	organization	organization	PROPN
ajlsi-2441	56	7	’s	’s	PART
ajlsi-2441	56	8	interim	interim	ADJ
ajlsi-2441	56	9	guidelines	guideline	NOUN
ajlsi-2441	56	10	,	,	PUNCT
ajlsi-2441	56	11	confirmation	confirmation	NOUN
ajlsi-2441	56	12	of	of	ADP
ajlsi-2441	56	13	covid-19	covid-19	PROPN
ajlsi-2441	56	14	depended	depend	VERB
ajlsi-2441	56	15	on	on	ADP
ajlsi-2441	56	16	positive	positive	ADJ
ajlsi-2441	56	17	results	result	NOUN
ajlsi-2441	56	18	from	from	ADP
ajlsi-2441	56	19	high	high	ADJ
ajlsi-2441	56	20	-	-	PUNCT
ajlsi-2441	56	21	throughput	throughput	NOUN
ajlsi-2441	56	22	sequencing	sequencing	NOUN
ajlsi-2441	56	23	or	or	CCONJ
ajlsi-2441	56	24	real	real	ADJ
ajlsi-2441	56	25	-	-	PUNCT
ajlsi-2441	56	26	time	time	NOUN
ajlsi-2441	56	27	reverse	reverse	ADJ
ajlsi-2441	56	28	transcription	transcription	NOUN
ajlsi-2441	56	29	-	-	PUNCT
ajlsi-2441	56	30	polymerase	polymerase	NOUN
ajlsi-2441	56	31	chain	chain	NOUN
ajlsi-2441	56	32	reaction	reaction	NOUN
ajlsi-2441	56	33	(	(	PUNCT
ajlsi-2441	56	34	rt	rt	NOUN
ajlsi-2441	56	35	-	-	PUNCT
ajlsi-2441	56	36	pcr	pcr	NOUN
ajlsi-2441	56	37	)	)	PUNCT
ajlsi-2441	56	38	assays	assay	NOUN
ajlsi-2441	56	39	of	of	ADP
ajlsi-2441	56	40	nasal	nasal	NOUN
ajlsi-2441	56	41	and	and	CCONJ
ajlsi-2441	56	42	pharyngeal	pharyngeal	ADJ
ajlsi-2441	56	43	swab	swab	NOUN
ajlsi-2441	56	44	specimens	specimen	NOUN
ajlsi-2441	56	45	.	.	PUNCT
ajlsi-2441	57	1	following	follow	VERB
ajlsi-2441	57	2	admission	admission	NOUN
ajlsi-2441	57	3	,	,	PUNCT
ajlsi-2441	57	4	patients	patient	NOUN
ajlsi-2441	57	5	were	be	AUX
ajlsi-2441	57	6	observed	observe	VERB
ajlsi-2441	57	7	for	for	ADP
ajlsi-2441	57	8	at	at	ADV
ajlsi-2441	57	9	least	least	ADV
ajlsi-2441	57	10	14	14	NUM
ajlsi-2441	57	11	days	day	NOUN
ajlsi-2441	57	12	to	to	PART
ajlsi-2441	57	13	determine	determine	VERB
ajlsi-2441	57	14	whether	whether	SCONJ
ajlsi-2441	57	15	severe	severe	ADJ
ajlsi-2441	57	16	pneumonia	pneumonia	NOUN
ajlsi-2441	57	17	had	have	AUX
ajlsi-2441	57	18	developed	develop	VERB
ajlsi-2441	57	19	.	.	PUNCT
ajlsi-2441	58	1	pa	pa	PROPN
ajlsi-2441	58	2	ge	ge	PROPN
ajlsi-2441	58	3	30	30	NUM
ajlsi-2441	58	4	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	58	5	am	am	NOUN
ajlsi-2441	58	6	.	.	PUNCT
ajlsi-2441	59	1	j.	j.	PROPN
ajlsi-2441	59	2	life	life	PROPN
ajlsi-2441	59	3	sci	sci	PROPN
ajlsi-2441	59	4	.	.	PUNCT
ajlsi-2441	59	5	innov	innov	PROPN
ajlsi-2441	59	6	.	.	PUNCT
ajlsi-2441	60	1	3(1	3(1	NUM
ajlsi-2441	60	2	)	)	PUNCT
ajlsi-2441	60	3	28	28	NUM
ajlsi-2441	60	4	-	-	SYM
ajlsi-2441	60	5	36	36	NUM
ajlsi-2441	60	6	,	,	PUNCT
ajlsi-2441	60	7	2024	2024	NUM
ajlsi-2441	60	8	ethical	ethical	ADJ
ajlsi-2441	60	9	approval	approval	NOUN
ajlsi-2441	60	10	the	the	DET
ajlsi-2441	60	11	affiliated	affiliated	ADJ
ajlsi-2441	60	12	hospital	hospital	NOUN
ajlsi-2441	60	13	of	of	ADP
ajlsi-2441	60	14	xuzhou	xuzhou	PROPN
ajlsi-2441	60	15	medical	medical	PROPN
ajlsi-2441	60	16	university	university	PROPN
ajlsi-2441	60	17	’s	’s	PART
ajlsi-2441	60	18	ethics	ethic	NOUN
ajlsi-2441	60	19	committee	committee	PROPN
ajlsi-2441	60	20	approved	approve	VERB
ajlsi-2441	60	21	the	the	DET
ajlsi-2441	60	22	study	study	NOUN
ajlsi-2441	60	23	protocol	protocol	NOUN
ajlsi-2441	60	24	(	(	PUNCT
ajlsi-2441	60	25	protocol	protocol	NOUN
ajlsi-2441	60	26	i	i	PROPN
ajlsi-2441	60	27	d	d	PROPN
ajlsi-2441	60	28	:	:	PUNCT
ajlsi-2441	60	29	xyfy2022	xyfy2022	PROPN
ajlsi-2441	60	30	-	-	PUNCT
ajlsi-2441	60	31	kl034	kl034	PROPN
ajlsi-2441	60	32	-	-	PUNCT
ajlsi-2441	60	33	01	01	NUM
ajlsi-2441	60	34	)	)	PUNCT
ajlsi-2441	60	35	.	.	PUNCT
ajlsi-2441	61	1	data	datum	NOUN
ajlsi-2441	61	2	collection	collection	NOUN
ajlsi-2441	61	3	standardized	standardize	VERB
ajlsi-2441	61	4	data	datum	NOUN
ajlsi-2441	61	5	collection	collection	NOUN
ajlsi-2441	61	6	forms	form	NOUN
ajlsi-2441	61	7	were	be	AUX
ajlsi-2441	61	8	used	use	VERB
ajlsi-2441	61	9	to	to	PART
ajlsi-2441	61	10	gather	gather	VERB
ajlsi-2441	61	11	information	information	NOUN
ajlsi-2441	61	12	from	from	ADP
ajlsi-2441	61	13	electronic	electronic	ADJ
ajlsi-2441	61	14	medical	medical	ADJ
ajlsi-2441	61	15	records	record	NOUN
ajlsi-2441	61	16	about	about	ADP
ajlsi-2441	61	17	the	the	DET
ajlsi-2441	61	18	following	follow	VERB
ajlsi-2441	61	19	:	:	PUNCT
ajlsi-2441	61	20	demographics	demographic	NOUN
ajlsi-2441	61	21	(	(	PUNCT
ajlsi-2441	61	22	age	age	NOUN
ajlsi-2441	61	23	,	,	PUNCT
ajlsi-2441	61	24	gender	gender	NOUN
ajlsi-2441	61	25	)	)	PUNCT
ajlsi-2441	61	26	,	,	PUNCT
ajlsi-2441	61	27	comorbidities	comorbiditie	NOUN
ajlsi-2441	61	28	(	(	PUNCT
ajlsi-2441	61	29	diabetes	diabetes	NOUN
ajlsi-2441	61	30	,	,	PUNCT
ajlsi-2441	61	31	hypertension	hypertension	NOUN
ajlsi-2441	61	32	,	,	PUNCT
ajlsi-2441	61	33	coronary	coronary	ADJ
ajlsi-2441	61	34	heart	heart	NOUN
ajlsi-2441	61	35	disease	disease	NOUN
ajlsi-2441	61	36	)	)	PUNCT
ajlsi-2441	61	37	,	,	PUNCT
ajlsi-2441	61	38	and	and	CCONJ
ajlsi-2441	61	39	laboratory	laboratory	NOUN
ajlsi-2441	61	40	parameters	parameter	NOUN
ajlsi-2441	61	41	(	(	PUNCT
ajlsi-2441	61	42	such	such	ADJ
ajlsi-2441	61	43	as	as	ADP
ajlsi-2441	61	44	white	white	ADJ
ajlsi-2441	61	45	blood	blood	NOUN
ajlsi-2441	61	46	cell	cell	NOUN
ajlsi-2441	61	47	wbc	wbc	PROPN
ajlsi-2441	61	48	,	,	PUNCT
ajlsi-2441	61	49	lymphocyte	lymphocyte	NOUN
ajlsi-2441	61	50	ly	ly	NOUN
ajlsi-2441	61	51	,	,	PUNCT
ajlsi-2441	61	52	eosinophil	eosinophil	ADJ
ajlsi-2441	61	53	cell	cell	NOUN
ajlsi-2441	61	54	eos	eos	PROPN
ajlsi-2441	61	55	,	,	PUNCT
ajlsi-2441	61	56	platelet	platelet	NOUN
ajlsi-2441	61	57	plt	plt	NOUN
ajlsi-2441	61	58	,	,	PUNCT
ajlsi-2441	62	1	mean	mean	VERB
ajlsi-2441	62	2	platelet	platelet	NOUN
ajlsi-2441	62	3	volume	volume	NOUN
ajlsi-2441	62	4	mpv	mpv	PROPN
ajlsi-2441	62	5	,	,	PUNCT
ajlsi-2441	62	6	red	red	ADJ
ajlsi-2441	62	7	cell	cell	NOUN
ajlsi-2441	62	8	distribution	distribution	NOUN
ajlsi-2441	62	9	width	width	NOUN
ajlsi-2441	62	10	rdw	rdw	ADJ
ajlsi-2441	62	11	,	,	PUNCT
ajlsi-2441	62	12	red	red	ADJ
ajlsi-2441	62	13	cell	cell	NOUN
ajlsi-2441	62	14	distribution	distribution	NOUN
ajlsi-2441	62	15	width	width	NOUN
ajlsi-2441	62	16	to	to	PART
ajlsi-2441	62	17	platelet	platelet	VERB
ajlsi-2441	62	18	count	count	VERB
ajlsi-2441	62	19	ratio	ratio	NOUN
ajlsi-2441	62	20	rdw	rdw	X
ajlsi-2441	62	21	/	/	SYM
ajlsi-2441	62	22	plt	plt	NOUN
ajlsi-2441	62	23	,	,	PUNCT
ajlsi-2441	62	24	aspartate	aspartate	NOUN
ajlsi-2441	62	25	aminotransferase	aminotransferase	PROPN
ajlsi-2441	62	26	alt	alt	ADJ
ajlsi-2441	62	27	,	,	PUNCT
ajlsi-2441	62	28	alanine	alanine	NOUN
ajlsi-2441	62	29	aminotransferase	aminotransferase	PROPN
ajlsi-2441	62	30	alt	alt	ADJ
ajlsi-2441	62	31	,	,	PUNCT
ajlsi-2441	62	32	albumin	albumin	ADJ
ajlsi-2441	62	33	alb	alb	PROPN
ajlsi-2441	62	34	,	,	PUNCT
ajlsi-2441	62	35	creatinine	creatinine	PROPN
ajlsi-2441	62	36	crea	crea	NOUN
ajlsi-2441	62	37	,	,	PUNCT
ajlsi-2441	62	38	c	c	NOUN
ajlsi-2441	62	39	-	-	PUNCT
ajlsi-2441	62	40	reactive	reactive	ADJ
ajlsi-2441	62	41	protein	protein	NOUN
ajlsi-2441	62	42	crp	crp	PROPN
ajlsi-2441	62	43	,	,	PUNCT
ajlsi-2441	62	44	and	and	CCONJ
ajlsi-2441	62	45	interleukin-6	interleukin-6	PROPN
ajlsi-2441	62	46	il-6	il-6	NUM
ajlsi-2441	62	47	)	)	PUNCT
ajlsi-2441	62	48	.	.	PUNCT
ajlsi-2441	63	1	patients	patient	NOUN
ajlsi-2441	63	2	were	be	AUX
ajlsi-2441	63	3	categorized	categorize	VERB
ajlsi-2441	63	4	into	into	ADP
ajlsi-2441	63	5	the	the	DET
ajlsi-2441	63	6	progressive	progressive	ADJ
ajlsi-2441	63	7	group	group	NOUN
ajlsi-2441	63	8	(	(	PUNCT
ajlsi-2441	63	9	17	17	NUM
ajlsi-2441	63	10	cases	case	NOUN
ajlsi-2441	63	11	)	)	PUNCT
ajlsi-2441	63	12	and	and	CCONJ
ajlsi-2441	63	13	the	the	DET
ajlsi-2441	63	14	stable	stable	ADJ
ajlsi-2441	63	15	group	group	NOUN
ajlsi-2441	63	16	(	(	PUNCT
ajlsi-2441	63	17	36	36	NUM
ajlsi-2441	63	18	cases	case	NOUN
ajlsi-2441	63	19	)	)	PUNCT
ajlsi-2441	63	20	based	base	VERB
ajlsi-2441	63	21	on	on	ADP
ajlsi-2441	63	22	the	the	DET
ajlsi-2441	63	23	development	development	NOUN
ajlsi-2441	63	24	of	of	ADP
ajlsi-2441	63	25	severe	severe	ADJ
ajlsi-2441	63	26	illness	illness	NOUN
ajlsi-2441	63	27	within	within	ADP
ajlsi-2441	63	28	3	3	NUM
ajlsi-2441	63	29	days	day	NOUN
ajlsi-2441	63	30	post	post	ADJ
ajlsi-2441	63	31	-	-	ADJ
ajlsi-2441	63	32	sample	sample	ADJ
ajlsi-2441	63	33	collection	collection	NOUN
ajlsi-2441	63	34	.	.	PUNCT
ajlsi-2441	64	1	patients	patient	NOUN
ajlsi-2441	64	2	already	already	ADV
ajlsi-2441	64	3	categorized	categorize	VERB
ajlsi-2441	64	4	as	as	ADP
ajlsi-2441	64	5	severe	severe	ADJ
ajlsi-2441	64	6	at	at	ADP
ajlsi-2441	64	7	admission	admission	NOUN
ajlsi-2441	64	8	were	be	AUX
ajlsi-2441	64	9	excluded	exclude	VERB
ajlsi-2441	64	10	from	from	ADP
ajlsi-2441	64	11	statistical	statistical	ADJ
ajlsi-2441	64	12	analyses	analysis	NOUN
ajlsi-2441	64	13	.	.	PUNCT
ajlsi-2441	65	1	clinical	clinical	ADJ
ajlsi-2441	65	2	classification	classification	NOUN
ajlsi-2441	65	3	of	of	ADP
ajlsi-2441	65	4	covid-19	covid-19	PROPN
ajlsi-2441	65	5	pneumonia	pneumonia	NOUN
ajlsi-2441	65	6	based	base	VERB
ajlsi-2441	65	7	on	on	ADP
ajlsi-2441	65	8	the	the	DET
ajlsi-2441	65	9	severity	severity	NOUN
ajlsi-2441	65	10	of	of	ADP
ajlsi-2441	65	11	their	their	PRON
ajlsi-2441	65	12	illness	illness	NOUN
ajlsi-2441	65	13	,	,	PUNCT
ajlsi-2441	65	14	patients	patient	NOUN
ajlsi-2441	65	15	with	with	ADP
ajlsi-2441	65	16	covid-19	covid-19	PROPN
ajlsi-2441	65	17	pneumonia	pneumonia	NOUN
ajlsi-2441	65	18	were	be	AUX
ajlsi-2441	65	19	divided	divide	VERB
ajlsi-2441	65	20	into	into	ADP
ajlsi-2441	65	21	various	various	ADJ
ajlsi-2441	65	22	clinical	clinical	ADJ
ajlsi-2441	65	23	groups	group	NOUN
ajlsi-2441	65	24	in	in	ADP
ajlsi-2441	65	25	this	this	DET
ajlsi-2441	65	26	study	study	NOUN
ajlsi-2441	65	27	.	.	PUNCT
ajlsi-2441	66	1	a	a	DET
ajlsi-2441	66	2	decrease	decrease	NOUN
ajlsi-2441	66	3	in	in	ADP
ajlsi-2441	66	4	oxygen	oxygen	NOUN
ajlsi-2441	66	5	saturation	saturation	NOUN
ajlsi-2441	66	6	,	,	PUNCT
ajlsi-2441	66	7	aberrant	aberrant	ADJ
ajlsi-2441	66	8	chest	chest	NOUN
ajlsi-2441	66	9	imaging	imaging	NOUN
ajlsi-2441	66	10	,	,	PUNCT
ajlsi-2441	66	11	or	or	CCONJ
ajlsi-2441	66	12	the	the	DET
ajlsi-2441	66	13	manifestation	manifestation	NOUN
ajlsi-2441	66	14	of	of	ADP
ajlsi-2441	66	15	covid-19	covid-19	PROPN
ajlsi-2441	66	16	symptoms	symptom	NOUN
ajlsi-2441	66	17	without	without	ADP
ajlsi-2441	66	18	dyspnea	dyspnea	PROPN
ajlsi-2441	66	19	were	be	AUX
ajlsi-2441	66	20	among	among	ADP
ajlsi-2441	66	21	the	the	DET
ajlsi-2441	66	22	characteristics	characteristic	NOUN
ajlsi-2441	66	23	that	that	PRON
ajlsi-2441	66	24	classified	classify	VERB
ajlsi-2441	66	25	the	the	DET
ajlsi-2441	66	26	condition	condition	NOUN
ajlsi-2441	66	27	as	as	ADP
ajlsi-2441	66	28	mild	mild	ADJ
ajlsi-2441	66	29	.	.	PUNCT
ajlsi-2441	67	1	people	people	NOUN
ajlsi-2441	67	2	who	who	PRON
ajlsi-2441	67	3	showed	show	VERB
ajlsi-2441	67	4	signs	sign	NOUN
ajlsi-2441	67	5	of	of	ADP
ajlsi-2441	67	6	a	a	DET
ajlsi-2441	67	7	lower	low	ADJ
ajlsi-2441	67	8	respiratory	respiratory	ADJ
ajlsi-2441	67	9	disease	disease	NOUN
ajlsi-2441	67	10	but	but	CCONJ
ajlsi-2441	67	11	were	be	AUX
ajlsi-2441	67	12	still	still	ADV
ajlsi-2441	67	13	able	able	ADJ
ajlsi-2441	67	14	to	to	PART
ajlsi-2441	67	15	maintain	maintain	VERB
ajlsi-2441	67	16	a	a	DET
ajlsi-2441	67	17	sufficient	sufficient	ADJ
ajlsi-2441	67	18	oxygen	oxygen	NOUN
ajlsi-2441	67	19	saturation	saturation	NOUN
ajlsi-2441	67	20	(	(	PUNCT
ajlsi-2441	67	21	spo2	spo2	PROPN
ajlsi-2441	67	22	)	)	PUNCT
ajlsi-2441	67	23	of	of	ADP
ajlsi-2441	67	24	≥94	≥94	NOUN
ajlsi-2441	67	25	%	%	NOUN
ajlsi-2441	67	26	on	on	ADP
ajlsi-2441	67	27	room	room	NOUN
ajlsi-2441	67	28	air	air	NOUN
ajlsi-2441	67	29	at	at	ADP
ajlsi-2441	67	30	sea	sea	NOUN
ajlsi-2441	67	31	level	level	NOUN
ajlsi-2441	67	32	were	be	AUX
ajlsi-2441	67	33	classified	classify	VERB
ajlsi-2441	67	34	as	as	ADP
ajlsi-2441	67	35	having	have	VERB
ajlsi-2441	67	36	a	a	DET
ajlsi-2441	67	37	moderate	moderate	ADJ
ajlsi-2441	67	38	illness	illness	NOUN
ajlsi-2441	67	39	.	.	PUNCT
ajlsi-2441	68	1	individuals	individual	NOUN
ajlsi-2441	68	2	classified	classify	VERB
ajlsi-2441	68	3	as	as	ADP
ajlsi-2441	68	4	having	have	VERB
ajlsi-2441	68	5	a	a	DET
ajlsi-2441	68	6	severe	severe	ADJ
ajlsi-2441	68	7	illness	illness	NOUN
ajlsi-2441	68	8	included	include	VERB
ajlsi-2441	68	9	those	those	PRON
ajlsi-2441	68	10	with	with	ADP
ajlsi-2441	68	11	heart	heart	NOUN
ajlsi-2441	68	12	rates	rate	NOUN
ajlsi-2441	68	13	under	under	ADP
ajlsi-2441	68	14	94	94	NUM
ajlsi-2441	68	15	%	%	NOUN
ajlsi-2441	68	16	,	,	PUNCT
ajlsi-2441	68	17	arterial	arterial	ADJ
ajlsi-2441	68	18	partial	partial	ADJ
ajlsi-2441	68	19	pressure	pressure	NOUN
ajlsi-2441	68	20	of	of	ADP
ajlsi-2441	68	21	oxygen	oxygen	NOUN
ajlsi-2441	68	22	to	to	ADP
ajlsi-2441	68	23	fraction	fraction	NOUN
ajlsi-2441	68	24	of	of	ADP
ajlsi-2441	68	25	inspired	inspire	VERB
ajlsi-2441	68	26	oxygen	oxygen	NOUN
ajlsi-2441	68	27	(	(	PUNCT
ajlsi-2441	68	28	pao2	pao2	NOUN
ajlsi-2441	68	29	/	/	SYM
ajlsi-2441	68	30	fio2	fio2	PROPN
ajlsi-2441	68	31	)	)	PUNCT
ajlsi-2441	68	32	ratios	ratio	VERB
ajlsi-2441	68	33	less	less	ADJ
ajlsi-2441	68	34	than	than	ADP
ajlsi-2441	68	35	300	300	NUM
ajlsi-2441	68	36	mm	mm	NUM
ajlsi-2441	68	37	hg	hg	NOUN
ajlsi-2441	68	38	,	,	PUNCT
ajlsi-2441	68	39	elevated	elevate	VERB
ajlsi-2441	68	40	respiratory	respiratory	ADJ
ajlsi-2441	68	41	rates	rate	NOUN
ajlsi-2441	68	42	greater	great	ADJ
ajlsi-2441	68	43	than	than	ADP
ajlsi-2441	68	44	30	30	NUM
ajlsi-2441	68	45	breaths	breath	NOUN
ajlsi-2441	68	46	per	per	ADP
ajlsi-2441	68	47	minute	minute	NOUN
ajlsi-2441	68	48	,	,	PUNCT
ajlsi-2441	68	49	or	or	CCONJ
ajlsi-2441	68	50	lung	lung	NOUN
ajlsi-2441	68	51	infiltrates	infiltrate	VERB
ajlsi-2441	68	52	greater	great	ADJ
ajlsi-2441	68	53	than	than	ADP
ajlsi-2441	68	54	50	50	NUM
ajlsi-2441	68	55	%	%	NOUN
ajlsi-2441	68	56	.	.	PUNCT
ajlsi-2441	69	1	these	these	DET
ajlsi-2441	69	2	categorizations	categorization	NOUN
ajlsi-2441	69	3	were	be	AUX
ajlsi-2441	69	4	crucial	crucial	ADJ
ajlsi-2441	69	5	in	in	ADP
ajlsi-2441	69	6	distinguishing	distinguish	VERB
ajlsi-2441	69	7	and	and	CCONJ
ajlsi-2441	69	8	describing	describe	VERB
ajlsi-2441	69	9	the	the	DET
ajlsi-2441	69	10	different	different	ADJ
ajlsi-2441	69	11	levels	level	NOUN
ajlsi-2441	69	12	of	of	ADP
ajlsi-2441	69	13	severity	severity	NOUN
ajlsi-2441	69	14	among	among	ADP
ajlsi-2441	69	15	the	the	DET
ajlsi-2441	69	16	covid-19	covid-19	PROPN
ajlsi-2441	69	17	pneumonia	pneumonia	NOUN
ajlsi-2441	69	18	cases	case	NOUN
ajlsi-2441	69	19	in	in	ADP
ajlsi-2441	69	20	this	this	DET
ajlsi-2441	69	21	investigation	investigation	NOUN
ajlsi-2441	69	22	.	.	PUNCT
ajlsi-2441	70	1	statistical	statistical	ADJ
ajlsi-2441	70	2	analysis	analysis	NOUN
ajlsi-2441	70	3	all	all	DET
ajlsi-2441	70	4	statistical	statistical	ADJ
ajlsi-2441	70	5	analysis	analysis	NOUN
ajlsi-2441	70	6	was	be	AUX
ajlsi-2441	70	7	performed	perform	VERB
ajlsi-2441	70	8	on	on	ADP
ajlsi-2441	70	9	spss	spss	PROPN
ajlsi-2441	70	10	26.0	26.0	NUM
ajlsi-2441	70	11	and	and	CCONJ
ajlsi-2441	70	12	graphpad	graphpad	NOUN
ajlsi-2441	70	13	prism	prism	NOUN
ajlsi-2441	70	14	8.0	8.0	NUM
ajlsi-2441	70	15	.	.	PUNCT
ajlsi-2441	71	1	the	the	DET
ajlsi-2441	71	2	formats	format	NOUN
ajlsi-2441	71	3	for	for	ADP
ajlsi-2441	71	4	descriptive	descriptive	ADJ
ajlsi-2441	71	5	statistics	statistic	NOUN
ajlsi-2441	71	6	are	be	AUX
ajlsi-2441	71	7	mean	mean	PROPN
ajlsi-2441	71	8	±	±	NUM
ajlsi-2441	71	9	sd	sd	NOUN
ajlsi-2441	71	10	,	,	PUNCT
ajlsi-2441	71	11	median	median	NOUN
ajlsi-2441	71	12	(	(	PUNCT
ajlsi-2441	71	13	iqr	iqr	NOUN
ajlsi-2441	71	14	)	)	PUNCT
ajlsi-2441	71	15	,	,	PUNCT
ajlsi-2441	71	16	and	and	CCONJ
ajlsi-2441	71	17	n	n	CCONJ
ajlsi-2441	71	18	(	(	PUNCT
ajlsi-2441	71	19	%	%	NOUN
ajlsi-2441	71	20	)	)	PUNCT
ajlsi-2441	71	21	.	.	PUNCT
ajlsi-2441	72	1	the	the	DET
ajlsi-2441	72	2	chi	chi	ADJ
ajlsi-2441	72	3	-	-	PUNCT
ajlsi-2441	72	4	square	square	NOUN
ajlsi-2441	72	5	test	test	NOUN
ajlsi-2441	72	6	or	or	CCONJ
ajlsi-2441	72	7	fisher	fisher	PROPN
ajlsi-2441	72	8	’s	’s	PART
ajlsi-2441	72	9	exact	exact	ADJ
ajlsi-2441	72	10	test	test	NOUN
ajlsi-2441	72	11	were	be	AUX
ajlsi-2441	72	12	used	use	VERB
ajlsi-2441	72	13	to	to	PART
ajlsi-2441	72	14	analyze	analyze	VERB
ajlsi-2441	72	15	categorical	categorical	ADJ
ajlsi-2441	72	16	variables	variable	NOUN
ajlsi-2441	72	17	,	,	PUNCT
ajlsi-2441	72	18	and	and	CCONJ
ajlsi-2441	72	19	the	the	DET
ajlsi-2441	72	20	student	student	NOUN
ajlsi-2441	72	21	’s	’s	PART
ajlsi-2441	72	22	t	t	PROPN
ajlsi-2441	72	23	-	-	PUNCT
ajlsi-2441	72	24	test	test	NOUN
ajlsi-2441	72	25	or	or	CCONJ
ajlsi-2441	72	26	mann	mann	PROPN
ajlsi-2441	72	27	-	-	PUNCT
ajlsi-2441	72	28	whitney	whitney	PROPN
ajlsi-2441	72	29	u	u	NOUN
ajlsi-2441	72	30	-	-	NOUN
ajlsi-2441	72	31	test	test	NOUN
ajlsi-2441	72	32	were	be	AUX
ajlsi-2441	72	33	used	use	VERB
ajlsi-2441	72	34	to	to	PART
ajlsi-2441	72	35	analyze	analyze	VERB
ajlsi-2441	72	36	continuous	continuous	ADJ
ajlsi-2441	72	37	variables	variable	NOUN
ajlsi-2441	72	38	.	.	PUNCT
ajlsi-2441	73	1	if	if	SCONJ
ajlsi-2441	73	2	the	the	DET
ajlsi-2441	73	3	two	two	NUM
ajlsi-2441	73	4	-	-	PUNCT
ajlsi-2441	73	5	sided	sided	ADJ
ajlsi-2441	73	6	p	p	NOUN
ajlsi-2441	73	7	value	value	NOUN
ajlsi-2441	73	8	was	be	AUX
ajlsi-2441	73	9	less	less	ADJ
ajlsi-2441	73	10	than	than	ADP
ajlsi-2441	73	11	0.05	0.05	NUM
ajlsi-2441	73	12	,	,	PUNCT
ajlsi-2441	73	13	it	it	PRON
ajlsi-2441	73	14	was	be	AUX
ajlsi-2441	73	15	considered	consider	VERB
ajlsi-2441	73	16	statistically	statistically	ADV
ajlsi-2441	73	17	significant	significant	ADJ
ajlsi-2441	73	18	.	.	PUNCT
ajlsi-2441	74	1	using	use	VERB
ajlsi-2441	74	2	single	single	ADJ
ajlsi-2441	74	3	-	-	PUNCT
ajlsi-2441	74	4	variable	variable	ADJ
ajlsi-2441	74	5	logistic	logistic	ADJ
ajlsi-2441	74	6	regression	regression	NOUN
ajlsi-2441	74	7	based	base	VERB
ajlsi-2441	74	8	on	on	ADP
ajlsi-2441	74	9	the	the	DET
ajlsi-2441	74	10	likelihood	likelihood	NOUN
ajlsi-2441	74	11	ratio	ratio	NOUN
ajlsi-2441	74	12	,	,	PUNCT
ajlsi-2441	74	13	risk	risk	NOUN
ajlsi-2441	74	14	factors	factor	NOUN
ajlsi-2441	74	15	were	be	AUX
ajlsi-2441	74	16	found	find	VERB
ajlsi-2441	74	17	,	,	PUNCT
ajlsi-2441	74	18	and	and	CCONJ
ajlsi-2441	74	19	these	these	DET
ajlsi-2441	74	20	risk	risk	NOUN
ajlsi-2441	74	21	components	component	NOUN
ajlsi-2441	74	22	were	be	AUX
ajlsi-2441	74	23	then	then	ADV
ajlsi-2441	74	24	combined	combine	VERB
ajlsi-2441	74	25	to	to	PART
ajlsi-2441	74	26	create	create	VERB
ajlsi-2441	74	27	a	a	DET
ajlsi-2441	74	28	forest	forest	NOUN
ajlsi-2441	74	29	plot	plot	NOUN
ajlsi-2441	74	30	.	.	PUNCT
ajlsi-2441	75	1	the	the	DET
ajlsi-2441	75	2	area	area	NOUN
ajlsi-2441	75	3	under	under	ADP
ajlsi-2441	75	4	the	the	DET
ajlsi-2441	75	5	curve	curve	NOUN
ajlsi-2441	75	6	(	(	PUNCT
ajlsi-2441	75	7	auc	auc	NOUN
ajlsi-2441	75	8	)	)	PUNCT
ajlsi-2441	75	9	was	be	AUX
ajlsi-2441	75	10	used	use	VERB
ajlsi-2441	75	11	to	to	PART
ajlsi-2441	75	12	evaluate	evaluate	VERB
ajlsi-2441	75	13	discrimination	discrimination	NOUN
ajlsi-2441	75	14	performance	performance	NOUN
ajlsi-2441	75	15	.	.	PUNCT
ajlsi-2441	76	1	results	result	VERB
ajlsi-2441	76	2	patient	patient	ADJ
ajlsi-2441	76	3	characteristics	characteristic	NOUN
ajlsi-2441	76	4	and	and	CCONJ
ajlsi-2441	76	5	group	group	NOUN
ajlsi-2441	76	6	classification	classification	NOUN
ajlsi-2441	76	7	the	the	DET
ajlsi-2441	76	8	rigorous	rigorous	ADJ
ajlsi-2441	76	9	application	application	NOUN
ajlsi-2441	76	10	of	of	ADP
ajlsi-2441	76	11	inclusion	inclusion	NOUN
ajlsi-2441	76	12	criteria	criterion	NOUN
ajlsi-2441	76	13	yielded	yield	VERB
ajlsi-2441	76	14	a	a	DET
ajlsi-2441	76	15	cohort	cohort	NOUN
ajlsi-2441	76	16	of	of	ADP
ajlsi-2441	76	17	64	64	NUM
ajlsi-2441	76	18	individuals	individual	NOUN
ajlsi-2441	76	19	diagnosed	diagnose	VERB
ajlsi-2441	76	20	with	with	ADP
ajlsi-2441	76	21	covid-19	covid-19	PROPN
ajlsi-2441	76	22	.	.	PUNCT
ajlsi-2441	77	1	following	follow	VERB
ajlsi-2441	77	2	careful	careful	ADJ
ajlsi-2441	77	3	screening	screening	NOUN
ajlsi-2441	77	4	,	,	PUNCT
ajlsi-2441	77	5	11	11	NUM
ajlsi-2441	77	6	patients	patient	NOUN
ajlsi-2441	77	7	were	be	AUX
ajlsi-2441	77	8	excluded	exclude	VERB
ajlsi-2441	77	9	due	due	ADP
ajlsi-2441	77	10	to	to	ADP
ajlsi-2441	77	11	severe	severe	ADJ
ajlsi-2441	77	12	/	/	SYM
ajlsi-2441	77	13	critical	critical	ADJ
ajlsi-2441	77	14	covid-19	covid-19	PROPN
ajlsi-2441	77	15	status	status	NOUN
ajlsi-2441	77	16	at	at	ADP
ajlsi-2441	77	17	admission	admission	NOUN
ajlsi-2441	77	18	or	or	CCONJ
ajlsi-2441	77	19	being	be	AUX
ajlsi-2441	77	20	below	below	ADP
ajlsi-2441	77	21	18	18	NUM
ajlsi-2441	77	22	years	year	NOUN
ajlsi-2441	77	23	of	of	ADP
ajlsi-2441	77	24	age	age	NOUN
ajlsi-2441	77	25	,	,	PUNCT
ajlsi-2441	77	26	resulting	result	VERB
ajlsi-2441	77	27	in	in	ADP
ajlsi-2441	77	28	a	a	DET
ajlsi-2441	77	29	final	final	ADJ
ajlsi-2441	77	30	study	study	NOUN
ajlsi-2441	77	31	population	population	NOUN
ajlsi-2441	77	32	of	of	ADP
ajlsi-2441	77	33	53	53	NUM
ajlsi-2441	77	34	patients	patient	NOUN
ajlsi-2441	77	35	.	.	PUNCT
ajlsi-2441	78	1	among	among	ADP
ajlsi-2441	78	2	these	these	PRON
ajlsi-2441	78	3	,	,	PUNCT
ajlsi-2441	78	4	a	a	DET
ajlsi-2441	78	5	subgroup	subgroup	NOUN
ajlsi-2441	78	6	of	of	ADP
ajlsi-2441	78	7	17	17	NUM
ajlsi-2441	78	8	patients	patient	NOUN
ajlsi-2441	78	9	experienced	experience	VERB
ajlsi-2441	78	10	a	a	DET
ajlsi-2441	78	11	distressing	distressing	ADJ
ajlsi-2441	78	12	progression	progression	NOUN
ajlsi-2441	78	13	to	to	ADP
ajlsi-2441	78	14	severe	severe	ADJ
ajlsi-2441	78	15	pneumonia	pneumonia	NOUN
ajlsi-2441	78	16	during	during	ADP
ajlsi-2441	78	17	their	their	PRON
ajlsi-2441	78	18	hospital	hospital	NOUN
ajlsi-2441	78	19	stay	stay	NOUN
ajlsi-2441	78	20	,	,	PUNCT
ajlsi-2441	78	21	prompting	prompt	VERB
ajlsi-2441	78	22	a	a	DET
ajlsi-2441	78	23	comparative	comparative	ADJ
ajlsi-2441	78	24	evaluation	evaluation	NOUN
ajlsi-2441	78	25	to	to	ADP
ajlsi-2441	78	26	discern	discern	ADJ
ajlsi-2441	78	27	distinguishing	distinguish	VERB
ajlsi-2441	78	28	clinical	clinical	ADJ
ajlsi-2441	78	29	features	feature	NOUN
ajlsi-2441	78	30	,	,	PUNCT
ajlsi-2441	78	31	as	as	SCONJ
ajlsi-2441	78	32	shown	show	VERB
ajlsi-2441	78	33	in	in	ADP
ajlsi-2441	78	34	figure	figure	NOUN
ajlsi-2441	78	35	1	1	NUM
ajlsi-2441	78	36	.	.	PUNCT
ajlsi-2441	78	37	figure	figure	NOUN
ajlsi-2441	78	38	1	1	NUM
ajlsi-2441	78	39	:	:	PUNCT
ajlsi-2441	78	40	the	the	DET
ajlsi-2441	78	41	flow	flow	NOUN
ajlsi-2441	78	42	diagram	diagram	NOUN
ajlsi-2441	78	43	shows	show	VERB
ajlsi-2441	78	44	the	the	DET
ajlsi-2441	78	45	study	study	NOUN
ajlsi-2441	78	46	population	population	NOUN
ajlsi-2441	78	47	enrollment	enrollment	NOUN
ajlsi-2441	78	48	pa	pa	PROPN
ajlsi-2441	78	49	ge	ge	PROPN
ajlsi-2441	78	50	31	31	NUM
ajlsi-2441	78	51	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	78	52	am	am	NOUN
ajlsi-2441	78	53	.	.	PUNCT
ajlsi-2441	79	1	j.	j.	PROPN
ajlsi-2441	79	2	life	life	PROPN
ajlsi-2441	79	3	sci	sci	PROPN
ajlsi-2441	79	4	.	.	PUNCT
ajlsi-2441	79	5	innov	innov	PROPN
ajlsi-2441	79	6	.	.	PUNCT
ajlsi-2441	80	1	3(1	3(1	NUM
ajlsi-2441	80	2	)	)	PUNCT
ajlsi-2441	80	3	28	28	NUM
ajlsi-2441	80	4	-	-	SYM
ajlsi-2441	80	5	36	36	NUM
ajlsi-2441	80	6	,	,	PUNCT
ajlsi-2441	80	7	2024	2024	NUM
ajlsi-2441	80	8	comparison	comparison	NOUN
ajlsi-2441	80	9	between	between	ADP
ajlsi-2441	80	10	stable	stable	ADJ
ajlsi-2441	80	11	and	and	CCONJ
ajlsi-2441	80	12	progressive	progressive	ADJ
ajlsi-2441	80	13	patients	patient	NOUN
ajlsi-2441	80	14	a	a	DET
ajlsi-2441	80	15	thorough	thorough	ADJ
ajlsi-2441	80	16	comparison	comparison	NOUN
ajlsi-2441	80	17	of	of	ADP
ajlsi-2441	80	18	the	the	DET
ajlsi-2441	80	19	clinical	clinical	ADJ
ajlsi-2441	80	20	and	and	CCONJ
ajlsi-2441	80	21	demographic	demographic	ADJ
ajlsi-2441	80	22	traits	trait	NOUN
ajlsi-2441	80	23	of	of	ADP
ajlsi-2441	80	24	patients	patient	NOUN
ajlsi-2441	80	25	who	who	PRON
ajlsi-2441	80	26	developed	develop	VERB
ajlsi-2441	80	27	severe	severe	ADJ
ajlsi-2441	80	28	covid-19	covid-19	PROPN
ajlsi-2441	80	29	and	and	CCONJ
ajlsi-2441	80	30	those	those	PRON
ajlsi-2441	80	31	who	who	PRON
ajlsi-2441	80	32	kept	keep	VERB
ajlsi-2441	80	33	their	their	PRON
ajlsi-2441	80	34	condition	condition	NOUN
ajlsi-2441	80	35	stable	stable	ADJ
ajlsi-2441	80	36	is	be	AUX
ajlsi-2441	80	37	shown	show	VERB
ajlsi-2441	80	38	in	in	ADP
ajlsi-2441	80	39	table	table	NOUN
ajlsi-2441	80	40	1	1	NUM
ajlsi-2441	80	41	.	.	PUNCT
ajlsi-2441	81	1	interestingly	interestingly	ADV
ajlsi-2441	81	2	,	,	PUNCT
ajlsi-2441	81	3	the	the	DET
ajlsi-2441	81	4	mean	mean	ADJ
ajlsi-2441	81	5	age	age	NOUN
ajlsi-2441	81	6	of	of	ADP
ajlsi-2441	81	7	patients	patient	NOUN
ajlsi-2441	81	8	in	in	ADP
ajlsi-2441	81	9	the	the	DET
ajlsi-2441	81	10	progressive	progressive	ADJ
ajlsi-2441	81	11	group	group	NOUN
ajlsi-2441	81	12	was	be	AUX
ajlsi-2441	81	13	7.88	7.88	NUM
ajlsi-2441	81	14	years	year	NOUN
ajlsi-2441	81	15	±	±	NUM
ajlsi-2441	81	16	14.66	14.66	NUM
ajlsi-2441	81	17	years	year	NOUN
ajlsi-2441	81	18	,	,	PUNCT
ajlsi-2441	81	19	which	which	PRON
ajlsi-2441	81	20	was	be	AUX
ajlsi-2441	81	21	significantly	significantly	ADV
ajlsi-2441	81	22	higher	high	ADJ
ajlsi-2441	81	23	than	than	ADP
ajlsi-2441	81	24	the	the	DET
ajlsi-2441	81	25	mean	mean	ADJ
ajlsi-2441	81	26	age	age	NOUN
ajlsi-2441	81	27	of	of	ADP
ajlsi-2441	81	28	patients	patient	NOUN
ajlsi-2441	81	29	in	in	ADP
ajlsi-2441	81	30	the	the	DET
ajlsi-2441	81	31	stable	stable	ADJ
ajlsi-2441	81	32	group	group	NOUN
ajlsi-2441	81	33	(	(	PUNCT
ajlsi-2441	81	34	58.97	58.97	NUM
ajlsi-2441	81	35	years	year	NOUN
ajlsi-2441	81	36	±	±	NUM
ajlsi-2441	81	37	18.94	18.94	NUM
ajlsi-2441	81	38	)	)	PUNCT
ajlsi-2441	81	39	(	(	PUNCT
ajlsi-2441	81	40	p	p	X
ajlsi-2441	81	41	=	=	PROPN
ajlsi-2441	81	42	0.021	0.021	NUM
ajlsi-2441	81	43	)	)	PUNCT
ajlsi-2441	81	44	.	.	PUNCT
ajlsi-2441	82	1	moreover	moreover	ADV
ajlsi-2441	82	2	,	,	PUNCT
ajlsi-2441	82	3	individuals	individual	NOUN
ajlsi-2441	82	4	with	with	ADP
ajlsi-2441	82	5	underlying	underlying	ADJ
ajlsi-2441	82	6	coronary	coronary	ADJ
ajlsi-2441	82	7	heart	heart	NOUN
ajlsi-2441	82	8	disease	disease	NOUN
ajlsi-2441	82	9	were	be	AUX
ajlsi-2441	82	10	notably	notably	ADV
ajlsi-2441	82	11	more	more	ADV
ajlsi-2441	82	12	prevalent	prevalent	ADJ
ajlsi-2441	82	13	within	within	ADP
ajlsi-2441	82	14	the	the	DET
ajlsi-2441	82	15	progressive	progressive	ADJ
ajlsi-2441	82	16	group	group	NOUN
ajlsi-2441	82	17	(	(	PUNCT
ajlsi-2441	82	18	41.2	41.2	NUM
ajlsi-2441	82	19	%	%	NOUN
ajlsi-2441	82	20	)	)	PUNCT
ajlsi-2441	82	21	than	than	ADP
ajlsi-2441	82	22	in	in	ADP
ajlsi-2441	82	23	the	the	DET
ajlsi-2441	82	24	stable	stable	ADJ
ajlsi-2441	82	25	group	group	NOUN
ajlsi-2441	82	26	(	(	PUNCT
ajlsi-2441	82	27	2.8	2.8	NUM
ajlsi-2441	82	28	%	%	NOUN
ajlsi-2441	82	29	)	)	PUNCT
ajlsi-2441	83	1	(	(	PUNCT
ajlsi-2441	83	2	p	p	NOUN
ajlsi-2441	83	3	=	=	NOUN
ajlsi-2441	83	4	0.001	0.001	NUM
ajlsi-2441	83	5	)	)	PUNCT
ajlsi-2441	83	6	.	.	PUNCT
ajlsi-2441	84	1	notably	notably	ADV
ajlsi-2441	84	2	,	,	PUNCT
ajlsi-2441	84	3	various	various	ADJ
ajlsi-2441	84	4	laboratory	laboratory	NOUN
ajlsi-2441	84	5	parameters	parameter	NOUN
ajlsi-2441	84	6	manifested	manifest	VERB
ajlsi-2441	84	7	pronounced	pronounce	VERB
ajlsi-2441	84	8	differences	difference	NOUN
ajlsi-2441	84	9	between	between	ADP
ajlsi-2441	84	10	the	the	DET
ajlsi-2441	84	11	groups	group	NOUN
ajlsi-2441	84	12	,	,	PUNCT
ajlsi-2441	84	13	with	with	ADP
ajlsi-2441	84	14	significantly	significantly	ADV
ajlsi-2441	84	15	higher	high	ADJ
ajlsi-2441	84	16	levels	level	NOUN
ajlsi-2441	84	17	of	of	ADP
ajlsi-2441	84	18	rdw	rdw	ADJ
ajlsi-2441	84	19	-	-	PUNCT
ajlsi-2441	84	20	sd	sd	NOUN
ajlsi-2441	84	21	,	,	PUNCT
ajlsi-2441	84	22	rdw	rdw	X
ajlsi-2441	84	23	/	/	SYM
ajlsi-2441	84	24	plt	plt	NOUN
ajlsi-2441	84	25	,	,	PUNCT
ajlsi-2441	84	26	ast	ast	PROPN
ajlsi-2441	84	27	,	,	PUNCT
ajlsi-2441	84	28	crea	crea	NOUN
ajlsi-2441	84	29	,	,	PUNCT
ajlsi-2441	84	30	crp	crp	PROPN
ajlsi-2441	84	31	,	,	PUNCT
ajlsi-2441	84	32	and	and	CCONJ
ajlsi-2441	84	33	il-6	il-6	NOUN
ajlsi-2441	84	34	observed	observe	VERB
ajlsi-2441	84	35	in	in	ADP
ajlsi-2441	84	36	the	the	DET
ajlsi-2441	84	37	progressive	progressive	ADJ
ajlsi-2441	84	38	cohort	cohort	NOUN
ajlsi-2441	84	39	(	(	PUNCT
ajlsi-2441	84	40	all	all	PRON
ajlsi-2441	84	41	p	p	X
ajlsi-2441	84	42	<	<	X
ajlsi-2441	84	43	0.05	0.05	NUM
ajlsi-2441	84	44	)	)	PUNCT
ajlsi-2441	84	45	.	.	PUNCT
ajlsi-2441	85	1	table	table	NOUN
ajlsi-2441	85	2	1	1	NUM
ajlsi-2441	85	3	:	:	PUNCT
ajlsi-2441	85	4	characteristics	characteristic	NOUN
ajlsi-2441	85	5	between	between	ADP
ajlsi-2441	85	6	the	the	DET
ajlsi-2441	85	7	stable	stable	ADJ
ajlsi-2441	85	8	and	and	CCONJ
ajlsi-2441	85	9	progressive	progressive	ADJ
ajlsi-2441	85	10	patients	patient	NOUN
ajlsi-2441	85	11	characteristic	characteristic	ADJ
ajlsi-2441	85	12	stable	stable	ADJ
ajlsi-2441	85	13	group	group	NOUN
ajlsi-2441	85	14	progressive	progressive	PROPN
ajlsi-2441	85	15	group	group	NOUN
ajlsi-2441	85	16	p	p	NOUN
ajlsi-2441	85	17	gender	gender	NOUN
ajlsi-2441	85	18	,	,	PUNCT
ajlsi-2441	85	19	n	n	CCONJ
ajlsi-2441	85	20	(	(	PUNCT
ajlsi-2441	85	21	%	%	INTJ
ajlsi-2441	85	22	)	)	PUNCT
ajlsi-2441	85	23	male	male	NOUN
ajlsi-2441	85	24	15	15	NUM
ajlsi-2441	85	25	(	(	PUNCT
ajlsi-2441	85	26	41.7	41.7	NUM
ajlsi-2441	85	27	%	%	NOUN
ajlsi-2441	85	28	)	)	PUNCT
ajlsi-2441	85	29	11	11	NUM
ajlsi-2441	85	30	(	(	PUNCT
ajlsi-2441	85	31	64.7	64.7	NUM
ajlsi-2441	85	32	%	%	NOUN
ajlsi-2441	85	33	)	)	PUNCT
ajlsi-2441	85	34	0.117	0.117	NUM
ajlsi-2441	85	35	female	female	ADJ
ajlsi-2441	85	36	21	21	NUM
ajlsi-2441	85	37	(	(	PUNCT
ajlsi-2441	85	38	58.3	58.3	NUM
ajlsi-2441	85	39	%	%	NOUN
ajlsi-2441	85	40	)	)	PUNCT
ajlsi-2441	85	41	6	6	NUM
ajlsi-2441	85	42	(	(	PUNCT
ajlsi-2441	85	43	35.3	35.3	NUM
ajlsi-2441	85	44	%	%	NOUN
ajlsi-2441	85	45	)	)	PUNCT
ajlsi-2441	85	46	age	age	NOUN
ajlsi-2441	85	47	,	,	PUNCT
ajlsi-2441	85	48	years	year	NOUN
ajlsi-2441	85	49	58.97	58.97	NUM
ajlsi-2441	85	50	±	±	NUM
ajlsi-2441	85	51	18.94	18.94	NUM
ajlsi-2441	85	52	70.88	70.88	NUM
ajlsi-2441	85	53	±	±	NUM
ajlsi-2441	85	54	14.66	14.66	NUM
ajlsi-2441	85	55	0.021	0.021	NUM
ajlsi-2441	85	56	times	time	NOUN
ajlsi-2441	85	57	of	of	ADP
ajlsi-2441	85	58	vaccination	vaccination	NOUN
ajlsi-2441	85	59	0	0	NUM
ajlsi-2441	85	60	19	19	NUM
ajlsi-2441	85	61	(	(	PUNCT
ajlsi-2441	85	62	52.8	52.8	NUM
ajlsi-2441	85	63	%	%	NOUN
ajlsi-2441	85	64	)	)	PUNCT
ajlsi-2441	85	65	8	8	NUM
ajlsi-2441	85	66	(	(	PUNCT
ajlsi-2441	85	67	47.1	47.1	NUM
ajlsi-2441	85	68	%	%	NOUN
ajlsi-2441	85	69	)	)	PUNCT
ajlsi-2441	85	70	0.832	0.832	NUM
ajlsi-2441	85	71	1	1	NUM
ajlsi-2441	85	72	6	6	NUM
ajlsi-2441	85	73	(	(	PUNCT
ajlsi-2441	85	74	16.7	16.7	NUM
ajlsi-2441	85	75	%	%	NOUN
ajlsi-2441	85	76	)	)	PUNCT
ajlsi-2441	85	77	4	4	NUM
ajlsi-2441	85	78	(	(	PUNCT
ajlsi-2441	85	79	23.5	23.5	NUM
ajlsi-2441	85	80	%	%	NOUN
ajlsi-2441	85	81	)	)	PUNCT
ajlsi-2441	85	82	2	2	NUM
ajlsi-2441	85	83	11	11	NUM
ajlsi-2441	85	84	(	(	PUNCT
ajlsi-2441	85	85	30.6	30.6	NUM
ajlsi-2441	85	86	)	)	SYM
ajlsi-2441	85	87	5	5	NUM
ajlsi-2441	85	88	(	(	PUNCT
ajlsi-2441	85	89	29.4	29.4	NUM
ajlsi-2441	85	90	)	)	PUNCT
ajlsi-2441	85	91	comorbidities	comorbiditie	NOUN
ajlsi-2441	85	92	,	,	PUNCT
ajlsi-2441	85	93	n	n	CCONJ
ajlsi-2441	85	94	(	(	PUNCT
ajlsi-2441	85	95	%	%	INTJ
ajlsi-2441	85	96	)	)	PUNCT
ajlsi-2441	85	97	diabetes	diabetes	NOUN
ajlsi-2441	85	98	4	4	NUM
ajlsi-2441	85	99	(	(	PUNCT
ajlsi-2441	85	100	11.1	11.1	NUM
ajlsi-2441	85	101	%	%	NOUN
ajlsi-2441	85	102	)	)	PUNCT
ajlsi-2441	85	103	4	4	NUM
ajlsi-2441	85	104	(	(	PUNCT
ajlsi-2441	85	105	23.5	23.5	NUM
ajlsi-2441	85	106	%	%	NOUN
ajlsi-2441	85	107	)	)	PUNCT
ajlsi-2441	85	108	0.443	0.443	NUM
ajlsi-2441	85	109	hypertension	hypertension	NOUN
ajlsi-2441	85	110	12	12	NUM
ajlsi-2441	85	111	(	(	PUNCT
ajlsi-2441	85	112	33.3	33.3	NUM
ajlsi-2441	85	113	%	%	NOUN
ajlsi-2441	85	114	)	)	PUNCT
ajlsi-2441	85	115	5	5	NUM
ajlsi-2441	85	116	(	(	PUNCT
ajlsi-2441	85	117	29.4	29.4	NUM
ajlsi-2441	85	118	%	%	NOUN
ajlsi-2441	85	119	)	)	PUNCT
ajlsi-2441	86	1	0.775	0.775	NUM
ajlsi-2441	86	2	coronary	coronary	ADJ
ajlsi-2441	86	3	heart	heart	NOUN
ajlsi-2441	86	4	disease	disease	NOUN
ajlsi-2441	86	5	1	1	NUM
ajlsi-2441	86	6	(	(	PUNCT
ajlsi-2441	86	7	2.8	2.8	NUM
ajlsi-2441	86	8	%	%	NOUN
ajlsi-2441	86	9	)	)	PUNCT
ajlsi-2441	86	10	7	7	NUM
ajlsi-2441	86	11	(	(	PUNCT
ajlsi-2441	86	12	41.2	41.2	NUM
ajlsi-2441	86	13	%	%	NOUN
ajlsi-2441	86	14	)	)	PUNCT
ajlsi-2441	86	15	0.001	0.001	NUM
ajlsi-2441	86	16	laboratory	laboratory	NOUN
ajlsi-2441	86	17	findings	finding	NOUN
ajlsi-2441	86	18	wbc	wbc	PROPN
ajlsi-2441	86	19	(	(	PUNCT
ajlsi-2441	86	20	×109	×109	PROPN
ajlsi-2441	86	21	/	/	SYM
ajlsi-2441	86	22	l	l	NOUN
ajlsi-2441	86	23	)	)	PUNCT
ajlsi-2441	86	24	4.57	4.57	NUM
ajlsi-2441	86	25	±	±	NUM
ajlsi-2441	86	26	1.56	1.56	NUM
ajlsi-2441	86	27	4.61	4.61	NUM
ajlsi-2441	86	28	±	±	NUM
ajlsi-2441	86	29	1.81	1.81	NUM
ajlsi-2441	86	30	0.929	0.929	NUM
ajlsi-2441	86	31	ly	ly	ADP
ajlsi-2441	86	32	(	(	PUNCT
ajlsi-2441	86	33	×109	×109	ADJ
ajlsi-2441	86	34	/	/	SYM
ajlsi-2441	86	35	l	l	NOUN
ajlsi-2441	86	36	)	)	PUNCT
ajlsi-2441	86	37	1.18	1.18	NUM
ajlsi-2441	86	38	±	±	NUM
ajlsi-2441	86	39	0.53	0.53	NUM
ajlsi-2441	86	40	0.89	0.89	NUM
ajlsi-2441	86	41	±	±	NUM
ajlsi-2441	86	42	0.36	0.36	NUM
ajlsi-2441	86	43	0.051	0.051	NUM
ajlsi-2441	86	44	eos	eos	PROPN
ajlsi-2441	86	45	(	(	PUNCT
ajlsi-2441	86	46	×109	×109	PROPN
ajlsi-2441	86	47	/	/	SYM
ajlsi-2441	86	48	l	l	NOUN
ajlsi-2441	86	49	)	)	PUNCT
ajlsi-2441	86	50	0.01	0.01	NUM
ajlsi-2441	86	51	(	(	PUNCT
ajlsi-2441	86	52	0.00	0.00	NUM
ajlsi-2441	86	53	-	-	SYM
ajlsi-2441	86	54	0.08	0.08	NUM
ajlsi-2441	86	55	)	)	PUNCT
ajlsi-2441	86	56	0.00(0.00	0.00(0.00	NOUN
ajlsi-2441	86	57	-	-	PUNCT
ajlsi-2441	86	58	0.00	0.00	NUM
ajlsi-2441	86	59	)	)	PUNCT
ajlsi-2441	86	60	0.003	0.003	NUM
ajlsi-2441	86	61	plt	plt	NOUN
ajlsi-2441	86	62	(	(	PUNCT
ajlsi-2441	86	63	×109	×109	PROPN
ajlsi-2441	86	64	/l	/l	PUNCT
ajlsi-2441	86	65	)	)	PUNCT
ajlsi-2441	86	66	146.50	146.50	NUM
ajlsi-2441	86	67	(	(	PUNCT
ajlsi-2441	86	68	124.25	124.25	NUM
ajlsi-2441	86	69	-	-	SYM
ajlsi-2441	86	70	193.25	193.25	NUM
ajlsi-2441	86	71	)	)	PUNCT
ajlsi-2441	86	72	92.00	92.00	NUM
ajlsi-2441	86	73	(	(	PUNCT
ajlsi-2441	86	74	66.50	66.50	NUM
ajlsi-2441	86	75	-	-	SYM
ajlsi-2441	86	76	106.5	106.5	NUM
ajlsi-2441	86	77	)	)	PUNCT
ajlsi-2441	86	78	0.000	0.000	NUM
ajlsi-2441	86	79	mpv	mpv	PROPN
ajlsi-2441	86	80	(	(	PUNCT
ajlsi-2441	86	81	fl	fl	PROPN
ajlsi-2441	86	82	)	)	PUNCT
ajlsi-2441	86	83	11.59	11.59	NUM
ajlsi-2441	86	84	±	±	NUM
ajlsi-2441	86	85	1.13	1.13	NUM
ajlsi-2441	86	86	11.98	11.98	NUM
ajlsi-2441	86	87	±	±	NUM
ajlsi-2441	86	88	1.08	1.08	NUM
ajlsi-2441	86	89	0.240	0.240	NUM
ajlsi-2441	86	90	rdw	rdw	ADJ
ajlsi-2441	86	91	-	-	PUNCT
ajlsi-2441	86	92	sd	sd	ADP
ajlsi-2441	86	93	40.58	40.58	NUM
ajlsi-2441	86	94	±	±	NUM
ajlsi-2441	86	95	2.35	2.35	NUM
ajlsi-2441	86	96	42.98	42.98	NUM
ajlsi-2441	86	97	±	±	NUM
ajlsi-2441	86	98	2.15	2.15	NUM
ajlsi-2441	86	99	0.001	0.001	NUM
ajlsi-2441	86	100	rdw	rdw	ADJ
ajlsi-2441	86	101	/	/	SYM
ajlsi-2441	86	102	plt	plt	NOUN
ajlsi-2441	86	103	(	(	PUNCT
ajlsi-2441	86	104	×10	×10	NOUN
ajlsi-2441	86	105	-	-	PUNCT
ajlsi-2441	86	106	2	2	NUM
ajlsi-2441	86	107	)	)	PUNCT
ajlsi-2441	86	108	27.25	27.25	NUM
ajlsi-2441	86	109	(	(	PUNCT
ajlsi-2441	86	110	20.43	20.43	NUM
ajlsi-2441	86	111	-	-	SYM
ajlsi-2441	86	112	33.60	33.60	NUM
ajlsi-2441	86	113	)	)	PUNCT
ajlsi-2441	86	114	46.80	46.80	NUM
ajlsi-2441	86	115	(	(	PUNCT
ajlsi-2441	86	116	38.95	38.95	NUM
ajlsi-2441	86	117	-	-	SYM
ajlsi-2441	86	118	64.95	64.95	NUM
ajlsi-2441	86	119	)	)	PUNCT
ajlsi-2441	86	120	0.000	0.000	NUM
ajlsi-2441	86	121	ast	ast	NOUN
ajlsi-2441	86	122	(	(	PUNCT
ajlsi-2441	86	123	u	u	NOUN
ajlsi-2441	86	124	/	/	SYM
ajlsi-2441	86	125	l	l	NOUN
ajlsi-2441	86	126	)	)	PUNCT
ajlsi-2441	86	127	21.50	21.50	NUM
ajlsi-2441	86	128	(	(	PUNCT
ajlsi-2441	86	129	18.50	18.50	NUM
ajlsi-2441	86	130	-	-	SYM
ajlsi-2441	86	131	34.00	34.00	NUM
ajlsi-2441	86	132	)	)	PUNCT
ajlsi-2441	86	133	50.20	50.20	NUM
ajlsi-2441	86	134	(	(	PUNCT
ajlsi-2441	86	135	29.80	29.80	NUM
ajlsi-2441	86	136	-	-	SYM
ajlsi-2441	86	137	88.40	88.40	NUM
ajlsi-2441	86	138	)	)	PUNCT
ajlsi-2441	86	139	0.000	0.000	NUM
ajlsi-2441	86	140	alt	alt	NOUN
ajlsi-2441	86	141	(	(	PUNCT
ajlsi-2441	86	142	u	u	NOUN
ajlsi-2441	86	143	/	/	SYM
ajlsi-2441	86	144	l	l	NOUN
ajlsi-2441	86	145	)	)	PUNCT
ajlsi-2441	86	146	25.89	25.89	NUM
ajlsi-2441	86	147	±	±	NUM
ajlsi-2441	86	148	21.85	21.85	NUM
ajlsi-2441	86	149	38.25	38.25	NUM
ajlsi-2441	86	150	±	±	NUM
ajlsi-2441	86	151	21.39	21.39	NUM
ajlsi-2441	86	152	0.059	0.059	NUM
ajlsi-2441	86	153	alb	alb	NOUN
ajlsi-2441	86	154	(	(	PUNCT
ajlsi-2441	86	155	g	g	PROPN
ajlsi-2441	86	156	/	/	SYM
ajlsi-2441	86	157	l	l	NOUN
ajlsi-2441	86	158	)	)	PUNCT
ajlsi-2441	86	159	44.11	44.11	NUM
ajlsi-2441	86	160	±	±	NUM
ajlsi-2441	86	161	3.37	3.37	NUM
ajlsi-2441	86	162	38.91	38.91	NUM
ajlsi-2441	86	163	±	±	NUM
ajlsi-2441	86	164	3.81	3.81	NUM
ajlsi-2441	86	165	0.000	0.000	NUM
ajlsi-2441	86	166	crea	crea	NOUN
ajlsi-2441	86	167	(	(	PUNCT
ajlsi-2441	86	168	umol	umol	PROPN
ajlsi-2441	86	169	/	/	SYM
ajlsi-2441	86	170	l	l	NOUN
ajlsi-2441	86	171	)	)	PUNCT
ajlsi-2441	86	172	68.50	68.50	NUM
ajlsi-2441	86	173	(	(	PUNCT
ajlsi-2441	86	174	61.00	61.00	NUM
ajlsi-2441	86	175	-	-	SYM
ajlsi-2441	86	176	88.00	88.00	NUM
ajlsi-2441	86	177	)	)	PUNCT
ajlsi-2441	86	178	90.00	90.00	NUM
ajlsi-2441	86	179	(	(	PUNCT
ajlsi-2441	86	180	64	64	NUM
ajlsi-2441	86	181	-	-	SYM
ajlsi-2441	86	182	113	113	NUM
ajlsi-2441	86	183	)	)	PUNCT
ajlsi-2441	86	184	0.038	0.038	NUM
ajlsi-2441	86	185	crp	crp	NOUN
ajlsi-2441	86	186	(	(	PUNCT
ajlsi-2441	86	187	mg/	mg/	PROPN
ajlsi-2441	86	188	l	l	NOUN
ajlsi-2441	86	189	)	)	PUNCT
ajlsi-2441	86	190	22.92	22.92	NUM
ajlsi-2441	86	191	(	(	PUNCT
ajlsi-2441	86	192	9.43	9.43	NUM
ajlsi-2441	86	193	-	-	SYM
ajlsi-2441	86	194	33.07	33.07	NUM
ajlsi-2441	86	195	)	)	PUNCT
ajlsi-2441	86	196	58.00	58.00	NUM
ajlsi-2441	86	197	(	(	PUNCT
ajlsi-2441	86	198	39.35	39.35	NUM
ajlsi-2441	86	199	-	-	SYM
ajlsi-2441	86	200	91.70	91.70	NUM
ajlsi-2441	86	201	)	)	PUNCT
ajlsi-2441	86	202	0.000	0.000	NUM
ajlsi-2441	86	203	il-6	il-6	NOUN
ajlsi-2441	86	204	(	(	PUNCT
ajlsi-2441	86	205	pg	pg	NOUN
ajlsi-2441	86	206	/	/	SYM
ajlsi-2441	86	207	ml	ml	VERB
ajlsi-2441	86	208	)	)	PUNCT
ajlsi-2441	86	209	21.85	21.85	NUM
ajlsi-2441	86	210	(	(	PUNCT
ajlsi-2441	86	211	13.75	13.75	NUM
ajlsi-2441	86	212	-	-	SYM
ajlsi-2441	86	213	32.85	32.85	NUM
ajlsi-2441	86	214	)	)	PUNCT
ajlsi-2441	86	215	81.50	81.50	NUM
ajlsi-2441	86	216	(	(	PUNCT
ajlsi-2441	86	217	39.35	39.35	NUM
ajlsi-2441	86	218	-	-	SYM
ajlsi-2441	86	219	115.30	115.30	NUM
ajlsi-2441	86	220	)	)	PUNCT
ajlsi-2441	86	221	0.000	0.000	NUM
ajlsi-2441	86	222	predictors	predictor	NOUN
ajlsi-2441	86	223	of	of	ADP
ajlsi-2441	86	224	progression	progression	NOUN
ajlsi-2441	86	225	from	from	ADP
ajlsi-2441	86	226	moderate	moderate	ADJ
ajlsi-2441	86	227	to	to	ADP
ajlsi-2441	86	228	severe	severe	ADJ
ajlsi-2441	86	229	covid-19	covid-19	PROPN
ajlsi-2441	86	230	univariate	univariate	ADJ
ajlsi-2441	86	231	logistic	logistic	ADJ
ajlsi-2441	86	232	regression	regression	NOUN
ajlsi-2441	86	233	analysis	analysis	NOUN
ajlsi-2441	86	234	illuminated	illuminate	VERB
ajlsi-2441	86	235	several	several	ADJ
ajlsi-2441	86	236	potential	potential	ADJ
ajlsi-2441	86	237	predictors	predictor	NOUN
ajlsi-2441	86	238	of	of	ADP
ajlsi-2441	86	239	disease	disease	NOUN
ajlsi-2441	86	240	progression	progression	NOUN
ajlsi-2441	86	241	,	,	PUNCT
ajlsi-2441	86	242	unveiling	unveil	VERB
ajlsi-2441	86	243	age	age	NOUN
ajlsi-2441	86	244	,	,	PUNCT
ajlsi-2441	86	245	plt	plt	NOUN
ajlsi-2441	86	246	,	,	PUNCT
ajlsi-2441	86	247	rdw	rdw	NOUN
ajlsi-2441	86	248	-	-	PUNCT
ajlsi-2441	86	249	sd	sd	NOUN
ajlsi-2441	86	250	,	,	PUNCT
ajlsi-2441	86	251	rdw	rdw	X
ajlsi-2441	86	252	/	/	SYM
ajlsi-2441	86	253	plt	plt	NOUN
ajlsi-2441	86	254	,	,	PUNCT
ajlsi-2441	86	255	ast	ast	NOUN
ajlsi-2441	86	256	,	,	PUNCT
ajlsi-2441	86	257	alb	alb	PROPN
ajlsi-2441	86	258	,	,	PUNCT
ajlsi-2441	86	259	crp	crp	PROPN
ajlsi-2441	86	260	,	,	PUNCT
ajlsi-2441	86	261	and	and	CCONJ
ajlsi-2441	86	262	il-6	il-6	NOUN
ajlsi-2441	86	263	as	as	SCONJ
ajlsi-2441	86	264	significantly	significantly	ADV
ajlsi-2441	86	265	associated	associate	VERB
ajlsi-2441	86	266	with	with	ADP
ajlsi-2441	86	267	the	the	DET
ajlsi-2441	86	268	transition	transition	NOUN
ajlsi-2441	86	269	to	to	ADP
ajlsi-2441	86	270	severe	severe	ADJ
ajlsi-2441	86	271	covid-19	covid-19	PROPN
ajlsi-2441	86	272	pneumonia	pneumonia	NOUN
ajlsi-2441	86	273	,	,	PUNCT
ajlsi-2441	86	274	as	as	SCONJ
ajlsi-2441	86	275	shown	show	VERB
ajlsi-2441	86	276	in	in	ADP
ajlsi-2441	86	277	table	table	NOUN
ajlsi-2441	86	278	2	2	NUM
ajlsi-2441	86	279	.	.	PUNCT
ajlsi-2441	87	1	the	the	DET
ajlsi-2441	87	2	construction	construction	NOUN
ajlsi-2441	87	3	of	of	ADP
ajlsi-2441	87	4	a	a	DET
ajlsi-2441	87	5	forest	forest	NOUN
ajlsi-2441	87	6	plot	plot	NOUN
ajlsi-2441	87	7	,	,	PUNCT
ajlsi-2441	87	8	which	which	PRON
ajlsi-2441	87	9	is	be	AUX
ajlsi-2441	87	10	shown	show	VERB
ajlsi-2441	87	11	in	in	ADP
ajlsi-2441	87	12	table	table	NOUN
ajlsi-2441	87	13	2	2	NUM
ajlsi-2441	87	14	:	:	PUNCT
ajlsi-2441	87	15	univariate	univariate	ADJ
ajlsi-2441	87	16	logistic	logistic	ADJ
ajlsi-2441	87	17	regression	regression	NOUN
ajlsi-2441	87	18	analysis	analysis	NOUN
ajlsi-2441	87	19	independent	independent	ADJ
ajlsi-2441	87	20	high	high	ADJ
ajlsi-2441	87	21	-	-	PUNCT
ajlsi-2441	87	22	risk	risk	NOUN
ajlsi-2441	87	23	factors	factor	NOUN
ajlsi-2441	87	24	for	for	ADP
ajlsi-2441	87	25	severity	severity	NOUN
ajlsi-2441	87	26	of	of	ADP
ajlsi-2441	87	27	covid-19	covid-19	PROPN
ajlsi-2441	87	28	patients	patient	NOUN
ajlsi-2441	87	29	variables	variable	NOUN
ajlsi-2441	87	30	or	or	CCONJ
ajlsi-2441	87	31	(	(	PUNCT
ajlsi-2441	87	32	95%ci	95%ci	NUM
ajlsi-2441	87	33	)	)	PUNCT
ajlsi-2441	87	34	p	p	NOUN
ajlsi-2441	87	35	value	value	NOUN
ajlsi-2441	87	36	age	age	NOUN
ajlsi-2441	87	37	1.05	1.05	NUM
ajlsi-2441	87	38	(	(	PUNCT
ajlsi-2441	87	39	1.00	1.00	NUM
ajlsi-2441	87	40	-	-	SYM
ajlsi-2441	87	41	1.09	1.09	NUM
ajlsi-2441	87	42	)	)	PUNCT
ajlsi-2441	87	43	0.029	0.029	NUM
ajlsi-2441	87	44	eo	eo	PROPN
ajlsi-2441	87	45	0.00	0.00	NUM
ajlsi-2441	87	46	(	(	PUNCT
ajlsi-2441	87	47	0.00	0.00	NUM
ajlsi-2441	87	48	-	-	SYM
ajlsi-2441	87	49	455.76	455.76	NUM
ajlsi-2441	87	50	)	)	PUNCT
ajlsi-2441	87	51	0.349	0.349	NUM
ajlsi-2441	87	52	plt	plt	NOUN
ajlsi-2441	87	53	0.94	0.94	NUM
ajlsi-2441	87	54	(	(	PUNCT
ajlsi-2441	87	55	0.90	0.90	NUM
ajlsi-2441	87	56	-	-	PUNCT
ajlsi-2441	87	57	0.97	0.97	NUM
ajlsi-2441	87	58	)	)	PUNCT
ajlsi-2441	87	59	<	<	X
ajlsi-2441	87	60	0.001	0.001	NUM
ajlsi-2441	87	61	rdw	rdw	ADJ
ajlsi-2441	87	62	-	-	PUNCT
ajlsi-2441	87	63	sd	sd	ADP
ajlsi-2441	87	64	1.05	1.05	NUM
ajlsi-2441	87	65	(	(	PUNCT
ajlsi-2441	87	66	1.02	1.02	NUM
ajlsi-2441	87	67	-	-	SYM
ajlsi-2441	87	68	1.08	1.08	NUM
ajlsi-2441	87	69	)	)	PUNCT
ajlsi-2441	87	70	0.004	0.004	NUM
ajlsi-2441	87	71	rdw	rdw	X
ajlsi-2441	87	72	/	/	SYM
ajlsi-2441	87	73	plt	plt	NOUN
ajlsi-2441	87	74	1.21	1.21	NUM
ajlsi-2441	87	75	(	(	PUNCT
ajlsi-2441	87	76	1.08	1.08	NUM
ajlsi-2441	87	77	-	-	SYM
ajlsi-2441	87	78	1.36	1.36	NUM
ajlsi-2441	87	79	)	)	PUNCT
ajlsi-2441	87	80	<	<	X
ajlsi-2441	87	81	0.001	0.001	NUM
ajlsi-2441	87	82	ast	ast	NOUN
ajlsi-2441	87	83	1.04	1.04	NUM
ajlsi-2441	87	84	(	(	PUNCT
ajlsi-2441	87	85	1.02	1.02	NUM
ajlsi-2441	87	86	-	-	SYM
ajlsi-2441	87	87	1.07	1.07	NUM
ajlsi-2441	87	88	)	)	PUNCT
ajlsi-2441	87	89	0.002	0.002	NUM
ajlsi-2441	87	90	pa	pa	PROPN
ajlsi-2441	87	91	ge	ge	PROPN
ajlsi-2441	87	92	32	32	NUM
ajlsi-2441	87	93	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	87	94	am	am	NOUN
ajlsi-2441	87	95	.	.	PUNCT
ajlsi-2441	88	1	j.	j.	PROPN
ajlsi-2441	88	2	life	life	PROPN
ajlsi-2441	88	3	sci	sci	PROPN
ajlsi-2441	88	4	.	.	PUNCT
ajlsi-2441	88	5	innov	innov	PROPN
ajlsi-2441	88	6	.	.	PUNCT
ajlsi-2441	89	1	3(1	3(1	NUM
ajlsi-2441	89	2	)	)	PUNCT
ajlsi-2441	89	3	28	28	NUM
ajlsi-2441	89	4	-	-	SYM
ajlsi-2441	89	5	36	36	NUM
ajlsi-2441	89	6	,	,	PUNCT
ajlsi-2441	89	7	2024	2024	NUM
ajlsi-2441	89	8	figure	figure	NOUN
ajlsi-2441	89	9	2	2	NUM
ajlsi-2441	89	10	,	,	PUNCT
ajlsi-2441	89	11	further	far	ADV
ajlsi-2441	89	12	underscored	underscore	VERB
ajlsi-2441	89	13	the	the	DET
ajlsi-2441	89	14	prominence	prominence	NOUN
ajlsi-2441	89	15	of	of	ADP
ajlsi-2441	89	16	rdw/	rdw/	PROPN
ajlsi-2441	89	17	plt	plt	NOUN
ajlsi-2441	89	18	,	,	PUNCT
ajlsi-2441	89	19	il-6	il-6	NUM
ajlsi-2441	89	20	,	,	PUNCT
ajlsi-2441	89	21	crp	crp	PROPN
ajlsi-2441	89	22	,	,	PUNCT
ajlsi-2441	89	23	rdw	rdw	X
ajlsi-2441	89	24	-	-	PUNCT
ajlsi-2441	89	25	sd	sd	NOUN
ajlsi-2441	89	26	,	,	PUNCT
ajlsi-2441	89	27	age	age	NOUN
ajlsi-2441	89	28	,	,	PUNCT
ajlsi-2441	89	29	and	and	CCONJ
ajlsi-2441	89	30	ast	ast	NOUN
ajlsi-2441	89	31	as	as	ADP
ajlsi-2441	89	32	prominent	prominent	ADJ
ajlsi-2441	89	33	predictors	predictor	NOUN
ajlsi-2441	89	34	in	in	ADP
ajlsi-2441	89	35	delineating	delineate	VERB
ajlsi-2441	89	36	disease	disease	NOUN
ajlsi-2441	89	37	severity	severity	NOUN
ajlsi-2441	89	38	.	.	PUNCT
ajlsi-2441	90	1	predictive	predictive	ADJ
ajlsi-2441	90	2	value	value	NOUN
ajlsi-2441	90	3	of	of	ADP
ajlsi-2441	90	4	rdw	rdw	X
ajlsi-2441	90	5	/	/	SYM
ajlsi-2441	90	6	plt	plt	NOUN
ajlsi-2441	90	7	intriguingly	intriguingly	ADV
ajlsi-2441	90	8	,	,	PUNCT
ajlsi-2441	90	9	receiver	receiver	ADV
ajlsi-2441	90	10	operating	operate	VERB
ajlsi-2441	90	11	characteristic	characteristic	NOUN
ajlsi-2441	90	12	(	(	PUNCT
ajlsi-2441	90	13	roc	roc	PROPN
ajlsi-2441	90	14	)	)	PUNCT
ajlsi-2441	90	15	curve	curve	NOUN
ajlsi-2441	90	16	analysis	analysis	NOUN
ajlsi-2441	90	17	highlighted	highlight	VERB
ajlsi-2441	90	18	the	the	DET
ajlsi-2441	90	19	remarkable	remarkable	ADJ
ajlsi-2441	90	20	predictive	predictive	ADJ
ajlsi-2441	90	21	capacity	capacity	NOUN
ajlsi-2441	90	22	of	of	ADP
ajlsi-2441	90	23	rdw	rdw	ADJ
ajlsi-2441	90	24	/	/	SYM
ajlsi-2441	90	25	plt	plt	NOUN
ajlsi-2441	90	26	in	in	ADP
ajlsi-2441	90	27	forecasting	forecast	VERB
ajlsi-2441	90	28	the	the	DET
ajlsi-2441	90	29	risk	risk	NOUN
ajlsi-2441	90	30	of	of	ADP
ajlsi-2441	90	31	progression	progression	NOUN
ajlsi-2441	90	32	in	in	ADP
ajlsi-2441	90	33	covid-19	covid-19	PROPN
ajlsi-2441	90	34	patients	patient	NOUN
ajlsi-2441	90	35	.	.	PUNCT
ajlsi-2441	91	1	with	with	ADP
ajlsi-2441	91	2	an	an	DET
ajlsi-2441	91	3	impressive	impressive	ADJ
ajlsi-2441	91	4	area	area	NOUN
ajlsi-2441	91	5	under	under	ADP
ajlsi-2441	91	6	the	the	DET
ajlsi-2441	91	7	curve	curve	NOUN
ajlsi-2441	91	8	(	(	PUNCT
ajlsi-2441	91	9	auc	auc	NOUN
ajlsi-2441	91	10	)	)	PUNCT
ajlsi-2441	91	11	of	of	ADP
ajlsi-2441	91	12	0.925	0.925	NUM
ajlsi-2441	91	13	(	(	PUNCT
ajlsi-2441	91	14	95	95	NUM
ajlsi-2441	91	15	%	%	NOUN
ajlsi-2441	91	16	ci	ci	NOUN
ajlsi-2441	91	17	0.858–0.991	0.858–0.991	NUM
ajlsi-2441	91	18	)	)	PUNCT
ajlsi-2441	91	19	,	,	PUNCT
ajlsi-2441	91	20	rdw	rdw	X
ajlsi-2441	91	21	/	/	SYM
ajlsi-2441	91	22	plt	plt	NOUN
ajlsi-2441	91	23	emerged	emerge	VERB
ajlsi-2441	91	24	as	as	ADP
ajlsi-2441	91	25	the	the	DET
ajlsi-2441	91	26	most	most	ADV
ajlsi-2441	91	27	robust	robust	ADJ
ajlsi-2441	91	28	single	single	ADJ
ajlsi-2441	91	29	parameter	parameter	NOUN
ajlsi-2441	91	30	.	.	PUNCT
ajlsi-2441	92	1	utilizing	utilize	VERB
ajlsi-2441	92	2	a	a	DET
ajlsi-2441	92	3	cutoff	cutoff	NOUN
ajlsi-2441	92	4	value	value	NOUN
ajlsi-2441	92	5	of	of	ADP
ajlsi-2441	92	6	0.355	0.355	NUM
ajlsi-2441	92	7	,	,	PUNCT
ajlsi-2441	92	8	rdw	rdw	X
ajlsi-2441	92	9	/	/	SYM
ajlsi-2441	92	10	plt	plt	NOUN
ajlsi-2441	92	11	showcased	showcase	VERB
ajlsi-2441	92	12	a	a	DET
ajlsi-2441	92	13	high	high	ADJ
ajlsi-2441	92	14	sensitivity	sensitivity	NOUN
ajlsi-2441	92	15	of	of	ADP
ajlsi-2441	92	16	94.12	94.12	NUM
ajlsi-2441	92	17	%	%	NOUN
ajlsi-2441	92	18	and	and	CCONJ
ajlsi-2441	92	19	specificity	specificity	NOUN
ajlsi-2441	92	20	of	of	ADP
ajlsi-2441	92	21	80.56	80.56	NUM
ajlsi-2441	92	22	%	%	NOUN
ajlsi-2441	92	23	in	in	ADP
ajlsi-2441	92	24	predicting	predict	VERB
ajlsi-2441	92	25	the	the	DET
ajlsi-2441	92	26	risk	risk	NOUN
ajlsi-2441	92	27	of	of	ADP
ajlsi-2441	92	28	progression	progression	NOUN
ajlsi-2441	92	29	,	,	PUNCT
ajlsi-2441	92	30	which	which	PRON
ajlsi-2441	92	31	is	be	AUX
ajlsi-2441	92	32	shown	show	VERB
ajlsi-2441	92	33	in	in	ADP
ajlsi-2441	92	34	figure	figure	NOUN
ajlsi-2441	92	35	3	3	NUM
ajlsi-2441	92	36	.	.	PUNCT
ajlsi-2441	93	1	alb	alb	PROPN
ajlsi-2441	93	2	0.68	0.68	NUM
ajlsi-2441	93	3	(	(	PUNCT
ajlsi-2441	93	4	0.54	0.54	NUM
ajlsi-2441	93	5	-	-	SYM
ajlsi-2441	93	6	0.84	0.84	NUM
ajlsi-2441	93	7	)	)	PUNCT
ajlsi-2441	93	8	<	<	X
ajlsi-2441	93	9	0.001	0.001	NUM
ajlsi-2441	93	10	crea	crea	X
ajlsi-2441	93	11	1.02	1.02	NUM
ajlsi-2441	93	12	(	(	PUNCT
ajlsi-2441	93	13	1.00	1.00	NUM
ajlsi-2441	93	14	-	-	SYM
ajlsi-2441	93	15	1.04	1.04	NUM
ajlsi-2441	93	16	)	)	PUNCT
ajlsi-2441	93	17	0.052	0.052	NUM
ajlsi-2441	93	18	crp	crp	PROPN
ajlsi-2441	93	19	1.06	1.06	NUM
ajlsi-2441	93	20	(	(	PUNCT
ajlsi-2441	93	21	1.03	1.03	NUM
ajlsi-2441	93	22	-	-	SYM
ajlsi-2441	93	23	1.10	1.10	NUM
ajlsi-2441	93	24	)	)	PUNCT
ajlsi-2441	93	25	<	<	X
ajlsi-2441	93	26	0.001	0.001	NUM
ajlsi-2441	93	27	il-6	il-6	NUM
ajlsi-2441	93	28	1.07	1.07	NUM
ajlsi-2441	93	29	(	(	PUNCT
ajlsi-2441	93	30	1.03	1.03	NUM
ajlsi-2441	93	31	-	-	NUM
ajlsi-2441	93	32	1.12	1.12	NUM
ajlsi-2441	93	33	)	)	PUNCT
ajlsi-2441	93	34	<	<	X
ajlsi-2441	93	35	0.001	0.001	NUM
ajlsi-2441	93	36	figure	figure	NOUN
ajlsi-2441	93	37	2	2	NUM
ajlsi-2441	93	38	:	:	PUNCT
ajlsi-2441	93	39	forest	forest	NOUN
ajlsi-2441	93	40	plot	plot	NOUN
ajlsi-2441	93	41	figure	figure	NOUN
ajlsi-2441	93	42	3	3	NUM
ajlsi-2441	93	43	:	:	PUNCT
ajlsi-2441	93	44	roc	roc	NOUN
ajlsi-2441	93	45	curve	curve	NOUN
ajlsi-2441	93	46	for	for	ADP
ajlsi-2441	93	47	the	the	DET
ajlsi-2441	93	48	prediction	prediction	NOUN
ajlsi-2441	93	49	of	of	ADP
ajlsi-2441	93	50	developing	develop	VERB
ajlsi-2441	93	51	severe	severe	ADJ
ajlsi-2441	93	52	covid-19	covid-19	PROPN
ajlsi-2441	93	53	pneumonia	pneumonia	NOUN
ajlsi-2441	93	54	interpretation	interpretation	NOUN
ajlsi-2441	93	55	and	and	CCONJ
ajlsi-2441	93	56	implications	implication	NOUN
ajlsi-2441	93	57	these	these	DET
ajlsi-2441	93	58	findings	finding	NOUN
ajlsi-2441	93	59	underscore	underscore	VERB
ajlsi-2441	93	60	the	the	DET
ajlsi-2441	93	61	clinical	clinical	ADJ
ajlsi-2441	93	62	relevance	relevance	NOUN
ajlsi-2441	93	63	of	of	ADP
ajlsi-2441	93	64	specific	specific	ADJ
ajlsi-2441	93	65	hematological	hematological	ADJ
ajlsi-2441	93	66	and	and	CCONJ
ajlsi-2441	93	67	demographic	demographic	ADJ
ajlsi-2441	93	68	markers	marker	NOUN
ajlsi-2441	93	69	in	in	ADP
ajlsi-2441	93	70	predicting	predict	VERB
ajlsi-2441	93	71	the	the	DET
ajlsi-2441	93	72	trajectory	trajectory	NOUN
ajlsi-2441	93	73	of	of	ADP
ajlsi-2441	93	74	covid-19	covid-19	PROPN
ajlsi-2441	93	75	pneumonia	pneumonia	NOUN
ajlsi-2441	93	76	.	.	PUNCT
ajlsi-2441	94	1	notably	notably	ADV
ajlsi-2441	94	2	,	,	PUNCT
ajlsi-2441	94	3	the	the	DET
ajlsi-2441	94	4	identification	identification	NOUN
ajlsi-2441	94	5	of	of	ADP
ajlsi-2441	94	6	rdw	rdw	X
ajlsi-2441	94	7	/	/	SYM
ajlsi-2441	94	8	plt	plt	NOUN
ajlsi-2441	94	9	as	as	ADP
ajlsi-2441	94	10	a	a	DET
ajlsi-2441	94	11	robust	robust	ADJ
ajlsi-2441	94	12	predictor	predictor	NOUN
ajlsi-2441	94	13	of	of	ADP
ajlsi-2441	94	14	disease	disease	NOUN
ajlsi-2441	94	15	progression	progression	NOUN
ajlsi-2441	94	16	signifies	signify	VERB
ajlsi-2441	94	17	its	its	PRON
ajlsi-2441	94	18	potential	potential	ADJ
ajlsi-2441	94	19	utility	utility	NOUN
ajlsi-2441	94	20	as	as	ADP
ajlsi-2441	94	21	an	an	DET
ajlsi-2441	94	22	early	early	ADJ
ajlsi-2441	94	23	prognostic	prognostic	ADJ
ajlsi-2441	94	24	marker	marker	NOUN
ajlsi-2441	94	25	,	,	PUNCT
ajlsi-2441	94	26	allowing	allow	VERB
ajlsi-2441	94	27	for	for	ADP
ajlsi-2441	94	28	prompt	prompt	ADJ
ajlsi-2441	94	29	interventions	intervention	NOUN
ajlsi-2441	94	30	and	and	CCONJ
ajlsi-2441	94	31	focused	focus	VERB
ajlsi-2441	94	32	clinical	clinical	ADJ
ajlsi-2441	94	33	management	management	NOUN
ajlsi-2441	94	34	.	.	PUNCT
ajlsi-2441	95	1	discussion	discussion	NOUN
ajlsi-2441	95	2	according	accord	VERB
ajlsi-2441	95	3	to	to	ADP
ajlsi-2441	95	4	the	the	DET
ajlsi-2441	95	5	study	study	NOUN
ajlsi-2441	95	6	’s	’s	PART
ajlsi-2441	95	7	findings	finding	NOUN
ajlsi-2441	95	8	,	,	PUNCT
ajlsi-2441	95	9	the	the	DET
ajlsi-2441	95	10	red	red	ADJ
ajlsi-2441	95	11	cell	cell	NOUN
ajlsi-2441	95	12	distribution	distribution	NOUN
ajlsi-2441	95	13	width	width	NOUN
ajlsi-2441	95	14	to	to	PART
ajlsi-2441	95	15	platelet	platelet	NOUN
ajlsi-2441	95	16	ratio	ratio	NOUN
ajlsi-2441	95	17	(	(	PUNCT
ajlsi-2441	95	18	rdw	rdw	X
ajlsi-2441	95	19	/	/	SYM
ajlsi-2441	95	20	plt	plt	NOUN
ajlsi-2441	95	21	)	)	PUNCT
ajlsi-2441	95	22	may	may	AUX
ajlsi-2441	95	23	prove	prove	VERB
ajlsi-2441	95	24	to	to	PART
ajlsi-2441	95	25	be	be	AUX
ajlsi-2441	95	26	a	a	DET
ajlsi-2441	95	27	useful	useful	ADJ
ajlsi-2441	95	28	biomarker	biomarker	NOUN
ajlsi-2441	95	29	for	for	ADP
ajlsi-2441	95	30	determining	determine	VERB
ajlsi-2441	95	31	when	when	SCONJ
ajlsi-2441	95	32	covid-19	covid-19	PROPN
ajlsi-2441	95	33	pneumonia	pneumonia	NOUN
ajlsi-2441	95	34	will	will	AUX
ajlsi-2441	95	35	progress	progress	VERB
ajlsi-2441	95	36	from	from	ADP
ajlsi-2441	95	37	a	a	DET
ajlsi-2441	95	38	moderate	moderate	ADJ
ajlsi-2441	95	39	to	to	ADP
ajlsi-2441	95	40	a	a	DET
ajlsi-2441	95	41	severe	severe	ADJ
ajlsi-2441	95	42	stage	stage	NOUN
ajlsi-2441	95	43	(	(	PUNCT
ajlsi-2441	95	44	alballa	alballa	PROPN
ajlsi-2441	95	45	&	&	CCONJ
ajlsi-2441	95	46	al	al	PROPN
ajlsi-2441	95	47	-	-	PUNCT
ajlsi-2441	95	48	turaiki	turaiki	PROPN
ajlsi-2441	95	49	,	,	PUNCT
ajlsi-2441	95	50	2021	2021	NUM
ajlsi-2441	95	51	;	;	PUNCT
ajlsi-2441	95	52	ghahramani	ghahramani	PROPN
ajlsi-2441	95	53	et	et	PROPN
ajlsi-2441	95	54	al	al	PROPN
ajlsi-2441	95	55	.	.	PROPN
ajlsi-2441	95	56	,	,	PUNCT
ajlsi-2441	95	57	2020	2020	NUM
ajlsi-2441	95	58	;	;	PUNCT
ajlsi-2441	95	59	yamada	yamada	PROPN
ajlsi-2441	95	60	et	et	PROPN
ajlsi-2441	95	61	al	al	PROPN
ajlsi-2441	95	62	.	.	PROPN
ajlsi-2441	95	63	,	,	PUNCT
ajlsi-2441	95	64	2020	2020	NUM
ajlsi-2441	95	65	)	)	PUNCT
ajlsi-2441	95	66	.	.	PUNCT
ajlsi-2441	96	1	since	since	SCONJ
ajlsi-2441	96	2	elevated	elevate	VERB
ajlsi-2441	96	3	rdw	rdw	ADJ
ajlsi-2441	96	4	/	/	SYM
ajlsi-2441	96	5	plt	plt	NOUN
ajlsi-2441	96	6	values	value	NOUN
ajlsi-2441	96	7	have	have	AUX
ajlsi-2441	96	8	been	be	AUX
ajlsi-2441	96	9	associated	associate	VERB
ajlsi-2441	96	10	with	with	ADP
ajlsi-2441	96	11	disease	disease	NOUN
ajlsi-2441	96	12	progression	progression	NOUN
ajlsi-2441	96	13	,	,	PUNCT
ajlsi-2441	96	14	pa	pa	PROPN
ajlsi-2441	96	15	ge	ge	PROPN
ajlsi-2441	96	16	33	33	NUM
ajlsi-2441	96	17	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	96	18	am	am	NOUN
ajlsi-2441	96	19	.	.	PUNCT
ajlsi-2441	97	1	j.	j.	PROPN
ajlsi-2441	97	2	life	life	PROPN
ajlsi-2441	97	3	sci	sci	PROPN
ajlsi-2441	97	4	.	.	PUNCT
ajlsi-2441	97	5	innov	innov	PROPN
ajlsi-2441	97	6	.	.	PUNCT
ajlsi-2441	98	1	3(1	3(1	NUM
ajlsi-2441	98	2	)	)	PUNCT
ajlsi-2441	98	3	28	28	NUM
ajlsi-2441	98	4	-	-	SYM
ajlsi-2441	98	5	36	36	NUM
ajlsi-2441	98	6	,	,	PUNCT
ajlsi-2441	98	7	2024	2024	NUM
ajlsi-2441	98	8	physicians	physician	NOUN
ajlsi-2441	98	9	may	may	AUX
ajlsi-2441	98	10	be	be	AUX
ajlsi-2441	98	11	able	able	ADJ
ajlsi-2441	98	12	to	to	PART
ajlsi-2441	98	13	use	use	VERB
ajlsi-2441	98	14	them	they	PRON
ajlsi-2441	98	15	as	as	ADP
ajlsi-2441	98	16	a	a	DET
ajlsi-2441	98	17	preemptive	preemptive	ADJ
ajlsi-2441	98	18	measure	measure	NOUN
ajlsi-2441	98	19	to	to	PART
ajlsi-2441	98	20	identify	identify	VERB
ajlsi-2441	98	21	patients	patient	NOUN
ajlsi-2441	98	22	who	who	PRON
ajlsi-2441	98	23	are	be	AUX
ajlsi-2441	98	24	more	more	ADV
ajlsi-2441	98	25	likely	likely	ADJ
ajlsi-2441	98	26	to	to	PART
ajlsi-2441	98	27	develop	develop	VERB
ajlsi-2441	98	28	severe	severe	ADJ
ajlsi-2441	98	29	illness	illness	NOUN
ajlsi-2441	98	30	in	in	ADP
ajlsi-2441	98	31	the	the	DET
ajlsi-2441	98	32	future	future	NOUN
ajlsi-2441	98	33	(	(	PUNCT
ajlsi-2441	98	34	alnor	alnor	PROPN
ajlsi-2441	98	35	et	et	PROPN
ajlsi-2441	98	36	al	al	PROPN
ajlsi-2441	98	37	.	.	PROPN
ajlsi-2441	98	38	,	,	PUNCT
ajlsi-2441	98	39	2020	2020	NUM
ajlsi-2441	98	40	;	;	PUNCT
ajlsi-2441	98	41	gong	gong	PROPN
ajlsi-2441	98	42	et	et	PROPN
ajlsi-2441	98	43	al	al	PROPN
ajlsi-2441	98	44	.	.	PROPN
ajlsi-2441	98	45	,	,	PUNCT
ajlsi-2441	98	46	2021	2021	NUM
ajlsi-2441	98	47	)	)	PUNCT
ajlsi-2441	98	48	.	.	PUNCT
ajlsi-2441	99	1	early	early	ADJ
ajlsi-2441	99	2	detection	detection	NOUN
ajlsi-2441	99	3	could	could	AUX
ajlsi-2441	99	4	result	result	VERB
ajlsi-2441	99	5	in	in	ADP
ajlsi-2441	99	6	targeted	target	VERB
ajlsi-2441	99	7	therapy	therapy	NOUN
ajlsi-2441	99	8	,	,	PUNCT
ajlsi-2441	99	9	attentive	attentive	ADJ
ajlsi-2441	99	10	observation	observation	NOUN
ajlsi-2441	99	11	,	,	PUNCT
ajlsi-2441	99	12	and	and	CCONJ
ajlsi-2441	99	13	intervention	intervention	NOUN
ajlsi-2441	99	14	strategies	strategy	NOUN
ajlsi-2441	99	15	that	that	PRON
ajlsi-2441	99	16	could	could	AUX
ajlsi-2441	99	17	enhance	enhance	VERB
ajlsi-2441	99	18	patient	patient	ADJ
ajlsi-2441	99	19	outcomes	outcome	NOUN
ajlsi-2441	99	20	(	(	PUNCT
ajlsi-2441	99	21	bonetti	bonetti	PROPN
ajlsi-2441	99	22	et	et	PROPN
ajlsi-2441	99	23	al	al	PROPN
ajlsi-2441	99	24	.	.	PROPN
ajlsi-2441	99	25	,	,	PUNCT
ajlsi-2441	99	26	2020	2020	NUM
ajlsi-2441	99	27	)	)	PUNCT
ajlsi-2441	99	28	.	.	PUNCT
ajlsi-2441	100	1	the	the	DET
ajlsi-2441	100	2	study	study	NOUN
ajlsi-2441	100	3	’s	’s	PART
ajlsi-2441	100	4	findings	finding	NOUN
ajlsi-2441	100	5	indicate	indicate	VERB
ajlsi-2441	100	6	that	that	SCONJ
ajlsi-2441	100	7	the	the	DET
ajlsi-2441	100	8	red	red	ADJ
ajlsi-2441	100	9	cell	cell	NOUN
ajlsi-2441	100	10	distribution	distribution	NOUN
ajlsi-2441	100	11	width	width	NOUN
ajlsi-2441	100	12	to	to	PART
ajlsi-2441	100	13	platelet	platelet	NOUN
ajlsi-2441	100	14	ratio	ratio	NOUN
ajlsi-2441	100	15	(	(	PUNCT
ajlsi-2441	100	16	rdw	rdw	X
ajlsi-2441	100	17	/	/	SYM
ajlsi-2441	100	18	plt	plt	NOUN
ajlsi-2441	100	19	)	)	PUNCT
ajlsi-2441	100	20	may	may	AUX
ajlsi-2441	100	21	be	be	AUX
ajlsi-2441	100	22	a	a	DET
ajlsi-2441	100	23	valuable	valuable	ADJ
ajlsi-2441	100	24	biomarker	biomarker	NOUN
ajlsi-2441	100	25	for	for	ADP
ajlsi-2441	100	26	predicting	predict	VERB
ajlsi-2441	100	27	how	how	SCONJ
ajlsi-2441	100	28	covid-19	covid-19	PROPN
ajlsi-2441	100	29	will	will	AUX
ajlsi-2441	100	30	progress	progress	VERB
ajlsi-2441	100	31	.	.	PUNCT
ajlsi-2441	101	1	numerous	numerous	ADJ
ajlsi-2441	101	2	studies	study	NOUN
ajlsi-2441	101	3	have	have	AUX
ajlsi-2441	101	4	reported	report	VERB
ajlsi-2441	101	5	a	a	DET
ajlsi-2441	101	6	relationship	relationship	NOUN
ajlsi-2441	101	7	between	between	ADP
ajlsi-2441	101	8	rdw	rdw	ADJ
ajlsi-2441	101	9	and	and	CCONJ
ajlsi-2441	101	10	disease	disease	NOUN
ajlsi-2441	101	11	severity	severity	NOUN
ajlsi-2441	101	12	for	for	ADP
ajlsi-2441	101	13	a	a	DET
ajlsi-2441	101	14	range	range	NOUN
ajlsi-2441	101	15	of	of	ADP
ajlsi-2441	101	16	medical	medical	ADJ
ajlsi-2441	101	17	conditions	condition	NOUN
ajlsi-2441	101	18	,	,	PUNCT
ajlsi-2441	101	19	including	include	VERB
ajlsi-2441	101	20	cancer	cancer	NOUN
ajlsi-2441	101	21	,	,	PUNCT
ajlsi-2441	101	22	pulmonary	pulmonary	ADJ
ajlsi-2441	101	23	disorders	disorder	NOUN
ajlsi-2441	101	24	,	,	PUNCT
ajlsi-2441	101	25	and	and	CCONJ
ajlsi-2441	101	26	cardiovascular	cardiovascular	ADJ
ajlsi-2441	101	27	diseases	disease	NOUN
ajlsi-2441	101	28	(	(	PUNCT
ajlsi-2441	101	29	foy	foy	PROPN
ajlsi-2441	101	30	et	et	PROPN
ajlsi-2441	101	31	al	al	PROPN
ajlsi-2441	101	32	.	.	PROPN
ajlsi-2441	101	33	,	,	PUNCT
ajlsi-2441	101	34	2020b	2020b	NUM
ajlsi-2441	101	35	)	)	PUNCT
ajlsi-2441	101	36	.	.	PUNCT
ajlsi-2441	102	1	rdw	rdw	PROPN
ajlsi-2441	102	2	is	be	AUX
ajlsi-2441	102	3	a	a	DET
ajlsi-2441	102	4	measure	measure	NOUN
ajlsi-2441	102	5	of	of	ADP
ajlsi-2441	102	6	the	the	DET
ajlsi-2441	102	7	heterogeneity	heterogeneity	NOUN
ajlsi-2441	102	8	in	in	ADP
ajlsi-2441	102	9	red	red	ADJ
ajlsi-2441	102	10	blood	blood	NOUN
ajlsi-2441	102	11	cell	cell	NOUN
ajlsi-2441	102	12	size	size	NOUN
ajlsi-2441	102	13	that	that	PRON
ajlsi-2441	102	14	is	be	AUX
ajlsi-2441	102	15	caused	cause	VERB
ajlsi-2441	102	16	by	by	ADP
ajlsi-2441	102	17	oxidative	oxidative	ADJ
ajlsi-2441	102	18	stress	stress	NOUN
ajlsi-2441	102	19	,	,	PUNCT
ajlsi-2441	102	20	inflammatory	inflammatory	ADJ
ajlsi-2441	102	21	reactions	reaction	NOUN
ajlsi-2441	102	22	,	,	PUNCT
ajlsi-2441	102	23	and	and	CCONJ
ajlsi-2441	102	24	decreased	decrease	VERB
ajlsi-2441	102	25	erythropoiesis	erythropoiesis	NOUN
ajlsi-2441	102	26	.	.	PUNCT
ajlsi-2441	103	1	within	within	ADP
ajlsi-2441	103	2	the	the	DET
ajlsi-2441	103	3	framework	framework	NOUN
ajlsi-2441	103	4	of	of	ADP
ajlsi-2441	103	5	covid-19	covid-19	PROPN
ajlsi-2441	103	6	,	,	PUNCT
ajlsi-2441	103	7	the	the	DET
ajlsi-2441	103	8	noted	note	VERB
ajlsi-2441	103	9	increase	increase	NOUN
ajlsi-2441	103	10	in	in	ADP
ajlsi-2441	103	11	rdw	rdw	PROPN
ajlsi-2441	103	12	could	could	AUX
ajlsi-2441	103	13	be	be	AUX
ajlsi-2441	103	14	linked	link	VERB
ajlsi-2441	103	15	to	to	ADP
ajlsi-2441	103	16	the	the	DET
ajlsi-2441	103	17	inflammatory	inflammatory	ADJ
ajlsi-2441	103	18	reaction	reaction	NOUN
ajlsi-2441	103	19	and	and	CCONJ
ajlsi-2441	103	20	subsequent	subsequent	ADJ
ajlsi-2441	103	21	cytokine	cytokine	NOUN
ajlsi-2441	103	22	storm	storm	NOUN
ajlsi-2441	103	23	,	,	PUNCT
ajlsi-2441	103	24	which	which	PRON
ajlsi-2441	103	25	could	could	AUX
ajlsi-2441	103	26	lead	lead	VERB
ajlsi-2441	103	27	to	to	ADP
ajlsi-2441	103	28	modifications	modification	NOUN
ajlsi-2441	103	29	in	in	ADP
ajlsi-2441	103	30	red	red	ADJ
ajlsi-2441	103	31	blood	blood	NOUN
ajlsi-2441	103	32	cell	cell	NOUN
ajlsi-2441	103	33	properties	property	NOUN
ajlsi-2441	103	34	(	(	PUNCT
ajlsi-2441	103	35	liu	liu	PROPN
ajlsi-2441	103	36	et	et	PROPN
ajlsi-2441	103	37	al	al	PROPN
ajlsi-2441	103	38	.	.	PROPN
ajlsi-2441	103	39	,	,	PUNCT
ajlsi-2441	103	40	2020	2020	NUM
ajlsi-2441	103	41	;	;	PUNCT
ajlsi-2441	103	42	pongpirul	pongpirul	NOUN
ajlsi-2441	103	43	et	et	PROPN
ajlsi-2441	103	44	al	al	PROPN
ajlsi-2441	103	45	.	.	PROPN
ajlsi-2441	103	46	,	,	PUNCT
ajlsi-2441	103	47	2020	2020	NUM
ajlsi-2441	103	48	)	)	PUNCT
ajlsi-2441	103	49	.	.	PUNCT
ajlsi-2441	104	1	furthermore	furthermore	ADV
ajlsi-2441	104	2	,	,	PUNCT
ajlsi-2441	104	3	the	the	DET
ajlsi-2441	104	4	correlation	correlation	NOUN
ajlsi-2441	104	5	between	between	ADP
ajlsi-2441	104	6	rdw	rdw	PROPN
ajlsi-2441	104	7	/	/	SYM
ajlsi-2441	104	8	plt	plt	NOUN
ajlsi-2441	104	9	and	and	CCONJ
ajlsi-2441	104	10	the	the	DET
ajlsi-2441	104	11	severity	severity	NOUN
ajlsi-2441	104	12	of	of	ADP
ajlsi-2441	104	13	the	the	DET
ajlsi-2441	104	14	covid-19	covid-19	PROPN
ajlsi-2441	104	15	virus	virus	NOUN
ajlsi-2441	104	16	is	be	AUX
ajlsi-2441	104	17	consistent	consistent	ADJ
ajlsi-2441	104	18	with	with	ADP
ajlsi-2441	104	19	decreased	decrease	VERB
ajlsi-2441	104	20	platelet	platelet	NOUN
ajlsi-2441	104	21	counts	count	NOUN
ajlsi-2441	104	22	,	,	PUNCT
ajlsi-2441	104	23	which	which	PRON
ajlsi-2441	104	24	are	be	AUX
ajlsi-2441	104	25	frequently	frequently	ADV
ajlsi-2441	104	26	observed	observe	VERB
ajlsi-2441	104	27	in	in	ADP
ajlsi-2441	104	28	cases	case	NOUN
ajlsi-2441	104	29	of	of	ADP
ajlsi-2441	104	30	severe	severe	ADJ
ajlsi-2441	104	31	viral	viral	ADJ
ajlsi-2441	104	32	infections	infection	NOUN
ajlsi-2441	104	33	(	(	PUNCT
ajlsi-2441	104	34	ponti	ponti	X
ajlsi-2441	104	35	et	et	PROPN
ajlsi-2441	104	36	al	al	PROPN
ajlsi-2441	104	37	.	.	PROPN
ajlsi-2441	104	38	,	,	PUNCT
ajlsi-2441	104	39	2020	2020	NUM
ajlsi-2441	104	40	)	)	PUNCT
ajlsi-2441	104	41	.	.	PUNCT
ajlsi-2441	105	1	this	this	DET
ajlsi-2441	105	2	study	study	NOUN
ajlsi-2441	105	3	’s	’s	PART
ajlsi-2441	105	4	findings	finding	NOUN
ajlsi-2441	105	5	align	align	VERB
ajlsi-2441	105	6	with	with	ADP
ajlsi-2441	105	7	previous	previous	ADJ
ajlsi-2441	105	8	investigations	investigation	NOUN
ajlsi-2441	105	9	highlighting	highlight	VERB
ajlsi-2441	105	10	the	the	DET
ajlsi-2441	105	11	role	role	NOUN
ajlsi-2441	105	12	of	of	ADP
ajlsi-2441	105	13	rdw	rdw	ADJ
ajlsi-2441	105	14	and	and	CCONJ
ajlsi-2441	105	15	platelet	platelet	NOUN
ajlsi-2441	105	16	count	count	NOUN
ajlsi-2441	105	17	as	as	ADP
ajlsi-2441	105	18	markers	marker	NOUN
ajlsi-2441	105	19	of	of	ADP
ajlsi-2441	105	20	systemic	systemic	ADJ
ajlsi-2441	105	21	inflammation	inflammation	NOUN
ajlsi-2441	105	22	and	and	CCONJ
ajlsi-2441	105	23	hematological	hematological	ADJ
ajlsi-2441	105	24	abnormalities	abnormality	NOUN
ajlsi-2441	105	25	(	(	PUNCT
ajlsi-2441	105	26	c.	c.	PROPN
ajlsi-2441	105	27	wang	wang	PROPN
ajlsi-2441	105	28	et	et	PROPN
ajlsi-2441	105	29	al	al	PROPN
ajlsi-2441	105	30	.	.	PROPN
ajlsi-2441	105	31	,	,	PUNCT
ajlsi-2441	105	32	2020	2020	NUM
ajlsi-2441	105	33	)	)	PUNCT
ajlsi-2441	105	34	.	.	PUNCT
ajlsi-2441	106	1	elevated	elevated	PROPN
ajlsi-2441	106	2	rdw	rdw	PROPN
ajlsi-2441	106	3	has	have	AUX
ajlsi-2441	106	4	consistently	consistently	ADV
ajlsi-2441	106	5	been	be	AUX
ajlsi-2441	106	6	linked	link	VERB
ajlsi-2441	106	7	to	to	ADP
ajlsi-2441	106	8	adverse	adverse	ADJ
ajlsi-2441	106	9	outcomes	outcome	NOUN
ajlsi-2441	106	10	in	in	ADP
ajlsi-2441	106	11	diverse	diverse	ADJ
ajlsi-2441	106	12	medical	medical	ADJ
ajlsi-2441	106	13	conditions	condition	NOUN
ajlsi-2441	106	14	,	,	PUNCT
ajlsi-2441	106	15	including	include	VERB
ajlsi-2441	106	16	cardiovascular	cardiovascular	ADJ
ajlsi-2441	106	17	and	and	CCONJ
ajlsi-2441	106	18	respiratory	respiratory	ADJ
ajlsi-2441	106	19	disorders	disorder	NOUN
ajlsi-2441	106	20	(	(	PUNCT
ajlsi-2441	106	21	yuan	yuan	NOUN
ajlsi-2441	106	22	et	et	NOUN
ajlsi-2441	106	23	al	al	PROPN
ajlsi-2441	106	24	.	.	PROPN
ajlsi-2441	106	25	,	,	PUNCT
ajlsi-2441	106	26	2020	2020	NUM
ajlsi-2441	106	27	)	)	PUNCT
ajlsi-2441	106	28	.	.	PUNCT
ajlsi-2441	107	1	similarly	similarly	ADV
ajlsi-2441	107	2	,	,	PUNCT
ajlsi-2441	107	3	alterations	alteration	NOUN
ajlsi-2441	107	4	in	in	ADP
ajlsi-2441	107	5	platelet	platelet	NOUN
ajlsi-2441	107	6	count	count	NOUN
ajlsi-2441	107	7	have	have	AUX
ajlsi-2441	107	8	been	be	AUX
ajlsi-2441	107	9	associated	associate	VERB
ajlsi-2441	107	10	with	with	ADP
ajlsi-2441	107	11	inflammatory	inflammatory	ADJ
ajlsi-2441	107	12	responses	response	NOUN
ajlsi-2441	107	13	and	and	CCONJ
ajlsi-2441	107	14	endothelial	endothelial	ADJ
ajlsi-2441	107	15	dysfunction	dysfunction	NOUN
ajlsi-2441	107	16	(	(	PUNCT
ajlsi-2441	107	17	li	li	PROPN
ajlsi-2441	107	18	et	et	PROPN
ajlsi-2441	107	19	al	al	PROPN
ajlsi-2441	107	20	.	.	PROPN
ajlsi-2441	107	21	,	,	PUNCT
ajlsi-2441	107	22	2020	2020	NUM
ajlsi-2441	107	23	)	)	PUNCT
ajlsi-2441	107	24	.	.	PUNCT
ajlsi-2441	108	1	this	this	DET
ajlsi-2441	108	2	study	study	NOUN
ajlsi-2441	108	3	contributes	contribute	VERB
ajlsi-2441	108	4	by	by	ADP
ajlsi-2441	108	5	emphasizing	emphasize	VERB
ajlsi-2441	108	6	the	the	DET
ajlsi-2441	108	7	utility	utility	NOUN
ajlsi-2441	108	8	of	of	ADP
ajlsi-2441	108	9	the	the	DET
ajlsi-2441	108	10	composite	composite	ADJ
ajlsi-2441	108	11	rdw	rdw	ADJ
ajlsi-2441	108	12	/	/	SYM
ajlsi-2441	108	13	plt	plt	NOUN
ajlsi-2441	108	14	ratio	ratio	NOUN
ajlsi-2441	108	15	as	as	ADP
ajlsi-2441	108	16	a	a	DET
ajlsi-2441	108	17	potential	potential	ADJ
ajlsi-2441	108	18	biomarker	biomarker	NOUN
ajlsi-2441	108	19	,	,	PUNCT
ajlsi-2441	108	20	specifically	specifically	ADV
ajlsi-2441	108	21	within	within	ADP
ajlsi-2441	108	22	the	the	DET
ajlsi-2441	108	23	context	context	NOUN
ajlsi-2441	108	24	of	of	ADP
ajlsi-2441	108	25	covid-19	covid-19	PROPN
ajlsi-2441	108	26	pneumonia	pneumonia	NOUN
ajlsi-2441	108	27	(	(	PUNCT
ajlsi-2441	108	28	ballaz	ballaz	PROPN
ajlsi-2441	108	29	et	et	PROPN
ajlsi-2441	108	30	al	al	PROPN
ajlsi-2441	108	31	.	.	PROPN
ajlsi-2441	108	32	,	,	PUNCT
ajlsi-2441	108	33	2021	2021	NUM
ajlsi-2441	108	34	)	)	PUNCT
ajlsi-2441	108	35	.	.	PUNCT
ajlsi-2441	109	1	a	a	DET
ajlsi-2441	109	2	plausible	plausible	ADJ
ajlsi-2441	109	3	underlying	underlying	ADJ
ajlsi-2441	109	4	mechanism	mechanism	NOUN
ajlsi-2441	109	5	for	for	ADP
ajlsi-2441	109	6	the	the	DET
ajlsi-2441	109	7	observed	observed	ADJ
ajlsi-2441	109	8	association	association	NOUN
ajlsi-2441	109	9	involves	involve	VERB
ajlsi-2441	109	10	the	the	DET
ajlsi-2441	109	11	systemic	systemic	ADJ
ajlsi-2441	109	12	inflammation	inflammation	NOUN
ajlsi-2441	109	13	and	and	CCONJ
ajlsi-2441	109	14	oxidative	oxidative	ADJ
ajlsi-2441	109	15	stress	stress	NOUN
ajlsi-2441	109	16	triggered	trigger	VERB
ajlsi-2441	109	17	by	by	ADP
ajlsi-2441	109	18	sars	sar	NOUN
ajlsi-2441	109	19	-	-	PUNCT
ajlsi-2441	109	20	cov-2	cov-2	PART
ajlsi-2441	109	21	infection	infection	NOUN
ajlsi-2441	109	22	(	(	PUNCT
ajlsi-2441	109	23	shiri	shiri	PROPN
ajlsi-2441	109	24	et	et	PROPN
ajlsi-2441	109	25	al	al	PROPN
ajlsi-2441	109	26	.	.	PROPN
ajlsi-2441	109	27	,	,	PUNCT
ajlsi-2441	109	28	2021	2021	NUM
ajlsi-2441	109	29	)	)	PUNCT
ajlsi-2441	109	30	.	.	PUNCT
ajlsi-2441	110	1	the	the	DET
ajlsi-2441	110	2	virus	virus	NOUN
ajlsi-2441	110	3	-	-	PUNCT
ajlsi-2441	110	4	induced	induce	VERB
ajlsi-2441	110	5	inflammatory	inflammatory	ADJ
ajlsi-2441	110	6	response	response	NOUN
ajlsi-2441	110	7	might	might	AUX
ajlsi-2441	110	8	lead	lead	VERB
ajlsi-2441	110	9	to	to	ADP
ajlsi-2441	110	10	hematological	hematological	ADJ
ajlsi-2441	110	11	changes	change	NOUN
ajlsi-2441	110	12	,	,	PUNCT
ajlsi-2441	110	13	affecting	affect	VERB
ajlsi-2441	110	14	red	red	ADJ
ajlsi-2441	110	15	cell	cell	NOUN
ajlsi-2441	110	16	distribution	distribution	NOUN
ajlsi-2441	110	17	and	and	CCONJ
ajlsi-2441	110	18	platelet	platelet	NOUN
ajlsi-2441	110	19	activation	activation	NOUN
ajlsi-2441	110	20	(	(	PUNCT
ajlsi-2441	110	21	khosravi	khosravi	NOUN
ajlsi-2441	110	22	et	et	PROPN
ajlsi-2441	110	23	al	al	PROPN
ajlsi-2441	110	24	.	.	PROPN
ajlsi-2441	110	25	,	,	PUNCT
ajlsi-2441	110	26	2021	2021	NUM
ajlsi-2441	110	27	)	)	PUNCT
ajlsi-2441	110	28	.	.	PUNCT
ajlsi-2441	111	1	the	the	DET
ajlsi-2441	111	2	rdw	rdw	PROPN
ajlsi-2441	111	3	/	/	SYM
ajlsi-2441	111	4	plt	plt	NOUN
ajlsi-2441	111	5	ratio	ratio	NOUN
ajlsi-2441	111	6	could	could	AUX
ajlsi-2441	111	7	capture	capture	VERB
ajlsi-2441	111	8	these	these	DET
ajlsi-2441	111	9	underlying	underlying	ADJ
ajlsi-2441	111	10	pathophysiological	pathophysiological	ADJ
ajlsi-2441	111	11	processes	process	NOUN
ajlsi-2441	111	12	,	,	PUNCT
ajlsi-2441	111	13	serving	serve	VERB
ajlsi-2441	111	14	as	as	ADP
ajlsi-2441	111	15	an	an	DET
ajlsi-2441	111	16	indicator	indicator	NOUN
ajlsi-2441	111	17	of	of	ADP
ajlsi-2441	111	18	disease	disease	NOUN
ajlsi-2441	111	19	severity	severity	NOUN
ajlsi-2441	111	20	(	(	PUNCT
ajlsi-2441	111	21	x.	x.	NOUN
ajlsi-2441	111	22	wang	wang	PROPN
ajlsi-2441	111	23	et	et	PROPN
ajlsi-2441	111	24	al	al	PROPN
ajlsi-2441	111	25	.	.	PROPN
ajlsi-2441	111	26	,	,	PUNCT
ajlsi-2441	111	27	2020	2020	NUM
ajlsi-2441	111	28	)	)	PUNCT
ajlsi-2441	111	29	.	.	PUNCT
ajlsi-2441	112	1	furthermore	furthermore	ADV
ajlsi-2441	112	2	,	,	PUNCT
ajlsi-2441	112	3	leveraging	leverage	VERB
ajlsi-2441	112	4	the	the	DET
ajlsi-2441	112	5	rdw	rdw	ADJ
ajlsi-2441	112	6	/	/	SYM
ajlsi-2441	112	7	plt	plt	NOUN
ajlsi-2441	112	8	ratio	ratio	NOUN
ajlsi-2441	112	9	as	as	ADP
ajlsi-2441	112	10	a	a	DET
ajlsi-2441	112	11	predictive	predictive	ADJ
ajlsi-2441	112	12	tool	tool	NOUN
ajlsi-2441	112	13	may	may	AUX
ajlsi-2441	112	14	contribute	contribute	VERB
ajlsi-2441	112	15	to	to	ADP
ajlsi-2441	112	16	personalized	personalized	ADJ
ajlsi-2441	112	17	approaches	approach	NOUN
ajlsi-2441	112	18	to	to	ADP
ajlsi-2441	112	19	managing	manage	VERB
ajlsi-2441	112	20	covid-19	covid-19	PROPN
ajlsi-2441	112	21	.	.	PUNCT
ajlsi-2441	112	22	table	table	NOUN
ajlsi-2441	112	23	1	1	NUM
ajlsi-2441	112	24	and	and	CCONJ
ajlsi-2441	112	25	table	table	NOUN
ajlsi-2441	112	26	2	2	NUM
ajlsi-2441	112	27	in	in	ADP
ajlsi-2441	112	28	the	the	DET
ajlsi-2441	112	29	current	current	ADJ
ajlsi-2441	112	30	study	study	NOUN
ajlsi-2441	112	31	elucidate	elucidate	VERB
ajlsi-2441	112	32	demographic	demographic	ADJ
ajlsi-2441	112	33	,	,	PUNCT
ajlsi-2441	112	34	clinical	clinical	ADJ
ajlsi-2441	112	35	,	,	PUNCT
ajlsi-2441	112	36	and	and	CCONJ
ajlsi-2441	112	37	laboratory	laboratory	NOUN
ajlsi-2441	112	38	characteristics	characteristic	NOUN
ajlsi-2441	112	39	associated	associate	VERB
ajlsi-2441	112	40	with	with	ADP
ajlsi-2441	112	41	the	the	DET
ajlsi-2441	112	42	progression	progression	NOUN
ajlsi-2441	112	43	of	of	ADP
ajlsi-2441	112	44	covid-19	covid-19	PROPN
ajlsi-2441	112	45	pneumonia	pneumonia	NOUN
ajlsi-2441	112	46	.	.	PUNCT
ajlsi-2441	113	1	similar	similar	ADJ
ajlsi-2441	113	2	analyses	analysis	NOUN
ajlsi-2441	113	3	in	in	ADP
ajlsi-2441	113	4	previous	previous	ADJ
ajlsi-2441	113	5	studies	study	NOUN
ajlsi-2441	113	6	have	have	AUX
ajlsi-2441	113	7	often	often	ADV
ajlsi-2441	113	8	highlighted	highlight	VERB
ajlsi-2441	113	9	age	age	NOUN
ajlsi-2441	113	10	,	,	PUNCT
ajlsi-2441	113	11	comorbidities	comorbiditie	NOUN
ajlsi-2441	113	12	,	,	PUNCT
ajlsi-2441	113	13	and	and	CCONJ
ajlsi-2441	113	14	specific	specific	ADJ
ajlsi-2441	113	15	laboratory	laboratory	NOUN
ajlsi-2441	113	16	parameters	parameter	NOUN
ajlsi-2441	113	17	,	,	PUNCT
ajlsi-2441	113	18	such	such	ADJ
ajlsi-2441	113	19	as	as	ADP
ajlsi-2441	113	20	inflammatory	inflammatory	ADJ
ajlsi-2441	113	21	markers	marker	NOUN
ajlsi-2441	113	22	(	(	PUNCT
ajlsi-2441	113	23	e.g.	e.g.	ADV
ajlsi-2441	113	24	,	,	PUNCT
ajlsi-2441	113	25	crp	crp	PROPN
ajlsi-2441	113	26	,	,	PUNCT
ajlsi-2441	113	27	il6	il6	PROPN
ajlsi-2441	113	28	)	)	PUNCT
ajlsi-2441	113	29	,	,	PUNCT
ajlsi-2441	113	30	as	as	ADP
ajlsi-2441	113	31	crucial	crucial	ADJ
ajlsi-2441	113	32	predictors	predictor	NOUN
ajlsi-2441	113	33	of	of	ADP
ajlsi-2441	113	34	disease	disease	NOUN
ajlsi-2441	113	35	severity	severity	NOUN
ajlsi-2441	113	36	(	(	PUNCT
ajlsi-2441	113	37	tjendra	tjendra	NOUN
ajlsi-2441	113	38	et	et	PROPN
ajlsi-2441	113	39	al	al	PROPN
ajlsi-2441	113	40	.	.	PROPN
ajlsi-2441	113	41	,	,	PUNCT
ajlsi-2441	113	42	2020	2020	NUM
ajlsi-2441	113	43	)	)	PUNCT
ajlsi-2441	113	44	.	.	PUNCT
ajlsi-2441	114	1	however	however	ADV
ajlsi-2441	114	2	,	,	PUNCT
ajlsi-2441	114	3	the	the	DET
ajlsi-2441	114	4	current	current	ADJ
ajlsi-2441	114	5	study	study	NOUN
ajlsi-2441	114	6	emphasizes	emphasize	VERB
ajlsi-2441	114	7	the	the	DET
ajlsi-2441	114	8	rdw/	rdw/	NOUN
ajlsi-2441	114	9	plt	plt	NOUN
ajlsi-2441	114	10	ratio	ratio	NOUN
ajlsi-2441	114	11	,	,	PUNCT
ajlsi-2441	114	12	which	which	PRON
ajlsi-2441	114	13	might	might	AUX
ajlsi-2441	114	14	have	have	AUX
ajlsi-2441	114	15	been	be	AUX
ajlsi-2441	114	16	less	less	ADV
ajlsi-2441	114	17	extensively	extensively	ADV
ajlsi-2441	114	18	in	in	ADP
ajlsi-2441	114	19	prior	prior	ADJ
ajlsi-2441	114	20	literature	literature	NOUN
ajlsi-2441	114	21	for	for	ADP
ajlsi-2441	114	22	covid-19	covid-19	PROPN
ajlsi-2441	114	23	severity	severity	NOUN
ajlsi-2441	114	24	prediction	prediction	NOUN
ajlsi-2441	114	25	.	.	PUNCT
ajlsi-2441	115	1	figure	figure	NOUN
ajlsi-2441	115	2	2	2	NUM
ajlsi-2441	115	3	,	,	PUNCT
ajlsi-2441	115	4	displaying	display	VERB
ajlsi-2441	115	5	a	a	DET
ajlsi-2441	115	6	forest	forest	NOUN
ajlsi-2441	115	7	plot	plot	NOUN
ajlsi-2441	115	8	of	of	ADP
ajlsi-2441	115	9	predictors	predictor	NOUN
ajlsi-2441	115	10	,	,	PUNCT
ajlsi-2441	115	11	echoes	echo	VERB
ajlsi-2441	115	12	findings	finding	NOUN
ajlsi-2441	115	13	from	from	ADP
ajlsi-2441	115	14	previous	previous	ADJ
ajlsi-2441	115	15	studies	study	NOUN
ajlsi-2441	115	16	,	,	PUNCT
ajlsi-2441	115	17	often	often	ADV
ajlsi-2441	115	18	revealing	reveal	VERB
ajlsi-2441	115	19	multiple	multiple	ADJ
ajlsi-2441	115	20	factors	factor	NOUN
ajlsi-2441	115	21	associated	associate	VERB
ajlsi-2441	115	22	with	with	ADP
ajlsi-2441	115	23	disease	disease	NOUN
ajlsi-2441	115	24	severity	severity	NOUN
ajlsi-2441	115	25	.	.	PUNCT
ajlsi-2441	116	1	previous	previous	ADJ
ajlsi-2441	116	2	studies	study	NOUN
ajlsi-2441	116	3	have	have	AUX
ajlsi-2441	116	4	reported	report	VERB
ajlsi-2441	116	5	diverse	diverse	ADJ
ajlsi-2441	116	6	predictors	predictor	NOUN
ajlsi-2441	116	7	,	,	PUNCT
ajlsi-2441	116	8	ranging	range	VERB
ajlsi-2441	116	9	from	from	ADP
ajlsi-2441	116	10	inflammatory	inflammatory	ADJ
ajlsi-2441	116	11	markers	marker	NOUN
ajlsi-2441	116	12	to	to	ADP
ajlsi-2441	116	13	specific	specific	ADJ
ajlsi-2441	116	14	clinical	clinical	ADJ
ajlsi-2441	116	15	parameters	parameter	NOUN
ajlsi-2441	116	16	,	,	PUNCT
ajlsi-2441	116	17	consistently	consistently	ADV
ajlsi-2441	116	18	emphasizing	emphasize	VERB
ajlsi-2441	116	19	the	the	DET
ajlsi-2441	116	20	multifactorial	multifactorial	ADJ
ajlsi-2441	116	21	nature	nature	NOUN
ajlsi-2441	116	22	of	of	ADP
ajlsi-2441	116	23	disease	disease	NOUN
ajlsi-2441	116	24	progression	progression	NOUN
ajlsi-2441	116	25	(	(	PUNCT
ajlsi-2441	116	26	krintus	krintus	NOUN
ajlsi-2441	116	27	et	et	PROPN
ajlsi-2441	116	28	al	al	PROPN
ajlsi-2441	116	29	.	.	PROPN
ajlsi-2441	116	30	,	,	PUNCT
ajlsi-2441	116	31	2014	2014	NUM
ajlsi-2441	116	32	)	)	PUNCT
ajlsi-2441	116	33	.	.	PUNCT
ajlsi-2441	117	1	figure	figure	VERB
ajlsi-2441	117	2	3	3	NUM
ajlsi-2441	117	3	exhibits	exhibit	VERB
ajlsi-2441	117	4	roc	roc	PROPN
ajlsi-2441	117	5	curve	curve	NOUN
ajlsi-2441	117	6	analysis	analysis	NOUN
ajlsi-2441	117	7	,	,	PUNCT
ajlsi-2441	117	8	demonstrating	demonstrate	VERB
ajlsi-2441	117	9	the	the	DET
ajlsi-2441	117	10	predictive	predictive	ADJ
ajlsi-2441	117	11	performance	performance	NOUN
ajlsi-2441	117	12	of	of	ADP
ajlsi-2441	117	13	individual	individual	ADJ
ajlsi-2441	117	14	parameters	parameter	NOUN
ajlsi-2441	117	15	for	for	ADP
ajlsi-2441	117	16	severe	severe	ADJ
ajlsi-2441	117	17	covid-19	covid-19	PROPN
ajlsi-2441	117	18	pneumonia	pneumonia	NOUN
ajlsi-2441	117	19	.	.	PUNCT
ajlsi-2441	118	1	prior	prior	ADJ
ajlsi-2441	118	2	research	research	NOUN
ajlsi-2441	118	3	often	often	ADV
ajlsi-2441	118	4	presents	present	VERB
ajlsi-2441	118	5	roc	roc	PROPN
ajlsi-2441	118	6	analyses	analysis	NOUN
ajlsi-2441	118	7	assessing	assess	VERB
ajlsi-2441	118	8	the	the	DET
ajlsi-2441	118	9	diagnostic	diagnostic	ADJ
ajlsi-2441	118	10	or	or	CCONJ
ajlsi-2441	118	11	predictive	predictive	ADJ
ajlsi-2441	118	12	accuracy	accuracy	NOUN
ajlsi-2441	118	13	of	of	ADP
ajlsi-2441	118	14	various	various	ADJ
ajlsi-2441	118	15	markers	marker	NOUN
ajlsi-2441	118	16	,	,	PUNCT
ajlsi-2441	118	17	with	with	ADP
ajlsi-2441	118	18	auc	auc	NOUN
ajlsi-2441	118	19	values	value	NOUN
ajlsi-2441	118	20	serving	serve	VERB
ajlsi-2441	118	21	as	as	ADP
ajlsi-2441	118	22	indicators	indicator	NOUN
ajlsi-2441	118	23	of	of	ADP
ajlsi-2441	118	24	predictive	predictive	ADJ
ajlsi-2441	118	25	strength	strength	NOUN
ajlsi-2441	118	26	.	.	PUNCT
ajlsi-2441	119	1	in	in	ADP
ajlsi-2441	119	2	comparison	comparison	NOUN
ajlsi-2441	119	3	to	to	ADP
ajlsi-2441	119	4	previous	previous	ADJ
ajlsi-2441	119	5	studies	study	NOUN
ajlsi-2441	119	6	,	,	PUNCT
ajlsi-2441	119	7	the	the	DET
ajlsi-2441	119	8	current	current	ADJ
ajlsi-2441	119	9	study	study	NOUN
ajlsi-2441	119	10	highlights	highlight	VERB
ajlsi-2441	119	11	the	the	DET
ajlsi-2441	119	12	rdw	rdw	PROPN
ajlsi-2441	119	13	/	/	SYM
ajlsi-2441	119	14	plt	plt	NOUN
ajlsi-2441	119	15	ratio	ratio	NOUN
ajlsi-2441	119	16	as	as	ADP
ajlsi-2441	119	17	a	a	DET
ajlsi-2441	119	18	potential	potential	ADJ
ajlsi-2441	119	19	strong	strong	ADJ
ajlsi-2441	119	20	predictor	predictor	NOUN
ajlsi-2441	119	21	for	for	ADP
ajlsi-2441	119	22	disease	disease	NOUN
ajlsi-2441	119	23	progression	progression	NOUN
ajlsi-2441	119	24	(	(	PUNCT
ajlsi-2441	119	25	cai	cai	X
ajlsi-2441	119	26	et	et	PROPN
ajlsi-2441	119	27	al	al	PROPN
ajlsi-2441	119	28	.	.	PROPN
ajlsi-2441	119	29	,	,	PUNCT
ajlsi-2441	119	30	2019	2019	NUM
ajlsi-2441	119	31	)	)	PUNCT
ajlsi-2441	119	32	.	.	PUNCT
ajlsi-2441	120	1	the	the	DET
ajlsi-2441	120	2	study	study	NOUN
ajlsi-2441	120	3	highlights	highlight	VERB
ajlsi-2441	120	4	the	the	DET
ajlsi-2441	120	5	potential	potential	NOUN
ajlsi-2441	120	6	of	of	ADP
ajlsi-2441	120	7	this	this	DET
ajlsi-2441	120	8	readily	readily	ADV
ajlsi-2441	120	9	available	available	ADJ
ajlsi-2441	120	10	and	and	CCONJ
ajlsi-2441	120	11	cost	cost	NOUN
ajlsi-2441	120	12	-	-	PUNCT
ajlsi-2441	120	13	effective	effective	ADJ
ajlsi-2441	120	14	measure	measure	NOUN
ajlsi-2441	120	15	to	to	PART
ajlsi-2441	120	16	aid	aid	VERB
ajlsi-2441	120	17	risk	risk	NOUN
ajlsi-2441	120	18	classification	classification	NOUN
ajlsi-2441	120	19	and	and	CCONJ
ajlsi-2441	120	20	guide	guide	VERB
ajlsi-2441	120	21	clinical	clinical	ADJ
ajlsi-2441	120	22	decision	decision	NOUN
ajlsi-2441	120	23	-	-	PUNCT
ajlsi-2441	120	24	making	making	NOUN
ajlsi-2441	120	25	(	(	PUNCT
ajlsi-2441	120	26	henry	henry	PROPN
ajlsi-2441	120	27	,	,	PUNCT
ajlsi-2441	120	28	de	de	PROPN
ajlsi-2441	120	29	oliveira	oliveira	PROPN
ajlsi-2441	120	30	,	,	PUNCT
ajlsi-2441	120	31	et	et	PROPN
ajlsi-2441	120	32	al	al	PROPN
ajlsi-2441	120	33	.	.	PROPN
ajlsi-2441	120	34	,	,	PUNCT
ajlsi-2441	120	35	2020	2020	NUM
ajlsi-2441	120	36	)	)	PUNCT
ajlsi-2441	120	37	.	.	PUNCT
ajlsi-2441	121	1	however	however	ADV
ajlsi-2441	121	2	,	,	PUNCT
ajlsi-2441	121	3	validation	validation	NOUN
ajlsi-2441	121	4	of	of	ADP
ajlsi-2441	121	5	these	these	DET
ajlsi-2441	121	6	findings	finding	NOUN
ajlsi-2441	121	7	,	,	PUNCT
ajlsi-2441	121	8	exploring	explore	VERB
ajlsi-2441	121	9	underlying	underlie	VERB
ajlsi-2441	121	10	mechanisms	mechanism	NOUN
ajlsi-2441	121	11	,	,	PUNCT
ajlsi-2441	121	12	and	and	CCONJ
ajlsi-2441	121	13	assessing	assess	VERB
ajlsi-2441	121	14	the	the	DET
ajlsi-2441	121	15	rdw	rdw	ADJ
ajlsi-2441	121	16	/	/	SYM
ajlsi-2441	121	17	plt	plt	NOUN
ajlsi-2441	121	18	ratio	ratio	NOUN
ajlsi-2441	121	19	’s	’s	PART
ajlsi-2441	121	20	value	value	NOUN
ajlsi-2441	121	21	in	in	ADP
ajlsi-2441	121	22	larger	large	ADJ
ajlsi-2441	121	23	patient	patient	NOUN
ajlsi-2441	121	24	cohorts	cohort	NOUN
ajlsi-2441	121	25	necessitate	necessitate	ADJ
ajlsi-2441	121	26	further	further	ADJ
ajlsi-2441	121	27	investigation	investigation	NOUN
ajlsi-2441	121	28	.	.	PUNCT
ajlsi-2441	122	1	the	the	DET
ajlsi-2441	122	2	prospective	prospective	ADJ
ajlsi-2441	122	3	application	application	NOUN
ajlsi-2441	122	4	of	of	ADP
ajlsi-2441	122	5	the	the	DET
ajlsi-2441	122	6	rdw/	rdw/	NOUN
ajlsi-2441	122	7	plt	plt	NOUN
ajlsi-2441	122	8	ratio	ratio	NOUN
ajlsi-2441	122	9	in	in	ADP
ajlsi-2441	122	10	clinical	clinical	ADJ
ajlsi-2441	122	11	practice	practice	NOUN
ajlsi-2441	122	12	holds	hold	VERB
ajlsi-2441	122	13	promise	promise	NOUN
ajlsi-2441	122	14	for	for	ADP
ajlsi-2441	122	15	enhancing	enhance	VERB
ajlsi-2441	122	16	patient	patient	ADJ
ajlsi-2441	122	17	outcomes	outcome	NOUN
ajlsi-2441	122	18	in	in	ADP
ajlsi-2441	122	19	covid-19	covid-19	PROPN
ajlsi-2441	122	20	pneumonia	pneumonia	NOUN
ajlsi-2441	122	21	.	.	PUNCT
ajlsi-2441	123	1	conclusion	conclusion	NOUN
ajlsi-2441	123	2	this	this	DET
ajlsi-2441	123	3	study	study	NOUN
ajlsi-2441	123	4	concludes	conclude	VERB
ajlsi-2441	123	5	that	that	SCONJ
ajlsi-2441	123	6	elevated	elevated	ADJ
ajlsi-2441	123	7	rdw	rdw	ADJ
ajlsi-2441	123	8	/	/	SYM
ajlsi-2441	123	9	plt	plt	NOUN
ajlsi-2441	123	10	values	value	NOUN
ajlsi-2441	123	11	are	be	AUX
ajlsi-2441	123	12	linked	link	VERB
ajlsi-2441	123	13	to	to	ADP
ajlsi-2441	123	14	the	the	DET
ajlsi-2441	123	15	advancement	advancement	NOUN
ajlsi-2441	123	16	of	of	ADP
ajlsi-2441	123	17	illness	illness	NOUN
ajlsi-2441	123	18	,	,	PUNCT
ajlsi-2441	123	19	indicating	indicate	VERB
ajlsi-2441	123	20	the	the	DET
ajlsi-2441	123	21	practicality	practicality	NOUN
ajlsi-2441	123	22	of	of	ADP
ajlsi-2441	123	23	utilizing	utilize	VERB
ajlsi-2441	123	24	this	this	DET
ajlsi-2441	123	25	readily	readily	ADV
ajlsi-2441	123	26	available	available	ADJ
ajlsi-2441	123	27	parameter	parameter	NOUN
ajlsi-2441	123	28	in	in	ADP
ajlsi-2441	123	29	clinical	clinical	ADJ
ajlsi-2441	123	30	settings	setting	NOUN
ajlsi-2441	123	31	.	.	PUNCT
ajlsi-2441	124	1	identifying	identify	VERB
ajlsi-2441	124	2	patients	patient	NOUN
ajlsi-2441	124	3	at	at	ADP
ajlsi-2441	124	4	higher	high	ADJ
ajlsi-2441	124	5	risk	risk	NOUN
ajlsi-2441	124	6	of	of	ADP
ajlsi-2441	124	7	developing	develop	VERB
ajlsi-2441	124	8	severe	severe	ADJ
ajlsi-2441	124	9	illness	illness	NOUN
ajlsi-2441	124	10	early	early	ADV
ajlsi-2441	124	11	on	on	ADV
ajlsi-2441	124	12	could	could	AUX
ajlsi-2441	124	13	facilitate	facilitate	VERB
ajlsi-2441	124	14	timely	timely	ADJ
ajlsi-2441	124	15	interventions	intervention	NOUN
ajlsi-2441	124	16	,	,	PUNCT
ajlsi-2441	124	17	enhanced	enhanced	ADJ
ajlsi-2441	124	18	surveillance	surveillance	NOUN
ajlsi-2441	124	19	,	,	PUNCT
ajlsi-2441	124	20	and	and	CCONJ
ajlsi-2441	124	21	more	more	ADV
ajlsi-2441	124	22	effective	effective	ADJ
ajlsi-2441	124	23	allocation	allocation	NOUN
ajlsi-2441	124	24	of	of	ADP
ajlsi-2441	124	25	healthcare	healthcare	NOUN
ajlsi-2441	124	26	resources	resource	NOUN
ajlsi-2441	124	27	.	.	PUNCT
ajlsi-2441	125	1	it	it	PRON
ajlsi-2441	125	2	provides	provide	VERB
ajlsi-2441	125	3	initial	initial	ADJ
ajlsi-2441	125	4	evidence	evidence	NOUN
ajlsi-2441	125	5	supporting	support	VERB
ajlsi-2441	125	6	the	the	DET
ajlsi-2441	125	7	potential	potential	NOUN
ajlsi-2441	125	8	of	of	ADP
ajlsi-2441	125	9	the	the	DET
ajlsi-2441	125	10	rdw	rdw	ADJ
ajlsi-2441	125	11	/	/	SYM
ajlsi-2441	125	12	plt	plt	NOUN
ajlsi-2441	125	13	ratio	ratio	NOUN
ajlsi-2441	125	14	as	as	ADP
ajlsi-2441	125	15	a	a	DET
ajlsi-2441	125	16	prognostic	prognostic	ADJ
ajlsi-2441	125	17	biomarker	biomarker	NOUN
ajlsi-2441	125	18	in	in	ADP
ajlsi-2441	125	19	predicting	predict	VERB
ajlsi-2441	125	20	the	the	DET
ajlsi-2441	125	21	progression	progression	NOUN
ajlsi-2441	125	22	of	of	ADP
ajlsi-2441	125	23	covid-19	covid-19	PROPN
ajlsi-2441	125	24	pneumonia	pneumonia	NOUN
ajlsi-2441	125	25	from	from	ADP
ajlsi-2441	125	26	moderate	moderate	ADJ
ajlsi-2441	125	27	to	to	ADP
ajlsi-2441	125	28	severe	severe	ADJ
ajlsi-2441	125	29	stages	stage	NOUN
ajlsi-2441	125	30	.	.	PUNCT
ajlsi-2441	126	1	strengths	strength	NOUN
ajlsi-2441	126	2	and	and	CCONJ
ajlsi-2441	126	3	limitations	limitation	NOUN
ajlsi-2441	126	4	the	the	DET
ajlsi-2441	126	5	strength	strength	NOUN
ajlsi-2441	126	6	of	of	ADP
ajlsi-2441	126	7	this	this	DET
ajlsi-2441	126	8	study	study	NOUN
ajlsi-2441	126	9	is	be	AUX
ajlsi-2441	126	10	that	that	SCONJ
ajlsi-2441	126	11	it	it	PRON
ajlsi-2441	126	12	investigates	investigate	VERB
ajlsi-2441	126	13	rdw/	rdw/	PROPN
ajlsi-2441	126	14	plt	plt	NOUN
ajlsi-2441	126	15	as	as	ADP
ajlsi-2441	126	16	a	a	DET
ajlsi-2441	126	17	potential	potential	ADJ
ajlsi-2441	126	18	predictor	predictor	NOUN
ajlsi-2441	126	19	for	for	ADP
ajlsi-2441	126	20	covid-19	covid-19	PROPN
ajlsi-2441	126	21	pneumonia	pneumonia	NOUN
ajlsi-2441	126	22	progression	progression	NOUN
ajlsi-2441	126	23	using	use	VERB
ajlsi-2441	126	24	robust	robust	ADJ
ajlsi-2441	126	25	statistical	statistical	ADJ
ajlsi-2441	126	26	analyses	analysis	NOUN
ajlsi-2441	126	27	.	.	PUNCT
ajlsi-2441	127	1	clear	clear	ADJ
ajlsi-2441	127	2	inclusion	inclusion	NOUN
ajlsi-2441	127	3	criteria	criterion	NOUN
ajlsi-2441	127	4	and	and	CCONJ
ajlsi-2441	127	5	focus	focus	VERB
ajlsi-2441	127	6	on	on	ADP
ajlsi-2441	127	7	moderate	moderate	ADJ
ajlsi-2441	127	8	covid-19	covid-19	PROPN
ajlsi-2441	127	9	cases	case	NOUN
ajlsi-2441	127	10	enhance	enhance	VERB
ajlsi-2441	127	11	specificity	specificity	NOUN
ajlsi-2441	127	12	.	.	PUNCT
ajlsi-2441	128	1	the	the	DET
ajlsi-2441	128	2	limitations	limitation	NOUN
ajlsi-2441	128	3	are	be	AUX
ajlsi-2441	128	4	retrospective	retrospective	ADJ
ajlsi-2441	128	5	design	design	NOUN
ajlsi-2441	128	6	and	and	CCONJ
ajlsi-2441	128	7	small	small	ADJ
ajlsi-2441	128	8	,	,	PUNCT
ajlsi-2441	128	9	singlecenter	singlecenter	NOUN
ajlsi-2441	128	10	sample	sample	NOUN
ajlsi-2441	128	11	size	size	NOUN
ajlsi-2441	128	12	,	,	PUNCT
ajlsi-2441	128	13	which	which	PRON
ajlsi-2441	128	14	may	may	AUX
ajlsi-2441	128	15	introduce	introduce	VERB
ajlsi-2441	128	16	biases	bias	NOUN
ajlsi-2441	128	17	and	and	CCONJ
ajlsi-2441	128	18	limit	limit	VERB
ajlsi-2441	128	19	generalizability	generalizability	NOUN
ajlsi-2441	128	20	.	.	PUNCT
ajlsi-2441	129	1	unaccounted	unaccounte	VERB
ajlsi-2441	129	2	confounding	confound	VERB
ajlsi-2441	129	3	factors	factor	NOUN
ajlsi-2441	129	4	and	and	CCONJ
ajlsi-2441	129	5	the	the	DET
ajlsi-2441	129	6	need	need	NOUN
ajlsi-2441	129	7	for	for	ADP
ajlsi-2441	129	8	prospective	prospective	ADJ
ajlsi-2441	129	9	validation	validation	NOUN
ajlsi-2441	129	10	in	in	ADP
ajlsi-2441	129	11	larger	large	ADJ
ajlsi-2441	129	12	cohorts	cohort	NOUN
ajlsi-2441	129	13	pose	pose	VERB
ajlsi-2441	129	14	limitations	limitation	NOUN
ajlsi-2441	129	15	.	.	PUNCT
ajlsi-2441	130	1	acknowledgements	acknowledgement	NOUN
ajlsi-2441	130	2	conception	conception	NOUN
ajlsi-2441	130	3	and	and	CCONJ
ajlsi-2441	130	4	design	design	NOUN
ajlsi-2441	130	5	of	of	ADP
ajlsi-2441	130	6	the	the	DET
ajlsi-2441	130	7	study	study	NOUN
ajlsi-2441	130	8	:	:	PUNCT
ajlsi-2441	130	9	suming	sum	VERB
ajlsi-2441	130	10	zhang	zhang	PROPN
ajlsi-2441	130	11	.	.	PUNCT
ajlsi-2441	130	12	acquisition	acquisition	PROPN
ajlsi-2441	130	13	of	of	ADP
ajlsi-2441	130	14	data	data	PROPN
ajlsi-2441	130	15	:	:	PUNCT
ajlsi-2441	130	16	suming	sum	VERB
ajlsi-2441	130	17	zhang	zhang	PROPN
ajlsi-2441	130	18	,	,	PUNCT
ajlsi-2441	130	19	pengfei	pengfei	PROPN
ajlsi-2441	130	20	liu	liu	PROPN
ajlsi-2441	130	21	,	,	PUNCT
ajlsi-2441	130	22	salwa	salwa	PROPN
ajlsi-2441	130	23	mohammad	mohammad	PROPN
ajlsi-2441	130	24	imran	imran	PROPN
ajlsi-2441	130	25	.	.	PUNCT
ajlsi-2441	131	1	analysis	analysis	NOUN
ajlsi-2441	131	2	and	and	CCONJ
ajlsi-2441	131	3	interpretation	interpretation	NOUN
ajlsi-2441	131	4	of	of	ADP
ajlsi-2441	131	5	data	datum	NOUN
ajlsi-2441	131	6	:	:	PUNCT
ajlsi-2441	131	7	suming	sum	VERB
ajlsi-2441	131	8	zhang	zhang	PROPN
ajlsi-2441	131	9	.	.	PUNCT
ajlsi-2441	132	1	drafting	draft	VERB
ajlsi-2441	132	2	the	the	DET
ajlsi-2441	132	3	article	article	NOUN
ajlsi-2441	132	4	:	:	PUNCT
ajlsi-2441	132	5	salwa	salwa	PROPN
ajlsi-2441	132	6	mohammad	mohammad	PROPN
ajlsi-2441	132	7	imran	imran	PROPN
ajlsi-2441	132	8	,	,	PUNCT
ajlsi-2441	132	9	wafa	wafa	PROPN
ajlsi-2441	132	10	mohammad	mohammad	PROPN
ajlsi-2441	132	11	.	.	PUNCT
ajlsi-2441	133	1	revising	revise	VERB
ajlsi-2441	133	2	it	it	PRON
ajlsi-2441	133	3	critically	critically	ADV
ajlsi-2441	133	4	for	for	ADP
ajlsi-2441	133	5	pa	pa	PROPN
ajlsi-2441	133	6	ge	ge	PROPN
ajlsi-2441	133	7	34	34	NUM
ajlsi-2441	133	8	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	133	9	am	am	NOUN
ajlsi-2441	133	10	.	.	PUNCT
ajlsi-2441	134	1	j.	j.	PROPN
ajlsi-2441	134	2	life	life	PROPN
ajlsi-2441	134	3	sci	sci	PROPN
ajlsi-2441	134	4	.	.	PUNCT
ajlsi-2441	134	5	innov	innov	PROPN
ajlsi-2441	134	6	.	.	PUNCT
ajlsi-2441	135	1	3(1	3(1	NUM
ajlsi-2441	135	2	)	)	PUNCT
ajlsi-2441	135	3	28	28	NUM
ajlsi-2441	135	4	-	-	SYM
ajlsi-2441	135	5	36	36	NUM
ajlsi-2441	135	6	,	,	PUNCT
ajlsi-2441	135	7	2024	2024	NUM
ajlsi-2441	135	8	important	important	ADJ
ajlsi-2441	135	9	intellectual	intellectual	ADJ
ajlsi-2441	135	10	content	content	NOUN
ajlsi-2441	135	11	:	:	PUNCT
ajlsi-2441	135	12	suming	sum	VERB
ajlsi-2441	135	13	zhang	zhang	PROPN
ajlsi-2441	135	14	,	,	PUNCT
ajlsi-2441	135	15	salwa	salwa	PROPN
ajlsi-2441	135	16	mohammad	mohammad	PROPN
ajlsi-2441	135	17	imran	imran	PROPN
ajlsi-2441	135	18	.	.	PUNCT
ajlsi-2441	136	1	final	final	ADJ
ajlsi-2441	136	2	approval	approval	NOUN
ajlsi-2441	136	3	of	of	ADP
ajlsi-2441	136	4	the	the	DET
ajlsi-2441	136	5	version	version	NOUN
ajlsi-2441	136	6	to	to	PART
ajlsi-2441	136	7	be	be	AUX
ajlsi-2441	136	8	submitted	submit	VERB
ajlsi-2441	136	9	:	:	PUNCT
ajlsi-2441	136	10	all	all	DET
ajlsi-2441	136	11	authors	author	NOUN
ajlsi-2441	136	12	contributed	contribute	VERB
ajlsi-2441	136	13	to	to	ADP
ajlsi-2441	136	14	the	the	DET
ajlsi-2441	136	15	final	final	ADJ
ajlsi-2441	136	16	version	version	NOUN
ajlsi-2441	136	17	.	.	PUNCT
ajlsi-2441	137	1	suming	sum	VERB
ajlsi-2441	137	2	zhang	zhang	PROPN
ajlsi-2441	137	3	takes	take	VERB
ajlsi-2441	137	4	responsibility	responsibility	NOUN
ajlsi-2441	137	5	for	for	ADP
ajlsi-2441	137	6	the	the	DET
ajlsi-2441	137	7	paper	paper	NOUN
ajlsi-2441	137	8	as	as	ADP
ajlsi-2441	137	9	a	a	DET
ajlsi-2441	137	10	whole	whole	NOUN
ajlsi-2441	137	11	.	.	PUNCT
ajlsi-2441	138	1	funding	fund	VERB
ajlsi-2441	138	2	this	this	DET
ajlsi-2441	138	3	work	work	NOUN
ajlsi-2441	138	4	was	be	AUX
ajlsi-2441	138	5	supported	support	VERB
ajlsi-2441	138	6	by	by	ADP
ajlsi-2441	138	7	the	the	DET
ajlsi-2441	138	8	wu	wu	PROPN
ajlsi-2441	138	9	jieping	jieping	PROPN
ajlsi-2441	138	10	medical	medical	PROPN
ajlsi-2441	138	11	foundation	foundation	PROPN
ajlsi-2441	138	12	’s	’s	PART
ajlsi-2441	138	13	special	special	ADJ
ajlsi-2441	138	14	fund	fund	NOUN
ajlsi-2441	138	15	for	for	ADP
ajlsi-2441	138	16	clinical	clinical	ADJ
ajlsi-2441	138	17	research	research	NOUN
ajlsi-2441	138	18	under	under	ADP
ajlsi-2441	138	19	grant	grant	NOUN
ajlsi-2441	138	20	(	(	PUNCT
ajlsi-2441	138	21	320.6750.2021	320.6750.2021	NUM
ajlsi-2441	138	22	-	-	SYM
ajlsi-2441	138	23	08	08	NUM
ajlsi-2441	138	24	-	-	PUNCT
ajlsi-2441	138	25	3	3	NUM
ajlsi-2441	138	26	)	)	PUNCT
ajlsi-2441	138	27	and	and	CCONJ
ajlsi-2441	138	28	the	the	DET
ajlsi-2441	138	29	xuzhou	xuzhou	PROPN
ajlsi-2441	138	30	youth	youth	PROPN
ajlsi-2441	138	31	science	science	NOUN
ajlsi-2441	138	32	and	and	CCONJ
ajlsi-2441	138	33	technology	technology	NOUN
ajlsi-2441	138	34	talent	talent	NOUN
ajlsi-2441	138	35	project	project	NOUN
ajlsi-2441	138	36	under	under	ADP
ajlsi-2441	138	37	grant	grant	NOUN
ajlsi-2441	138	38	(	(	PUNCT
ajlsi-2441	138	39	kc2204	kc2204	PROPN
ajlsi-2441	138	40	)	)	PUNCT
ajlsi-2441	138	41	.	.	PUNCT
ajlsi-2441	139	1	declaration	declaration	NOUN
ajlsi-2441	139	2	of	of	ADP
ajlsi-2441	139	3	interest	interest	NOUN
ajlsi-2441	139	4	the	the	DET
ajlsi-2441	139	5	authors	author	NOUN
ajlsi-2441	139	6	report	report	VERB
ajlsi-2441	139	7	that	that	SCONJ
ajlsi-2441	139	8	there	there	PRON
ajlsi-2441	139	9	are	be	VERB
ajlsi-2441	139	10	no	no	DET
ajlsi-2441	139	11	competing	compete	VERB
ajlsi-2441	139	12	interests	interest	NOUN
ajlsi-2441	139	13	to	to	PART
ajlsi-2441	139	14	declare	declare	VERB
ajlsi-2441	139	15	.	.	PUNCT
ajlsi-2441	140	1	references	reference	NOUN
ajlsi-2441	140	2	albahri	albahri	PROPN
ajlsi-2441	140	3	,	,	PUNCT
ajlsi-2441	140	4	o.	o.	PROPN
ajlsi-2441	140	5	s.	s.	PROPN
ajlsi-2441	140	6	,	,	PUNCT
ajlsi-2441	140	7	al	al	PROPN
ajlsi-2441	140	8	-	-	PUNCT
ajlsi-2441	140	9	obaidi	obaidi	PROPN
ajlsi-2441	140	10	,	,	PUNCT
ajlsi-2441	140	11	j.	j.	PROPN
ajlsi-2441	140	12	r.	r.	PROPN
ajlsi-2441	140	13	,	,	PUNCT
ajlsi-2441	140	14	zaidan	zaidan	PROPN
ajlsi-2441	140	15	,	,	PUNCT
ajlsi-2441	140	16	a.	a.	PROPN
ajlsi-2441	140	17	,	,	PUNCT
ajlsi-2441	140	18	albahri	albahri	PROPN
ajlsi-2441	140	19	,	,	PUNCT
ajlsi-2441	140	20	a.	a.	PROPN
ajlsi-2441	140	21	s.	s.	PROPN
ajlsi-2441	140	22	,	,	PUNCT
ajlsi-2441	140	23	zaidan	zaidan	PROPN
ajlsi-2441	140	24	,	,	PUNCT
ajlsi-2441	140	25	b.	b.	PROPN
ajlsi-2441	140	26	,	,	PUNCT
ajlsi-2441	140	27	salih	salih	PROPN
ajlsi-2441	140	28	,	,	PUNCT
ajlsi-2441	140	29	m.	m.	NOUN
ajlsi-2441	140	30	m.	m.	NOUN
ajlsi-2441	140	31	,	,	PUNCT
ajlsi-2441	140	32	qays	qays	PROPN
ajlsi-2441	140	33	,	,	PUNCT
ajlsi-2441	140	34	a.	a.	NOUN
ajlsi-2441	140	35	,	,	PUNCT
ajlsi-2441	140	36	dawood	dawood	PROPN
ajlsi-2441	140	37	,	,	PUNCT
ajlsi-2441	140	38	k.	k.	PROPN
ajlsi-2441	140	39	a.	a.	PROPN
ajlsi-2441	140	40	,	,	PUNCT
ajlsi-2441	140	41	mohammed	mohammed	PROPN
ajlsi-2441	140	42	,	,	PUNCT
ajlsi-2441	140	43	r.	r.	PROPN
ajlsi-2441	140	44	,	,	PUNCT
ajlsi-2441	140	45	&	&	CCONJ
ajlsi-2441	140	46	abdulkareem	abdulkareem	PROPN
ajlsi-2441	140	47	,	,	PUNCT
ajlsi-2441	140	48	k.	k.	PROPN
ajlsi-2441	140	49	h.	h.	PROPN
ajlsi-2441	140	50	(	(	PUNCT
ajlsi-2441	140	51	2020	2020	NUM
ajlsi-2441	140	52	)	)	PUNCT
ajlsi-2441	140	53	.	.	PUNCT
ajlsi-2441	141	1	helping	help	VERB
ajlsi-2441	141	2	doctors	doctor	NOUN
ajlsi-2441	141	3	hasten	hasten	VERB
ajlsi-2441	141	4	covid-19	covid-19	PROPN
ajlsi-2441	141	5	treatment	treatment	NOUN
ajlsi-2441	141	6	:	:	PUNCT
ajlsi-2441	141	7	towards	towards	ADP
ajlsi-2441	141	8	a	a	DET
ajlsi-2441	141	9	rescue	rescue	NOUN
ajlsi-2441	141	10	framework	framework	NOUN
ajlsi-2441	141	11	for	for	ADP
ajlsi-2441	141	12	the	the	DET
ajlsi-2441	141	13	transfusion	transfusion	NOUN
ajlsi-2441	141	14	of	of	ADP
ajlsi-2441	141	15	best	good	ADJ
ajlsi-2441	141	16	convalescent	convalescent	NOUN
ajlsi-2441	141	17	plasma	plasma	NOUN
ajlsi-2441	141	18	to	to	ADP
ajlsi-2441	141	19	the	the	DET
ajlsi-2441	141	20	most	most	ADV
ajlsi-2441	141	21	critical	critical	ADJ
ajlsi-2441	141	22	patients	patient	NOUN
ajlsi-2441	141	23	based	base	VERB
ajlsi-2441	141	24	on	on	ADP
ajlsi-2441	141	25	biological	biological	ADJ
ajlsi-2441	141	26	requirements	requirement	NOUN
ajlsi-2441	141	27	via	via	ADP
ajlsi-2441	141	28	ml	ml	NOUN
ajlsi-2441	141	29	and	and	CCONJ
ajlsi-2441	141	30	novel	novel	ADJ
ajlsi-2441	141	31	mcdm	mcdm	ADJ
ajlsi-2441	141	32	methods	method	NOUN
ajlsi-2441	141	33	.	.	PUNCT
ajlsi-2441	142	1	computer	computer	NOUN
ajlsi-2441	142	2	methods	method	NOUN
ajlsi-2441	142	3	and	and	CCONJ
ajlsi-2441	142	4	programs	program	NOUN
ajlsi-2441	142	5	in	in	ADP
ajlsi-2441	142	6	biomedicine	biomedicine	NOUN
ajlsi-2441	142	7	,	,	PUNCT
ajlsi-2441	142	8	196	196	NUM
ajlsi-2441	142	9	,	,	PUNCT
ajlsi-2441	142	10	105617	105617	NUM
ajlsi-2441	142	11	.	.	PUNCT
ajlsi-2441	143	1	alballa	alballa	PROPN
ajlsi-2441	143	2	,	,	PUNCT
ajlsi-2441	143	3	n.	n.	NOUN
ajlsi-2441	143	4	,	,	PUNCT
ajlsi-2441	143	5	&	&	CCONJ
ajlsi-2441	143	6	al	al	PROPN
ajlsi-2441	143	7	-	-	PUNCT
ajlsi-2441	143	8	turaiki	turaiki	PROPN
ajlsi-2441	143	9	,	,	PUNCT
ajlsi-2441	143	10	i.	i.	NOUN
ajlsi-2441	143	11	(	(	PUNCT
ajlsi-2441	143	12	2021	2021	NUM
ajlsi-2441	143	13	)	)	PUNCT
ajlsi-2441	143	14	.	.	PUNCT
ajlsi-2441	144	1	machine	machine	NOUN
ajlsi-2441	144	2	learning	learn	VERB
ajlsi-2441	144	3	approaches	approach	NOUN
ajlsi-2441	144	4	in	in	ADP
ajlsi-2441	144	5	covid-19	covid-19	PROPN
ajlsi-2441	144	6	diagnosis	diagnosis	NOUN
ajlsi-2441	144	7	,	,	PUNCT
ajlsi-2441	144	8	mortality	mortality	NOUN
ajlsi-2441	144	9	,	,	PUNCT
ajlsi-2441	144	10	and	and	CCONJ
ajlsi-2441	144	11	severity	severity	NOUN
ajlsi-2441	144	12	risk	risk	NOUN
ajlsi-2441	144	13	prediction	prediction	NOUN
ajlsi-2441	144	14	:	:	PUNCT
ajlsi-2441	144	15	a	a	DET
ajlsi-2441	144	16	review	review	NOUN
ajlsi-2441	144	17	.	.	PUNCT
ajlsi-2441	145	1	informatics	informatic	NOUN
ajlsi-2441	145	2	in	in	ADP
ajlsi-2441	145	3	medicine	medicine	NOUN
ajlsi-2441	145	4	unlocked	unlock	VERB
ajlsi-2441	145	5	,	,	PUNCT
ajlsi-2441	145	6	24	24	NUM
ajlsi-2441	145	7	,	,	PUNCT
ajlsi-2441	145	8	100564	100564	NUM
ajlsi-2441	145	9	.	.	PUNCT
ajlsi-2441	146	1	alnor	alnor	PROPN
ajlsi-2441	146	2	,	,	PUNCT
ajlsi-2441	146	3	a.	a.	PROPN
ajlsi-2441	146	4	,	,	PUNCT
ajlsi-2441	146	5	sandberg	sandberg	PROPN
ajlsi-2441	146	6	,	,	PUNCT
ajlsi-2441	146	7	m.	m.	PROPN
ajlsi-2441	146	8	b.	b.	PROPN
ajlsi-2441	146	9	,	,	PUNCT
ajlsi-2441	146	10	gils	gils	PROPN
ajlsi-2441	146	11	,	,	PUNCT
ajlsi-2441	146	12	c.	c.	PROPN
ajlsi-2441	146	13	,	,	PUNCT
ajlsi-2441	146	14	&	&	CCONJ
ajlsi-2441	146	15	vinholt	vinholt	PROPN
ajlsi-2441	146	16	,	,	PUNCT
ajlsi-2441	146	17	p.	p.	NOUN
ajlsi-2441	146	18	j.	j.	PROPN
ajlsi-2441	147	1	(	(	PUNCT
ajlsi-2441	147	2	2020	2020	NUM
ajlsi-2441	147	3	)	)	PUNCT
ajlsi-2441	147	4	.	.	PUNCT
ajlsi-2441	148	1	laboratory	laboratory	NOUN
ajlsi-2441	148	2	tests	test	NOUN
ajlsi-2441	148	3	and	and	CCONJ
ajlsi-2441	148	4	outcome	outcome	VERB
ajlsi-2441	148	5	for	for	ADP
ajlsi-2441	148	6	patients	patient	NOUN
ajlsi-2441	148	7	with	with	ADP
ajlsi-2441	148	8	coronavirus	coronavirus	NOUN
ajlsi-2441	148	9	disease	disease	NOUN
ajlsi-2441	148	10	2019	2019	NUM
ajlsi-2441	148	11	:	:	PUNCT
ajlsi-2441	148	12	a	a	DET
ajlsi-2441	148	13	systematic	systematic	ADJ
ajlsi-2441	148	14	review	review	NOUN
ajlsi-2441	148	15	and	and	CCONJ
ajlsi-2441	148	16	meta	meta	ADJ
ajlsi-2441	148	17	-	-	PUNCT
ajlsi-2441	148	18	analysis	analysis	NOUN
ajlsi-2441	148	19	.	.	PUNCT
ajlsi-2441	149	1	the	the	DET
ajlsi-2441	149	2	journal	journal	NOUN
ajlsi-2441	149	3	of	of	ADP
ajlsi-2441	149	4	applied	apply	VERB
ajlsi-2441	149	5	laboratory	laboratory	NOUN
ajlsi-2441	149	6	medicine	medicine	NOUN
ajlsi-2441	149	7	,	,	PUNCT
ajlsi-2441	149	8	5(5	5(5	NUM
ajlsi-2441	149	9	)	)	PUNCT
ajlsi-2441	149	10	,	,	PUNCT
ajlsi-2441	149	11	1038	1038	NUM
ajlsi-2441	149	12	-	-	SYM
ajlsi-2441	149	13	1049	1049	NUM
ajlsi-2441	149	14	.	.	PUNCT
ajlsi-2441	150	1	althaus	althaus	PROPN
ajlsi-2441	150	2	,	,	PUNCT
ajlsi-2441	150	3	k.	k.	PROPN
ajlsi-2441	150	4	,	,	PUNCT
ajlsi-2441	150	5	marini	marini	PROPN
ajlsi-2441	150	6	,	,	PUNCT
ajlsi-2441	150	7	i.	i.	NOUN
ajlsi-2441	150	8	,	,	PUNCT
ajlsi-2441	150	9	zlamal	zlamal	PROPN
ajlsi-2441	150	10	,	,	PUNCT
ajlsi-2441	150	11	j.	j.	PROPN
ajlsi-2441	150	12	,	,	PUNCT
ajlsi-2441	150	13	pelzl	pelzl	PROPN
ajlsi-2441	150	14	,	,	PUNCT
ajlsi-2441	150	15	l.	l.	PROPN
ajlsi-2441	150	16	,	,	PUNCT
ajlsi-2441	150	17	singh	singh	PROPN
ajlsi-2441	150	18	,	,	PUNCT
ajlsi-2441	150	19	a.	a.	NOUN
ajlsi-2441	150	20	,	,	PUNCT
ajlsi-2441	150	21	häberle	häberle	PROPN
ajlsi-2441	150	22	,	,	PUNCT
ajlsi-2441	150	23	h.	h.	PROPN
ajlsi-2441	150	24	,	,	PUNCT
ajlsi-2441	150	25	mehrländer	mehrländer	NOUN
ajlsi-2441	150	26	,	,	PUNCT
ajlsi-2441	150	27	m.	m.	NOUN
ajlsi-2441	150	28	,	,	PUNCT
ajlsi-2441	150	29	hammer	hammer	NOUN
ajlsi-2441	150	30	,	,	PUNCT
ajlsi-2441	150	31	s.	s.	PROPN
ajlsi-2441	150	32	,	,	PUNCT
ajlsi-2441	150	33	schulze	schulze	NOUN
ajlsi-2441	150	34	,	,	PUNCT
ajlsi-2441	150	35	h.	h.	PROPN
ajlsi-2441	150	36	,	,	PUNCT
ajlsi-2441	150	37	&	&	CCONJ
ajlsi-2441	150	38	bitzer	bitzer	PROPN
ajlsi-2441	150	39	,	,	PUNCT
ajlsi-2441	150	40	m.	m.	NOUN
ajlsi-2441	150	41	(	(	PUNCT
ajlsi-2441	150	42	2021	2021	NUM
ajlsi-2441	150	43	)	)	PUNCT
ajlsi-2441	150	44	.	.	PUNCT
ajlsi-2441	151	1	antibody	antibody	NOUN
ajlsi-2441	151	2	-	-	PUNCT
ajlsi-2441	151	3	induced	induce	VERB
ajlsi-2441	151	4	procoagulant	procoagulant	NOUN
ajlsi-2441	151	5	platelets	platelet	NOUN
ajlsi-2441	151	6	in	in	ADP
ajlsi-2441	151	7	severe	severe	ADJ
ajlsi-2441	151	8	covid-19	covid-19	PROPN
ajlsi-2441	151	9	infection	infection	NOUN
ajlsi-2441	151	10	.	.	PUNCT
ajlsi-2441	152	1	blood	blood	NOUN
ajlsi-2441	152	2	,	,	PUNCT
ajlsi-2441	152	3	the	the	DET
ajlsi-2441	152	4	journal	journal	NOUN
ajlsi-2441	152	5	of	of	ADP
ajlsi-2441	152	6	the	the	DET
ajlsi-2441	152	7	american	american	ADJ
ajlsi-2441	152	8	society	society	NOUN
ajlsi-2441	152	9	of	of	ADP
ajlsi-2441	152	10	hematology	hematology	NOUN
ajlsi-2441	152	11	,	,	PUNCT
ajlsi-2441	152	12	137(8	137(8	NUM
ajlsi-2441	152	13	)	)	PUNCT
ajlsi-2441	152	14	,	,	PUNCT
ajlsi-2441	152	15	1061	1061	NUM
ajlsi-2441	152	16	-	-	SYM
ajlsi-2441	152	17	1071	1071	NUM
ajlsi-2441	152	18	.	.	PUNCT
ajlsi-2441	153	1	ballaz	ballaz	PROPN
ajlsi-2441	153	2	,	,	PUNCT
ajlsi-2441	153	3	s.	s.	PROPN
ajlsi-2441	153	4	j.	j.	PROPN
ajlsi-2441	153	5	,	,	PUNCT
ajlsi-2441	153	6	pulgar	pulgar	NOUN
ajlsi-2441	153	7	-	-	PUNCT
ajlsi-2441	153	8	sánchez	sánchez	NOUN
ajlsi-2441	153	9	,	,	PUNCT
ajlsi-2441	153	10	m.	m.	NOUN
ajlsi-2441	153	11	,	,	PUNCT
ajlsi-2441	153	12	chamorro	chamorro	PROPN
ajlsi-2441	153	13	,	,	PUNCT
ajlsi-2441	153	14	k.	k.	PROPN
ajlsi-2441	153	15	,	,	PUNCT
ajlsi-2441	153	16	fernández	fernández	PROPN
ajlsi-2441	153	17	-	-	PUNCT
ajlsi-2441	153	18	moreira	moreira	PROPN
ajlsi-2441	153	19	,	,	PUNCT
ajlsi-2441	153	20	e.	e.	PROPN
ajlsi-2441	153	21	,	,	PUNCT
ajlsi-2441	153	22	ramírez	ramírez	PROPN
ajlsi-2441	153	23	,	,	PUNCT
ajlsi-2441	153	24	h.	h.	PROPN
ajlsi-2441	153	25	,	,	PUNCT
ajlsi-2441	153	26	mora	mora	PROPN
ajlsi-2441	153	27	,	,	PUNCT
ajlsi-2441	153	28	f.	f.	PROPN
ajlsi-2441	153	29	x.	x.	PROPN
ajlsi-2441	153	30	,	,	PUNCT
ajlsi-2441	153	31	&	&	CCONJ
ajlsi-2441	153	32	fors	for	NOUN
ajlsi-2441	153	33	,	,	PUNCT
ajlsi-2441	153	34	m.	m.	NOUN
ajlsi-2441	153	35	(	(	PUNCT
ajlsi-2441	153	36	2021	2021	NUM
ajlsi-2441	153	37	)	)	PUNCT
ajlsi-2441	153	38	.	.	PUNCT
ajlsi-2441	154	1	common	common	ADJ
ajlsi-2441	154	2	laboratory	laboratory	NOUN
ajlsi-2441	154	3	tests	test	NOUN
ajlsi-2441	154	4	as	as	ADP
ajlsi-2441	154	5	indicators	indicator	NOUN
ajlsi-2441	154	6	of	of	ADP
ajlsi-2441	154	7	covid-19	covid-19	PROPN
ajlsi-2441	154	8	severity	severity	NOUN
ajlsi-2441	154	9	on	on	ADP
ajlsi-2441	154	10	admission	admission	NOUN
ajlsi-2441	154	11	at	at	ADP
ajlsi-2441	154	12	high	high	ADJ
ajlsi-2441	154	13	altitude	altitude	NOUN
ajlsi-2441	154	14	:	:	PUNCT
ajlsi-2441	154	15	a	a	DET
ajlsi-2441	154	16	single	single	ADJ
ajlsi-2441	154	17	-	-	PUNCT
ajlsi-2441	154	18	center	center	NOUN
ajlsi-2441	154	19	retrospective	retrospective	ADJ
ajlsi-2441	154	20	study	study	NOUN
ajlsi-2441	154	21	in	in	ADP
ajlsi-2441	154	22	quito	quito	PROPN
ajlsi-2441	154	23	(	(	PUNCT
ajlsi-2441	154	24	ecuador	ecuador	PROPN
ajlsi-2441	154	25	)	)	PUNCT
ajlsi-2441	154	26	.	.	PUNCT
ajlsi-2441	155	1	clinical	clinical	ADJ
ajlsi-2441	155	2	chemistry	chemistry	NOUN
ajlsi-2441	155	3	and	and	CCONJ
ajlsi-2441	155	4	laboratory	laboratory	NOUN
ajlsi-2441	155	5	medicine	medicine	NOUN
ajlsi-2441	155	6	(	(	PUNCT
ajlsi-2441	155	7	cclm	cclm	PROPN
ajlsi-2441	155	8	)	)	PUNCT
ajlsi-2441	155	9	,	,	PUNCT
ajlsi-2441	155	10	59(8	59(8	NUM
ajlsi-2441	155	11	)	)	PUNCT
ajlsi-2441	155	12	,	,	PUNCT
ajlsi-2441	155	13	e326	e326	PROPN
ajlsi-2441	155	14	-	-	PUNCT
ajlsi-2441	155	15	e329	e329	PROPN
ajlsi-2441	155	16	.	.	PUNCT
ajlsi-2441	156	1	bonetti	bonetti	PROPN
ajlsi-2441	156	2	,	,	PUNCT
ajlsi-2441	156	3	g.	g.	PROPN
ajlsi-2441	156	4	,	,	PUNCT
ajlsi-2441	156	5	manelli	manelli	PROPN
ajlsi-2441	156	6	,	,	PUNCT
ajlsi-2441	156	7	f.	f.	PROPN
ajlsi-2441	156	8	,	,	PUNCT
ajlsi-2441	156	9	patroni	patroni	NOUN
ajlsi-2441	156	10	,	,	PUNCT
ajlsi-2441	156	11	a.	a.	NOUN
ajlsi-2441	156	12	,	,	PUNCT
ajlsi-2441	156	13	bettinardi	bettinardi	NOUN
ajlsi-2441	156	14	,	,	PUNCT
ajlsi-2441	156	15	a.	a.	NOUN
ajlsi-2441	156	16	,	,	PUNCT
ajlsi-2441	156	17	borrelli	borrelli	PROPN
ajlsi-2441	156	18	,	,	PUNCT
ajlsi-2441	156	19	g.	g.	PROPN
ajlsi-2441	156	20	,	,	PUNCT
ajlsi-2441	156	21	fiordalisi	fiordalisi	ADJ
ajlsi-2441	156	22	,	,	PUNCT
ajlsi-2441	156	23	g.	g.	PROPN
ajlsi-2441	156	24	,	,	PUNCT
ajlsi-2441	156	25	marino	marino	PROPN
ajlsi-2441	156	26	,	,	PUNCT
ajlsi-2441	156	27	a.	a.	PROPN
ajlsi-2441	156	28	,	,	PUNCT
ajlsi-2441	156	29	menolfi	menolfi	PROPN
ajlsi-2441	156	30	,	,	PUNCT
ajlsi-2441	156	31	a.	a.	NOUN
ajlsi-2441	156	32	,	,	PUNCT
ajlsi-2441	156	33	saggini	saggini	PROPN
ajlsi-2441	156	34	,	,	PUNCT
ajlsi-2441	156	35	s.	s.	PROPN
ajlsi-2441	156	36	,	,	PUNCT
ajlsi-2441	156	37	&	&	CCONJ
ajlsi-2441	156	38	volpi	volpi	PROPN
ajlsi-2441	156	39	,	,	PUNCT
ajlsi-2441	156	40	r.	r.	PROPN
ajlsi-2441	156	41	(	(	PUNCT
ajlsi-2441	156	42	2020	2020	NUM
ajlsi-2441	156	43	)	)	PUNCT
ajlsi-2441	156	44	.	.	PUNCT
ajlsi-2441	157	1	laboratory	laboratory	NOUN
ajlsi-2441	157	2	predictors	predictor	NOUN
ajlsi-2441	157	3	of	of	ADP
ajlsi-2441	157	4	death	death	NOUN
ajlsi-2441	157	5	from	from	ADP
ajlsi-2441	157	6	coronavirus	coronavirus	NOUN
ajlsi-2441	157	7	disease	disease	NOUN
ajlsi-2441	157	8	2019	2019	NUM
ajlsi-2441	157	9	(	(	PUNCT
ajlsi-2441	157	10	covid-19	covid-19	PROPN
ajlsi-2441	157	11	)	)	PUNCT
ajlsi-2441	157	12	in	in	ADP
ajlsi-2441	157	13	the	the	DET
ajlsi-2441	157	14	area	area	NOUN
ajlsi-2441	157	15	of	of	ADP
ajlsi-2441	157	16	valcamonica	valcamonica	PROPN
ajlsi-2441	157	17	,	,	PUNCT
ajlsi-2441	157	18	italy	italy	PROPN
ajlsi-2441	157	19	.	.	PUNCT
ajlsi-2441	158	1	clinical	clinical	ADJ
ajlsi-2441	158	2	chemistry	chemistry	NOUN
ajlsi-2441	158	3	and	and	CCONJ
ajlsi-2441	158	4	laboratory	laboratory	NOUN
ajlsi-2441	158	5	medicine	medicine	NOUN
ajlsi-2441	158	6	(	(	PUNCT
ajlsi-2441	158	7	cclm	cclm	PROPN
ajlsi-2441	158	8	)	)	PUNCT
ajlsi-2441	158	9	,	,	PUNCT
ajlsi-2441	158	10	58(7	58(7	NUM
ajlsi-2441	158	11	)	)	PUNCT
ajlsi-2441	158	12	,	,	PUNCT
ajlsi-2441	158	13	1100	1100	NUM
ajlsi-2441	158	14	-	-	SYM
ajlsi-2441	158	15	1105	1105	NUM
ajlsi-2441	158	16	.	.	PUNCT
ajlsi-2441	159	1	borghesi	borghesi	PROPN
ajlsi-2441	159	2	,	,	PUNCT
ajlsi-2441	159	3	a.	a.	NOUN
ajlsi-2441	159	4	,	,	PUNCT
ajlsi-2441	159	5	zigliani	zigliani	NOUN
ajlsi-2441	159	6	,	,	PUNCT
ajlsi-2441	159	7	a.	a.	NOUN
ajlsi-2441	159	8	,	,	PUNCT
ajlsi-2441	159	9	masciullo	masciullo	PROPN
ajlsi-2441	159	10	,	,	PUNCT
ajlsi-2441	159	11	r.	r.	PROPN
ajlsi-2441	159	12	,	,	PUNCT
ajlsi-2441	159	13	golemi	golemi	PROPN
ajlsi-2441	159	14	,	,	PUNCT
ajlsi-2441	159	15	s.	s.	PROPN
ajlsi-2441	159	16	,	,	PUNCT
ajlsi-2441	159	17	maculotti	maculotti	PROPN
ajlsi-2441	159	18	,	,	PUNCT
ajlsi-2441	159	19	p.	p.	PROPN
ajlsi-2441	159	20	,	,	PUNCT
ajlsi-2441	159	21	farina	farina	PROPN
ajlsi-2441	159	22	,	,	PUNCT
ajlsi-2441	159	23	d.	d.	PROPN
ajlsi-2441	159	24	,	,	PUNCT
ajlsi-2441	159	25	&	&	CCONJ
ajlsi-2441	159	26	maroldi	maroldi	PROPN
ajlsi-2441	159	27	,	,	PUNCT
ajlsi-2441	159	28	r.	r.	PROPN
ajlsi-2441	159	29	(	(	PUNCT
ajlsi-2441	159	30	2020	2020	NUM
ajlsi-2441	159	31	)	)	PUNCT
ajlsi-2441	159	32	.	.	PUNCT
ajlsi-2441	160	1	radiographic	radiographic	ADJ
ajlsi-2441	160	2	severity	severity	NOUN
ajlsi-2441	160	3	index	index	NOUN
ajlsi-2441	160	4	in	in	ADP
ajlsi-2441	160	5	covid-19	covid-19	PROPN
ajlsi-2441	160	6	pneumonia	pneumonia	NOUN
ajlsi-2441	160	7	:	:	PUNCT
ajlsi-2441	160	8	relationship	relationship	NOUN
ajlsi-2441	160	9	to	to	ADP
ajlsi-2441	160	10	age	age	NOUN
ajlsi-2441	160	11	and	and	CCONJ
ajlsi-2441	160	12	sex	sex	NOUN
ajlsi-2441	160	13	in	in	ADP
ajlsi-2441	160	14	783	783	NUM
ajlsi-2441	160	15	italian	italian	ADJ
ajlsi-2441	160	16	patients	patient	NOUN
ajlsi-2441	160	17	.	.	PUNCT
ajlsi-2441	161	1	la	la	PRON
ajlsi-2441	161	2	radiologia	radiologia	PROPN
ajlsi-2441	161	3	medica	medica	PROPN
ajlsi-2441	161	4	,	,	PUNCT
ajlsi-2441	161	5	125	125	NUM
ajlsi-2441	161	6	,	,	PUNCT
ajlsi-2441	161	7	461	461	NUM
ajlsi-2441	161	8	-	-	SYM
ajlsi-2441	161	9	464	464	NUM
ajlsi-2441	161	10	.	.	PUNCT
ajlsi-2441	162	1	cai	cai	X
ajlsi-2441	162	2	,	,	PUNCT
ajlsi-2441	162	3	y.	y.	PROPN
ajlsi-2441	162	4	,	,	PUNCT
ajlsi-2441	162	5	liu	liu	PROPN
ajlsi-2441	162	6	,	,	PUNCT
ajlsi-2441	162	7	d.	d.	PROPN
ajlsi-2441	162	8	,	,	PUNCT
ajlsi-2441	162	9	cui	cui	PROPN
ajlsi-2441	162	10	,	,	PUNCT
ajlsi-2441	162	11	j.	j.	PROPN
ajlsi-2441	162	12	,	,	PUNCT
ajlsi-2441	162	13	sha	sha	PROPN
ajlsi-2441	162	14	,	,	PUNCT
ajlsi-2441	162	15	y.	y.	PROPN
ajlsi-2441	162	16	,	,	PUNCT
ajlsi-2441	162	17	zhou	zhou	PROPN
ajlsi-2441	162	18	,	,	PUNCT
ajlsi-2441	162	19	h.	h.	PROPN
ajlsi-2441	162	20	,	,	PUNCT
ajlsi-2441	162	21	tang	tang	PROPN
ajlsi-2441	162	22	,	,	PUNCT
ajlsi-2441	162	23	n.	n.	PROPN
ajlsi-2441	162	24	,	,	PUNCT
ajlsi-2441	162	25	wang	wang	PROPN
ajlsi-2441	162	26	,	,	PUNCT
ajlsi-2441	162	27	n.	n.	PROPN
ajlsi-2441	162	28	,	,	PUNCT
ajlsi-2441	162	29	huang	huang	PROPN
ajlsi-2441	162	30	,	,	PUNCT
ajlsi-2441	162	31	a.	a.	PROPN
ajlsi-2441	162	32	,	,	PUNCT
ajlsi-2441	162	33	&	&	CCONJ
ajlsi-2441	162	34	xia	xia	PROPN
ajlsi-2441	162	35	,	,	PUNCT
ajlsi-2441	162	36	j.	j.	PROPN
ajlsi-2441	162	37	(	(	PUNCT
ajlsi-2441	162	38	2019	2019	NUM
ajlsi-2441	162	39	)	)	PUNCT
ajlsi-2441	162	40	.	.	PUNCT
ajlsi-2441	163	1	diagnostic	diagnostic	ADJ
ajlsi-2441	163	2	accuracy	accuracy	NOUN
ajlsi-2441	163	3	of	of	ADP
ajlsi-2441	163	4	red	red	ADJ
ajlsi-2441	163	5	blood	blood	NOUN
ajlsi-2441	163	6	cell	cell	NOUN
ajlsi-2441	163	7	distribution	distribution	NOUN
ajlsi-2441	163	8	width	width	NOUN
ajlsi-2441	163	9	to	to	PART
ajlsi-2441	163	10	platelet	platelet	VERB
ajlsi-2441	163	11	ratio	ratio	NOUN
ajlsi-2441	163	12	for	for	ADP
ajlsi-2441	163	13	predicting	predict	VERB
ajlsi-2441	163	14	staging	stage	VERB
ajlsi-2441	163	15	liver	liver	NOUN
ajlsi-2441	163	16	fibrosis	fibrosis	NOUN
ajlsi-2441	163	17	in	in	ADP
ajlsi-2441	163	18	chronic	chronic	ADJ
ajlsi-2441	163	19	liver	liver	NOUN
ajlsi-2441	163	20	disease	disease	NOUN
ajlsi-2441	163	21	patients	patient	NOUN
ajlsi-2441	163	22	:	:	PUNCT
ajlsi-2441	163	23	a	a	DET
ajlsi-2441	163	24	systematic	systematic	ADJ
ajlsi-2441	163	25	review	review	NOUN
ajlsi-2441	163	26	and	and	CCONJ
ajlsi-2441	163	27	metaanalysis	metaanalysis	NOUN
ajlsi-2441	163	28	.	.	PUNCT
ajlsi-2441	164	1	medicine	medicine	NOUN
ajlsi-2441	164	2	,	,	PUNCT
ajlsi-2441	164	3	98(14	98(14	NOUN
ajlsi-2441	164	4	)	)	PUNCT
ajlsi-2441	164	5	.	.	PUNCT
ajlsi-2441	165	1	cases	case	NOUN
ajlsi-2441	165	2	,	,	PUNCT
ajlsi-2441	165	3	c.	c.	NOUN
ajlsi-2441	165	4	(	(	PUNCT
ajlsi-2441	165	5	2020	2020	NUM
ajlsi-2441	165	6	)	)	PUNCT
ajlsi-2441	165	7	.	.	PUNCT
ajlsi-2441	166	1	worldometer	worldometer	PROPN
ajlsi-2441	166	2	.	.	PUNCT
ajlsi-2441	167	1	retrieved	retrieve	VERB
ajlsi-2441	167	2	on	on	ADP
ajlsi-2441	167	3	,	,	PUNCT
ajlsi-2441	167	4	30	30	NUM
ajlsi-2441	167	5	.	.	PUNCT
ajlsi-2441	168	1	chen	chen	PROPN
ajlsi-2441	168	2	,	,	PUNCT
ajlsi-2441	168	3	n.	n.	PROPN
ajlsi-2441	168	4	,	,	PUNCT
ajlsi-2441	168	5	zhou	zhou	PROPN
ajlsi-2441	168	6	,	,	PUNCT
ajlsi-2441	168	7	m.	m.	NOUN
ajlsi-2441	168	8	,	,	PUNCT
ajlsi-2441	168	9	dong	dong	PROPN
ajlsi-2441	168	10	,	,	PUNCT
ajlsi-2441	168	11	x.	x.	PROPN
ajlsi-2441	168	12	,	,	PUNCT
ajlsi-2441	168	13	qu	qu	PROPN
ajlsi-2441	168	14	,	,	PUNCT
ajlsi-2441	168	15	j.	j.	PROPN
ajlsi-2441	168	16	,	,	PUNCT
ajlsi-2441	168	17	gong	gong	PROPN
ajlsi-2441	168	18	,	,	PUNCT
ajlsi-2441	168	19	f.	f.	PROPN
ajlsi-2441	168	20	,	,	PUNCT
ajlsi-2441	168	21	han	han	PROPN
ajlsi-2441	168	22	,	,	PUNCT
ajlsi-2441	168	23	y.	y.	PROPN
ajlsi-2441	168	24	,	,	PUNCT
ajlsi-2441	168	25	qiu	qiu	PROPN
ajlsi-2441	168	26	,	,	PUNCT
ajlsi-2441	168	27	y.	y.	PROPN
ajlsi-2441	168	28	,	,	PUNCT
ajlsi-2441	168	29	wang	wang	PROPN
ajlsi-2441	168	30	,	,	PUNCT
ajlsi-2441	168	31	j.	j.	PROPN
ajlsi-2441	168	32	,	,	PUNCT
ajlsi-2441	168	33	liu	liu	PROPN
ajlsi-2441	168	34	,	,	PUNCT
ajlsi-2441	168	35	y.	y.	PROPN
ajlsi-2441	168	36	,	,	PUNCT
ajlsi-2441	168	37	&	&	CCONJ
ajlsi-2441	168	38	wei	wei	PROPN
ajlsi-2441	168	39	,	,	PUNCT
ajlsi-2441	168	40	y.	y.	PROPN
ajlsi-2441	168	41	(	(	PUNCT
ajlsi-2441	168	42	2020	2020	NUM
ajlsi-2441	168	43	)	)	PUNCT
ajlsi-2441	168	44	.	.	PUNCT
ajlsi-2441	169	1	epidemiological	epidemiological	ADJ
ajlsi-2441	169	2	and	and	CCONJ
ajlsi-2441	169	3	clinical	clinical	ADJ
ajlsi-2441	169	4	characteristics	characteristic	NOUN
ajlsi-2441	169	5	of	of	ADP
ajlsi-2441	169	6	99	99	NUM
ajlsi-2441	169	7	cases	case	NOUN
ajlsi-2441	169	8	of	of	ADP
ajlsi-2441	169	9	2019	2019	NUM
ajlsi-2441	169	10	novel	novel	ADJ
ajlsi-2441	169	11	coronavirus	coronavirus	NOUN
ajlsi-2441	169	12	pneumonia	pneumonia	NOUN
ajlsi-2441	169	13	in	in	ADP
ajlsi-2441	169	14	wuhan	wuhan	PROPN
ajlsi-2441	169	15	,	,	PUNCT
ajlsi-2441	169	16	china	china	PROPN
ajlsi-2441	169	17	:	:	PUNCT
ajlsi-2441	169	18	a	a	DET
ajlsi-2441	169	19	descriptive	descriptive	ADJ
ajlsi-2441	169	20	study	study	NOUN
ajlsi-2441	169	21	.	.	PUNCT
ajlsi-2441	170	1	the	the	DET
ajlsi-2441	170	2	lancet	lancet	NOUN
ajlsi-2441	170	3	,	,	PUNCT
ajlsi-2441	170	4	395(10223	395(10223	NUM
ajlsi-2441	170	5	)	)	PUNCT
ajlsi-2441	170	6	,	,	PUNCT
ajlsi-2441	170	7	507513	507513	NUM
ajlsi-2441	170	8	.	.	PUNCT
ajlsi-2441	171	1	fernandes	fernandes	PROPN
ajlsi-2441	171	2	,	,	PUNCT
ajlsi-2441	171	3	f.	f.	PROPN
ajlsi-2441	171	4	t.	t.	PROPN
ajlsi-2441	171	5	,	,	PUNCT
ajlsi-2441	171	6	de	de	PROPN
ajlsi-2441	171	7	oliveira	oliveira	PROPN
ajlsi-2441	171	8	,	,	PUNCT
ajlsi-2441	171	9	t.	t.	PROPN
ajlsi-2441	171	10	a.	a.	PROPN
ajlsi-2441	171	11	,	,	PUNCT
ajlsi-2441	171	12	teixeira	teixeira	PROPN
ajlsi-2441	171	13	,	,	PUNCT
ajlsi-2441	171	14	c.	c.	PROPN
ajlsi-2441	171	15	e.	e.	PROPN
ajlsi-2441	171	16	,	,	PUNCT
ajlsi-2441	171	17	batista	batista	PROPN
ajlsi-2441	171	18	,	,	PUNCT
ajlsi-2441	171	19	a.	a.	PROPN
ajlsi-2441	171	20	f.	f.	PROPN
ajlsi-2441	171	21	d.	d.	PROPN
ajlsi-2441	171	22	m.	m.	PROPN
ajlsi-2441	171	23	,	,	PUNCT
ajlsi-2441	171	24	dalla	dalla	PROPN
ajlsi-2441	171	25	costa	costa	PROPN
ajlsi-2441	171	26	,	,	PUNCT
ajlsi-2441	171	27	g.	g.	PROPN
ajlsi-2441	171	28	,	,	PUNCT
ajlsi-2441	171	29	&	&	CCONJ
ajlsi-2441	171	30	chiavegatto	chiavegatto	PROPN
ajlsi-2441	171	31	filho	filho	PROPN
ajlsi-2441	171	32	,	,	PUNCT
ajlsi-2441	171	33	a.	a.	PROPN
ajlsi-2441	171	34	d.	d.	PROPN
ajlsi-2441	171	35	p.	p.	PROPN
ajlsi-2441	171	36	(	(	PUNCT
ajlsi-2441	171	37	2021	2021	NUM
ajlsi-2441	171	38	)	)	PUNCT
ajlsi-2441	171	39	.	.	PUNCT
ajlsi-2441	172	1	a	a	DET
ajlsi-2441	172	2	multipurpose	multipurpose	NOUN
ajlsi-2441	172	3	machine	machine	NOUN
ajlsi-2441	172	4	learning	learn	VERB
ajlsi-2441	172	5	approach	approach	NOUN
ajlsi-2441	172	6	to	to	PART
ajlsi-2441	172	7	predict	predict	VERB
ajlsi-2441	172	8	covid-19	covid-19	PROPN
ajlsi-2441	172	9	negative	negative	ADJ
ajlsi-2441	172	10	prognosis	prognosis	NOUN
ajlsi-2441	172	11	in	in	ADP
ajlsi-2441	172	12	são	são	PROPN
ajlsi-2441	172	13	paulo	paulo	PROPN
ajlsi-2441	172	14	,	,	PUNCT
ajlsi-2441	172	15	brazil	brazil	PROPN
ajlsi-2441	172	16	.	.	PUNCT
ajlsi-2441	173	1	scientific	scientific	ADJ
ajlsi-2441	173	2	reports	report	NOUN
ajlsi-2441	173	3	,	,	PUNCT
ajlsi-2441	173	4	11(1	11(1	NUM
ajlsi-2441	173	5	)	)	PUNCT
ajlsi-2441	173	6	,	,	PUNCT
ajlsi-2441	173	7	3343	3343	NUM
ajlsi-2441	173	8	.	.	PUNCT
ajlsi-2441	174	1	foy	foy	PROPN
ajlsi-2441	174	2	,	,	PUNCT
ajlsi-2441	174	3	b.	b.	PROPN
ajlsi-2441	174	4	h.	h.	PROPN
ajlsi-2441	174	5	,	,	PUNCT
ajlsi-2441	174	6	carlson	carlson	PROPN
ajlsi-2441	174	7	,	,	PUNCT
ajlsi-2441	174	8	j.	j.	PROPN
ajlsi-2441	174	9	c.	c.	PROPN
ajlsi-2441	174	10	,	,	PUNCT
ajlsi-2441	174	11	reinertsen	reinertsen	PROPN
ajlsi-2441	174	12	,	,	PUNCT
ajlsi-2441	174	13	e.	e.	PROPN
ajlsi-2441	174	14	,	,	PUNCT
ajlsi-2441	174	15	valls	valls	PROPN
ajlsi-2441	174	16	,	,	PUNCT
ajlsi-2441	174	17	r.	r.	PROPN
ajlsi-2441	174	18	p.	p.	PROPN
ajlsi-2441	174	19	,	,	PUNCT
ajlsi-2441	174	20	lopez	lopez	PROPN
ajlsi-2441	174	21	,	,	PUNCT
ajlsi-2441	174	22	r.	r.	PROPN
ajlsi-2441	174	23	p.	p.	PROPN
ajlsi-2441	174	24	,	,	PUNCT
ajlsi-2441	174	25	palanques	palanque	NOUN
ajlsi-2441	174	26	-	-	PUNCT
ajlsi-2441	174	27	tost	tost	PROPN
ajlsi-2441	174	28	,	,	PUNCT
ajlsi-2441	174	29	e.	e.	PROPN
ajlsi-2441	174	30	,	,	PUNCT
ajlsi-2441	174	31	...	...	PUNCT
ajlsi-2441	174	32	&	&	CCONJ
ajlsi-2441	174	33	higgins	higgins	PROPN
ajlsi-2441	174	34	,	,	PUNCT
ajlsi-2441	174	35	j.	j.	PROPN
ajlsi-2441	174	36	m.	m.	PROPN
ajlsi-2441	174	37	(	(	PUNCT
ajlsi-2441	174	38	2020	2020	NUM
ajlsi-2441	174	39	)	)	PUNCT
ajlsi-2441	174	40	.	.	PUNCT
ajlsi-2441	175	1	elevated	elevate	VERB
ajlsi-2441	175	2	rdw	rdw	PROPN
ajlsi-2441	175	3	is	be	AUX
ajlsi-2441	175	4	associated	associate	VERB
ajlsi-2441	175	5	with	with	ADP
ajlsi-2441	175	6	increased	increase	VERB
ajlsi-2441	175	7	mortality	mortality	NOUN
ajlsi-2441	175	8	risk	risk	NOUN
ajlsi-2441	175	9	in	in	ADP
ajlsi-2441	175	10	covid-19	covid-19	PROPN
ajlsi-2441	175	11	.	.	PUNCT
ajlsi-2441	176	1	medrxiv	medrxiv	PROPN
ajlsi-2441	176	2	,	,	PUNCT
ajlsi-2441	176	3	2020	2020	NUM
ajlsi-2441	176	4	-	-	SYM
ajlsi-2441	176	5	05	05	NUM
ajlsi-2441	176	6	.	.	PUNCT
ajlsi-2441	177	1	foy	foy	PROPN
ajlsi-2441	177	2	,	,	PUNCT
ajlsi-2441	177	3	b.	b.	PROPN
ajlsi-2441	177	4	h.	h.	PROPN
ajlsi-2441	177	5	,	,	PUNCT
ajlsi-2441	177	6	carlson	carlson	PROPN
ajlsi-2441	177	7	,	,	PUNCT
ajlsi-2441	177	8	j.	j.	PROPN
ajlsi-2441	177	9	c.	c.	PROPN
ajlsi-2441	177	10	,	,	PUNCT
ajlsi-2441	177	11	reinertsen	reinertsen	PROPN
ajlsi-2441	177	12	,	,	PUNCT
ajlsi-2441	177	13	e.	e.	PROPN
ajlsi-2441	177	14	,	,	PUNCT
ajlsi-2441	177	15	valls	valls	PROPN
ajlsi-2441	177	16	,	,	PUNCT
ajlsi-2441	177	17	r.	r.	PROPN
ajlsi-2441	177	18	p.	p.	PROPN
ajlsi-2441	177	19	i.	i.	PROPN
ajlsi-2441	177	20	,	,	PUNCT
ajlsi-2441	177	21	lopez	lopez	PROPN
ajlsi-2441	177	22	,	,	PUNCT
ajlsi-2441	177	23	r.	r.	PROPN
ajlsi-2441	177	24	p.	p.	PROPN
ajlsi-2441	177	25	,	,	PUNCT
ajlsi-2441	177	26	palanques	palanque	NOUN
ajlsi-2441	177	27	-	-	PUNCT
ajlsi-2441	177	28	tost	tost	PROPN
ajlsi-2441	177	29	,	,	PUNCT
ajlsi-2441	177	30	e.	e.	PROPN
ajlsi-2441	177	31	,	,	PUNCT
ajlsi-2441	177	32	mow	mow	PROPN
ajlsi-2441	177	33	,	,	PUNCT
ajlsi-2441	177	34	c.	c.	PROPN
ajlsi-2441	177	35	,	,	PUNCT
ajlsi-2441	177	36	westover	westover	PROPN
ajlsi-2441	177	37	,	,	PUNCT
ajlsi-2441	177	38	m.	m.	PROPN
ajlsi-2441	177	39	b.	b.	PROPN
ajlsi-2441	177	40	,	,	PUNCT
ajlsi-2441	177	41	aguirre	aguirre	PROPN
ajlsi-2441	177	42	,	,	PUNCT
ajlsi-2441	177	43	a.	a.	PROPN
ajlsi-2441	177	44	d.	d.	PROPN
ajlsi-2441	177	45	,	,	PUNCT
ajlsi-2441	177	46	&	&	CCONJ
ajlsi-2441	177	47	higgins	higgins	PROPN
ajlsi-2441	177	48	,	,	PUNCT
ajlsi-2441	177	49	j.	j.	PROPN
ajlsi-2441	177	50	m.	m.	PROPN
ajlsi-2441	177	51	(	(	PUNCT
ajlsi-2441	177	52	2020b	2020b	NUM
ajlsi-2441	177	53	)	)	PUNCT
ajlsi-2441	177	54	.	.	PUNCT
ajlsi-2441	178	1	association	association	NOUN
ajlsi-2441	178	2	of	of	ADP
ajlsi-2441	178	3	red	red	ADJ
ajlsi-2441	178	4	blood	blood	NOUN
ajlsi-2441	178	5	cell	cell	NOUN
ajlsi-2441	178	6	distribution	distribution	NOUN
ajlsi-2441	178	7	width	width	NOUN
ajlsi-2441	178	8	with	with	ADP
ajlsi-2441	178	9	mortality	mortality	NOUN
ajlsi-2441	178	10	risk	risk	NOUN
ajlsi-2441	178	11	in	in	ADP
ajlsi-2441	178	12	hospitalized	hospitalize	VERB
ajlsi-2441	178	13	adults	adult	NOUN
ajlsi-2441	178	14	with	with	ADP
ajlsi-2441	178	15	sars	sar	NOUN
ajlsi-2441	178	16	-	-	PUNCT
ajlsi-2441	178	17	cov-2	cov-2	PART
ajlsi-2441	178	18	infection	infection	NOUN
ajlsi-2441	178	19	.	.	PUNCT
ajlsi-2441	179	1	jama	jama	PROPN
ajlsi-2441	179	2	network	network	PROPN
ajlsi-2441	179	3	open	open	VERB
ajlsi-2441	179	4	,	,	PUNCT
ajlsi-2441	179	5	3(9	3(9	NUM
ajlsi-2441	179	6	)	)	PUNCT
ajlsi-2441	179	7	,	,	PUNCT
ajlsi-2441	180	1	e2022058	e2022058	NOUN
ajlsi-2441	180	2	-	-	PUNCT
ajlsi-2441	180	3	e2022058	e2022058	NOUN
ajlsi-2441	180	4	.	.	PUNCT
ajlsi-2441	180	5	ghahramani	ghahramani	PROPN
ajlsi-2441	180	6	,	,	PUNCT
ajlsi-2441	180	7	s.	s.	PROPN
ajlsi-2441	180	8	,	,	PUNCT
ajlsi-2441	180	9	tabrizi	tabrizi	NOUN
ajlsi-2441	180	10	,	,	PUNCT
ajlsi-2441	180	11	r.	r.	PROPN
ajlsi-2441	180	12	,	,	PUNCT
ajlsi-2441	180	13	lankarani	lankarani	PROPN
ajlsi-2441	180	14	,	,	PUNCT
ajlsi-2441	180	15	k.	k.	PROPN
ajlsi-2441	180	16	b.	b.	PROPN
ajlsi-2441	180	17	,	,	PUNCT
ajlsi-2441	180	18	kashani	kashani	PROPN
ajlsi-2441	180	19	,	,	PUNCT
ajlsi-2441	180	20	s.	s.	PROPN
ajlsi-2441	180	21	m.	m.	PROPN
ajlsi-2441	180	22	a.	a.	PROPN
ajlsi-2441	180	23	,	,	PUNCT
ajlsi-2441	180	24	rezaei	rezaei	PROPN
ajlsi-2441	180	25	,	,	PUNCT
ajlsi-2441	180	26	s.	s.	PROPN
ajlsi-2441	180	27	,	,	PUNCT
ajlsi-2441	180	28	zeidi	zeidi	PROPN
ajlsi-2441	180	29	,	,	PUNCT
ajlsi-2441	180	30	n.	n.	NOUN
ajlsi-2441	180	31	,	,	PUNCT
ajlsi-2441	180	32	akbari	akbari	PROPN
ajlsi-2441	180	33	,	,	PUNCT
ajlsi-2441	180	34	m.	m.	NOUN
ajlsi-2441	180	35	,	,	PUNCT
ajlsi-2441	180	36	heydari	heydari	NOUN
ajlsi-2441	180	37	,	,	PUNCT
ajlsi-2441	180	38	s.	s.	PROPN
ajlsi-2441	180	39	t.	t.	PROPN
ajlsi-2441	180	40	,	,	PUNCT
ajlsi-2441	180	41	akbari	akbari	PROPN
ajlsi-2441	180	42	,	,	PUNCT
ajlsi-2441	180	43	h.	h.	PROPN
ajlsi-2441	180	44	,	,	PUNCT
ajlsi-2441	180	45	nowrouzi	nowrouzi	NOUN
ajlsi-2441	180	46	-	-	PUNCT
ajlsi-2441	180	47	sohrabi	sohrabi	PROPN
ajlsi-2441	180	48	,	,	PUNCT
ajlsi-2441	180	49	p.	p.	NOUN
ajlsi-2441	180	50	,	,	PUNCT
ajlsi-2441	180	51	&	&	CCONJ
ajlsi-2441	180	52	ahmadizar	ahmadizar	PROPN
ajlsi-2441	180	53	,	,	PUNCT
ajlsi-2441	180	54	f.	f.	PROPN
ajlsi-2441	180	55	(	(	PUNCT
ajlsi-2441	180	56	2020	2020	NUM
ajlsi-2441	180	57	)	)	PUNCT
ajlsi-2441	180	58	.	.	PUNCT
ajlsi-2441	181	1	laboratory	laboratory	NOUN
ajlsi-2441	181	2	features	feature	NOUN
ajlsi-2441	181	3	of	of	ADP
ajlsi-2441	181	4	severe	severe	ADJ
ajlsi-2441	181	5	vs.	vs.	X
ajlsi-2441	181	6	non	non	ADJ
ajlsi-2441	181	7	-	-	ADJ
ajlsi-2441	181	8	severe	severe	ADJ
ajlsi-2441	181	9	covid-19	covid-19	PROPN
ajlsi-2441	181	10	patients	patient	NOUN
ajlsi-2441	181	11	in	in	ADP
ajlsi-2441	181	12	asian	asian	ADJ
ajlsi-2441	181	13	populations	population	NOUN
ajlsi-2441	181	14	:	:	PUNCT
ajlsi-2441	181	15	a	a	DET
ajlsi-2441	181	16	systematic	systematic	ADJ
ajlsi-2441	181	17	review	review	NOUN
ajlsi-2441	181	18	and	and	CCONJ
ajlsi-2441	181	19	meta	meta	ADJ
ajlsi-2441	181	20	-	-	PUNCT
ajlsi-2441	181	21	analysis	analysis	NOUN
ajlsi-2441	181	22	.	.	PUNCT
ajlsi-2441	182	1	eur	eur	PROPN
ajlsi-2441	182	2	j	j	PROPN
ajlsi-2441	182	3	med	med	PROPN
ajlsi-2441	182	4	res	re	NOUN
ajlsi-2441	182	5	,	,	PUNCT
ajlsi-2441	182	6	25(1	25(1	NUM
ajlsi-2441	182	7	)	)	PUNCT
ajlsi-2441	182	8	,	,	PUNCT
ajlsi-2441	182	9	30	30	NUM
ajlsi-2441	182	10	.	.	PUNCT
ajlsi-2441	183	1	https://doi.org/10.1186/s40001-020-00432-3	https://doi.org/10.1186/s40001-020-00432-3	NUM
ajlsi-2441	184	1	gong	gong	PROPN
ajlsi-2441	184	2	,	,	PUNCT
ajlsi-2441	184	3	k.	k.	PROPN
ajlsi-2441	184	4	,	,	PUNCT
ajlsi-2441	184	5	wu	wu	PROPN
ajlsi-2441	184	6	,	,	PUNCT
ajlsi-2441	184	7	d.	d.	PROPN
ajlsi-2441	184	8	,	,	PUNCT
ajlsi-2441	184	9	arru	arru	PROPN
ajlsi-2441	184	10	,	,	PUNCT
ajlsi-2441	184	11	c.	c.	PROPN
ajlsi-2441	184	12	d.	d.	PROPN
ajlsi-2441	184	13	,	,	PUNCT
ajlsi-2441	184	14	homayounieh	homayounieh	PROPN
ajlsi-2441	184	15	,	,	PUNCT
ajlsi-2441	184	16	f.	f.	PROPN
ajlsi-2441	184	17	,	,	PUNCT
ajlsi-2441	184	18	neumark	neumark	PROPN
ajlsi-2441	184	19	,	,	PUNCT
ajlsi-2441	184	20	n.	n.	PROPN
ajlsi-2441	184	21	,	,	PUNCT
ajlsi-2441	184	22	guan	guan	PROPN
ajlsi-2441	184	23	,	,	PUNCT
ajlsi-2441	184	24	j.	j.	PROPN
ajlsi-2441	184	25	,	,	PUNCT
ajlsi-2441	184	26	buch	buch	PROPN
ajlsi-2441	184	27	,	,	PUNCT
ajlsi-2441	184	28	v.	v.	PROPN
ajlsi-2441	184	29	,	,	PUNCT
ajlsi-2441	184	30	kim	kim	PROPN
ajlsi-2441	184	31	,	,	PUNCT
ajlsi-2441	184	32	k.	k.	PROPN
ajlsi-2441	184	33	,	,	PUNCT
ajlsi-2441	184	34	bizzo	bizzo	PROPN
ajlsi-2441	184	35	,	,	PUNCT
ajlsi-2441	184	36	b.	b.	PROPN
ajlsi-2441	184	37	c.	c.	PROPN
ajlsi-2441	184	38	,	,	PUNCT
ajlsi-2441	184	39	&	&	CCONJ
ajlsi-2441	184	40	ren	ren	PROPN
ajlsi-2441	184	41	,	,	PUNCT
ajlsi-2441	184	42	h.	h.	PROPN
ajlsi-2441	184	43	(	(	PUNCT
ajlsi-2441	184	44	2021	2021	NUM
ajlsi-2441	184	45	)	)	PUNCT
ajlsi-2441	184	46	.	.	PUNCT
ajlsi-2441	185	1	a	a	DET
ajlsi-2441	185	2	multi	multi	ADJ
ajlsi-2441	185	3	-	-	ADJ
ajlsi-2441	185	4	center	center	ADJ
ajlsi-2441	185	5	study	study	NOUN
ajlsi-2441	185	6	of	of	ADP
ajlsi-2441	185	7	covid-19	covid-19	PROPN
ajlsi-2441	185	8	patient	patient	ADJ
ajlsi-2441	185	9	prognosis	prognosis	NOUN
ajlsi-2441	185	10	using	use	VERB
ajlsi-2441	185	11	deep	deep	ADJ
ajlsi-2441	185	12	learning	learning	NOUN
ajlsi-2441	185	13	-	-	PUNCT
ajlsi-2441	185	14	based	base	VERB
ajlsi-2441	185	15	ct	ct	NOUN
ajlsi-2441	185	16	image	image	NOUN
ajlsi-2441	185	17	analysis	analysis	NOUN
ajlsi-2441	185	18	and	and	CCONJ
ajlsi-2441	185	19	electronic	electronic	ADJ
ajlsi-2441	185	20	health	health	NOUN
ajlsi-2441	185	21	records	record	NOUN
ajlsi-2441	185	22	.	.	PUNCT
ajlsi-2441	186	1	european	european	ADJ
ajlsi-2441	186	2	journal	journal	PROPN
ajlsi-2441	186	3	of	of	ADP
ajlsi-2441	186	4	radiology	radiology	NOUN
ajlsi-2441	186	5	,	,	PUNCT
ajlsi-2441	186	6	139	139	NUM
ajlsi-2441	186	7	,	,	PUNCT
ajlsi-2441	186	8	109583	109583	NUM
ajlsi-2441	186	9	.	.	PUNCT
ajlsi-2441	187	1	henry	henry	PROPN
ajlsi-2441	187	2	,	,	PUNCT
ajlsi-2441	187	3	b.	b.	PROPN
ajlsi-2441	187	4	m.	m.	PROPN
ajlsi-2441	187	5	,	,	PUNCT
ajlsi-2441	187	6	aggarwal	aggarwal	PROPN
ajlsi-2441	187	7	,	,	PUNCT
ajlsi-2441	187	8	g.	g.	PROPN
ajlsi-2441	187	9	,	,	PUNCT
ajlsi-2441	187	10	wong	wong	PROPN
ajlsi-2441	187	11	,	,	PUNCT
ajlsi-2441	187	12	j.	j.	PROPN
ajlsi-2441	187	13	,	,	PUNCT
ajlsi-2441	187	14	benoit	benoit	PROPN
ajlsi-2441	187	15	,	,	PUNCT
ajlsi-2441	187	16	s.	s.	PROPN
ajlsi-2441	187	17	,	,	PUNCT
ajlsi-2441	187	18	vikse	vikse	PROPN
ajlsi-2441	187	19	,	,	PUNCT
ajlsi-2441	187	20	j.	j.	PROPN
ajlsi-2441	187	21	,	,	PUNCT
ajlsi-2441	187	22	plebani	plebani	PROPN
ajlsi-2441	187	23	,	,	PUNCT
ajlsi-2441	187	24	m.	m.	NOUN
ajlsi-2441	187	25	,	,	PUNCT
ajlsi-2441	187	26	&	&	CCONJ
ajlsi-2441	187	27	lippi	lippi	PROPN
ajlsi-2441	187	28	,	,	PUNCT
ajlsi-2441	187	29	g.	g.	PROPN
ajlsi-2441	187	30	(	(	PUNCT
ajlsi-2441	187	31	2020	2020	NUM
ajlsi-2441	187	32	)	)	PUNCT
ajlsi-2441	187	33	.	.	PUNCT
ajlsi-2441	188	1	lactate	lactate	NOUN
ajlsi-2441	188	2	dehydrogenase	dehydrogenase	NOUN
ajlsi-2441	188	3	levels	level	NOUN
ajlsi-2441	188	4	predict	predict	VERB
ajlsi-2441	188	5	coronavirus	coronavirus	NOUN
ajlsi-2441	188	6	disease	disease	NOUN
ajlsi-2441	188	7	2019	2019	NUM
ajlsi-2441	188	8	(	(	PUNCT
ajlsi-2441	188	9	covid-19	covid-19	PROPN
ajlsi-2441	188	10	)	)	PUNCT
ajlsi-2441	188	11	severity	severity	NOUN
ajlsi-2441	188	12	and	and	CCONJ
ajlsi-2441	188	13	mortality	mortality	NOUN
ajlsi-2441	188	14	:	:	PUNCT
ajlsi-2441	188	15	a	a	DET
ajlsi-2441	188	16	pooled	pooled	ADJ
ajlsi-2441	188	17	analysis	analysis	NOUN
ajlsi-2441	188	18	.	.	PUNCT
ajlsi-2441	189	1	the	the	DET
ajlsi-2441	189	2	american	american	PROPN
ajlsi-2441	189	3	journal	journal	PROPN
ajlsi-2441	189	4	of	of	ADP
ajlsi-2441	189	5	emergency	emergency	NOUN
ajlsi-2441	189	6	medicine	medicine	NOUN
ajlsi-2441	189	7	,	,	PUNCT
ajlsi-2441	189	8	38(9	38(9	NOUN
ajlsi-2441	189	9	)	)	PUNCT
ajlsi-2441	189	10	,	,	PUNCT
ajlsi-2441	189	11	1722	1722	NUM
ajlsi-2441	189	12	-	-	SYM
ajlsi-2441	189	13	1726	1726	NUM
ajlsi-2441	189	14	.	.	PUNCT
ajlsi-2441	190	1	henry	henry	PROPN
ajlsi-2441	190	2	,	,	PUNCT
ajlsi-2441	190	3	b.	b.	PROPN
ajlsi-2441	190	4	m.	m.	PROPN
ajlsi-2441	190	5	,	,	PUNCT
ajlsi-2441	190	6	de	de	PROPN
ajlsi-2441	190	7	oliveira	oliveira	PROPN
ajlsi-2441	190	8	,	,	PUNCT
ajlsi-2441	190	9	m.	m.	PROPN
ajlsi-2441	190	10	h.	h.	PROPN
ajlsi-2441	190	11	s.	s.	PROPN
ajlsi-2441	190	12	,	,	PUNCT
ajlsi-2441	190	13	benoit	benoit	PROPN
ajlsi-2441	190	14	,	,	PUNCT
ajlsi-2441	190	15	s.	s.	PROPN
ajlsi-2441	190	16	,	,	PUNCT
ajlsi-2441	190	17	plebani	plebani	PROPN
ajlsi-2441	190	18	,	,	PUNCT
ajlsi-2441	190	19	m.	m.	NOUN
ajlsi-2441	190	20	,	,	PUNCT
ajlsi-2441	190	21	&	&	CCONJ
ajlsi-2441	190	22	lippi	lippi	PROPN
ajlsi-2441	190	23	,	,	PUNCT
ajlsi-2441	190	24	g.	g.	PROPN
ajlsi-2441	190	25	(	(	PUNCT
ajlsi-2441	190	26	2020	2020	NUM
ajlsi-2441	190	27	)	)	PUNCT
ajlsi-2441	190	28	.	.	PUNCT
ajlsi-2441	191	1	hematologic	hematologic	NOUN
ajlsi-2441	191	2	,	,	PUNCT
ajlsi-2441	191	3	biochemical	biochemical	ADJ
ajlsi-2441	191	4	and	and	CCONJ
ajlsi-2441	191	5	immune	immune	ADJ
ajlsi-2441	191	6	biomarker	biomarker	NOUN
ajlsi-2441	191	7	abnormalities	abnormality	NOUN
ajlsi-2441	191	8	associated	associate	VERB
ajlsi-2441	191	9	with	with	ADP
ajlsi-2441	191	10	severe	severe	ADJ
ajlsi-2441	191	11	illness	illness	NOUN
ajlsi-2441	191	12	and	and	CCONJ
ajlsi-2441	191	13	mortality	mortality	NOUN
ajlsi-2441	191	14	in	in	ADP
ajlsi-2441	191	15	coronavirus	coronavirus	NOUN
ajlsi-2441	191	16	disease	disease	NOUN
ajlsi-2441	191	17	2019	2019	NUM
ajlsi-2441	191	18	(	(	PUNCT
ajlsi-2441	191	19	covid-19	covid-19	PROPN
ajlsi-2441	191	20	):	):	PUNCT
ajlsi-2441	191	21	a	a	DET
ajlsi-2441	191	22	meta	meta	ADJ
ajlsi-2441	191	23	-	-	PUNCT
ajlsi-2441	191	24	analysis	analysis	NOUN
ajlsi-2441	191	25	.	.	PUNCT
ajlsi-2441	192	1	clinical	clinical	ADJ
ajlsi-2441	192	2	chemistry	chemistry	NOUN
ajlsi-2441	192	3	and	and	CCONJ
ajlsi-2441	192	4	laboratory	laboratory	NOUN
ajlsi-2441	192	5	medicine	medicine	NOUN
ajlsi-2441	192	6	(	(	PUNCT
ajlsi-2441	192	7	cclm	cclm	PROPN
ajlsi-2441	192	8	)	)	PUNCT
ajlsi-2441	192	9	,	,	PUNCT
ajlsi-2441	192	10	58(7	58(7	NUM
ajlsi-2441	192	11	)	)	PUNCT
ajlsi-2441	192	12	,	,	PUNCT
ajlsi-2441	192	13	1021	1021	NUM
ajlsi-2441	192	14	-	-	SYM
ajlsi-2441	192	15	1028	1028	NUM
ajlsi-2441	192	16	.	.	PUNCT
ajlsi-2441	193	1	huang	huang	PROPN
ajlsi-2441	193	2	,	,	PUNCT
ajlsi-2441	193	3	c.	c.	PROPN
ajlsi-2441	193	4	,	,	PUNCT
ajlsi-2441	193	5	wang	wang	PROPN
ajlsi-2441	193	6	,	,	PUNCT
ajlsi-2441	193	7	y.	y.	PROPN
ajlsi-2441	193	8	,	,	PUNCT
ajlsi-2441	193	9	li	li	PROPN
ajlsi-2441	193	10	,	,	PUNCT
ajlsi-2441	193	11	x.	x.	PROPN
ajlsi-2441	193	12	,	,	PUNCT
ajlsi-2441	193	13	ren	ren	PROPN
ajlsi-2441	193	14	,	,	PUNCT
ajlsi-2441	193	15	l.	l.	PROPN
ajlsi-2441	193	16	,	,	PUNCT
ajlsi-2441	193	17	zhao	zhao	PROPN
ajlsi-2441	193	18	,	,	PUNCT
ajlsi-2441	193	19	j.	j.	PROPN
ajlsi-2441	193	20	,	,	PUNCT
ajlsi-2441	193	21	hu	hu	PROPN
ajlsi-2441	193	22	,	,	PUNCT
ajlsi-2441	193	23	y.	y.	PROPN
ajlsi-2441	193	24	,	,	PUNCT
ajlsi-2441	193	25	zhang	zhang	PROPN
ajlsi-2441	193	26	,	,	PUNCT
ajlsi-2441	193	27	l.	l.	PROPN
ajlsi-2441	193	28	,	,	PUNCT
ajlsi-2441	193	29	fan	fan	PROPN
ajlsi-2441	193	30	,	,	PUNCT
ajlsi-2441	193	31	g.	g.	PROPN
ajlsi-2441	193	32	,	,	PUNCT
ajlsi-2441	193	33	xu	xu	PROPN
ajlsi-2441	193	34	,	,	PUNCT
ajlsi-2441	193	35	j.	j.	PROPN
ajlsi-2441	193	36	,	,	PUNCT
ajlsi-2441	193	37	&	&	CCONJ
ajlsi-2441	193	38	gu	gu	PROPN
ajlsi-2441	193	39	,	,	PUNCT
ajlsi-2441	193	40	x.	x.	NOUN
ajlsi-2441	193	41	(	(	PUNCT
ajlsi-2441	193	42	2020	2020	NUM
ajlsi-2441	193	43	)	)	PUNCT
ajlsi-2441	193	44	.	.	PUNCT
ajlsi-2441	194	1	clinical	clinical	ADJ
ajlsi-2441	194	2	features	feature	NOUN
ajlsi-2441	194	3	of	of	ADP
ajlsi-2441	194	4	patients	patient	NOUN
ajlsi-2441	194	5	infected	infect	VERB
ajlsi-2441	194	6	with	with	ADP
ajlsi-2441	194	7	2019	2019	NUM
ajlsi-2441	194	8	novel	novel	ADJ
ajlsi-2441	194	9	coronavirus	coronavirus	NOUN
ajlsi-2441	194	10	in	in	ADP
ajlsi-2441	194	11	pa	pa	PROPN
ajlsi-2441	194	12	ge	ge	PROPN
ajlsi-2441	194	13	35	35	NUM
ajlsi-2441	194	14	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	194	15	am	am	NOUN
ajlsi-2441	194	16	.	.	PUNCT
ajlsi-2441	195	1	j.	j.	PROPN
ajlsi-2441	195	2	life	life	PROPN
ajlsi-2441	195	3	sci	sci	PROPN
ajlsi-2441	195	4	.	.	PUNCT
ajlsi-2441	195	5	innov	innov	PROPN
ajlsi-2441	195	6	.	.	PUNCT
ajlsi-2441	196	1	3(1	3(1	NUM
ajlsi-2441	196	2	)	)	PUNCT
ajlsi-2441	196	3	28	28	NUM
ajlsi-2441	196	4	-	-	SYM
ajlsi-2441	196	5	36	36	NUM
ajlsi-2441	196	6	,	,	PUNCT
ajlsi-2441	196	7	2024	2024	NUM
ajlsi-2441	196	8	wuhan	wuhan	PROPN
ajlsi-2441	196	9	,	,	PUNCT
ajlsi-2441	196	10	china	china	PROPN
ajlsi-2441	196	11	.	.	PUNCT
ajlsi-2441	197	1	the	the	DET
ajlsi-2441	197	2	lancet	lancet	PROPN
ajlsi-2441	197	3	,	,	PUNCT
ajlsi-2441	197	4	395(10223	395(10223	NUM
ajlsi-2441	197	5	)	)	PUNCT
ajlsi-2441	197	6	,	,	PUNCT
ajlsi-2441	197	7	497	497	NUM
ajlsi-2441	197	8	-	-	SYM
ajlsi-2441	197	9	506	506	NUM
ajlsi-2441	197	10	.	.	PUNCT
ajlsi-2441	198	1	khosravi	khosravi	NOUN
ajlsi-2441	198	2	,	,	PUNCT
ajlsi-2441	198	3	b.	b.	PROPN
ajlsi-2441	198	4	,	,	PUNCT
ajlsi-2441	198	5	aghaghazvini	aghaghazvini	PROPN
ajlsi-2441	198	6	,	,	PUNCT
ajlsi-2441	198	7	l.	l.	PROPN
ajlsi-2441	198	8	,	,	PUNCT
ajlsi-2441	198	9	sorouri	sorouri	NOUN
ajlsi-2441	198	10	,	,	PUNCT
ajlsi-2441	198	11	m.	m.	NOUN
ajlsi-2441	198	12	,	,	PUNCT
ajlsi-2441	198	13	atashi	atashi	PROPN
ajlsi-2441	198	14	,	,	PUNCT
ajlsi-2441	198	15	s.	s.	PROPN
ajlsi-2441	198	16	n.	n.	PROPN
ajlsi-2441	198	17	,	,	PUNCT
ajlsi-2441	198	18	abdollahi	abdollahi	NOUN
ajlsi-2441	198	19	,	,	PUNCT
ajlsi-2441	198	20	m.	m.	NOUN
ajlsi-2441	198	21	,	,	PUNCT
ajlsi-2441	198	22	mojtabavi	mojtabavi	NOUN
ajlsi-2441	198	23	,	,	PUNCT
ajlsi-2441	198	24	h.	h.	PROPN
ajlsi-2441	198	25	,	,	PUNCT
ajlsi-2441	198	26	khodabakhshi	khodabakhshi	PROPN
ajlsi-2441	198	27	,	,	PUNCT
ajlsi-2441	198	28	m.	m.	NOUN
ajlsi-2441	198	29	,	,	PUNCT
ajlsi-2441	198	30	motamedi	motamedi	PROPN
ajlsi-2441	198	31	,	,	PUNCT
ajlsi-2441	198	32	f.	f.	PROPN
ajlsi-2441	198	33	,	,	PUNCT
ajlsi-2441	198	34	azizi	azizi	PROPN
ajlsi-2441	198	35	,	,	PUNCT
ajlsi-2441	198	36	f.	f.	PROPN
ajlsi-2441	198	37	,	,	PUNCT
ajlsi-2441	198	38	&	&	CCONJ
ajlsi-2441	198	39	rajabi	rajabi	PROPN
ajlsi-2441	198	40	,	,	PUNCT
ajlsi-2441	198	41	z.	z.	PROPN
ajlsi-2441	198	42	(	(	PUNCT
ajlsi-2441	198	43	2021	2021	NUM
ajlsi-2441	198	44	)	)	PUNCT
ajlsi-2441	198	45	.	.	PUNCT
ajlsi-2441	199	1	predictive	predictive	ADJ
ajlsi-2441	199	2	value	value	NOUN
ajlsi-2441	199	3	of	of	ADP
ajlsi-2441	199	4	initial	initial	ADJ
ajlsi-2441	199	5	ct	ct	PROPN
ajlsi-2441	199	6	scan	scan	NOUN
ajlsi-2441	199	7	for	for	ADP
ajlsi-2441	199	8	various	various	ADJ
ajlsi-2441	199	9	adverse	adverse	ADJ
ajlsi-2441	199	10	outcomes	outcome	NOUN
ajlsi-2441	199	11	in	in	ADP
ajlsi-2441	199	12	patients	patient	NOUN
ajlsi-2441	199	13	with	with	ADP
ajlsi-2441	199	14	covid-19	covid-19	PROPN
ajlsi-2441	199	15	pneumonia	pneumonia	NOUN
ajlsi-2441	199	16	.	.	PUNCT
ajlsi-2441	200	1	heart	heart	NOUN
ajlsi-2441	200	2	&	&	CCONJ
ajlsi-2441	200	3	lung	lung	PROPN
ajlsi-2441	200	4	,	,	PUNCT
ajlsi-2441	200	5	50(1	50(1	PROPN
ajlsi-2441	200	6	)	)	PUNCT
ajlsi-2441	200	7	,	,	PUNCT
ajlsi-2441	200	8	13	13	NUM
ajlsi-2441	200	9	-	-	SYM
ajlsi-2441	200	10	20	20	NUM
ajlsi-2441	200	11	.	.	PUNCT
ajlsi-2441	201	1	kilercik	kilercik	PROPN
ajlsi-2441	201	2	,	,	PUNCT
ajlsi-2441	201	3	m.	m.	NOUN
ajlsi-2441	201	4	,	,	PUNCT
ajlsi-2441	201	5	demirelce	demirelce	PROPN
ajlsi-2441	201	6	,	,	PUNCT
ajlsi-2441	201	7	ö.	ö.	PROPN
ajlsi-2441	201	8	,	,	PUNCT
ajlsi-2441	201	9	serdar	serdar	PROPN
ajlsi-2441	201	10	,	,	PUNCT
ajlsi-2441	201	11	m.	m.	NOUN
ajlsi-2441	201	12	a.	a.	PROPN
ajlsi-2441	201	13	,	,	PUNCT
ajlsi-2441	201	14	mikailova	mikailova	X
ajlsi-2441	201	15	,	,	PUNCT
ajlsi-2441	201	16	p.	p.	NOUN
ajlsi-2441	201	17	,	,	PUNCT
ajlsi-2441	201	18	&	&	CCONJ
ajlsi-2441	201	19	serteser	serteser	ADV
ajlsi-2441	201	20	,	,	PUNCT
ajlsi-2441	201	21	m.	m.	NOUN
ajlsi-2441	201	22	(	(	PUNCT
ajlsi-2441	201	23	2021	2021	NUM
ajlsi-2441	201	24	)	)	PUNCT
ajlsi-2441	201	25	.	.	PUNCT
ajlsi-2441	202	1	a	a	DET
ajlsi-2441	202	2	new	new	ADJ
ajlsi-2441	202	3	haematocytometric	haematocytometric	ADJ
ajlsi-2441	202	4	index	index	NOUN
ajlsi-2441	202	5	:	:	PUNCT
ajlsi-2441	202	6	predicting	predict	VERB
ajlsi-2441	202	7	severity	severity	NOUN
ajlsi-2441	202	8	and	and	CCONJ
ajlsi-2441	202	9	mortality	mortality	NOUN
ajlsi-2441	202	10	risk	risk	NOUN
ajlsi-2441	202	11	value	value	NOUN
ajlsi-2441	202	12	in	in	ADP
ajlsi-2441	202	13	covid-19	covid-19	PROPN
ajlsi-2441	202	14	patients	patient	NOUN
ajlsi-2441	202	15	.	.	PUNCT
ajlsi-2441	203	1	plos	plos	PROPN
ajlsi-2441	203	2	one	one	NUM
ajlsi-2441	203	3	,	,	PUNCT
ajlsi-2441	203	4	16(8	16(8	NUM
ajlsi-2441	203	5	)	)	PUNCT
ajlsi-2441	203	6	,	,	PUNCT
ajlsi-2441	203	7	e0254073	e0254073	PROPN
ajlsi-2441	203	8	.	.	PUNCT
ajlsi-2441	204	1	krintus	krintus	NOUN
ajlsi-2441	204	2	,	,	PUNCT
ajlsi-2441	204	3	m.	m.	NOUN
ajlsi-2441	204	4	,	,	PUNCT
ajlsi-2441	204	5	kozinski	kozinski	PROPN
ajlsi-2441	204	6	,	,	PUNCT
ajlsi-2441	204	7	m.	m.	NOUN
ajlsi-2441	204	8	,	,	PUNCT
ajlsi-2441	204	9	kubica	kubica	PROPN
ajlsi-2441	204	10	,	,	PUNCT
ajlsi-2441	204	11	j.	j.	PROPN
ajlsi-2441	204	12	,	,	PUNCT
ajlsi-2441	204	13	&	&	CCONJ
ajlsi-2441	204	14	sypniewska	sypniewska	PROPN
ajlsi-2441	204	15	,	,	PUNCT
ajlsi-2441	204	16	g.	g.	PROPN
ajlsi-2441	204	17	(	(	PUNCT
ajlsi-2441	204	18	2014	2014	NUM
ajlsi-2441	204	19	)	)	PUNCT
ajlsi-2441	204	20	.	.	PUNCT
ajlsi-2441	205	1	critical	critical	ADJ
ajlsi-2441	205	2	appraisal	appraisal	NOUN
ajlsi-2441	205	3	of	of	ADP
ajlsi-2441	205	4	inflammatory	inflammatory	ADJ
ajlsi-2441	205	5	markers	marker	NOUN
ajlsi-2441	205	6	in	in	ADP
ajlsi-2441	205	7	cardiovascular	cardiovascular	ADJ
ajlsi-2441	205	8	risk	risk	NOUN
ajlsi-2441	205	9	stratification	stratification	NOUN
ajlsi-2441	205	10	.	.	PUNCT
ajlsi-2441	206	1	critical	critical	ADJ
ajlsi-2441	206	2	reviews	review	NOUN
ajlsi-2441	206	3	in	in	ADP
ajlsi-2441	206	4	clinical	clinical	ADJ
ajlsi-2441	206	5	laboratory	laboratory	NOUN
ajlsi-2441	206	6	sciences	science	NOUN
ajlsi-2441	206	7	,	,	PUNCT
ajlsi-2441	206	8	51(5	51(5	NUM
ajlsi-2441	206	9	)	)	PUNCT
ajlsi-2441	206	10	,	,	PUNCT
ajlsi-2441	206	11	263	263	NUM
ajlsi-2441	206	12	-	-	SYM
ajlsi-2441	206	13	279	279	NUM
ajlsi-2441	206	14	.	.	PUNCT
ajlsi-2441	207	1	levi	levi	PROPN
ajlsi-2441	207	2	,	,	PUNCT
ajlsi-2441	207	3	m.	m.	NOUN
ajlsi-2441	207	4	,	,	PUNCT
ajlsi-2441	207	5	thachil	thachil	PROPN
ajlsi-2441	207	6	,	,	PUNCT
ajlsi-2441	207	7	j.	j.	PROPN
ajlsi-2441	207	8	,	,	PUNCT
ajlsi-2441	207	9	iba	iba	PROPN
ajlsi-2441	207	10	,	,	PUNCT
ajlsi-2441	207	11	t.	t.	PROPN
ajlsi-2441	207	12	,	,	PUNCT
ajlsi-2441	207	13	&	&	CCONJ
ajlsi-2441	207	14	levy	levy	PROPN
ajlsi-2441	207	15	,	,	PUNCT
ajlsi-2441	207	16	j.	j.	PROPN
ajlsi-2441	207	17	h.	h.	PROPN
ajlsi-2441	207	18	(	(	PUNCT
ajlsi-2441	207	19	2020	2020	NUM
ajlsi-2441	207	20	)	)	PUNCT
ajlsi-2441	207	21	.	.	PUNCT
ajlsi-2441	208	1	coagulation	coagulation	NOUN
ajlsi-2441	208	2	abnormalities	abnormality	NOUN
ajlsi-2441	208	3	and	and	CCONJ
ajlsi-2441	208	4	thrombosis	thrombosis	NOUN
ajlsi-2441	208	5	in	in	ADP
ajlsi-2441	208	6	patients	patient	NOUN
ajlsi-2441	208	7	with	with	ADP
ajlsi-2441	208	8	covid-19	covid-19	PROPN
ajlsi-2441	208	9	.	.	PUNCT
ajlsi-2441	209	1	the	the	DET
ajlsi-2441	209	2	lancet	lancet	PROPN
ajlsi-2441	209	3	haematology	haematology	NOUN
ajlsi-2441	209	4	,	,	PUNCT
ajlsi-2441	209	5	7(6	7(6	NUM
ajlsi-2441	209	6	)	)	PUNCT
ajlsi-2441	209	7	,	,	PUNCT
ajlsi-2441	209	8	e438	e438	PROPN
ajlsi-2441	209	9	-	-	SYM
ajlsi-2441	209	10	e440	e440	PROPN
ajlsi-2441	209	11	.	.	PUNCT
ajlsi-2441	210	1	li	li	PROPN
ajlsi-2441	210	2	,	,	PUNCT
ajlsi-2441	210	3	x.	x.	PROPN
ajlsi-2441	210	4	,	,	PUNCT
ajlsi-2441	210	5	liu	liu	PROPN
ajlsi-2441	210	6	,	,	PUNCT
ajlsi-2441	210	7	c.	c.	PROPN
ajlsi-2441	210	8	,	,	PUNCT
ajlsi-2441	210	9	mao	mao	PROPN
ajlsi-2441	210	10	,	,	PUNCT
ajlsi-2441	210	11	z.	z.	PROPN
ajlsi-2441	210	12	,	,	PUNCT
ajlsi-2441	210	13	xiao	xiao	PROPN
ajlsi-2441	210	14	,	,	PUNCT
ajlsi-2441	210	15	m.	m.	NOUN
ajlsi-2441	210	16	,	,	PUNCT
ajlsi-2441	210	17	wang	wang	PROPN
ajlsi-2441	210	18	,	,	PUNCT
ajlsi-2441	210	19	l.	l.	PROPN
ajlsi-2441	210	20	,	,	PUNCT
ajlsi-2441	210	21	qi	qi	PROPN
ajlsi-2441	210	22	,	,	PUNCT
ajlsi-2441	210	23	s.	s.	PROPN
ajlsi-2441	210	24	,	,	PUNCT
ajlsi-2441	210	25	&	&	CCONJ
ajlsi-2441	210	26	zhou	zhou	PROPN
ajlsi-2441	210	27	,	,	PUNCT
ajlsi-2441	210	28	f.	f.	PROPN
ajlsi-2441	210	29	(	(	PUNCT
ajlsi-2441	210	30	2020	2020	NUM
ajlsi-2441	210	31	)	)	PUNCT
ajlsi-2441	210	32	.	.	PUNCT
ajlsi-2441	211	1	predictive	predictive	ADJ
ajlsi-2441	211	2	values	value	NOUN
ajlsi-2441	211	3	of	of	ADP
ajlsi-2441	211	4	neutrophil	neutrophil	ADJ
ajlsi-2441	211	5	-	-	PUNCT
ajlsi-2441	211	6	tolymphocyte	tolymphocyte	NOUN
ajlsi-2441	211	7	ratio	ratio	NOUN
ajlsi-2441	211	8	on	on	ADP
ajlsi-2441	211	9	disease	disease	NOUN
ajlsi-2441	211	10	severity	severity	NOUN
ajlsi-2441	211	11	and	and	CCONJ
ajlsi-2441	211	12	mortality	mortality	NOUN
ajlsi-2441	211	13	in	in	ADP
ajlsi-2441	211	14	covid-19	covid-19	PROPN
ajlsi-2441	211	15	patients	patient	NOUN
ajlsi-2441	211	16	:	:	PUNCT
ajlsi-2441	211	17	a	a	DET
ajlsi-2441	211	18	systematic	systematic	ADJ
ajlsi-2441	211	19	review	review	NOUN
ajlsi-2441	211	20	and	and	CCONJ
ajlsi-2441	211	21	metaanalysis	metaanalysis	NOUN
ajlsi-2441	211	22	.	.	PUNCT
ajlsi-2441	212	1	critical	critical	ADJ
ajlsi-2441	212	2	care	care	NOUN
ajlsi-2441	212	3	,	,	PUNCT
ajlsi-2441	212	4	24(1	24(1	NUM
ajlsi-2441	212	5	)	)	PUNCT
ajlsi-2441	212	6	,	,	PUNCT
ajlsi-2441	212	7	1	1	NUM
ajlsi-2441	212	8	-	-	SYM
ajlsi-2441	212	9	10	10	NUM
ajlsi-2441	212	10	.	.	PUNCT
ajlsi-2441	213	1	lippi	lippi	PROPN
ajlsi-2441	213	2	,	,	PUNCT
ajlsi-2441	213	3	g.	g.	PROPN
ajlsi-2441	213	4	,	,	PUNCT
ajlsi-2441	213	5	&	&	CCONJ
ajlsi-2441	213	6	favaloro	favaloro	PROPN
ajlsi-2441	213	7	,	,	PUNCT
ajlsi-2441	213	8	e.	e.	PROPN
ajlsi-2441	213	9	j.	j.	PROPN
ajlsi-2441	213	10	(	(	PUNCT
ajlsi-2441	213	11	2020	2020	NUM
ajlsi-2441	213	12	)	)	PUNCT
ajlsi-2441	213	13	.	.	PUNCT
ajlsi-2441	214	1	d	d	X
ajlsi-2441	214	2	-	-	PUNCT
ajlsi-2441	214	3	dimer	dimer	NOUN
ajlsi-2441	214	4	is	be	AUX
ajlsi-2441	214	5	associated	associate	VERB
ajlsi-2441	214	6	with	with	ADP
ajlsi-2441	214	7	severity	severity	NOUN
ajlsi-2441	214	8	of	of	ADP
ajlsi-2441	214	9	coronavirus	coronavirus	NOUN
ajlsi-2441	214	10	disease	disease	NOUN
ajlsi-2441	214	11	2019	2019	NUM
ajlsi-2441	214	12	:	:	PUNCT
ajlsi-2441	214	13	a	a	DET
ajlsi-2441	214	14	pooled	pooled	ADJ
ajlsi-2441	214	15	analysis	analysis	NOUN
ajlsi-2441	214	16	.	.	PUNCT
ajlsi-2441	215	1	thrombosis	thrombosis	NOUN
ajlsi-2441	215	2	and	and	CCONJ
ajlsi-2441	215	3	haemostasis	haemostasis	NOUN
ajlsi-2441	215	4	,	,	PUNCT
ajlsi-2441	215	5	120(05	120(05	NUM
ajlsi-2441	215	6	)	)	PUNCT
ajlsi-2441	215	7	,	,	PUNCT
ajlsi-2441	215	8	876	876	NUM
ajlsi-2441	215	9	-	-	SYM
ajlsi-2441	215	10	878	878	NUM
ajlsi-2441	215	11	.	.	PUNCT
ajlsi-2441	216	1	lippi	lippi	PROPN
ajlsi-2441	216	2	,	,	PUNCT
ajlsi-2441	216	3	g.	g.	PROPN
ajlsi-2441	216	4	,	,	PUNCT
ajlsi-2441	216	5	&	&	CCONJ
ajlsi-2441	216	6	mattiuzzi	mattiuzzi	PROPN
ajlsi-2441	216	7	,	,	PUNCT
ajlsi-2441	216	8	c.	c.	PROPN
ajlsi-2441	216	9	(	(	PUNCT
ajlsi-2441	216	10	2020	2020	NUM
ajlsi-2441	216	11	)	)	PUNCT
ajlsi-2441	216	12	.	.	PUNCT
ajlsi-2441	217	1	hemoglobin	hemoglobin	NOUN
ajlsi-2441	217	2	value	value	NOUN
ajlsi-2441	217	3	may	may	AUX
ajlsi-2441	217	4	be	be	AUX
ajlsi-2441	217	5	decreased	decrease	VERB
ajlsi-2441	217	6	in	in	ADP
ajlsi-2441	217	7	patients	patient	NOUN
ajlsi-2441	217	8	with	with	ADP
ajlsi-2441	217	9	severe	severe	ADJ
ajlsi-2441	217	10	coronavirus	coronavirus	NOUN
ajlsi-2441	217	11	disease	disease	NOUN
ajlsi-2441	217	12	2019	2019	NUM
ajlsi-2441	217	13	.	.	PUNCT
ajlsi-2441	218	1	hematology	hematology	NOUN
ajlsi-2441	218	2	,	,	PUNCT
ajlsi-2441	218	3	transfusion	transfusion	NOUN
ajlsi-2441	218	4	and	and	CCONJ
ajlsi-2441	218	5	cell	cell	NOUN
ajlsi-2441	218	6	therapy	therapy	NOUN
ajlsi-2441	218	7	,	,	PUNCT
ajlsi-2441	218	8	42	42	NUM
ajlsi-2441	218	9	,	,	PUNCT
ajlsi-2441	218	10	116	116	NUM
ajlsi-2441	218	11	-	-	SYM
ajlsi-2441	218	12	117	117	NUM
ajlsi-2441	218	13	.	.	PUNCT
ajlsi-2441	219	1	lippi	lippi	PROPN
ajlsi-2441	219	2	,	,	PUNCT
ajlsi-2441	219	3	g.	g.	PROPN
ajlsi-2441	219	4	,	,	PUNCT
ajlsi-2441	219	5	&	&	CCONJ
ajlsi-2441	219	6	plebani	plebani	PROPN
ajlsi-2441	219	7	,	,	PUNCT
ajlsi-2441	219	8	m.	m.	NOUN
ajlsi-2441	219	9	(	(	PUNCT
ajlsi-2441	219	10	2020	2020	NUM
ajlsi-2441	219	11	)	)	PUNCT
ajlsi-2441	219	12	.	.	PUNCT
ajlsi-2441	220	1	the	the	DET
ajlsi-2441	220	2	critical	critical	ADJ
ajlsi-2441	220	3	role	role	NOUN
ajlsi-2441	220	4	of	of	ADP
ajlsi-2441	220	5	laboratory	laboratory	NOUN
ajlsi-2441	220	6	medicine	medicine	NOUN
ajlsi-2441	220	7	during	during	ADP
ajlsi-2441	220	8	coronavirus	coronavirus	NOUN
ajlsi-2441	220	9	disease	disease	NOUN
ajlsi-2441	220	10	2019	2019	NUM
ajlsi-2441	220	11	(	(	PUNCT
ajlsi-2441	220	12	covid-19	covid-19	PROPN
ajlsi-2441	220	13	)	)	PUNCT
ajlsi-2441	220	14	and	and	CCONJ
ajlsi-2441	220	15	other	other	ADJ
ajlsi-2441	220	16	viral	viral	ADJ
ajlsi-2441	220	17	outbreaks	outbreak	NOUN
ajlsi-2441	220	18	.	.	PUNCT
ajlsi-2441	221	1	clinical	clinical	ADJ
ajlsi-2441	221	2	chemistry	chemistry	NOUN
ajlsi-2441	221	3	and	and	CCONJ
ajlsi-2441	221	4	laboratory	laboratory	NOUN
ajlsi-2441	221	5	medicine	medicine	NOUN
ajlsi-2441	221	6	(	(	PUNCT
ajlsi-2441	221	7	cclm	cclm	PROPN
ajlsi-2441	221	8	)	)	PUNCT
ajlsi-2441	221	9	,	,	PUNCT
ajlsi-2441	221	10	58(7	58(7	NUM
ajlsi-2441	221	11	)	)	PUNCT
ajlsi-2441	221	12	,	,	PUNCT
ajlsi-2441	221	13	10631069	10631069	NUM
ajlsi-2441	221	14	.	.	PUNCT
ajlsi-2441	222	1	liu	liu	PROPN
ajlsi-2441	222	2	,	,	PUNCT
ajlsi-2441	222	3	x.	x.	PROPN
ajlsi-2441	222	4	,	,	PUNCT
ajlsi-2441	222	5	zhang	zhang	PROPN
ajlsi-2441	222	6	,	,	PUNCT
ajlsi-2441	222	7	r.	r.	PROPN
ajlsi-2441	222	8	,	,	PUNCT
ajlsi-2441	222	9	&	&	CCONJ
ajlsi-2441	222	10	he	he	PRON
ajlsi-2441	222	11	,	,	PUNCT
ajlsi-2441	222	12	g.	g.	PROPN
ajlsi-2441	222	13	(	(	PUNCT
ajlsi-2441	222	14	2020	2020	NUM
ajlsi-2441	222	15	)	)	PUNCT
ajlsi-2441	222	16	.	.	PUNCT
ajlsi-2441	223	1	hematological	hematological	ADJ
ajlsi-2441	223	2	findings	finding	NOUN
ajlsi-2441	223	3	in	in	ADP
ajlsi-2441	223	4	coronavirus	coronavirus	NOUN
ajlsi-2441	223	5	disease	disease	NOUN
ajlsi-2441	223	6	2019	2019	NUM
ajlsi-2441	223	7	:	:	PUNCT
ajlsi-2441	223	8	indications	indication	NOUN
ajlsi-2441	223	9	of	of	ADP
ajlsi-2441	223	10	progression	progression	NOUN
ajlsi-2441	223	11	of	of	ADP
ajlsi-2441	223	12	disease	disease	NOUN
ajlsi-2441	223	13	.	.	PUNCT
ajlsi-2441	224	1	annals	annal	NOUN
ajlsi-2441	224	2	of	of	ADP
ajlsi-2441	224	3	hematology	hematology	NOUN
ajlsi-2441	224	4	,	,	PUNCT
ajlsi-2441	224	5	99	99	NUM
ajlsi-2441	224	6	,	,	PUNCT
ajlsi-2441	224	7	14211428	14211428	NUM
ajlsi-2441	224	8	.	.	PUNCT
ajlsi-2441	225	1	patel	patel	PROPN
ajlsi-2441	225	2	,	,	PUNCT
ajlsi-2441	225	3	h.	h.	PROPN
ajlsi-2441	225	4	h.	h.	PROPN
ajlsi-2441	225	5	,	,	PUNCT
ajlsi-2441	225	6	patel	patel	PROPN
ajlsi-2441	225	7	,	,	PUNCT
ajlsi-2441	225	8	h.	h.	PROPN
ajlsi-2441	225	9	r.	r.	PROPN
ajlsi-2441	225	10	,	,	PUNCT
ajlsi-2441	225	11	&	&	CCONJ
ajlsi-2441	225	12	higgins	higgins	PROPN
ajlsi-2441	225	13	,	,	PUNCT
ajlsi-2441	225	14	j.	j.	PROPN
ajlsi-2441	225	15	m.	m.	PROPN
ajlsi-2441	225	16	(	(	PUNCT
ajlsi-2441	225	17	2015	2015	NUM
ajlsi-2441	225	18	)	)	PUNCT
ajlsi-2441	225	19	.	.	PUNCT
ajlsi-2441	226	1	modulation	modulation	NOUN
ajlsi-2441	226	2	of	of	ADP
ajlsi-2441	226	3	red	red	ADJ
ajlsi-2441	226	4	blood	blood	NOUN
ajlsi-2441	226	5	cell	cell	NOUN
ajlsi-2441	226	6	population	population	NOUN
ajlsi-2441	226	7	dynamics	dynamic	NOUN
ajlsi-2441	226	8	is	be	AUX
ajlsi-2441	226	9	a	a	DET
ajlsi-2441	226	10	fundamental	fundamental	ADJ
ajlsi-2441	226	11	homeostatic	homeostatic	ADJ
ajlsi-2441	226	12	response	response	NOUN
ajlsi-2441	226	13	to	to	ADP
ajlsi-2441	226	14	disease	disease	NOUN
ajlsi-2441	226	15	.	.	PUNCT
ajlsi-2441	227	1	american	american	PROPN
ajlsi-2441	227	2	journal	journal	PROPN
ajlsi-2441	227	3	of	of	ADP
ajlsi-2441	227	4	hematology	hematology	NOUN
ajlsi-2441	227	5	,	,	PUNCT
ajlsi-2441	227	6	90(5	90(5	NUM
ajlsi-2441	227	7	)	)	PUNCT
ajlsi-2441	227	8	,	,	PUNCT
ajlsi-2441	227	9	422	422	NUM
ajlsi-2441	227	10	-	-	SYM
ajlsi-2441	227	11	428	428	NUM
ajlsi-2441	227	12	.	.	PUNCT
ajlsi-2441	227	13	pongpirul	pongpirul	NOUN
ajlsi-2441	227	14	,	,	PUNCT
ajlsi-2441	227	15	w.	w.	PROPN
ajlsi-2441	227	16	a.	a.	PROPN
ajlsi-2441	227	17	,	,	PUNCT
ajlsi-2441	227	18	wiboonchutikul	wiboonchutikul	VERB
ajlsi-2441	227	19	,	,	PUNCT
ajlsi-2441	227	20	s.	s.	PROPN
ajlsi-2441	227	21	,	,	PUNCT
ajlsi-2441	227	22	charoenpong	charoenpong	PROPN
ajlsi-2441	227	23	,	,	PUNCT
ajlsi-2441	227	24	l.	l.	PROPN
ajlsi-2441	227	25	,	,	PUNCT
ajlsi-2441	227	26	panitantum	panitantum	PROPN
ajlsi-2441	227	27	,	,	PUNCT
ajlsi-2441	227	28	n.	n.	NOUN
ajlsi-2441	227	29	,	,	PUNCT
ajlsi-2441	227	30	vachiraphan	vachiraphan	PROPN
ajlsi-2441	227	31	,	,	PUNCT
ajlsi-2441	227	32	a.	a.	NOUN
ajlsi-2441	227	33	,	,	PUNCT
ajlsi-2441	227	34	uttayamakul	uttayamakul	ADJ
ajlsi-2441	227	35	,	,	PUNCT
ajlsi-2441	227	36	s.	s.	PROPN
ajlsi-2441	227	37	,	,	PUNCT
ajlsi-2441	227	38	pongpirul	pongpirul	NOUN
ajlsi-2441	227	39	,	,	PUNCT
ajlsi-2441	227	40	k.	k.	PROPN
ajlsi-2441	227	41	,	,	PUNCT
ajlsi-2441	227	42	manosuthi	manosuthi	PROPN
ajlsi-2441	227	43	,	,	PUNCT
ajlsi-2441	227	44	w.	w.	PROPN
ajlsi-2441	227	45	,	,	PUNCT
ajlsi-2441	227	46	&	&	CCONJ
ajlsi-2441	227	47	prasithsirikul	prasithsirikul	PROPN
ajlsi-2441	227	48	,	,	PUNCT
ajlsi-2441	227	49	w.	w.	PROPN
ajlsi-2441	227	50	(	(	PUNCT
ajlsi-2441	227	51	2020	2020	NUM
ajlsi-2441	227	52	)	)	PUNCT
ajlsi-2441	227	53	.	.	PUNCT
ajlsi-2441	228	1	clinical	clinical	ADJ
ajlsi-2441	228	2	course	course	NOUN
ajlsi-2441	228	3	and	and	CCONJ
ajlsi-2441	228	4	potential	potential	ADJ
ajlsi-2441	228	5	predictive	predictive	ADJ
ajlsi-2441	228	6	factors	factor	NOUN
ajlsi-2441	228	7	for	for	ADP
ajlsi-2441	228	8	pneumonia	pneumonia	NOUN
ajlsi-2441	228	9	of	of	ADP
ajlsi-2441	228	10	adult	adult	NOUN
ajlsi-2441	228	11	patients	patient	NOUN
ajlsi-2441	228	12	with	with	ADP
ajlsi-2441	228	13	coronavirus	coronavirus	NOUN
ajlsi-2441	228	14	disease	disease	NOUN
ajlsi-2441	228	15	2019	2019	NUM
ajlsi-2441	228	16	(	(	PUNCT
ajlsi-2441	228	17	covid-19	covid-19	PROPN
ajlsi-2441	228	18	):	):	PUNCT
ajlsi-2441	228	19	a	a	DET
ajlsi-2441	228	20	retrospective	retrospective	ADJ
ajlsi-2441	228	21	observational	observational	ADJ
ajlsi-2441	228	22	analysis	analysis	NOUN
ajlsi-2441	228	23	of	of	ADP
ajlsi-2441	228	24	193	193	NUM
ajlsi-2441	228	25	confirmed	confirm	VERB
ajlsi-2441	228	26	cases	case	NOUN
ajlsi-2441	228	27	in	in	ADP
ajlsi-2441	228	28	thailand	thailand	PROPN
ajlsi-2441	228	29	.	.	PUNCT
ajlsi-2441	229	1	plos	plos	PROPN
ajlsi-2441	229	2	neglected	neglect	VERB
ajlsi-2441	229	3	tropical	tropical	ADJ
ajlsi-2441	229	4	diseases	disease	NOUN
ajlsi-2441	229	5	,	,	PUNCT
ajlsi-2441	229	6	14(10	14(10	NUM
ajlsi-2441	229	7	)	)	PUNCT
ajlsi-2441	229	8	,	,	PUNCT
ajlsi-2441	229	9	e0008806	e0008806	PROPN
ajlsi-2441	229	10	.	.	PUNCT
ajlsi-2441	230	1	ponti	ponti	PROPN
ajlsi-2441	230	2	,	,	PUNCT
ajlsi-2441	230	3	g.	g.	PROPN
ajlsi-2441	230	4	,	,	PUNCT
ajlsi-2441	230	5	maccaferri	maccaferri	PROPN
ajlsi-2441	230	6	,	,	PUNCT
ajlsi-2441	230	7	m.	m.	NOUN
ajlsi-2441	230	8	,	,	PUNCT
ajlsi-2441	230	9	ruini	ruini	NOUN
ajlsi-2441	230	10	,	,	PUNCT
ajlsi-2441	230	11	c.	c.	NOUN
ajlsi-2441	230	12	,	,	PUNCT
ajlsi-2441	230	13	tomasi	tomasi	PROPN
ajlsi-2441	230	14	,	,	PUNCT
ajlsi-2441	230	15	a.	a.	PROPN
ajlsi-2441	230	16	,	,	PUNCT
ajlsi-2441	230	17	&	&	CCONJ
ajlsi-2441	230	18	ozben	ozben	PROPN
ajlsi-2441	230	19	,	,	PUNCT
ajlsi-2441	230	20	t.	t.	PROPN
ajlsi-2441	230	21	(	(	PUNCT
ajlsi-2441	230	22	2020	2020	NUM
ajlsi-2441	230	23	)	)	PUNCT
ajlsi-2441	230	24	.	.	PUNCT
ajlsi-2441	231	1	biomarkers	biomarker	NOUN
ajlsi-2441	231	2	associated	associate	VERB
ajlsi-2441	231	3	with	with	ADP
ajlsi-2441	231	4	covid-19	covid-19	PROPN
ajlsi-2441	231	5	disease	disease	NOUN
ajlsi-2441	231	6	progression	progression	NOUN
ajlsi-2441	231	7	.	.	PUNCT
ajlsi-2441	232	1	critical	critical	ADJ
ajlsi-2441	232	2	reviews	review	NOUN
ajlsi-2441	232	3	in	in	ADP
ajlsi-2441	232	4	clinical	clinical	ADJ
ajlsi-2441	232	5	laboratory	laboratory	NOUN
ajlsi-2441	232	6	sciences	science	NOUN
ajlsi-2441	232	7	,	,	PUNCT
ajlsi-2441	232	8	57(6	57(6	NUM
ajlsi-2441	232	9	)	)	PUNCT
ajlsi-2441	232	10	,	,	PUNCT
ajlsi-2441	232	11	389	389	NUM
ajlsi-2441	232	12	-	-	SYM
ajlsi-2441	232	13	399	399	NUM
ajlsi-2441	232	14	.	.	PUNCT
ajlsi-2441	233	1	pulgar	pulgar	NOUN
ajlsi-2441	233	2	-	-	PUNCT
ajlsi-2441	233	3	sánchez	sánchez	NOUN
ajlsi-2441	233	4	,	,	PUNCT
ajlsi-2441	233	5	m.	m.	NOUN
ajlsi-2441	233	6	,	,	PUNCT
ajlsi-2441	233	7	chamorro	chamorro	PROPN
ajlsi-2441	233	8	,	,	PUNCT
ajlsi-2441	233	9	k.	k.	PROPN
ajlsi-2441	233	10	,	,	PUNCT
ajlsi-2441	233	11	fors	for	NOUN
ajlsi-2441	233	12	,	,	PUNCT
ajlsi-2441	233	13	m.	m.	NOUN
ajlsi-2441	233	14	,	,	PUNCT
ajlsi-2441	233	15	mora	mora	PROPN
ajlsi-2441	233	16	,	,	PUNCT
ajlsi-2441	233	17	f.	f.	PROPN
ajlsi-2441	233	18	x.	x.	PROPN
ajlsi-2441	233	19	,	,	PUNCT
ajlsi-2441	233	20	ramírez	ramírez	PROPN
ajlsi-2441	233	21	,	,	PUNCT
ajlsi-2441	233	22	h.	h.	PROPN
ajlsi-2441	233	23	,	,	PUNCT
ajlsi-2441	233	24	fernandez	fernandez	PROPN
ajlsi-2441	233	25	-	-	PUNCT
ajlsi-2441	233	26	moreira	moreira	PROPN
ajlsi-2441	233	27	,	,	PUNCT
ajlsi-2441	233	28	e.	e.	PROPN
ajlsi-2441	233	29	,	,	PUNCT
ajlsi-2441	233	30	&	&	CCONJ
ajlsi-2441	233	31	ballaz	ballaz	PROPN
ajlsi-2441	233	32	,	,	PUNCT
ajlsi-2441	233	33	s.	s.	PROPN
ajlsi-2441	233	34	j.	j.	PROPN
ajlsi-2441	233	35	(	(	PUNCT
ajlsi-2441	233	36	2021	2021	NUM
ajlsi-2441	233	37	)	)	PUNCT
ajlsi-2441	233	38	.	.	PUNCT
ajlsi-2441	234	1	biomarkers	biomarker	NOUN
ajlsi-2441	234	2	of	of	ADP
ajlsi-2441	234	3	severe	severe	ADJ
ajlsi-2441	234	4	covid-19	covid-19	PROPN
ajlsi-2441	234	5	pneumonia	pneumonia	NOUN
ajlsi-2441	234	6	on	on	ADP
ajlsi-2441	234	7	admission	admission	NOUN
ajlsi-2441	234	8	using	use	VERB
ajlsi-2441	234	9	data	data	NOUN
ajlsi-2441	234	10	-	-	PUNCT
ajlsi-2441	234	11	mining	mining	NOUN
ajlsi-2441	234	12	powered	power	VERB
ajlsi-2441	234	13	by	by	ADP
ajlsi-2441	234	14	common	common	ADJ
ajlsi-2441	234	15	laboratory	laboratory	NOUN
ajlsi-2441	234	16	blood	blood	NOUN
ajlsi-2441	234	17	tests	test	NOUN
ajlsi-2441	234	18	-	-	PUNCT
ajlsi-2441	234	19	datasets	dataset	NOUN
ajlsi-2441	234	20	.	.	PUNCT
ajlsi-2441	235	1	comput	comput	PROPN
ajlsi-2441	235	2	biol	biol	PROPN
ajlsi-2441	235	3	med	me	VERB
ajlsi-2441	235	4	,	,	PUNCT
ajlsi-2441	235	5	136	136	NUM
ajlsi-2441	235	6	,	,	PUNCT
ajlsi-2441	235	7	104738	104738	NUM
ajlsi-2441	235	8	.	.	PUNCT
ajlsi-2441	236	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajlsi-2441	236	2	.	.	PUNCT
ajlsi-2441	237	1	compbiomed.2021.104738	compbiomed.2021.104738	PROPN
ajlsi-2441	237	2	sharma	sharma	PROPN
ajlsi-2441	237	3	,	,	PUNCT
ajlsi-2441	237	4	a.	a.	NOUN
ajlsi-2441	237	5	,	,	PUNCT
ajlsi-2441	237	6	rani	rani	PROPN
ajlsi-2441	237	7	,	,	PUNCT
ajlsi-2441	237	8	s.	s.	PROPN
ajlsi-2441	237	9	,	,	PUNCT
ajlsi-2441	237	10	&	&	CCONJ
ajlsi-2441	237	11	gupta	gupta	PROPN
ajlsi-2441	237	12	,	,	PUNCT
ajlsi-2441	237	13	d.	d.	PROPN
ajlsi-2441	237	14	(	(	PUNCT
ajlsi-2441	237	15	2020	2020	NUM
ajlsi-2441	237	16	)	)	PUNCT
ajlsi-2441	237	17	.	.	PUNCT
ajlsi-2441	238	1	artificial	artificial	ADJ
ajlsi-2441	238	2	intelligence	intelligence	NOUN
ajlsi-2441	238	3	-	-	PUNCT
ajlsi-2441	238	4	based	base	VERB
ajlsi-2441	238	5	classification	classification	NOUN
ajlsi-2441	238	6	of	of	ADP
ajlsi-2441	238	7	chest	chest	NOUN
ajlsi-2441	238	8	x	x	NOUN
ajlsi-2441	238	9	-	-	NOUN
ajlsi-2441	238	10	ray	ray	NOUN
ajlsi-2441	238	11	images	image	NOUN
ajlsi-2441	238	12	into	into	ADP
ajlsi-2441	238	13	covid-19	covid-19	PROPN
ajlsi-2441	238	14	and	and	CCONJ
ajlsi-2441	238	15	other	other	ADJ
ajlsi-2441	238	16	infectious	infectious	ADJ
ajlsi-2441	238	17	diseases	disease	NOUN
ajlsi-2441	238	18	.	.	PUNCT
ajlsi-2441	239	1	international	international	ADJ
ajlsi-2441	239	2	journal	journal	PROPN
ajlsi-2441	239	3	of	of	ADP
ajlsi-2441	239	4	biomedical	biomedical	ADJ
ajlsi-2441	239	5	imaging	imaging	NOUN
ajlsi-2441	239	6	,	,	PUNCT
ajlsi-2441	239	7	2020	2020	NUM
ajlsi-2441	239	8	,	,	PUNCT
ajlsi-2441	239	9	1	1	NUM
ajlsi-2441	239	10	-	-	SYM
ajlsi-2441	239	11	10	10	NUM
ajlsi-2441	239	12	.	.	PUNCT
ajlsi-2441	240	1	shiri	shiri	PROPN
ajlsi-2441	240	2	,	,	PUNCT
ajlsi-2441	240	3	i.	i.	PROPN
ajlsi-2441	240	4	,	,	PUNCT
ajlsi-2441	240	5	sorouri	sorouri	NOUN
ajlsi-2441	240	6	,	,	PUNCT
ajlsi-2441	240	7	m.	m.	NOUN
ajlsi-2441	240	8	,	,	PUNCT
ajlsi-2441	240	9	geramifar	geramifar	ADV
ajlsi-2441	240	10	,	,	PUNCT
ajlsi-2441	240	11	p.	p.	PROPN
ajlsi-2441	240	12	,	,	PUNCT
ajlsi-2441	240	13	nazari	nazari	PROPN
ajlsi-2441	240	14	,	,	PUNCT
ajlsi-2441	240	15	m.	m.	NOUN
ajlsi-2441	240	16	,	,	PUNCT
ajlsi-2441	240	17	abdollahi	abdollahi	NOUN
ajlsi-2441	240	18	,	,	PUNCT
ajlsi-2441	240	19	m.	m.	NOUN
ajlsi-2441	240	20	,	,	PUNCT
ajlsi-2441	240	21	salimi	salimi	PROPN
ajlsi-2441	240	22	,	,	PUNCT
ajlsi-2441	240	23	y.	y.	PROPN
ajlsi-2441	240	24	,	,	PUNCT
ajlsi-2441	240	25	khosravi	khosravi	NOUN
ajlsi-2441	240	26	,	,	PUNCT
ajlsi-2441	240	27	b.	b.	PROPN
ajlsi-2441	240	28	,	,	PUNCT
ajlsi-2441	240	29	askari	askari	PROPN
ajlsi-2441	240	30	,	,	PUNCT
ajlsi-2441	240	31	d.	d.	PROPN
ajlsi-2441	240	32	,	,	PUNCT
ajlsi-2441	240	33	aghaghazvini	aghaghazvini	PROPN
ajlsi-2441	240	34	,	,	PUNCT
ajlsi-2441	240	35	l.	l.	PROPN
ajlsi-2441	240	36	,	,	PUNCT
ajlsi-2441	240	37	&	&	CCONJ
ajlsi-2441	240	38	hajianfar	hajianfar	PROPN
ajlsi-2441	240	39	,	,	PUNCT
ajlsi-2441	240	40	g.	g.	PROPN
ajlsi-2441	240	41	(	(	PUNCT
ajlsi-2441	240	42	2021	2021	NUM
ajlsi-2441	240	43	)	)	PUNCT
ajlsi-2441	240	44	.	.	PUNCT
ajlsi-2441	241	1	machine	machine	NOUN
ajlsi-2441	241	2	learningbased	learningbase	VERB
ajlsi-2441	241	3	prognostic	prognostic	ADJ
ajlsi-2441	241	4	modeling	modeling	NOUN
ajlsi-2441	241	5	using	use	VERB
ajlsi-2441	241	6	clinical	clinical	ADJ
ajlsi-2441	241	7	data	datum	NOUN
ajlsi-2441	241	8	and	and	CCONJ
ajlsi-2441	241	9	quantitative	quantitative	ADJ
ajlsi-2441	241	10	radiomic	radiomic	ADJ
ajlsi-2441	241	11	features	feature	NOUN
ajlsi-2441	241	12	from	from	ADP
ajlsi-2441	241	13	chest	chest	NOUN
ajlsi-2441	241	14	ct	ct	NUM
ajlsi-2441	241	15	images	image	NOUN
ajlsi-2441	241	16	in	in	ADP
ajlsi-2441	241	17	covid-19	covid-19	PROPN
ajlsi-2441	241	18	patients	patient	NOUN
ajlsi-2441	241	19	.	.	PUNCT
ajlsi-2441	242	1	computers	computer	NOUN
ajlsi-2441	242	2	in	in	ADP
ajlsi-2441	242	3	biology	biology	NOUN
ajlsi-2441	242	4	and	and	CCONJ
ajlsi-2441	242	5	medicine	medicine	NOUN
ajlsi-2441	242	6	,	,	PUNCT
ajlsi-2441	242	7	132	132	NUM
ajlsi-2441	242	8	,	,	PUNCT
ajlsi-2441	242	9	104304	104304	NUM
ajlsi-2441	242	10	.	.	PUNCT
ajlsi-2441	243	1	sun	sun	PROPN
ajlsi-2441	243	2	,	,	PUNCT
ajlsi-2441	243	3	s.	s.	PROPN
ajlsi-2441	243	4	,	,	PUNCT
ajlsi-2441	243	5	cai	cai	PROPN
ajlsi-2441	243	6	,	,	PUNCT
ajlsi-2441	243	7	x.	x.	PROPN
ajlsi-2441	243	8	,	,	PUNCT
ajlsi-2441	243	9	wang	wang	PROPN
ajlsi-2441	243	10	,	,	PUNCT
ajlsi-2441	243	11	h.	h.	PROPN
ajlsi-2441	243	12	,	,	PUNCT
ajlsi-2441	243	13	he	he	PRON
ajlsi-2441	243	14	,	,	PUNCT
ajlsi-2441	243	15	g.	g.	PROPN
ajlsi-2441	243	16	,	,	PUNCT
ajlsi-2441	243	17	lin	lin	PROPN
ajlsi-2441	243	18	,	,	PUNCT
ajlsi-2441	243	19	y.	y.	PROPN
ajlsi-2441	243	20	,	,	PUNCT
ajlsi-2441	243	21	lu	lu	PROPN
ajlsi-2441	243	22	,	,	PUNCT
ajlsi-2441	243	23	b.	b.	PROPN
ajlsi-2441	243	24	,	,	PUNCT
ajlsi-2441	243	25	chen	chen	PROPN
ajlsi-2441	243	26	,	,	PUNCT
ajlsi-2441	243	27	c.	c.	PROPN
ajlsi-2441	243	28	,	,	PUNCT
ajlsi-2441	243	29	pan	pan	PROPN
ajlsi-2441	243	30	,	,	PUNCT
ajlsi-2441	243	31	y.	y.	PROPN
ajlsi-2441	243	32	,	,	PUNCT
ajlsi-2441	243	33	&	&	CCONJ
ajlsi-2441	243	34	hu	hu	PROPN
ajlsi-2441	243	35	,	,	PUNCT
ajlsi-2441	243	36	x.	x.	PROPN
ajlsi-2441	243	37	(	(	PUNCT
ajlsi-2441	243	38	2020	2020	NUM
ajlsi-2441	243	39	)	)	PUNCT
ajlsi-2441	243	40	.	.	PUNCT
ajlsi-2441	244	1	abnormalities	abnormality	NOUN
ajlsi-2441	244	2	of	of	ADP
ajlsi-2441	244	3	peripheral	peripheral	ADJ
ajlsi-2441	244	4	blood	blood	NOUN
ajlsi-2441	244	5	system	system	NOUN
ajlsi-2441	244	6	in	in	ADP
ajlsi-2441	244	7	patients	patient	NOUN
ajlsi-2441	244	8	with	with	ADP
ajlsi-2441	244	9	covid-19	covid-19	PROPN
ajlsi-2441	244	10	in	in	ADP
ajlsi-2441	244	11	wenzhou	wenzhou	PROPN
ajlsi-2441	244	12	,	,	PUNCT
ajlsi-2441	244	13	china	china	PROPN
ajlsi-2441	244	14	.	.	PUNCT
ajlsi-2441	245	1	clinica	clinica	PROPN
ajlsi-2441	245	2	chimica	chimica	PROPN
ajlsi-2441	245	3	acta	acta	PROPN
ajlsi-2441	245	4	,	,	PUNCT
ajlsi-2441	245	5	507	507	NUM
ajlsi-2441	245	6	,	,	PUNCT
ajlsi-2441	245	7	174	174	NUM
ajlsi-2441	245	8	-	-	SYM
ajlsi-2441	245	9	180	180	NUM
ajlsi-2441	245	10	.	.	PUNCT
ajlsi-2441	246	1	tay	tay	NOUN
ajlsi-2441	246	2	,	,	PUNCT
ajlsi-2441	246	3	m.	m.	NOUN
ajlsi-2441	246	4	z.	z.	PROPN
ajlsi-2441	246	5	,	,	PUNCT
ajlsi-2441	246	6	poh	poh	PROPN
ajlsi-2441	246	7	,	,	PUNCT
ajlsi-2441	246	8	c.	c.	PROPN
ajlsi-2441	246	9	m.	m.	NOUN
ajlsi-2441	246	10	,	,	PUNCT
ajlsi-2441	246	11	rénia	rénia	NOUN
ajlsi-2441	246	12	,	,	PUNCT
ajlsi-2441	246	13	l.	l.	PROPN
ajlsi-2441	246	14	,	,	PUNCT
ajlsi-2441	246	15	macary	macary	NOUN
ajlsi-2441	246	16	,	,	PUNCT
ajlsi-2441	246	17	p.	p.	NOUN
ajlsi-2441	246	18	a.	a.	PROPN
ajlsi-2441	246	19	,	,	PUNCT
ajlsi-2441	246	20	&	&	CCONJ
ajlsi-2441	246	21	ng	ng	PROPN
ajlsi-2441	246	22	,	,	PUNCT
ajlsi-2441	246	23	l.	l.	PROPN
ajlsi-2441	246	24	f.	f.	PROPN
ajlsi-2441	246	25	(	(	PUNCT
ajlsi-2441	246	26	2020	2020	NUM
ajlsi-2441	246	27	)	)	PUNCT
ajlsi-2441	246	28	.	.	PUNCT
ajlsi-2441	247	1	the	the	DET
ajlsi-2441	247	2	trinity	trinity	NOUN
ajlsi-2441	247	3	of	of	ADP
ajlsi-2441	247	4	covid-19	covid-19	PROPN
ajlsi-2441	247	5	:	:	PUNCT
ajlsi-2441	247	6	immunity	immunity	NOUN
ajlsi-2441	247	7	,	,	PUNCT
ajlsi-2441	247	8	inflammation	inflammation	NOUN
ajlsi-2441	247	9	and	and	CCONJ
ajlsi-2441	247	10	intervention	intervention	NOUN
ajlsi-2441	247	11	.	.	PUNCT
ajlsi-2441	248	1	nature	nature	NOUN
ajlsi-2441	248	2	reviews	review	VERB
ajlsi-2441	248	3	immunology	immunology	NOUN
ajlsi-2441	248	4	,	,	PUNCT
ajlsi-2441	248	5	20(6	20(6	NOUN
ajlsi-2441	248	6	)	)	PUNCT
ajlsi-2441	248	7	,	,	PUNCT
ajlsi-2441	248	8	363	363	NUM
ajlsi-2441	248	9	-	-	SYM
ajlsi-2441	248	10	374	374	NUM
ajlsi-2441	248	11	.	.	PUNCT
ajlsi-2441	249	1	tian	tian	PROPN
ajlsi-2441	249	2	,	,	PUNCT
ajlsi-2441	249	3	s.	s.	PROPN
ajlsi-2441	249	4	,	,	PUNCT
ajlsi-2441	249	5	hu	hu	PROPN
ajlsi-2441	249	6	,	,	PUNCT
ajlsi-2441	249	7	n.	n.	PROPN
ajlsi-2441	249	8	,	,	PUNCT
ajlsi-2441	249	9	lou	lou	PROPN
ajlsi-2441	249	10	,	,	PUNCT
ajlsi-2441	249	11	j.	j.	PROPN
ajlsi-2441	249	12	,	,	PUNCT
ajlsi-2441	249	13	chen	chen	PROPN
ajlsi-2441	249	14	,	,	PUNCT
ajlsi-2441	249	15	k.	k.	PROPN
ajlsi-2441	249	16	,	,	PUNCT
ajlsi-2441	249	17	kang	kang	PROPN
ajlsi-2441	249	18	,	,	PUNCT
ajlsi-2441	249	19	x.	x.	PROPN
ajlsi-2441	249	20	,	,	PUNCT
ajlsi-2441	249	21	xiang	xiang	PROPN
ajlsi-2441	249	22	,	,	PUNCT
ajlsi-2441	249	23	z.	z.	PROPN
ajlsi-2441	249	24	,	,	PUNCT
ajlsi-2441	249	25	chen	chen	PROPN
ajlsi-2441	249	26	,	,	PUNCT
ajlsi-2441	249	27	h.	h.	PROPN
ajlsi-2441	249	28	,	,	PUNCT
ajlsi-2441	249	29	wang	wang	PROPN
ajlsi-2441	249	30	,	,	PUNCT
ajlsi-2441	249	31	d.	d.	PROPN
ajlsi-2441	249	32	,	,	PUNCT
ajlsi-2441	249	33	liu	liu	PROPN
ajlsi-2441	249	34	,	,	PUNCT
ajlsi-2441	249	35	n.	n.	PROPN
ajlsi-2441	249	36	,	,	PUNCT
ajlsi-2441	249	37	&	&	CCONJ
ajlsi-2441	249	38	liu	liu	PROPN
ajlsi-2441	249	39	,	,	PUNCT
ajlsi-2441	249	40	d.	d.	PROPN
ajlsi-2441	249	41	(	(	PUNCT
ajlsi-2441	249	42	2020	2020	NUM
ajlsi-2441	249	43	)	)	PUNCT
ajlsi-2441	249	44	.	.	PUNCT
ajlsi-2441	250	1	characteristics	characteristic	NOUN
ajlsi-2441	250	2	of	of	ADP
ajlsi-2441	250	3	covid-19	covid-19	PROPN
ajlsi-2441	250	4	infection	infection	NOUN
ajlsi-2441	250	5	in	in	ADP
ajlsi-2441	250	6	beijing	beijing	PROPN
ajlsi-2441	250	7	.	.	PUNCT
ajlsi-2441	251	1	journal	journal	PROPN
ajlsi-2441	251	2	of	of	ADP
ajlsi-2441	251	3	infection	infection	NOUN
ajlsi-2441	251	4	,	,	PUNCT
ajlsi-2441	251	5	80(4	80(4	NUM
ajlsi-2441	251	6	)	)	PUNCT
ajlsi-2441	251	7	,	,	PUNCT
ajlsi-2441	251	8	401	401	NUM
ajlsi-2441	251	9	-	-	SYM
ajlsi-2441	251	10	406	406	NUM
ajlsi-2441	251	11	.	.	PUNCT
ajlsi-2441	252	1	tjendra	tjendra	NOUN
ajlsi-2441	252	2	,	,	PUNCT
ajlsi-2441	252	3	y.	y.	PROPN
ajlsi-2441	252	4	,	,	PUNCT
ajlsi-2441	252	5	al	al	PROPN
ajlsi-2441	252	6	mana	mana	PROPN
ajlsi-2441	252	7	,	,	PUNCT
ajlsi-2441	252	8	a.	a.	PROPN
ajlsi-2441	252	9	f.	f.	PROPN
ajlsi-2441	252	10	,	,	PUNCT
ajlsi-2441	252	11	espejo	espejo	ADJ
ajlsi-2441	252	12	,	,	PUNCT
ajlsi-2441	252	13	a.	a.	NOUN
ajlsi-2441	252	14	p.	p.	PROPN
ajlsi-2441	252	15	,	,	PUNCT
ajlsi-2441	252	16	akgun	akgun	PROPN
ajlsi-2441	252	17	,	,	PUNCT
ajlsi-2441	252	18	y.	y.	PROPN
ajlsi-2441	252	19	,	,	PUNCT
ajlsi-2441	252	20	millan	millan	PROPN
ajlsi-2441	252	21	,	,	PUNCT
ajlsi-2441	252	22	n.	n.	PROPN
ajlsi-2441	252	23	c.	c.	PROPN
ajlsi-2441	252	24	,	,	PUNCT
ajlsi-2441	252	25	gomez	gomez	NOUN
ajlsi-2441	252	26	-	-	PUNCT
ajlsi-2441	252	27	fernandez	fernandez	PROPN
ajlsi-2441	252	28	,	,	PUNCT
ajlsi-2441	252	29	c.	c.	PROPN
ajlsi-2441	252	30	,	,	PUNCT
ajlsi-2441	252	31	&	&	CCONJ
ajlsi-2441	252	32	cray	cray	PROPN
ajlsi-2441	252	33	,	,	PUNCT
ajlsi-2441	252	34	c.	c.	PROPN
ajlsi-2441	252	35	(	(	PUNCT
ajlsi-2441	252	36	2020	2020	NUM
ajlsi-2441	252	37	)	)	PUNCT
ajlsi-2441	252	38	.	.	PUNCT
ajlsi-2441	253	1	predicting	predict	VERB
ajlsi-2441	253	2	disease	disease	NOUN
ajlsi-2441	253	3	severity	severity	NOUN
ajlsi-2441	253	4	and	and	CCONJ
ajlsi-2441	253	5	outcome	outcome	VERB
ajlsi-2441	253	6	in	in	ADP
ajlsi-2441	253	7	covid-19	covid-19	PROPN
ajlsi-2441	253	8	patients	patient	NOUN
ajlsi-2441	253	9	:	:	PUNCT
ajlsi-2441	253	10	a	a	DET
ajlsi-2441	253	11	review	review	NOUN
ajlsi-2441	253	12	of	of	ADP
ajlsi-2441	253	13	multiple	multiple	ADJ
ajlsi-2441	253	14	biomarkers	biomarker	NOUN
ajlsi-2441	253	15	.	.	PUNCT
ajlsi-2441	254	1	archives	archive	NOUN
ajlsi-2441	254	2	of	of	ADP
ajlsi-2441	254	3	pathology	pathology	PROPN
ajlsi-2441	254	4	&	&	CCONJ
ajlsi-2441	254	5	laboratory	laboratory	PROPN
ajlsi-2441	254	6	medicine	medicine	NOUN
ajlsi-2441	254	7	,	,	PUNCT
ajlsi-2441	254	8	144(12	144(12	NUM
ajlsi-2441	254	9	)	)	PUNCT
ajlsi-2441	254	10	,	,	PUNCT
ajlsi-2441	254	11	1465	1465	NUM
ajlsi-2441	254	12	-	-	SYM
ajlsi-2441	254	13	1474	1474	NUM
ajlsi-2441	254	14	.	.	PUNCT
ajlsi-2441	255	1	ullah	ullah	PROPN
ajlsi-2441	255	2	,	,	PUNCT
ajlsi-2441	255	3	w.	w.	PROPN
ajlsi-2441	255	4	,	,	PUNCT
ajlsi-2441	255	5	basyal	basyal	PROPN
ajlsi-2441	255	6	,	,	PUNCT
ajlsi-2441	255	7	b.	b.	PROPN
ajlsi-2441	255	8	,	,	PUNCT
ajlsi-2441	255	9	tariq	tariq	PROPN
ajlsi-2441	255	10	,	,	PUNCT
ajlsi-2441	255	11	s.	s.	PROPN
ajlsi-2441	255	12	,	,	PUNCT
ajlsi-2441	255	13	almas	almas	PROPN
ajlsi-2441	255	14	,	,	PUNCT
ajlsi-2441	255	15	t.	t.	PROPN
ajlsi-2441	255	16	,	,	PUNCT
ajlsi-2441	255	17	saeed	saeed	PROPN
ajlsi-2441	255	18	,	,	PUNCT
ajlsi-2441	255	19	r.	r.	PROPN
ajlsi-2441	255	20	,	,	PUNCT
ajlsi-2441	255	21	roomi	roomi	PROPN
ajlsi-2441	255	22	,	,	PUNCT
ajlsi-2441	255	23	s.	s.	PROPN
ajlsi-2441	255	24	,	,	PUNCT
ajlsi-2441	255	25	haq	haq	PROPN
ajlsi-2441	255	26	,	,	PUNCT
ajlsi-2441	255	27	s.	s.	PROPN
ajlsi-2441	255	28	,	,	PUNCT
ajlsi-2441	255	29	madara	madara	PROPN
ajlsi-2441	255	30	,	,	PUNCT
ajlsi-2441	255	31	j.	j.	PROPN
ajlsi-2441	255	32	,	,	PUNCT
ajlsi-2441	255	33	boigon	boigon	PROPN
ajlsi-2441	255	34	,	,	PUNCT
ajlsi-2441	255	35	m.	m.	NOUN
ajlsi-2441	255	36	,	,	PUNCT
ajlsi-2441	255	37	&	&	CCONJ
ajlsi-2441	255	38	haas	haas	PROPN
ajlsi-2441	255	39	,	,	PUNCT
ajlsi-2441	255	40	d.	d.	PROPN
ajlsi-2441	255	41	c.	c.	PROPN
ajlsi-2441	255	42	(	(	PUNCT
ajlsi-2441	255	43	2020	2020	NUM
ajlsi-2441	255	44	)	)	PUNCT
ajlsi-2441	255	45	.	.	PUNCT
ajlsi-2441	256	1	lymphocyte	lymphocyte	NOUN
ajlsi-2441	256	2	-	-	PUNCT
ajlsi-2441	256	3	to	to	ADP
ajlsi-2441	256	4	-	-	PUNCT
ajlsi-2441	256	5	c	c	NOUN
ajlsi-2441	256	6	-	-	PUNCT
ajlsi-2441	256	7	reactive	reactive	ADJ
ajlsi-2441	256	8	protein	protein	NOUN
ajlsi-2441	256	9	ratio	ratio	NOUN
ajlsi-2441	256	10	:	:	PUNCT
ajlsi-2441	256	11	a	a	DET
ajlsi-2441	256	12	novel	novel	ADJ
ajlsi-2441	256	13	predictor	predictor	NOUN
ajlsi-2441	256	14	of	of	ADP
ajlsi-2441	256	15	adverse	adverse	ADJ
ajlsi-2441	256	16	outcomes	outcome	NOUN
ajlsi-2441	256	17	in	in	ADP
ajlsi-2441	256	18	covid-19	covid-19	PROPN
ajlsi-2441	256	19	.	.	PROPN
ajlsi-2441	256	20	journal	journal	PROPN
ajlsi-2441	256	21	of	of	ADP
ajlsi-2441	256	22	clinical	clinical	ADJ
ajlsi-2441	256	23	medicine	medicine	NOUN
ajlsi-2441	256	24	research	research	NOUN
ajlsi-2441	256	25	,	,	PUNCT
ajlsi-2441	256	26	12(7	12(7	NUM
ajlsi-2441	256	27	)	)	PUNCT
ajlsi-2441	256	28	,	,	PUNCT
ajlsi-2441	256	29	415	415	NUM
ajlsi-2441	256	30	.	.	PUNCT
ajlsi-2441	257	1	wang	wang	PROPN
ajlsi-2441	257	2	,	,	PUNCT
ajlsi-2441	257	3	c.	c.	PROPN
ajlsi-2441	257	4	,	,	PUNCT
ajlsi-2441	257	5	deng	deng	PROPN
ajlsi-2441	257	6	,	,	PUNCT
ajlsi-2441	257	7	r.	r.	PROPN
ajlsi-2441	257	8	,	,	PUNCT
ajlsi-2441	257	9	gou	gou	PROPN
ajlsi-2441	257	10	,	,	PUNCT
ajlsi-2441	257	11	l.	l.	PROPN
ajlsi-2441	257	12	,	,	PUNCT
ajlsi-2441	257	13	fu	fu	PROPN
ajlsi-2441	257	14	,	,	PUNCT
ajlsi-2441	257	15	z.	z.	PROPN
ajlsi-2441	257	16	,	,	PUNCT
ajlsi-2441	257	17	zhang	zhang	PROPN
ajlsi-2441	257	18	,	,	PUNCT
ajlsi-2441	257	19	x.	x.	PROPN
ajlsi-2441	257	20	,	,	PUNCT
ajlsi-2441	257	21	shao	shao	PROPN
ajlsi-2441	257	22	,	,	PUNCT
ajlsi-2441	257	23	f.	f.	PROPN
ajlsi-2441	257	24	,	,	PUNCT
ajlsi-2441	257	25	wang	wang	PROPN
ajlsi-2441	257	26	,	,	PUNCT
ajlsi-2441	257	27	g.	g.	PROPN
ajlsi-2441	257	28	,	,	PUNCT
ajlsi-2441	257	29	fu	fu	PROPN
ajlsi-2441	257	30	,	,	PUNCT
ajlsi-2441	257	31	w.	w.	PROPN
ajlsi-2441	257	32	,	,	PUNCT
ajlsi-2441	257	33	xiao	xiao	PROPN
ajlsi-2441	257	34	,	,	PUNCT
ajlsi-2441	257	35	j.	j.	PROPN
ajlsi-2441	257	36	,	,	PUNCT
ajlsi-2441	257	37	&	&	CCONJ
ajlsi-2441	257	38	ding	ding	PROPN
ajlsi-2441	257	39	,	,	PUNCT
ajlsi-2441	257	40	x.	x.	NOUN
ajlsi-2441	257	41	(	(	PUNCT
ajlsi-2441	257	42	2020	2020	NUM
ajlsi-2441	257	43	)	)	PUNCT
ajlsi-2441	257	44	.	.	PUNCT
ajlsi-2441	258	1	preliminary	preliminary	ADJ
ajlsi-2441	258	2	study	study	NOUN
ajlsi-2441	258	3	to	to	PART
ajlsi-2441	258	4	identify	identify	VERB
ajlsi-2441	258	5	severe	severe	ADJ
ajlsi-2441	258	6	from	from	ADP
ajlsi-2441	258	7	moderate	moderate	ADJ
ajlsi-2441	258	8	cases	case	NOUN
ajlsi-2441	258	9	of	of	ADP
ajlsi-2441	258	10	covid-19	covid-19	PROPN
ajlsi-2441	258	11	using	use	VERB
ajlsi-2441	258	12	combined	combined	ADJ
ajlsi-2441	258	13	hematology	hematology	NOUN
ajlsi-2441	258	14	parameters	parameter	NOUN
ajlsi-2441	258	15	.	.	PUNCT
ajlsi-2441	259	1	annals	annal	NOUN
ajlsi-2441	259	2	of	of	ADP
ajlsi-2441	259	3	translational	translational	ADJ
ajlsi-2441	259	4	medicine	medicine	NOUN
ajlsi-2441	259	5	,	,	PUNCT
ajlsi-2441	259	6	8(9	8(9	NUM
ajlsi-2441	259	7	)	)	PUNCT
ajlsi-2441	259	8	.	.	PUNCT
ajlsi-2441	260	1	wang	wang	PROPN
ajlsi-2441	260	2	,	,	PUNCT
ajlsi-2441	260	3	x.	x.	PROPN
ajlsi-2441	260	4	,	,	PUNCT
ajlsi-2441	260	5	li	li	PROPN
ajlsi-2441	260	6	,	,	PUNCT
ajlsi-2441	260	7	x.	x.	PROPN
ajlsi-2441	260	8	,	,	PUNCT
ajlsi-2441	260	9	shang	shang	PROPN
ajlsi-2441	260	10	,	,	PUNCT
ajlsi-2441	260	11	y.	y.	PROPN
ajlsi-2441	260	12	,	,	PUNCT
ajlsi-2441	260	13	wang	wang	PROPN
ajlsi-2441	260	14	,	,	PUNCT
ajlsi-2441	260	15	j.	j.	PROPN
ajlsi-2441	260	16	,	,	PUNCT
ajlsi-2441	260	17	zhang	zhang	PROPN
ajlsi-2441	260	18	,	,	PUNCT
ajlsi-2441	260	19	x.	x.	PROPN
ajlsi-2441	260	20	,	,	PUNCT
ajlsi-2441	260	21	su	su	PROPN
ajlsi-2441	260	22	,	,	PUNCT
ajlsi-2441	260	23	d.	d.	PROPN
ajlsi-2441	260	24	,	,	PUNCT
ajlsi-2441	260	25	zhao	zhao	PROPN
ajlsi-2441	260	26	,	,	PUNCT
ajlsi-2441	260	27	s.	s.	PROPN
ajlsi-2441	260	28	,	,	PUNCT
ajlsi-2441	260	29	wang	wang	PROPN
ajlsi-2441	260	30	,	,	PUNCT
ajlsi-2441	260	31	q.	q.	PROPN
ajlsi-2441	260	32	,	,	PUNCT
ajlsi-2441	260	33	liu	liu	PROPN
ajlsi-2441	260	34	,	,	PUNCT
ajlsi-2441	260	35	l.	l.	PROPN
ajlsi-2441	260	36	,	,	PUNCT
ajlsi-2441	260	37	&	&	CCONJ
ajlsi-2441	260	38	li	li	PROPN
ajlsi-2441	260	39	,	,	PUNCT
ajlsi-2441	260	40	y.	y.	PROPN
ajlsi-2441	260	41	(	(	PUNCT
ajlsi-2441	260	42	2020	2020	NUM
ajlsi-2441	260	43	)	)	PUNCT
ajlsi-2441	260	44	.	.	PUNCT
ajlsi-2441	261	1	ratios	ratio	NOUN
ajlsi-2441	261	2	of	of	ADP
ajlsi-2441	261	3	neutrophil	neutrophil	NOUN
ajlsi-2441	261	4	-	-	PUNCT
ajlsi-2441	261	5	to	to	ADP
ajlsi-2441	261	6	-	-	PUNCT
ajlsi-2441	261	7	lymphocyte	lymphocyte	ADJ
ajlsi-2441	261	8	and	and	CCONJ
ajlsi-2441	261	9	platelet	platelet	ADJ
ajlsi-2441	261	10	-	-	PUNCT
ajlsi-2441	261	11	tolymphocyte	tolymphocyte	NOUN
ajlsi-2441	261	12	predict	predict	VERB
ajlsi-2441	261	13	all	all	DET
ajlsi-2441	261	14	-	-	PUNCT
ajlsi-2441	261	15	cause	cause	NOUN
ajlsi-2441	261	16	mortality	mortality	NOUN
ajlsi-2441	261	17	in	in	ADP
ajlsi-2441	261	18	inpatients	inpatient	NOUN
ajlsi-2441	261	19	with	with	ADP
ajlsi-2441	261	20	coronavirus	coronavirus	NOUN
ajlsi-2441	261	21	disease	disease	NOUN
ajlsi-2441	261	22	2019	2019	NUM
ajlsi-2441	261	23	(	(	PUNCT
ajlsi-2441	261	24	covid-19	covid-19	PROPN
ajlsi-2441	261	25	):	):	PUNCT
ajlsi-2441	261	26	a	a	DET
ajlsi-2441	261	27	retrospective	retrospective	ADJ
ajlsi-2441	261	28	cohort	cohort	NOUN
ajlsi-2441	261	29	study	study	NOUN
ajlsi-2441	261	30	in	in	ADP
ajlsi-2441	261	31	a	a	DET
ajlsi-2441	261	32	single	single	ADJ
ajlsi-2441	261	33	medical	medical	ADJ
ajlsi-2441	261	34	centre	centre	NOUN
ajlsi-2441	261	35	.	.	PUNCT
ajlsi-2441	262	1	epidemiology	epidemiology	NOUN
ajlsi-2441	262	2	&	&	CCONJ
ajlsi-2441	262	3	infection	infection	NOUN
ajlsi-2441	262	4	,	,	PUNCT
ajlsi-2441	262	5	148	148	NUM
ajlsi-2441	262	6	,	,	PUNCT
ajlsi-2441	262	7	e211	e211	PROPN
ajlsi-2441	262	8	.	.	PUNCT
ajlsi-2441	262	9	wang	wang	PROPN
ajlsi-2441	262	10	,	,	PUNCT
ajlsi-2441	262	11	y.	y.	PROPN
ajlsi-2441	262	12	,	,	PUNCT
ajlsi-2441	262	13	li	li	PROPN
ajlsi-2441	262	14	,	,	PUNCT
ajlsi-2441	262	15	x.	x.	PROPN
ajlsi-2441	262	16	,	,	PUNCT
ajlsi-2441	262	17	xu	xu	PROPN
ajlsi-2441	262	18	,	,	PUNCT
ajlsi-2441	262	19	j.	j.	PROPN
ajlsi-2441	262	20	,	,	PUNCT
ajlsi-2441	262	21	&	&	CCONJ
ajlsi-2441	262	22	zhou	zhou	PROPN
ajlsi-2441	262	23	,	,	PUNCT
ajlsi-2441	262	24	q.	q.	PROPN
ajlsi-2441	262	25	(	(	PUNCT
ajlsi-2441	262	26	2022	2022	NUM
ajlsi-2441	262	27	)	)	PUNCT
ajlsi-2441	262	28	.	.	PUNCT
ajlsi-2441	263	1	a	a	DET
ajlsi-2441	263	2	complete	complete	ADJ
ajlsi-2441	263	3	blood	blood	NOUN
ajlsi-2441	263	4	count	count	NOUN
ajlsi-2441	263	5	-	-	PUNCT
ajlsi-2441	263	6	based	base	VERB
ajlsi-2441	263	7	multivariate	multivariate	NOUN
ajlsi-2441	263	8	model	model	NOUN
ajlsi-2441	263	9	for	for	ADP
ajlsi-2441	263	10	predicting	predict	VERB
ajlsi-2441	263	11	the	the	DET
ajlsi-2441	263	12	recovery	recovery	NOUN
ajlsi-2441	263	13	of	of	ADP
ajlsi-2441	263	14	patients	patient	NOUN
ajlsi-2441	263	15	with	with	ADP
ajlsi-2441	263	16	moderate	moderate	ADJ
ajlsi-2441	263	17	covid-19	covid-19	PROPN
ajlsi-2441	263	18	:	:	PUNCT
ajlsi-2441	263	19	a	a	DET
ajlsi-2441	263	20	retrospective	retrospective	ADJ
ajlsi-2441	263	21	study	study	NOUN
ajlsi-2441	263	22	.	.	PUNCT
ajlsi-2441	264	1	scientific	scientific	ADJ
ajlsi-2441	264	2	reports	report	NOUN
ajlsi-2441	264	3	,	,	PUNCT
ajlsi-2441	264	4	12(1	12(1	NUM
ajlsi-2441	264	5	)	)	PUNCT
ajlsi-2441	264	6	,	,	PUNCT
ajlsi-2441	264	7	18262	18262	NUM
ajlsi-2441	264	8	.	.	PUNCT
ajlsi-2441	265	1	wynants	wynants	PROPN
ajlsi-2441	265	2	,	,	PUNCT
ajlsi-2441	265	3	l.	l.	PROPN
ajlsi-2441	265	4	,	,	PUNCT
ajlsi-2441	265	5	van	van	PROPN
ajlsi-2441	265	6	calster	calster	PROPN
ajlsi-2441	265	7	,	,	PUNCT
ajlsi-2441	265	8	b.	b.	PROPN
ajlsi-2441	265	9	,	,	PUNCT
ajlsi-2441	265	10	collins	collins	PROPN
ajlsi-2441	265	11	,	,	PUNCT
ajlsi-2441	265	12	g.	g.	PROPN
ajlsi-2441	265	13	s.	s.	PROPN
ajlsi-2441	265	14	,	,	PUNCT
ajlsi-2441	265	15	riley	riley	PROPN
ajlsi-2441	265	16	,	,	PUNCT
ajlsi-2441	265	17	r.	r.	PROPN
ajlsi-2441	265	18	d.	d.	PROPN
ajlsi-2441	265	19	,	,	PUNCT
ajlsi-2441	265	20	heinze	heinze	PROPN
ajlsi-2441	265	21	,	,	PUNCT
ajlsi-2441	265	22	g.	g.	PROPN
ajlsi-2441	265	23	,	,	PUNCT
ajlsi-2441	265	24	schuit	schuit	NOUN
ajlsi-2441	265	25	,	,	PUNCT
ajlsi-2441	265	26	e.	e.	PROPN
ajlsi-2441	265	27	,	,	PUNCT
ajlsi-2441	265	28	albu	albu	PROPN
ajlsi-2441	265	29	,	,	PUNCT
ajlsi-2441	265	30	e.	e.	PROPN
ajlsi-2441	265	31	,	,	PUNCT
ajlsi-2441	265	32	arshi	arshi	PROPN
ajlsi-2441	265	33	,	,	PUNCT
ajlsi-2441	265	34	b.	b.	PROPN
ajlsi-2441	265	35	,	,	PUNCT
ajlsi-2441	265	36	bellou	bellou	PROPN
ajlsi-2441	265	37	,	,	PUNCT
ajlsi-2441	265	38	pa	pa	PROPN
ajlsi-2441	265	39	ge	ge	PROPN
ajlsi-2441	265	40	36	36	NUM
ajlsi-2441	265	41	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-2441	265	42	am	am	NOUN
ajlsi-2441	265	43	.	.	PUNCT
ajlsi-2441	266	1	j.	j.	PROPN
ajlsi-2441	266	2	life	life	PROPN
ajlsi-2441	266	3	sci	sci	PROPN
ajlsi-2441	266	4	.	.	PUNCT
ajlsi-2441	266	5	innov	innov	PROPN
ajlsi-2441	266	6	.	.	PUNCT
ajlsi-2441	267	1	3(1	3(1	NUM
ajlsi-2441	267	2	)	)	PUNCT
ajlsi-2441	267	3	28	28	NUM
ajlsi-2441	267	4	-	-	SYM
ajlsi-2441	267	5	36	36	NUM
ajlsi-2441	267	6	,	,	PUNCT
ajlsi-2441	267	7	2024	2024	NUM
ajlsi-2441	267	8	v.	v.	CCONJ
ajlsi-2441	267	9	,	,	PUNCT
ajlsi-2441	267	10	&	&	CCONJ
ajlsi-2441	267	11	bonten	bonten	VERB
ajlsi-2441	267	12	,	,	PUNCT
ajlsi-2441	267	13	m.	m.	NOUN
ajlsi-2441	267	14	m.	m.	NOUN
ajlsi-2441	267	15	(	(	PUNCT
ajlsi-2441	267	16	2020	2020	NUM
ajlsi-2441	267	17	)	)	PUNCT
ajlsi-2441	267	18	.	.	PUNCT
ajlsi-2441	268	1	prediction	prediction	NOUN
ajlsi-2441	268	2	models	model	NOUN
ajlsi-2441	268	3	for	for	ADP
ajlsi-2441	268	4	diagnosis	diagnosis	NOUN
ajlsi-2441	268	5	and	and	CCONJ
ajlsi-2441	268	6	prognosis	prognosis	NOUN
ajlsi-2441	268	7	of	of	ADP
ajlsi-2441	268	8	covid-19	covid-19	PROPN
ajlsi-2441	268	9	:	:	PUNCT
ajlsi-2441	268	10	systematic	systematic	ADJ
ajlsi-2441	268	11	review	review	NOUN
ajlsi-2441	268	12	and	and	CCONJ
ajlsi-2441	268	13	critical	critical	ADJ
ajlsi-2441	268	14	appraisal	appraisal	NOUN
ajlsi-2441	268	15	.	.	PUNCT
ajlsi-2441	269	1	bmj	bmj	PROPN
ajlsi-2441	269	2	,	,	PUNCT
ajlsi-2441	269	3	369	369	NUM
ajlsi-2441	269	4	.	.	PUNCT
ajlsi-2441	270	1	xu	xu	INTJ
ajlsi-2441	270	2	,	,	PUNCT
ajlsi-2441	270	3	p.	p.	PROPN
ajlsi-2441	270	4	,	,	PUNCT
ajlsi-2441	270	5	zhou	zhou	PROPN
ajlsi-2441	270	6	,	,	PUNCT
ajlsi-2441	270	7	q.	q.	PROPN
ajlsi-2441	270	8	,	,	PUNCT
ajlsi-2441	270	9	&	&	CCONJ
ajlsi-2441	270	10	xu	xu	PROPN
ajlsi-2441	270	11	,	,	PUNCT
ajlsi-2441	270	12	j.	j.	PROPN
ajlsi-2441	270	13	(	(	PUNCT
ajlsi-2441	270	14	2020	2020	NUM
ajlsi-2441	270	15	)	)	PUNCT
ajlsi-2441	270	16	.	.	PUNCT
ajlsi-2441	271	1	mechanism	mechanism	NOUN
ajlsi-2441	271	2	of	of	ADP
ajlsi-2441	271	3	thrombocytopenia	thrombocytopenia	PROPN
ajlsi-2441	271	4	in	in	ADP
ajlsi-2441	271	5	covid-19	covid-19	PROPN
ajlsi-2441	271	6	patients	patient	NOUN
ajlsi-2441	271	7	.	.	PUNCT
ajlsi-2441	272	1	annals	annal	NOUN
ajlsi-2441	272	2	of	of	ADP
ajlsi-2441	272	3	hematology	hematology	NOUN
ajlsi-2441	272	4	,	,	PUNCT
ajlsi-2441	272	5	99(6	99(6	NUM
ajlsi-2441	272	6	)	)	PUNCT
ajlsi-2441	272	7	,	,	PUNCT
ajlsi-2441	272	8	1205	1205	NUM
ajlsi-2441	272	9	-	-	SYM
ajlsi-2441	272	10	1208	1208	NUM
ajlsi-2441	272	11	.	.	PUNCT
ajlsi-2441	273	1	yamada	yamada	PROPN
ajlsi-2441	273	2	,	,	PUNCT
ajlsi-2441	273	3	t.	t.	PROPN
ajlsi-2441	273	4	,	,	PUNCT
ajlsi-2441	273	5	wakabayashi	wakabayashi	NOUN
ajlsi-2441	273	6	,	,	PUNCT
ajlsi-2441	273	7	m.	m.	NOUN
ajlsi-2441	273	8	,	,	PUNCT
ajlsi-2441	273	9	yamaji	yamaji	PROPN
ajlsi-2441	273	10	,	,	PUNCT
ajlsi-2441	273	11	t.	t.	PROPN
ajlsi-2441	273	12	,	,	PUNCT
ajlsi-2441	273	13	chopra	chopra	PROPN
ajlsi-2441	273	14	,	,	PUNCT
ajlsi-2441	273	15	n.	n.	PROPN
ajlsi-2441	273	16	,	,	PUNCT
ajlsi-2441	273	17	mikami	mikami	PROPN
ajlsi-2441	273	18	,	,	PUNCT
ajlsi-2441	273	19	t.	t.	PROPN
ajlsi-2441	273	20	,	,	PUNCT
ajlsi-2441	273	21	miyashita	miyashita	PROPN
ajlsi-2441	273	22	,	,	PUNCT
ajlsi-2441	273	23	h.	h.	PROPN
ajlsi-2441	273	24	,	,	PUNCT
ajlsi-2441	273	25	&	&	CCONJ
ajlsi-2441	273	26	miyashita	miyashita	PROPN
ajlsi-2441	273	27	,	,	PUNCT
ajlsi-2441	273	28	s.	s.	PROPN
ajlsi-2441	273	29	(	(	PUNCT
ajlsi-2441	273	30	2020	2020	NUM
ajlsi-2441	273	31	)	)	PUNCT
ajlsi-2441	273	32	.	.	PUNCT
ajlsi-2441	274	1	value	value	NOUN
ajlsi-2441	274	2	of	of	ADP
ajlsi-2441	274	3	leukocytosis	leukocytosis	NOUN
ajlsi-2441	274	4	and	and	CCONJ
ajlsi-2441	274	5	elevated	elevate	VERB
ajlsi-2441	274	6	c	c	ADJ
ajlsi-2441	274	7	-	-	ADJ
ajlsi-2441	274	8	reactive	reactive	ADJ
ajlsi-2441	274	9	protein	protein	NOUN
ajlsi-2441	274	10	in	in	ADP
ajlsi-2441	274	11	predicting	predict	VERB
ajlsi-2441	274	12	severe	severe	ADJ
ajlsi-2441	274	13	coronavirus	coronavirus	NOUN
ajlsi-2441	274	14	2019	2019	NUM
ajlsi-2441	274	15	(	(	PUNCT
ajlsi-2441	274	16	covid-19	covid-19	PROPN
ajlsi-2441	274	17	):	):	PUNCT
ajlsi-2441	274	18	a	a	DET
ajlsi-2441	274	19	systematic	systematic	ADJ
ajlsi-2441	274	20	review	review	NOUN
ajlsi-2441	274	21	and	and	CCONJ
ajlsi-2441	274	22	meta	meta	ADJ
ajlsi-2441	274	23	-	-	PUNCT
ajlsi-2441	274	24	analysis	analysis	NOUN
ajlsi-2441	274	25	.	.	PUNCT
ajlsi-2441	275	1	clinica	clinica	PROPN
ajlsi-2441	275	2	chimica	chimica	PROPN
ajlsi-2441	275	3	acta	acta	PROPN
ajlsi-2441	275	4	,	,	PUNCT
ajlsi-2441	275	5	509	509	NUM
ajlsi-2441	275	6	,	,	PUNCT
ajlsi-2441	275	7	235	235	NUM
ajlsi-2441	275	8	-	-	SYM
ajlsi-2441	275	9	243	243	NUM
ajlsi-2441	275	10	.	.	PUNCT
ajlsi-2441	276	1	yuan	yuan	NOUN
ajlsi-2441	276	2	,	,	PUNCT
ajlsi-2441	276	3	x.	x.	PROPN
ajlsi-2441	276	4	,	,	PUNCT
ajlsi-2441	276	5	huang	huang	PROPN
ajlsi-2441	276	6	,	,	PUNCT
ajlsi-2441	276	7	w.	w.	PROPN
ajlsi-2441	276	8	,	,	PUNCT
ajlsi-2441	276	9	ye	ye	PROPN
ajlsi-2441	276	10	,	,	PUNCT
ajlsi-2441	276	11	b.	b.	PROPN
ajlsi-2441	276	12	,	,	PUNCT
ajlsi-2441	276	13	chen	chen	PROPN
ajlsi-2441	276	14	,	,	PUNCT
ajlsi-2441	276	15	c.	c.	PROPN
ajlsi-2441	276	16	,	,	PUNCT
ajlsi-2441	276	17	huang	huang	PROPN
ajlsi-2441	276	18	,	,	PUNCT
ajlsi-2441	276	19	r.	r.	PROPN
ajlsi-2441	276	20	,	,	PUNCT
ajlsi-2441	276	21	wu	wu	PROPN
ajlsi-2441	276	22	,	,	PUNCT
ajlsi-2441	276	23	f.	f.	PROPN
ajlsi-2441	276	24	,	,	PUNCT
ajlsi-2441	276	25	wei	wei	PROPN
ajlsi-2441	276	26	,	,	PUNCT
ajlsi-2441	276	27	q.	q.	PROPN
ajlsi-2441	276	28	,	,	PUNCT
ajlsi-2441	276	29	zhang	zhang	PROPN
ajlsi-2441	276	30	,	,	PUNCT
ajlsi-2441	276	31	w.	w.	PROPN
ajlsi-2441	276	32	,	,	PUNCT
ajlsi-2441	276	33	&	&	CCONJ
ajlsi-2441	276	34	hu	hu	PROPN
ajlsi-2441	276	35	,	,	PUNCT
ajlsi-2441	276	36	j.	j.	PROPN
ajlsi-2441	276	37	(	(	PUNCT
ajlsi-2441	276	38	2020	2020	NUM
ajlsi-2441	276	39	)	)	PUNCT
ajlsi-2441	276	40	.	.	PUNCT
ajlsi-2441	277	1	changes	change	NOUN
ajlsi-2441	277	2	of	of	ADP
ajlsi-2441	277	3	hematological	hematological	ADJ
ajlsi-2441	277	4	and	and	CCONJ
ajlsi-2441	277	5	immunological	immunological	ADJ
ajlsi-2441	277	6	parameters	parameter	NOUN
ajlsi-2441	277	7	in	in	ADP
ajlsi-2441	277	8	covid-19	covid-19	PROPN
ajlsi-2441	277	9	patients	patient	NOUN
ajlsi-2441	277	10	.	.	PUNCT
ajlsi-2441	278	1	international	international	ADJ
ajlsi-2441	278	2	journal	journal	PROPN
ajlsi-2441	278	3	of	of	ADP
ajlsi-2441	278	4	hematology	hematology	NOUN
ajlsi-2441	278	5	,	,	PUNCT
ajlsi-2441	278	6	112	112	NUM
ajlsi-2441	278	7	,	,	PUNCT
ajlsi-2441	278	8	553	553	NUM
ajlsi-2441	278	9	-	-	SYM
ajlsi-2441	278	10	559	559	NUM
ajlsi-2441	278	11	.	.	PUNCT
ajlsi-2441	279	1	zhang	zhang	PROPN
ajlsi-2441	279	2	,	,	PUNCT
ajlsi-2441	279	3	c.	c.	PROPN
ajlsi-2441	279	4	,	,	PUNCT
ajlsi-2441	279	5	wu	wu	PROPN
ajlsi-2441	279	6	,	,	PUNCT
ajlsi-2441	279	7	z.	z.	PROPN
ajlsi-2441	279	8	,	,	PUNCT
ajlsi-2441	279	9	li	li	PROPN
ajlsi-2441	279	10	,	,	PUNCT
ajlsi-2441	279	11	j.-w	j.-w	PROPN
ajlsi-2441	279	12	.	.	PROPN
ajlsi-2441	279	13	,	,	PUNCT
ajlsi-2441	279	14	zhao	zhao	PROPN
ajlsi-2441	279	15	,	,	PUNCT
ajlsi-2441	279	16	h.	h.	PROPN
ajlsi-2441	279	17	,	,	PUNCT
ajlsi-2441	279	18	&	&	CCONJ
ajlsi-2441	279	19	wang	wang	PROPN
ajlsi-2441	279	20	,	,	PUNCT
ajlsi-2441	279	21	g.q	g.q	PROPN
ajlsi-2441	279	22	.	.	PROPN
ajlsi-2441	279	23	(	(	PUNCT
ajlsi-2441	279	24	2020	2020	NUM
ajlsi-2441	279	25	)	)	PUNCT
ajlsi-2441	279	26	.	.	PUNCT
ajlsi-2441	280	1	cytokine	cytokine	ADJ
ajlsi-2441	280	2	release	release	NOUN
ajlsi-2441	280	3	syndrome	syndrome	NOUN
ajlsi-2441	280	4	in	in	ADP
ajlsi-2441	280	5	severe	severe	ADJ
ajlsi-2441	280	6	covid-19	covid-19	PROPN
ajlsi-2441	280	7	:	:	PUNCT
ajlsi-2441	280	8	interleukin-6	interleukin-6	NUM
ajlsi-2441	280	9	receptor	receptor	NOUN
ajlsi-2441	280	10	antagonist	antagonist	NOUN
ajlsi-2441	280	11	tocilizumab	tocilizumab	NOUN
ajlsi-2441	280	12	may	may	AUX
ajlsi-2441	280	13	be	be	AUX
ajlsi-2441	280	14	the	the	DET
ajlsi-2441	280	15	key	key	NOUN
ajlsi-2441	280	16	to	to	PART
ajlsi-2441	280	17	reduce	reduce	VERB
ajlsi-2441	280	18	mortality	mortality	NOUN
ajlsi-2441	280	19	.	.	PUNCT
ajlsi-2441	281	1	international	international	ADJ
ajlsi-2441	281	2	journal	journal	PROPN
ajlsi-2441	281	3	of	of	ADP
ajlsi-2441	281	4	antimicrobial	antimicrobial	ADJ
ajlsi-2441	281	5	agents	agent	NOUN
ajlsi-2441	281	6	,	,	PUNCT
ajlsi-2441	281	7	55(5	55(5	NUM
ajlsi-2441	281	8	)	)	PUNCT
ajlsi-2441	281	9	,	,	PUNCT
ajlsi-2441	281	10	105954	105954	NUM
ajlsi-2441	281	11	.	.	PUNCT
ajlsi-2441	282	1	zhou	zhou	PROPN
ajlsi-2441	282	2	,	,	PUNCT
ajlsi-2441	282	3	f.	f.	PROPN
ajlsi-2441	282	4	,	,	PUNCT
ajlsi-2441	282	5	yu	yu	PROPN
ajlsi-2441	282	6	,	,	PUNCT
ajlsi-2441	282	7	t.	t.	PROPN
ajlsi-2441	282	8	,	,	PUNCT
ajlsi-2441	282	9	du	du	PROPN
ajlsi-2441	282	10	,	,	PUNCT
ajlsi-2441	282	11	r.	r.	PROPN
ajlsi-2441	282	12	,	,	PUNCT
ajlsi-2441	282	13	fan	fan	PROPN
ajlsi-2441	282	14	,	,	PUNCT
ajlsi-2441	282	15	g.	g.	PROPN
ajlsi-2441	282	16	,	,	PUNCT
ajlsi-2441	282	17	liu	liu	PROPN
ajlsi-2441	282	18	,	,	PUNCT
ajlsi-2441	282	19	y.	y.	PROPN
ajlsi-2441	282	20	,	,	PUNCT
ajlsi-2441	282	21	liu	liu	PROPN
ajlsi-2441	282	22	,	,	PUNCT
ajlsi-2441	282	23	z.	z.	PROPN
ajlsi-2441	282	24	,	,	PUNCT
ajlsi-2441	282	25	xiang	xiang	PROPN
ajlsi-2441	282	26	,	,	PUNCT
ajlsi-2441	282	27	j.	j.	PROPN
ajlsi-2441	282	28	,	,	PUNCT
ajlsi-2441	282	29	wang	wang	PROPN
ajlsi-2441	282	30	,	,	PUNCT
ajlsi-2441	282	31	y.	y.	PROPN
ajlsi-2441	282	32	,	,	PUNCT
ajlsi-2441	282	33	song	song	PROPN
ajlsi-2441	282	34	,	,	PUNCT
ajlsi-2441	282	35	b.	b.	PROPN
ajlsi-2441	282	36	,	,	PUNCT
ajlsi-2441	282	37	&	&	CCONJ
ajlsi-2441	282	38	gu	gu	PROPN
ajlsi-2441	282	39	,	,	PUNCT
ajlsi-2441	282	40	x.	x.	NOUN
ajlsi-2441	282	41	(	(	PUNCT
ajlsi-2441	282	42	2020	2020	NUM
ajlsi-2441	282	43	)	)	PUNCT
ajlsi-2441	282	44	.	.	PUNCT
ajlsi-2441	283	1	clinical	clinical	ADJ
ajlsi-2441	283	2	course	course	NOUN
ajlsi-2441	283	3	and	and	CCONJ
ajlsi-2441	283	4	risk	risk	NOUN
ajlsi-2441	283	5	factors	factor	NOUN
ajlsi-2441	283	6	for	for	ADP
ajlsi-2441	283	7	mortality	mortality	NOUN
ajlsi-2441	283	8	of	of	ADP
ajlsi-2441	283	9	adult	adult	NOUN
ajlsi-2441	283	10	inpatients	inpatient	NOUN
ajlsi-2441	283	11	with	with	ADP
ajlsi-2441	283	12	covid-19	covid-19	PROPN
ajlsi-2441	283	13	in	in	ADP
ajlsi-2441	283	14	wuhan	wuhan	PROPN
ajlsi-2441	283	15	,	,	PUNCT
ajlsi-2441	283	16	china	china	PROPN
ajlsi-2441	283	17	:	:	PUNCT
ajlsi-2441	283	18	a	a	DET
ajlsi-2441	283	19	retrospective	retrospective	ADJ
ajlsi-2441	283	20	cohort	cohort	NOUN
ajlsi-2441	283	21	study	study	NOUN
ajlsi-2441	283	22	.	.	PUNCT
ajlsi-2441	284	1	the	the	DET
ajlsi-2441	284	2	lancet	lancet	PROPN
ajlsi-2441	284	3	,	,	PUNCT
ajlsi-2441	284	4	395(10229	395(10229	NUM
ajlsi-2441	284	5	)	)	PUNCT
ajlsi-2441	284	6	,	,	PUNCT
ajlsi-2441	284	7	1054	1054	NUM
ajlsi-2441	284	8	-	-	SYM
ajlsi-2441	284	9	1062	1062	NUM
ajlsi-2441	284	10	.	.	PUNCT
ajlsi-2441	285	1	zorlu	zorlu	PROPN
ajlsi-2441	285	2	,	,	PUNCT
ajlsi-2441	285	3	a.	a.	NOUN
ajlsi-2441	285	4	,	,	PUNCT
ajlsi-2441	285	5	bektasoglu	bektasoglu	PROPN
ajlsi-2441	285	6	,	,	PUNCT
ajlsi-2441	285	7	g.	g.	PROPN
ajlsi-2441	285	8	,	,	PUNCT
ajlsi-2441	285	9	guven	guven	ADJ
ajlsi-2441	285	10	,	,	PUNCT
ajlsi-2441	285	11	f.	f.	PROPN
ajlsi-2441	285	12	m.	m.	PROPN
ajlsi-2441	285	13	k.	k.	PROPN
ajlsi-2441	285	14	,	,	PUNCT
ajlsi-2441	285	15	dogan	dogan	PROPN
ajlsi-2441	285	16	,	,	PUNCT
ajlsi-2441	285	17	o.	o.	PROPN
ajlsi-2441	285	18	t.	t.	PROPN
ajlsi-2441	285	19	,	,	PUNCT
ajlsi-2441	285	20	gucuk	gucuk	PROPN
ajlsi-2441	285	21	,	,	PUNCT
ajlsi-2441	285	22	e.	e.	PROPN
ajlsi-2441	285	23	,	,	PUNCT
ajlsi-2441	285	24	ege	ege	PROPN
ajlsi-2441	285	25	,	,	PUNCT
ajlsi-2441	285	26	m.	m.	NOUN
ajlsi-2441	285	27	r.	r.	PROPN
ajlsi-2441	285	28	,	,	PUNCT
ajlsi-2441	285	29	altay	altay	PROPN
ajlsi-2441	285	30	,	,	PUNCT
ajlsi-2441	285	31	h.	h.	PROPN
ajlsi-2441	285	32	,	,	PUNCT
ajlsi-2441	285	33	cınar	cınar	PROPN
ajlsi-2441	285	34	,	,	PUNCT
ajlsi-2441	285	35	z.	z.	PROPN
ajlsi-2441	285	36	,	,	PUNCT
ajlsi-2441	285	37	tandogan	tandogan	VERB
ajlsi-2441	285	38	,	,	PUNCT
ajlsi-2441	285	39	i.	i.	PROPN
ajlsi-2441	285	40	,	,	PUNCT
ajlsi-2441	285	41	&	&	CCONJ
ajlsi-2441	285	42	yilmaz	yilmaz	PROPN
ajlsi-2441	285	43	,	,	PUNCT
ajlsi-2441	285	44	m.	m.	PROPN
ajlsi-2441	285	45	b.	b.	PROPN
ajlsi-2441	285	46	(	(	PUNCT
ajlsi-2441	285	47	2012	2012	NUM
ajlsi-2441	285	48	)	)	PUNCT
ajlsi-2441	285	49	.	.	PUNCT
ajlsi-2441	286	1	usefulness	usefulness	NOUN
ajlsi-2441	286	2	of	of	ADP
ajlsi-2441	286	3	admission	admission	NOUN
ajlsi-2441	286	4	red	red	ADJ
ajlsi-2441	286	5	cell	cell	NOUN
ajlsi-2441	286	6	distribution	distribution	NOUN
ajlsi-2441	286	7	width	width	NOUN
ajlsi-2441	286	8	as	as	ADP
ajlsi-2441	286	9	a	a	DET
ajlsi-2441	286	10	predictor	predictor	NOUN
ajlsi-2441	286	11	of	of	ADP
ajlsi-2441	286	12	early	early	ADJ
ajlsi-2441	286	13	mortality	mortality	NOUN
ajlsi-2441	286	14	in	in	ADP
ajlsi-2441	286	15	patients	patient	NOUN
ajlsi-2441	286	16	with	with	ADP
ajlsi-2441	286	17	acute	acute	ADJ
ajlsi-2441	286	18	pulmonary	pulmonary	ADJ
ajlsi-2441	286	19	embolism	embolism	NOUN
ajlsi-2441	286	20	.	.	PUNCT
ajlsi-2441	287	1	the	the	DET
ajlsi-2441	287	2	american	american	PROPN
ajlsi-2441	287	3	journal	journal	PROPN
ajlsi-2441	287	4	of	of	ADP
ajlsi-2441	287	5	cardiology	cardiology	NOUN
ajlsi-2441	287	6	,	,	PUNCT
ajlsi-2441	287	7	109(1	109(1	NUM
ajlsi-2441	287	8	)	)	PUNCT
ajlsi-2441	287	9	,	,	PUNCT
ajlsi-2441	287	10	128	128	NUM
ajlsi-2441	287	11	-	-	SYM
ajlsi-2441	287	12	134	134	NUM
ajlsi-2441	287	13	.	.	PUNCT